data_1tuj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tuj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.303 0.573 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.81 -26.96 64.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.997 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -88.9 -23.45 22.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 121' ' ' LEU . 48.2 t -71.82 -51.41 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.222 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.96 -30.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.24 -31.42 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.419 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -79.53 -55.73 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.297 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.467 ' HH ' HG12 ' A' ' 75' ' ' ILE . 21.6 m-85 -56.21 -28.25 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 111.225 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.8 ttm -81.29 -54.99 5.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.102 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.75 -23.61 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -70.24 -25.31 63.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -147.07 39.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.483 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 34.8 ttm -61.41 -51.86 74.49 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.362 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.6 Cg_endo -70.45 0.17 6.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.915 1.744 . . . . 0.0 111.944 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -112.26 -14.22 13.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.02 -31.61 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.652 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -62.3 -31.99 8.68 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD3' ' HG3' ' A' ' 19' ' ' MET . 15.1 Cg_exo -68.9 -35.49 15.33 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.768 1.645 . . . . 0.0 111.942 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.56 -52.7 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.405 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -55.39 -34.42 64.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.697 0.284 . . . . 0.0 111.502 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.574 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.561 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 5.8 ttt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 m -65.07 -48.88 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -87.26 -12.73 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.638 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.552 HD22 HG23 ' A' ' 114' ' ' THR . 5.1 tt -74.27 -39.89 62.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.415 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.86 4.93 2.06 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.725 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -135.77 -61.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.545 0.212 . . . . 0.0 111.347 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD22 ' HA ' ' A' ' 22' ' ' ALA . 3.0 tm? -48.2 -44.37 32.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HD3' HD23 ' A' ' 47' ' ' LEU . 43.2 tttm -84.05 -20.36 32.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.649 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 49' ' ' CYS . . . -74.84 -15.91 60.71 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.121 0.486 . . . . 0.0 110.059 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.63 -33.3 75.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.432 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 t -69.21 -22.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.204 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.5 ' HB3' ' HE2' ' A' ' 60' ' ' MET . 48.8 mtt -75.38 -52.62 10.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.52 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -65.73 -16.42 63.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.592 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.0 tpm_? -70.93 -32.59 69.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 pt -102.37 23.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.228 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 60.95 49.83 5.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.559 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.5 ' HE2' ' HB3' ' A' ' 55' ' ' MET . 5.7 ttp -120.41 -18.33 7.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.446 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 tp -130.48 108.77 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.815 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.2 mmpt? -104.53 78.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.31 -70.71 2.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.038 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.0 p -137.35 9.7 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.18 103.34 15.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.93 114.62 23.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.452 . . . . 0.0 110.211 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -109.53 -167.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.968 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.477 ' HB ' HD13 ' A' ' 97' ' ' ILE . 10.6 p -163.1 -14.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.672 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 41.8 mt-10 -53.15 -54.37 45.35 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 10.8 Cg_endo -55.29 -29.4 67.26 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.006 1.804 . . . . 0.0 111.829 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 20.8 t -72.65 -39.44 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.352 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -57.48 -22.3 42.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -85.17 -37.11 20.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.105 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 11.9 ptm -80.4 -30.1 37.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.876 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 HG22 ' A' ' 86' ' ' ILE . 96.8 mt -59.39 -22.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 -54.72 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.266 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.01 -45.05 16.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -48.53 -27.19 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.271 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -118.54 54.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.609 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.92 51.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.97 -72.18 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.317 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.6 m120 -110.84 155.3 22.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 110.716 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -81.45 -37.44 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.52 -28.96 41.31 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.137 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -56.25 -31.88 63.96 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.586 HG22 HG22 ' A' ' 75' ' ' ILE . 87.9 mt -78.36 -32.92 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.08 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 13.2 mm100 -74.99 -19.8 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 tp -76.13 -55.58 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.618 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 75' ' ' ILE . 38.8 t -55.59 -28.89 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -58.12 -49.06 78.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.618 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.9 -26.96 69.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.253 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 120' ' ' LYS . 58.3 mt -61.49 -45.09 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.61 69.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.6 tp10 -65.42 -27.33 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.2 m -80.1 -28.81 38.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.951 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.477 HD13 ' HB ' ' A' ' 68' ' ' VAL . 78.0 mt -77.15 -43.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.87 -14.92 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.51 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t30 -94.22 -43.78 8.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 110.625 179.737 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.766 0.317 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.1 t70 -77.94 139.94 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.935 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.65 -61.73 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.0 m -54.17 -27.69 35.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.5 t-20 -72.28 -44.05 63.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.65 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.52 -47.27 93.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.025 0.441 . . . . 0.0 110.673 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.33 -41.42 85.68 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.337 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.561 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 2.2 t-20 -58.08 -36.94 73.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.11 0.455 . . . . 0.0 110.824 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.542 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 11.0 mmpt? -78.39 -37.54 43.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.52 -27.18 58.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.552 HG23 HD22 ' A' ' 47' ' ' LEU . 11.1 t -79.71 -46.88 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 110.249 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -46.45 -60.26 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -40.58 70.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.797 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -27.41 67.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.236 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -84.68 -32.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -69.83 -44.71 69.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.027 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.569 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 71.0 mmtt -87.05 -58.56 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 1.3 tm? -97.63 -15.73 20.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER 73.36 -19.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.592 0.234 . . . . 0.0 111.302 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 121' ' ' LEU . 36.8 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.818 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.875 0.369 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.85 -55.89 4.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.195 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 81.0 p -52.03 -31.52 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.715 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.47 -64.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.822 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.13 -60.67 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.29 -31.18 42.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.97 -59.13 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.113 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -52.56 -23.46 6.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 111.366 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 tpp -80.48 -56.78 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.15 -23.61 67.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.139 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.04 -33.75 72.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.024 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.404 HD13 HG23 ' A' ' 58' ' ' ILE . 65.5 mt -146.9 50.91 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.2 tmm? -71.45 -50.57 10.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.409 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 15' ' ' MET . 73.7 Cg_endo -75.05 -24.7 12.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.232 1.955 . . . . 0.0 112.62 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.39 -9.95 59.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.329 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.13 -27.81 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.361 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 62.3 mtt -53.1 -48.58 91.52 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 33.2 Cg_exo -60.85 -36.13 85.25 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.396 2.064 . . . . 0.0 112.703 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.8 m -54.83 -46.27 74.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.866 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.98 -46.53 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.148 179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.42 ' HB2' HD22 ' A' ' 111' ' ' ASN . 5.0 ptt? . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.776 0.322 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -65.39 -51.84 57.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.913 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.535 ' HB3' HD23 ' A' ' 50' ' ' LEU . 4.3 mm100 -87.15 -12.89 45.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HG ' HG23 ' A' ' 114' ' ' THR . 48.8 tp -66.51 -25.73 66.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.17 8.26 78.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.388 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . 13.6 m -137.01 -71.49 0.44 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.673 -0.263 . . . . 0.0 111.428 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -48.26 -39.72 22.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.419 ' HB2' HD12 ' A' ' 47' ' ' LEU . 8.4 tptp -84.26 -23.76 30.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.601 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 49' ' ' CYS . . . -70.74 -16.86 62.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.45 -37.9 79.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.914 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.22 -30.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.452 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.493 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 54.6 mtt -70.56 -58.5 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -61.1 -19.36 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.56 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -72.44 -29.55 63.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.459 HD11 ' SD ' ' A' ' 60' ' ' MET . 49.3 pt -106.24 13.98 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.64 55.69 1.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.07 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 17.6 ptm -133.3 15.01 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 0.0 110.183 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.463 HD12 HD13 ' A' ' 66' ' ' LEU . 66.6 tp -164.57 109.77 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.507 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -108.56 77.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.14 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.41 -28.48 0.7 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.224 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -175.54 -15.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -84.55 110.47 18.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD13 HD12 ' A' ' 61' ' ' LEU . 2.9 mm? -77.27 149.97 35.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 111.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 74.9 m-85 -147.07 136.04 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.9 15.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.841 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.8 mt-10 -67.64 -51.91 28.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 39.6 Cg_endo -70.77 -24.06 25.48 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.039 1.826 . . . . 0.0 112.564 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 75' ' ' ILE . 11.0 t -73.32 -50.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.253 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HA ' HD12 ' A' ' 75' ' ' ILE . 5.7 m-30 -51.37 -22.16 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.643 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -78.85 -42.36 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -77.76 -36.84 50.21 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 121.338 -0.145 . . . . 0.0 110.875 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 72' ' ' TYR . 72.4 mt -51.45 -21.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.361 0.601 . . . . 0.0 109.918 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HA ' HD13 ' A' ' 86' ' ' ILE . 44.9 mt-10 -63.89 -59.31 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.376 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.4 -41.64 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.904 0.383 . . . . 0.0 110.896 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.1 t -47.54 -26.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.485 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -125.11 55.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.76 55.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.71 -79.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.341 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.08 133.64 44.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 111.013 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.6 66.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.71 -28.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.959 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.74 -29.21 64.59 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 75' ' ' ILE . 82.7 mt -76.56 -30.72 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.111 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -81.5 -19.19 42.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.908 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -61.4 -32.48 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.808 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.53 -32.65 58.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.672 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.51 -23.32 43.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.04 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.6 mt -69.14 -30.74 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -64.39 -23.48 67.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.276 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -79.58 -33.56 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.15 -31.21 72.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 10.8 m -79.4 -21.45 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 93' ' ' ALA . 94.5 mt -76.12 -46.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 111.285 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.61 -30.16 70.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 4.7 t30 -80.51 -51.29 8.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.34 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.744 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.569 0.223 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 14.5 t70 -74.41 136.42 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -50.91 -68.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.92 -33.83 38.88 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.527 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 9.6 m120 -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -74.01 -32.62 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.49 -56.44 9.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.976 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 44' ' ' MET . 3.6 t-20 -48.95 -24.61 1.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 60.4 mtpt -86.6 -44.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.63 -59.32 4.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.059 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 110' ' ' GLY . 8.9 t -53.44 -46.14 69.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.207 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -42.28 -52.32 4.52 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.98 0.419 . . . . 0.0 111.264 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -44.32 93.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.06 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.285 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 40.6 mt -83.23 -20.46 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.76 -59.09 4.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.07 -54.9 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 123' ' ' SER . 33.0 tp -86.32 -10.82 53.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 19.8 t80 67.21 -9.23 0.4 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 110.783 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 121' ' ' LEU . 60.7 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.801 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.31 -27.0 60.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.3 p -82.66 -20.69 35.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.681 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.37 -63.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.726 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.01 -51.94 60.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.64 70.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.3 mmmt -88.27 -59.35 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.554 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -50.39 -20.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 0.0 111.019 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.7 mmm -85.39 -62.06 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.801 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.42 -51.9 32.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.772 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -52.87 -21.06 3.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.566 HD12 HG11 ' A' ' 54' ' ' VAL . 48.0 mt -133.92 26.03 3.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.596 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.565 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.6 ttp -71.95 -49.41 10.33 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 15' ' ' MET . 29.7 Cg_endo -61.8 -21.97 73.35 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.005 1.803 . . . . 0.0 112.649 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -102.03 -7.35 22.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.237 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.429 HD13 ' HZ1' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -85.09 -44.17 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.006 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.609 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 57.6 mtt -47.02 -49.83 48.54 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.52 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -57.89 -49.35 13.21 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.206 1.937 . . . . 0.0 112.671 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -56.55 -44.35 80.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.454 ' HA ' HD23 ' A' ' 50' ' ' LEU . . . -55.44 -47.17 76.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.166 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.445 . . . . 0.0 110.332 179.897 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.694 ' HG2' HD21 ' A' ' 111' ' ' ASN . 54.8 ttp . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -49.07 -55.23 12.77 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.635 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -86.9 -12.43 47.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.549 HD12 ' HB3' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -64.91 -37.48 87.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.026 0.441 . . . . 0.0 110.045 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 5.04 20.63 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.147 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -135.34 -70.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 2.3 tm? -45.77 -51.39 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.549 ' HB3' HD12 ' A' ' 47' ' ' LEU . 1.6 tpmt? -74.4 -24.65 59.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.418 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 49' ' ' CYS . . . -74.0 -14.12 60.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 3.6 t -64.41 -39.23 93.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.566 HG11 HD12 ' A' ' 14' ' ' LEU . 63.2 t -68.13 -28.86 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.755 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 86.9 mtp -58.86 -41.27 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -79.82 -15.69 56.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.079 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.8 mmp_? -71.91 -42.6 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.096 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 pt -92.1 24.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.564 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 57.25 30.47 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.421 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 25.7 ttt -99.95 -0.87 38.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.039 0.447 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 64.1 tp -157.95 99.87 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.96 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.3 mmpt? -86.9 76.56 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.225 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.3 3.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.54 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -147.12 4.03 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.697 0.284 . . . . 0.0 111.155 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 37.4 mt-10 -96.63 120.77 37.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.624 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.487 HD22 HD13 ' A' ' 61' ' ' LEU . 36.4 mt -78.91 151.06 31.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.946 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 60.9 m-85 -143.15 148.57 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.637 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.09 7.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.57 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mm-40 -73.5 -49.17 6.72 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.79 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 71.8 Cg_endo -77.26 -23.74 9.99 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.105 1.87 . . . . 0.0 113.137 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 2.3 p -73.41 -44.91 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.642 0.258 . . . . 0.0 111.192 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 18.6 m-30 -60.04 -22.32 62.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.81 -44.05 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.882 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 25.5 ptm -72.47 -43.21 64.03 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.202 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.575 HG22 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -49.2 -23.58 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' HD13 ' A' ' 86' ' ' ILE . 30.8 mt-10 -60.38 -59.49 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.414 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.31 -34.88 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.21 0.529 . . . . 0.0 110.951 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 40.7 t -58.71 -8.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.087 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.563 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 92.6 m-70 -141.04 52.11 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.429 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.69 136.54 53.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.182 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.53 -67.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.158 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 3.5 m-20 -124.37 142.6 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.55 -28.52 69.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 5.6 m-20 -83.78 -25.83 30.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.287 . . . . 0.0 110.349 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.1 t70 -57.97 -30.06 65.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.575 HG23 HG22 ' A' ' 75' ' ' ILE . 79.5 mt -83.95 -26.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.616 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -79.71 -22.01 43.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.497 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.2 tp -78.23 -58.5 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.019 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.41 -36.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 72' ' ' TYR . 1.7 mttm -60.66 -34.97 75.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.61 -25.14 54.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.39 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 120' ' ' LYS . 42.3 mm -69.71 -43.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.126 0.488 . . . . 0.0 111.109 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.36 -17.62 59.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.677 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.65 -22.67 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.973 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -82.54 -37.71 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.275 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.435 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 5.8 m -64.05 -27.65 69.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.0 mt -74.49 -34.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.608 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.1 p30 -91.42 -17.64 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 111.058 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.265 -179.783 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -92.26 123.56 35.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.482 ' HA ' HD11 ' A' ' 109' ' ' ILE . 9.9 tp10 -37.15 -65.58 0.29 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.934 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 96.0 m -46.76 -50.52 18.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.21 -36.14 68.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.482 HD11 ' HA ' ' A' ' 106' ' ' GLU . 56.2 mt -67.15 -41.4 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' HG21 ' A' ' 114' ' ' THR . . . -73.41 -45.37 30.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.147 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.694 HD21 ' HG2' ' A' ' 44' ' ' MET . 17.5 m120 -48.56 -60.78 2.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.883 0.341 . . . . 0.0 111.273 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -54.49 -37.08 64.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.469 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -69.31 -64.07 0.94 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.227 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 47' ' ' LEU . 4.1 t -47.3 -56.98 5.76 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -35.32 -54.54 0.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -51.4 -48.04 62.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.872 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -34.5 65.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.452 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 3.6 mp -81.77 -27.82 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.262 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.49 -47.28 56.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.812 0.339 . . . . 0.0 111.271 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.595 ' HB3' HD12 ' A' ' 92' ' ' ILE . 71.6 mmtt -87.02 -58.33 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.505 ' C ' ' H ' ' A' ' 123' ' ' SER . 26.1 tp -96.06 -10.18 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.74 -24.12 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.434 0.159 . . . . 0.0 110.602 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 4' ' ' ASP . 11.0 pm0 . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 121.048 0.451 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 3' ' ' GLN . 18.1 t70 -65.84 -54.86 21.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 53.5 p -57.36 -35.69 70.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 123' ' ' SER . 57.6 t -87.22 -64.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.598 HG11 ' HE3' ' A' ' 11' ' ' MET . 41.4 t -58.78 -62.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.78 42.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.2 mptm? -88.23 -54.6 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.714 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -57.88 -23.37 52.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.598 ' HE3' HG11 ' A' ' 7' ' ' VAL . 32.4 mtm -82.75 -56.13 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.84 -25.73 68.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.272 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -53.19 -46.26 68.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.263 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 18' ' ' ILE . 46.3 mt -152.1 45.11 0.74 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.766 0.317 . . . . 0.0 111.453 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.534 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 ttp -52.39 -50.25 80.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 15' ' ' MET . 33.4 Cg_endo -63.84 -32.33 66.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.051 1.834 . . . . 0.0 112.749 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.45 -9.66 58.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 14' ' ' LEU . 39.4 mt -86.37 -29.11 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.324 . . . . 0.0 110.855 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.476 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 25.5 mmt -54.75 -47.27 98.57 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.965 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 19' ' ' MET . 48.8 Cg_exo -37.83 -49.43 2.05 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.939 2.426 . . . . 0.0 113.475 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.9 m -85.01 -35.57 21.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.72 47.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 179.654 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 22.7 ttt . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -48.03 -40.47 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.411 ' NE2' ' HB2' ' A' ' 49' ' ' CYS . 13.2 tp60 -87.43 -27.93 22.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 2.9 mp -66.81 -7.5 21.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.05 7.07 73.03 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.187 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.411 ' HB2' ' NE2' ' A' ' 46' ' ' GLN . 36.2 m -131.75 -70.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.227 . . . . 0.0 111.452 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.7 tp -51.56 -55.07 21.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 1.4 tpmt? -64.68 -23.2 67.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.215 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HA ' ' HE1' ' A' ' 55' ' ' MET . . . -79.17 -15.85 57.48 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.581 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.06 -25.45 66.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.081 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.31 -36.87 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.524 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.406 ' HE1' ' HA ' ' A' ' 52' ' ' ALA . 72.6 mtm -68.5 -40.42 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HB2' ' HZ3' ' A' ' 56' ' ' LYS . 7.8 mtmp? -73.09 -20.02 61.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -86.06 -27.49 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 60' ' ' MET . 48.5 pt -94.75 17.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.1 34.22 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.413 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.433 ' HB2' HG13 ' A' ' 58' ' ' ILE . 26.6 ttt -104.35 1.9 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.166 0.507 . . . . 0.0 110.544 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 66' ' ' LEU . 50.0 tp -153.18 98.79 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.757 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.3 mmpt? -104.67 104.67 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . 48.14 51.61 19.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 63' ' ' GLY . 8.8 p 73.66 34.55 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.242 0.617 . . . . 0.0 111.479 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.0 106.08 9.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.679 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 61' ' ' LEU . 3.2 mm? -68.45 147.27 52.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.378 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.97 169.31 13.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.35 . . . . 0.0 111.223 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.06 -25.69 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.358 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.563 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 48.1 mt-10 -62.37 -47.96 88.18 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.115 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 36.9 Cg_endo -65.07 -42.46 13.95 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.275 1.983 . . . . 0.0 113.445 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.535 HG13 ' HD1' ' A' ' 72' ' ' TYR . 3.1 p -65.23 -46.51 90.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.592 0.234 . . . . 0.0 111.395 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' HD1' HG13 ' A' ' 71' ' ' VAL . 4.6 m-30 -59.29 -22.0 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.278 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 21.8 tptm -84.62 -45.56 12.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptp -70.84 -42.66 69.88 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.461 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 86' ' ' ILE . 95.5 mt -48.73 -27.81 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.739 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 36.9 mt-10 -59.64 -59.22 5.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.716 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.5 -39.72 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.083 0.468 . . . . 0.0 110.811 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.77 -9.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.362 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 93.5 m-70 -143.47 56.75 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.9 137.54 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.11 -53.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.43 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -128.05 154.66 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.81 -29.4 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.351 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 4.1 p30 -83.52 -29.34 27.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.76 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -28.56 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.57 HG22 HG21 ' A' ' 75' ' ' ILE . 88.9 mt -83.33 -29.06 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.237 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.78 -22.4 53.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.357 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 92' ' ' ILE . 69.6 tp -75.94 -60.12 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.768 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.481 HG13 HD21 ' A' ' 121' ' ' LEU . 35.0 t -55.23 -35.97 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.93 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -33.96 60.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.25 -28.75 24.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' A' ' 120' ' ' LYS . 31.3 mm -65.39 -36.29 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.0 64.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -74.21 -40.99 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.611 ' HG2' ' HE2' ' A' ' 120' ' ' LYS . 8.2 tp10 -62.57 -18.14 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.529 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 57.9 m -86.18 -53.89 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.747 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.6 mt -51.07 -30.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 111.295 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.52 -51.94 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.804 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.5 p30 -81.74 -5.93 58.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.647 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.863 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.689 0.281 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.96 144.95 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.01 -70.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.0 m -50.02 -24.15 2.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.684 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.09 -58.18 4.1 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -52.44 -41.66 36.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.315 179.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.87 -36.0 85.88 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.58 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.513 ' HA ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -68.62 -40.49 80.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.989 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -61.7 -27.15 68.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -59.32 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.001 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 111' ' ' ASN . 8.7 t -46.76 -45.14 19.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.814 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -48.12 -61.72 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -49.27 73.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -36.91 42.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.4 mm -79.49 -28.66 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 110.93 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 37.9 tt0 -69.53 -53.13 20.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.611 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 11.3 mptt -85.13 -55.94 3.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 123' ' ' SER . 39.0 tp -95.56 -11.32 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER 69.14 -16.93 0.22 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.548 ' H ' ' C ' ' A' ' 121' ' ' LEU . 37.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.92 0.39 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.13 -26.7 61.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 69.4 p -81.54 -20.87 39.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 109.716 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 123' ' ' SER . 87.0 t -82.38 -63.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.813 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.566 HG12 ' HE2' ' A' ' 11' ' ' MET . 24.4 t -65.13 -52.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.39 -27.98 68.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.05 -55.88 3.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.783 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -54.05 -24.24 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.566 ' HE2' HG12 ' A' ' 7' ' ' VAL . 32.4 mtm -79.23 -62.03 1.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.216 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.64 -23.62 67.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.792 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.472 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 5.2 t80 -56.56 -35.89 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.425 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 18' ' ' ILE . 41.4 mt -151.59 28.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.589 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 36.3 ttp -47.41 -50.44 49.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 21.5 Cg_exo -65.84 -30.7 49.12 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.213 1.942 . . . . 0.0 112.351 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.37 -7.55 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.425 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 14' ' ' LEU . 93.3 mt -83.95 -25.78 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.635 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.502 ' HA ' ' HE3' ' A' ' 19' ' ' MET . 32.4 mmt -49.11 -50.06 65.65 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.192 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 96.0 Cg_exo -41.93 -53.92 3.19 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.614 2.209 . . . . 0.0 113.251 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.0 m -82.29 -20.98 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.897 0.38 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -74.86 -2.73 28.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.769 179.6 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.701 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.3 m -52.41 -51.52 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 14.9 mm-40 -87.66 -28.5 21.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.766 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 44' ' ' MET . 6.5 mp -64.13 -21.85 66.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.77 -8.18 63.21 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.296 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -137.31 -62.47 0.62 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.414 HD21 ' O ' ' A' ' 50' ' ' LEU . 1.9 tm? -48.42 -41.81 30.3 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 26.2 ttpp -82.3 -23.93 34.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 49' ' ' CYS . . . -79.66 -6.62 57.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.273 0.558 . . . . 0.0 109.753 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.1 t -64.58 -28.19 69.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.722 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 14' ' ' LEU . 59.0 t -70.17 -26.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.933 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.25 -56.63 7.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -55.12 -26.7 40.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -72.1 -33.51 67.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 14' ' ' LEU . 42.7 pt -100.2 22.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.477 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 58.26 29.29 17.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.416 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -97.43 -10.04 26.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.75 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -149.15 114.66 5.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -107.82 77.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.58 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 -74.1 1.75 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -126.77 -1.57 6.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.503 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -91.0 156.16 18.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.605 HD23 HG13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -135.55 131.19 35.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.515 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.434 ' N ' HD12 ' A' ' 66' ' ' LEU . 31.3 m-85 -118.84 170.83 8.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 71' ' ' VAL . 31.4 m -137.72 -3.67 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 42.6 mt-10 -67.54 -49.51 40.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.1 Cg_endo -65.47 -28.23 53.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.101 1.867 . . . . 0.0 113.107 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -72.02 -41.63 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 111.083 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -56.6 -22.06 31.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.263 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.82 -40.49 22.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.791 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 14.4 ptm -77.44 -38.44 49.47 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.101 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 71' ' ' VAL . 94.1 mt -50.97 -23.57 2.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.041 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.59 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.095 0.474 . . . . 0.0 110.983 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.482 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 34.0 t -64.14 -7.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -144.58 50.76 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.58 134.83 55.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.52 -68.51 0.48 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.559 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.06 147.53 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.36 -21.47 53.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.408 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.54 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 7.5 m-20 -84.14 -27.17 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.956 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.22 -27.22 63.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.44 HG21 HG21 ' A' ' 75' ' ' ILE . 83.5 mt -85.93 -26.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.475 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -81.26 -21.41 39.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.819 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 92' ' ' ILE . 42.6 tp -81.33 -57.78 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.426 HG22 HD12 ' A' ' 121' ' ' LEU . 87.5 t -54.27 -36.22 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -62.66 -31.42 72.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.975 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.26 47.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.221 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 88' ' ' LEU . 74.3 mt -73.06 -40.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.684 0.278 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.89 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.55 -26.07 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.487 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.7 tp10 -77.97 -19.64 54.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.043 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -86.28 -43.4 12.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.501 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.605 HG13 HD23 ' A' ' 66' ' ' LEU . 2.0 mp -58.89 -41.67 83.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.678 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.31 -14.46 61.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.7 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 6.4 t30 -98.66 -75.21 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.111 179.637 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 109' ' ' ILE . 24.0 t70 -87.93 122.84 32.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.55 0.214 . . . . 0.0 110.763 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 109' ' ' ILE . 36.6 tt0 -42.07 -66.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.128 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.94 -36.13 16.62 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -67.46 -42.54 82.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 105' ' ' ASP . 50.6 mt -58.75 -50.75 78.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.491 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 114' ' ' THR . . . -64.82 -36.85 93.59 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.719 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -48.36 -38.36 19.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.011 0.405 . . . . 0.0 111.372 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 3.3 mptp? -86.43 -24.15 25.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.03 -64.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 110' ' ' GLY . 5.2 t -54.06 -28.51 39.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -53.36 -70.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.337 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -34.53 62.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.572 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -33.97 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 0.0 110.562 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.624 HD13 ' HE3' ' A' ' 44' ' ' MET . 75.1 mt -85.08 -17.14 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 110.271 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.21 -58.66 3.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 2.8 mptp? -87.36 -49.15 7.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -91.0 -12.02 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 71.54 -23.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -179.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 121' ' ' LEU . 64.0 p . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.996 0.427 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.94 -52.93 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.053 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.0 p -51.21 -29.98 15.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.128 0.49 . . . . 0.0 110.97 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 53.7 t -77.48 -63.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.589 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.05 -59.46 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.79 -35.91 15.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 31.1 mmmt -88.74 -59.42 2.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 13.7 m-85 -49.86 -29.1 7.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.31 . . . . 0.0 111.551 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.6 tpp -71.98 -55.46 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.69 -46.49 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.452 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 2.5 t80 -45.34 -39.87 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.352 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.447 ' HG ' ' HD1' ' A' ' 13' ' ' TYR . 26.3 mt -145.3 63.53 1.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.447 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.479 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 57.2 ttp -83.9 -52.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.599 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 71.6 Cg_endo -77.41 -27.31 6.52 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.968 1.779 . . . . 0.0 111.721 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 9.6 m-20 -72.38 -10.87 60.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.576 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 14' ' ' LEU . 2.8 mt -77.29 -39.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.594 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 17.0 mmt -48.54 -51.66 50.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.935 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 74.2 Cg_exo -49.57 -51.5 10.62 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.265 1.977 . . . . 0.0 112.746 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.44 -43.23 83.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.499 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -60.18 -44.08 95.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.402 ' HG2' ' ND2' ' A' ' 111' ' ' ASN . 49.9 ttp . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.304 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -51.98 -57.07 10.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.278 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -85.05 -12.33 53.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.483 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 16.5 tp -62.73 -39.74 95.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.084 0.468 . . . . 0.0 110.139 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.473 ' HA2' ' HA3' ' A' ' 110' ' ' GLY . . . -69.87 4.7 7.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.478 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 107' ' ' CYS . 1.8 m -131.48 -72.54 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.703 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm? -47.32 -54.05 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.36 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 16.8 tptp -71.97 -23.5 61.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.596 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.12 -18.63 61.88 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.036 0.446 . . . . 0.0 110.092 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.92 -36.13 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.222 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.415 HG11 HD13 ' A' ' 14' ' ' LEU . 67.0 t -59.58 -27.53 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.2 mtt -65.65 -51.84 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.575 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -66.09 -15.94 63.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.209 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.42 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 5.6 tpm_? -69.33 -45.81 68.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 60' ' ' MET . 36.8 pt -91.55 29.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.442 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 55.33 29.94 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 ttt -94.34 -17.73 22.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 60.4 tp -144.13 101.94 3.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 5.9 mmpt? -84.16 77.45 9.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.945 0.402 . . . . 0.0 110.124 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.42 -57.09 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.2 p -153.52 9.32 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 28.7 mm-40 -94.5 108.18 20.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 109' ' ' ILE . 7.6 mp -67.66 138.22 56.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 60' ' ' MET . 62.5 m-85 -139.31 159.75 41.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.26 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.444 HG11 ' HH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -138.22 -10.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.363 -179.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.1 mt-10 -56.85 -50.27 89.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.8 -14.13 35.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.001 1.801 . . . . 0.0 112.001 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -78.76 -47.44 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.045 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 90' ' ' LYS . 13.8 m-85 -63.3 -27.35 69.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -76.56 -30.08 56.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.256 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.5 ptm -85.73 -43.94 12.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.35 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.53 HG22 HG21 ' A' ' 86' ' ' ILE . 93.7 mt -51.62 -33.84 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 110.549 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.8 -57.49 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.97 -24.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 111.171 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 6.3 t -67.61 -11.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.944 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.542 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 90.5 m-70 -134.05 49.96 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.467 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.23 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.55 -70.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.16 148.35 31.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.913 0.387 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.09 -35.84 36.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.719 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 -30.85 51.32 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.955 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -21.78 6.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 75' ' ' ILE . 63.5 mt -85.93 -55.03 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.5 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.409 ' HA ' ' HG3' ' A' ' 90' ' ' LYS . 9.1 mm100 -52.81 -25.68 12.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.732 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 92' ' ' ILE . 63.8 tp -71.66 -46.55 58.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.588 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 121' ' ' LEU . 43.0 t -69.15 -41.71 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.317 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.501 ' HD3' HG22 ' A' ' 86' ' ' ILE . 9.2 mtmt -55.11 -27.12 42.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.28 -24.52 36.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.356 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 88' ' ' LEU . 47.2 mm -61.87 -40.16 86.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.725 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -59.88 -30.1 68.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.72 -23.53 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.04 -38.65 31.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.411 ' HA ' ' OD1' ' A' ' 99' ' ' ASN . 72.9 m -74.13 -36.36 64.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.653 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 93' ' ' ALA . 93.4 mt -56.46 -27.35 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -52.35 7.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.196 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.461 ' C ' HD21 ' A' ' 99' ' ' ASN . 0.4 OUTLIER -70.78 -17.13 62.79 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.433 ' N ' HD21 ' A' ' 99' ' ' ASN . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.635 0.255 . . . . 0.0 111.272 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.753 0.311 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.87 134.73 44.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.35 -61.6 2.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.726 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 54.0 m -60.59 -10.3 4.99 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -86.66 -53.61 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 110.243 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.51 HG12 HD12 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -51.31 -34.81 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.473 ' HA3' ' HA2' ' A' ' 48' ' ' GLY . . . -85.93 -51.47 3.58 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.891 -0.671 . . . . 0.0 114.296 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 2.3 t-20 -52.96 -23.86 8.16 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.7 0.75 . . . . 0.0 110.446 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -87.49 -40.82 13.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.923 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.15 -64.96 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.843 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 p -46.21 -45.57 17.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.988 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 14.7 t70 -43.9 -72.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.823 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.18 -32.32 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.822 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -56.18 -38.46 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 110.532 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.8 mt -83.45 -19.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 110.275 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -71.24 -60.11 2.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HB3' HD11 ' A' ' 92' ' ' ILE . 67.2 mttm -87.17 -50.77 6.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 123' ' ' SER . 57.0 tp -85.35 -11.87 53.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 6.3 t80 66.72 -6.03 0.58 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 0.0 110.504 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 121' ' ' LEU . 68.1 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.832 0.348 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.6 -43.98 87.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.552 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 5.6 t -52.54 -25.48 10.56 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.8 t -87.67 -64.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.449 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.72 -61.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.03 -28.27 23.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.4 mmtm -88.62 -59.6 2.19 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.53 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -51.14 -21.29 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.8 mtt -83.31 -61.59 1.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.306 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -52.56 64.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 4.8 t80 -43.9 -33.82 1.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.447 ' HG ' ' HD1' ' A' ' 13' ' ' TYR . 90.9 mt -146.64 59.75 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.431 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 37.9 tpp -89.15 -51.28 0.37 Allowed Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.7 Cg_endo -72.69 -12.46 26.68 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.991 1.794 . . . . 0.0 111.685 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.01 -9.86 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.884 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.21 -47.35 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.707 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.473 ' CG ' ' HD3' ' A' ' 20' ' ' PRO . 19.3 ptp -53.84 -34.05 18.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HD3' ' CG ' ' A' ' 19' ' ' MET . 52.2 Cg_exo -54.48 -52.55 7.92 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.419 1.413 . . . . 0.0 112.978 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.84 -22.88 60.72 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HA ' HD23 ' A' ' 50' ' ' LEU . . . -53.92 -42.17 68.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.646 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.332 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.577 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 10.2 ttt . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.558 0.218 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.7 p -59.05 -43.54 91.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.27 . . . . 0.0 110.703 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -87.81 -30.25 20.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 51' ' ' LYS . 1.5 tm? -54.29 -44.9 72.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 110.054 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 6.49 1.59 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.807 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.456 ' H ' ' C ' ' A' ' 47' ' ' LEU . 3.6 m -134.3 -72.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 22' ' ' ALA . 1.2 tm? -46.56 -51.49 15.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.522 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.579 ' HB3' HD11 ' A' ' 47' ' ' LEU . 27.4 tptp -75.37 -22.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.37 -20.13 62.98 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.5 t -60.99 -34.23 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.5 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.86 -26.88 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.7 mtm -69.06 -51.98 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.826 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 30.7 pttt -75.82 -15.75 60.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 2.5 tpm_? -70.45 -30.15 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.751 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.86 26.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.488 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 57.93 63.11 1.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -139.65 -10.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.53 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 30.0 tp -134.84 99.48 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.529 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -94.16 76.61 4.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.188 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.26 -58.73 3.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.285 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.9 p -148.25 4.26 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.714 0.292 . . . . 0.0 110.994 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt-10 -94.16 131.26 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.1 mt -113.74 113.83 25.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.139 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -106.15 177.85 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.61 25.49 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.541 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.439 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.7 mt-10 -79.19 -50.21 1.39 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.625 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 60.0 Cg_endo -74.44 -38.45 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.148 1.898 . . . . 0.0 113.067 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.429 ' HA ' ' HE1' ' A' ' 74' ' ' MET . 11.8 t -63.59 -46.1 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.633 0.254 . . . . 0.0 111.13 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -60.88 -21.81 63.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.371 . . . . 0.0 110.62 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -82.12 -48.01 11.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.743 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.429 ' HE1' ' HA ' ' A' ' 71' ' ' VAL . 14.7 ptt? -74.61 -35.43 62.94 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.91 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.667 HG23 HG22 ' A' ' 86' ' ' ILE . 9.6 mt -49.68 -26.15 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.076 0.465 . . . . 0.0 110.418 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -59.05 5.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.497 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.68 -24.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.198 0.523 . . . . 0.0 111.146 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 25.1 t -67.27 -7.39 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.458 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 88.9 m-70 -138.05 43.28 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.56 134.65 57.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.86 -60.92 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.408 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 85' ' ' ASP . 30.3 t30 -116.87 132.16 56.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 110.514 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.87 67.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 -22.3 30.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 13.8 t70 -62.04 -24.18 66.92 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 HG23 ' A' ' 75' ' ' ILE . 93.3 mt -85.13 -29.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.661 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -81.48 -21.98 38.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.578 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.97 -60.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.24 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 121' ' ' LEU . 24.3 m -54.93 -31.5 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -58.02 -41.95 84.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.648 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.7 -18.88 72.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.802 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 89' ' ' VAL . 50.9 mt -67.54 -41.03 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.728 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.96 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.283 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.3 -48.81 39.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.259 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.9 -21.21 57.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.445 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 29.3 m -86.24 -39.39 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.696 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 66' ' ' LEU . 93.2 mt -69.74 -42.04 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.808 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.98 -19.97 64.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.905 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 0.8 OUTLIER -109.33 -8.43 15.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.72 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.592 0.234 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.426 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -102.4 139.99 37.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.54 -65.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.415 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 64.9 m -50.34 -31.1 13.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -68.66 -40.36 80.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 105' ' ' ASP . 85.9 mt -69.41 -47.29 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.866 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.08 -52.3 50.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.909 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.577 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.0 t-20 -54.56 -39.47 67.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.078 0.439 . . . . 0.0 110.319 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -69.23 -25.65 64.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -83.72 -61.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.449 HG22 HD12 ' A' ' 47' ' ' LEU . 7.7 t -47.36 -47.93 25.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.375 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -44.93 -61.55 1.57 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.57 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -48.03 73.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -25.68 54.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.489 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.9 mm -85.12 -32.15 7.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.963 0.411 . . . . 0.0 111.171 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.23 -45.22 57.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.857 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -86.64 -56.53 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 123' ' ' SER . 28.9 tp -98.93 -11.84 21.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.0 OUTLIER 69.05 -16.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 110.862 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.228 -0.033 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -53.42 -50.5 65.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.416 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 40.3 p -64.91 -20.67 66.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.28 -63.18 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.09 -57.13 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.498 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.55 64.94 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB3' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.43 -59.29 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.959 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -51.49 -22.98 3.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 110.851 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.2 ttp -85.52 -62.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.346 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.6 -31.31 67.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.076 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -55.92 -45.22 78.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.437 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -141.03 40.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.56 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.486 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttp -58.34 -51.81 79.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.47 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 15' ' ' MET . 57.9 Cg_endo -70.83 -13.47 31.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.007 1.805 . . . . 0.0 112.218 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -101.96 -6.95 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.41 -43.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.509 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 84.8 mmm -53.02 -48.73 90.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 76.4 Cg_exo -43.79 -51.38 6.37 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.719 2.28 . . . . 0.0 113.149 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.3 -31.91 67.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.771 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.67 71.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 179.501 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.425 ' CG ' ' ND2' ' A' ' 111' ' ' ASN . 46.3 ttm . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -64.6 -57.43 9.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.498 0.189 . . . . 0.0 111.359 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.458 ' HA ' ' NE2' ' A' ' 46' ' ' GLN . 0.9 OUTLIER -86.9 -12.14 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 0.0 110.776 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 49' ' ' CYS . 55.4 tp -57.2 -41.99 80.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -74.54 13.61 4.88 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.504 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 5.1 m -147.3 -70.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 111.737 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' GLN . 12.2 tp -44.35 -55.91 4.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.398 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.16 -22.18 45.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 49' ' ' CYS . . . -76.15 -7.8 55.61 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.026 0.441 . . . . 0.0 110.626 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.0 t -72.15 -36.09 69.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.83 -22.22 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.0 mtt -69.84 -46.48 65.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.505 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 49.5 mttm -60.2 -18.8 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 4.4 tpm_? -67.59 -45.31 75.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.381 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.04 34.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.29 13.55 3.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.754 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.4 tpt -71.9 -14.3 61.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 31.9 tp -155.18 103.71 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -95.3 80.87 3.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 -70.56 1.61 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.893 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.7 p -145.54 27.19 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.21 110.53 21.08 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.413 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.583 HD22 HG23 ' A' ' 109' ' ' ILE . 86.0 mt -73.63 131.94 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.707 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -119.81 172.15 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.476 HG12 HD12 ' A' ' 97' ' ' ILE . 11.2 m -149.26 -17.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.547 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.3 mt-10 -58.61 -51.14 83.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.82 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 21.9 Cg_endo -61.21 -32.67 90.83 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.216 1.944 . . . . 0.0 112.625 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 75' ' ' ILE . 46.2 t -72.94 -48.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.179 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -54.09 -24.71 18.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -86.0 -36.76 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 20.0 ptm -75.75 -39.57 56.96 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.508 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.534 HG22 HG22 ' A' ' 86' ' ' ILE . 90.3 mt -50.48 -23.64 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.053 0.454 . . . . 0.0 110.189 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' A' ' 86' ' ' ILE . 43.9 mt-10 -59.01 -58.82 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.464 HG11 ' HD2' ' A' ' 9' ' ' LYS . 21.2 t -88.05 -24.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.151 0.5 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 9' ' ' LYS . 41.8 t -66.26 -8.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.941 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.432 ' NE2' HG22 ' A' ' 89' ' ' VAL . 92.0 m-70 -143.37 49.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.613 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.58 127.32 30.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -73.53 0.34 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.4 m-20 -104.6 136.69 43.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.688 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.5 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.613 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.07 -24.89 30.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.758 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.0 t70 -59.58 -26.56 65.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.534 HG22 HG22 ' A' ' 75' ' ' ILE . 81.1 mt -84.34 -27.73 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.475 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.83 -19.76 43.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.617 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.8 tp -78.25 -55.06 5.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.548 HG12 ' HG ' ' A' ' 121' ' ' LEU . 26.4 t -55.94 -36.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.572 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -61.83 -30.04 70.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.722 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.19 51.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.261 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.595 HG13 HD23 ' A' ' 121' ' ' LEU . 47.9 mm -74.38 -39.91 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 0.0 110.893 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -58.34 -23.72 57.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -75.48 -37.48 60.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HG3' ' HZ1' ' A' ' 120' ' ' LYS . 2.7 tm-20 -56.64 -28.45 60.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.466 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.531 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 59.8 m -80.68 -27.68 37.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 68' ' ' VAL . 39.6 mt -74.15 -21.8 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.933 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.0 -29.44 55.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 3.9 p30 -97.51 -40.74 8.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.191 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 179.854 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.231 0.115 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -96.03 143.34 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.303 . . . . 0.0 110.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.538 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 12.9 tp10 -65.41 -69.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.697 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 14.3 m -50.25 -24.11 2.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.516 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -76.81 -49.35 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.583 HG23 HD22 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -56.79 -43.82 80.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.5 -50.21 39.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.752 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 111' ' ' ASN . 1.7 t-20 -54.83 -33.78 62.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.08 -31.49 58.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.852 0.358 . . . . 0.0 111.014 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.96 -65.57 1.0 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.76 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -46.73 -42.9 17.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.142 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 17.0 t70 -46.0 -63.77 0.9 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.77 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.332 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.35 -51.21 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.898 0.38 . . . . 0.0 110.669 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.4 mt -78.17 -17.76 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.54 -60.01 3.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.602 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HZ1' ' HG3' ' A' ' 95' ' ' GLU . 90.9 mttt -86.93 -55.96 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.595 HD23 HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -85.34 -11.32 54.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.32 -14.24 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 110.524 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 121' ' ' LEU . 70.0 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.72 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.941 0.4 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.52 -57.0 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 15.3 t -49.8 -28.17 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.387 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -86.93 -64.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.844 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.89 -58.11 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.19 -29.49 22.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 mptp? -88.54 -59.09 2.33 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.517 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -51.28 -20.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.727 0.299 . . . . 0.0 111.362 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -85.0 -58.6 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.37 -23.48 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.55 -23.41 56.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.694 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.477 ' HB3' HG11 ' A' ' 54' ' ' VAL . 79.0 mt -135.02 15.98 3.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.482 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tmm? -58.27 -51.91 78.41 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.316 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 16.3 Cg_exo -69.86 -7.15 20.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.551 2.167 . . . . 0.0 112.321 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -104.75 -16.88 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 HG22 ' A' ' 54' ' ' VAL . 67.7 mt -89.21 -49.51 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.262 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 91.9 mmm -49.07 -49.65 67.88 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.7 Cg_exo -51.29 -52.18 9.6 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.242 1.961 . . . . 0.0 113.118 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -22.14 54.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.531 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.509 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -54.82 -35.78 64.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.561 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.566 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 11.3 ttm . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.4 p -63.06 -57.06 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.28 -12.54 59.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.579 ' HG ' HG23 ' A' ' 114' ' ' THR . 30.3 tp -84.46 -30.92 24.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.13 14.94 63.19 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -74.2 0.51 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.988 -0.606 . . . . 0.0 111.305 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.509 HD22 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -50.84 -45.67 59.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.351 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 58.3 tttm -74.65 -24.94 58.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . . . -68.15 -22.11 64.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.3 0.571 . . . . 0.0 109.851 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.4 t -73.75 -37.84 64.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.277 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.486 HG22 HG12 ' A' ' 18' ' ' ILE . 5.7 t -63.55 -20.9 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.434 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 17.1 mmt -63.92 -51.94 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.647 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.86 -16.19 48.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.17 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.2 mmp_? -73.08 -34.15 66.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.086 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' SD ' ' A' ' 60' ' ' MET . 33.1 pt -107.13 34.91 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 42.68 40.95 2.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.894 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.434 ' HG3' ' HB3' ' A' ' 55' ' ' MET . 18.2 ptm -112.02 8.97 20.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 110.091 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 44.4 tp -157.72 99.01 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 11.7 mmpt? -104.37 95.8 6.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.059 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.15 57.6 14.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.39 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p 73.03 22.85 2.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.038 0.535 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 20.3 mm-40 -115.75 104.94 12.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 100' ' ' ALA . 5.7 mp -78.51 141.27 38.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -112.86 -178.48 3.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.51 HG11 HD12 ' A' ' 97' ' ' ILE . 30.6 m -129.18 -28.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm-40 -64.71 -52.86 48.21 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.933 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 12.7 Cg_endo -58.13 -13.76 16.94 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.054 1.836 . . . . 0.0 112.402 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.47 HG12 ' HE1' ' A' ' 74' ' ' MET . 16.7 t -91.53 -46.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.77 -22.25 66.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.213 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -82.35 -47.68 12.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.47 ' HE1' HG12 ' A' ' 71' ' ' VAL . 25.0 ptt? -71.59 -41.27 69.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.861 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.604 HD11 HG13 ' A' ' 89' ' ' VAL . 26.5 mt -49.37 -30.5 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.005 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -54.71 -59.53 4.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.814 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.57 -29.09 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 111.142 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.05 -7.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.873 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -139.05 33.35 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.38 56.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.319 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.15 -53.08 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.209 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.8 m120 -116.19 110.28 18.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.69 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.51 69.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.1 m-20 -79.71 -18.84 50.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.81 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 37.2 t0 -62.9 -34.09 76.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 mt -76.42 -31.76 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.561 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -75.55 -30.95 59.89 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.779 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -83.75 -47.14 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.604 HG13 HD11 ' A' ' 75' ' ' ILE . 9.9 p -64.73 -32.88 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -52.69 -34.53 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.1 -30.44 31.28 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.38 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.55 HG13 HD21 ' A' ' 121' ' ' LEU . 34.8 mm -65.69 -35.64 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.36 -33.54 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.966 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.32 -21.73 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.29 -33.38 69.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.679 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.588 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 69.5 m -87.25 -53.65 4.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.47 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.51 HD12 HG11 ' A' ' 68' ' ' VAL . 65.1 mt -49.46 -28.8 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.63 -34.68 53.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.5 p30 -94.37 -3.88 49.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.443 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.832 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.404 ' HG1' ' N ' ' A' ' 105' ' ' ASP . 65.5 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.404 ' N ' ' HG1' ' A' ' 104' ' ' THR . 11.1 t70 -79.83 131.23 35.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.835 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -49.16 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.4 m -56.58 -21.53 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -81.61 -31.19 32.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.013 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 105' ' ' ASP . 90.7 mt -66.74 -40.49 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 52' ' ' ALA . . . -82.59 -37.03 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.368 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.566 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.6 t-20 -56.92 -48.31 78.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.674 0.273 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -53.59 -26.83 23.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.706 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.83 -65.8 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.917 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.579 HG23 ' HG ' ' A' ' 47' ' ' LEU . 9.7 t -53.19 -46.18 68.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -38.81 -58.44 1.08 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 p -76.81 -34.94 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.93 -32.5 66.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.876 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 54.3 mt -83.77 -20.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.224 0.535 . . . . 0.0 110.426 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.62 -58.26 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.0 -52.06 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.55 HD21 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -92.45 -11.44 34.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.19 -15.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.587 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 121' ' ' LEU . 58.8 m . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.81 -48.51 75.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.446 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.6 p -54.84 -24.52 23.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 123' ' ' SER . 58.4 t -86.41 -63.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.592 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.41 -62.11 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.24 -28.65 19.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.7 mmpt? -87.72 -59.15 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.491 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -52.06 -29.03 19.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -76.95 -62.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.98 -23.65 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.53 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -63.72 -48.19 78.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.483 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.481 ' O ' HG13 ' A' ' 18' ' ' ILE . 80.4 mt -137.89 36.68 2.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.491 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.0 ttm -55.3 -50.89 84.1 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 15' ' ' MET . 70.0 Cg_endo -71.24 -8.44 23.45 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.215 1.943 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.29 -16.1 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' LEU . 78.3 mt -80.88 -49.87 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.454 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 87.8 mtp -48.4 -47.98 67.52 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.068 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 19' ' ' MET . 53.3 Cg_exo -38.51 -60.31 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.684 2.256 . . . . 0.0 113.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m -69.64 -26.49 64.43 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.53 -44.83 66.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.877 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.207 179.465 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.455 ' HG2' HD21 ' A' ' 111' ' ' ASN . 20.6 ttm . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.9 t -86.5 -58.03 2.77 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 110.772 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.96 -16.38 36.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.058 0.456 . . . . 0.0 109.99 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.49 HD23 HD13 ' A' ' 118' ' ' ILE . 19.3 tp -71.59 -35.31 70.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.623 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.26 9.38 9.92 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.734 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.64 -62.99 0.3 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD11 ' C ' ' A' ' 50' ' ' LEU . 1.9 tm? -48.68 -42.68 35.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -81.16 -20.47 41.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.599 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.416 ' HA ' ' HE2' ' A' ' 55' ' ' MET . . . -70.53 -21.95 62.67 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 1.7 t -59.64 -31.44 69.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.02 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.97 -28.93 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.42 ' O ' ' HB3' ' A' ' 60' ' ' MET . 71.1 mtm -72.68 -65.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.16 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HG2' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -58.07 -15.34 9.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.471 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.1 tpm_? -72.18 -34.26 68.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.175 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 14' ' ' LEU . 40.2 pt -113.29 34.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.827 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 64.01 11.05 5.81 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.563 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.42 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.0 tpt -79.05 4.16 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.527 HD23 ' HG2' ' A' ' 56' ' ' LYS . 34.2 tp -166.81 99.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.93 78.33 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.7 -64.58 3.28 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.049 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.404 HG22 HD11 ' A' ' 109' ' ' ILE . 63.8 p -147.36 15.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.709 0.29 . . . . 0.0 110.835 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -108.83 110.22 21.53 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.68 135.01 49.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.33 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -106.4 174.31 5.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.73 -25.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.346 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.2 mm-40 -56.54 -51.86 77.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.504 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -63.53 -13.67 37.79 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.969 1.779 . . . . 0.0 112.099 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.05 -50.37 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.274 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -56.86 -22.54 37.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.839 0.352 . . . . 0.0 110.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -85.33 -44.21 13.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.319 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 ptp -71.98 -41.71 67.36 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.697 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.551 HD12 HG22 ' A' ' 89' ' ' VAL . 89.0 mt -48.66 -28.52 2.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.01 -56.36 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.12 -24.73 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 75' ' ' ILE . 40.8 t -69.83 -8.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.856 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -144.67 45.53 1.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.652 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.77 119.91 10.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.61 -74.4 0.27 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.47 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.618 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.0 m120 -100.13 123.89 44.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.66 -25.27 67.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.024 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 9.5 m-20 -84.3 -24.98 29.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.436 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.8 t0 -56.68 -36.1 69.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.463 HG23 HG23 ' A' ' 75' ' ' ILE . 96.9 mt -74.39 -28.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.6 tp60 -81.66 -23.56 36.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tt -78.37 -62.11 1.79 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.285 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.551 HG22 HD12 ' A' ' 75' ' ' ILE . 28.5 m -58.85 -27.77 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.653 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.4 tttt -56.82 -35.91 69.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.713 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.46 -19.15 62.69 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 89' ' ' VAL . 29.1 mm -73.87 -35.27 42.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 0.0 110.76 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.13 68.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -82.94 -27.15 30.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.608 ' HG2' ' HZ1' ' A' ' 120' ' ' LYS . 7.3 tp10 -69.86 -19.64 63.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.204 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.4 m -86.07 -42.3 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.48 -36.9 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.16 -36.93 76.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -5.06 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.605 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.853 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.232 0.155 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 109' ' ' ILE . 26.3 t70 -102.52 140.47 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.36 -69.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.666 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.9 m -53.82 -16.81 1.94 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.896 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 26.3 t-20 -87.06 -35.13 18.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.414 HG13 ' O ' ' A' ' 105' ' ' ASP . 84.6 mt -69.88 -55.57 14.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 114' ' ' THR . . . -61.25 -43.34 99.5 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.613 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.455 HD21 ' HG2' ' A' ' 44' ' ' MET . 26.5 t-20 -50.92 -30.39 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.6 -25.79 23.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.976 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -86.29 -63.47 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.735 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.6 t -49.3 -43.1 43.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -45.92 -38.54 7.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.59 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.22 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.339 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.51 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 0.0 111.584 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 61.4 mt -77.86 -21.23 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 110.718 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.57 -57.0 4.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.568 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.608 ' HZ1' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -87.2 -44.6 11.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 123' ' ' SER . 42.9 tp -99.9 -10.54 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER 72.79 -22.93 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.277 . . . . 0.0 110.968 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 121' ' ' LEU . 57.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.778 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 C--O 1.229 0.026 0 CA-C-O 120.751 0.31 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.1 -48.44 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 6.6 t -59.32 -24.96 63.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.08 -64.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.008 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.89 -59.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -27.58 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 5' ' ' THR . 13.5 mptt -88.42 -59.4 2.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.585 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.531 ' HH ' ' HE1' ' A' ' 74' ' ' MET . 3.8 m-85 -50.22 -24.7 3.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' MET . 0.7 OUTLIER -81.75 -62.21 1.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.99 -54.52 17.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -51.68 -23.41 4.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.459 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' A' ' 54' ' ' VAL . 96.3 mt -139.86 62.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.519 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.604 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 50.7 ttp -110.01 -51.45 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.366 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 31.3 Cg_exo -58.89 -14.79 24.02 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.989 1.793 . . . . 0.0 111.806 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -94.56 -19.86 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.9 mt -81.09 -36.91 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.561 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 58.5 mtt -45.57 -50.27 32.4 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 77.1 Cg_exo -50.19 -52.41 9.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.272 1.982 . . . . 0.0 113.302 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.3 m -85.29 -15.04 44.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.661 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -7.84 21.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.138 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 179.492 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.52 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 27.6 ttt . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.382 0.134 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.6 t -92.41 -57.35 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -88.06 -27.41 22.01 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 49' ' ' CYS . 4.6 tt -49.77 -46.78 51.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -76.02 29.65 1.35 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.65 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -132.71 -73.0 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 tp -51.99 -45.46 64.49 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -74.44 -25.27 59.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.485 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HB2' ' HE1' ' A' ' 55' ' ' MET . . . -78.83 -16.75 56.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 40.0 t -70.21 -33.39 71.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 14' ' ' LEU . 15.2 t -68.28 -24.99 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.985 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.442 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 51.3 mtm -60.79 -45.83 92.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 2.0 pttm -75.51 -15.84 60.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.615 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.9 mmp_? -76.94 -23.16 52.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 pt -113.01 26.08 3.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.81 63.21 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -139.31 -20.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 13.6 tp -124.93 99.99 6.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.559 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 10.4 mmpt? -124.14 87.57 2.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.14 59.44 10.03 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.367 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p 72.29 8.84 5.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.27 0.628 . . . . 0.0 111.171 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 42.8 mt-10 -92.91 122.51 35.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.21 113.85 25.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.958 0.409 . . . . 0.0 110.926 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.73 178.43 8.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.778 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 -12.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.754 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 36.6 mt-10 -70.65 -49.76 14.61 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.607 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 33.8 Cg_endo -66.6 -29.28 44.05 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.917 1.745 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 74' ' ' MET . 22.0 t -64.21 -53.64 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.926 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -55.26 -21.69 15.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -85.21 -38.43 18.96 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.13 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -72.92 -42.99 62.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.349 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.442 HG21 HG23 ' A' ' 86' ' ' ILE . 76.4 mt -51.91 -27.75 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 0.0 110.749 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.58 -58.22 9.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.855 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -86.35 -25.79 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.184 0.516 . . . . 0.0 110.835 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.61 -8.15 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.644 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.42 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 90.0 m-70 -145.21 43.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 132.12 48.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.185 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.65 -62.26 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -126.72 147.57 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -65.93 -33.6 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -82.91 -30.19 28.65 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.548 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -53.02 -30.73 37.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.442 HG23 HG21 ' A' ' 75' ' ' ILE . 95.0 mt -83.29 -34.56 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.412 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 15.0 mm100 -71.27 -19.76 62.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -78.06 -44.68 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 121' ' ' LEU . 21.3 t -70.43 -29.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.78 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.58 -35.9 54.99 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.408 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.83 -31.32 32.86 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.193 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 120' ' ' LYS . 34.6 mm -60.18 -35.36 61.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 -19.07 57.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -74.67 -42.04 59.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.343 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.95 -18.27 62.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -85.15 -38.03 19.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.471 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.76 -35.63 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.379 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.8 -13.27 62.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.299 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -106.75 -49.18 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.131 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.216 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 19.5 t70 -95.15 139.78 31.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -45.47 -64.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.908 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -56.3 -43.6 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.588 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.73 -37.98 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 105' ' ' ASP . 97.5 mt -60.12 -41.49 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.33 -29.22 25.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.17 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.533 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 21.3 m120 -58.15 -36.66 73.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.177 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.39 -38.26 30.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -68.65 -24.68 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.592 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 t -88.0 -42.81 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 110.25 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -43.17 -68.97 0.15 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.46 178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 p -54.26 -39.62 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.022 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.42 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.2 OUTLIER -54.34 -37.01 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.524 ' HA ' ' N ' ' A' ' 123' ' ' SER . 87.8 mt -85.29 -35.88 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.068 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.15 -46.25 72.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.931 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.514 ' HB3' HD11 ' A' ' 92' ' ' ILE . 12.3 mptt -86.14 -44.97 11.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.622 ' O ' ' HB3' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -100.16 -53.93 3.01 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 135.74 -6.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.254 1.422 . . . . 0.0 111.02 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.524 ' N ' ' HA ' ' A' ' 118' ' ' ILE . 89.9 p . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.782 0.325 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.6 -44.6 33.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.485 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 79' ' ' HIS . 25.9 m -47.49 -41.93 21.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.44 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.11 -62.43 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.18 -26.25 11.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.37 -59.34 2.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.875 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -56.5 -23.77 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.716 0.293 . . . . 0.0 111.479 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.3 ttt -84.49 -56.02 3.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.63 -23.86 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.65 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.511 ' HB3' HD12 ' A' ' 14' ' ' LEU . 1.2 t80 -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 13' ' ' TYR . 4.5 mp -137.97 32.45 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 ttp -50.43 -51.67 62.05 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.608 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 15' ' ' MET . 42.5 Cg_endo -67.14 -33.3 31.78 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.889 1.726 . . . . 0.0 112.112 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.425 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 m-20 -78.78 0.72 25.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 15' ' ' MET . 37.8 mt -89.42 -43.42 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.432 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 26.9 ptt? -57.87 -33.32 17.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 19' ' ' MET . 78.6 Cg_exo -50.37 -51.9 10.08 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.684 1.589 . . . . 0.0 112.68 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.0 m -74.68 -28.99 61.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.559 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.473 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.54 -40.53 62.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.729 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -78.11 -58.75 3.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.686 0.279 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.518 ' HA ' ' NE2' ' A' ' 46' ' ' GLN . 9.9 mm100 -88.74 -13.52 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.305 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 51' ' ' LYS . 2.6 tt -60.04 -43.26 95.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.065 0.46 . . . . 0.0 109.845 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.48 9.3 6.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.037 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' H ' ' C ' ' A' ' 47' ' ' LEU . 1.2 m -138.91 -78.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.232 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -48.64 -52.62 22.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.659 ' HB3' HD21 ' A' ' 47' ' ' LEU . 5.3 tmtt? -73.55 -22.87 59.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HA ' ' HE1' ' A' ' 55' ' ' MET . . . -76.06 -10.39 59.38 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.432 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.1 t -60.7 -35.71 76.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.753 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.99 -28.83 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.122 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 52' ' ' ALA . 39.5 mtt -65.18 -49.02 71.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.171 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HB2' ' HZ3' ' A' ' 56' ' ' LYS . 7.9 mtmp? -64.38 -27.3 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.795 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.3 -30.42 66.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 60' ' ' MET . 49.1 pt -96.45 15.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.828 0.347 . . . . 0.0 111.216 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 58.41 45.45 16.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.668 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.53 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 2.8 ppp? -121.11 -8.96 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.088 0.47 . . . . 0.0 110.447 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 58.6 tp -139.47 99.87 3.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.471 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.25 77.84 3.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.35 -63.73 3.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.741 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -147.23 15.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.641 0.257 . . . . 0.0 110.659 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -107.5 111.2 23.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.739 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.547 HD11 HG22 ' A' ' 109' ' ' ILE . 95.7 mt -84.23 139.14 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.53 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 6.4 m-85 -111.67 -172.55 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.57 -15.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.608 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 47.0 mt-10 -72.95 -47.33 8.41 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 50.0 Cg_exo -52.65 -51.42 11.16 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.274 1.983 . . . . 0.0 112.834 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.481 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 20.5 t -55.89 -44.38 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -55.51 -23.7 27.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.945 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -85.46 -34.79 21.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.22 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.481 ' HE3' ' HA ' ' A' ' 71' ' ' VAL . 18.7 mtm -71.6 -50.49 30.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.555 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.42 HG22 HG21 ' A' ' 86' ' ' ILE . 70.0 mt -49.35 -22.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.59 -59.71 3.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.427 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.8 -32.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 9' ' ' LYS . 37.6 t -61.08 -11.93 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.83 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.414 ' HA ' HG22 ' A' ' 5' ' ' THR . 89.6 m-70 -139.09 53.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.93 109.19 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.48 -67.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.359 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.11 153.18 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 0.0 110.648 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 -46.72 14.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.89 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.45 -26.46 61.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.925 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.45 -32.53 67.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 75' ' ' ILE . 93.8 mt -75.71 -29.79 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.123 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -81.34 -19.42 42.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.448 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -61.39 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.551 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.472 HG12 ' HH ' ' A' ' 117' ' ' TYR . 22.1 t -58.64 -30.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -60.0 -32.95 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.823 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.53 -24.96 37.36 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.604 HG13 HD23 ' A' ' 121' ' ' LEU . 38.7 mm -69.25 -35.77 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 110.977 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.46 -15.89 63.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.98 -27.68 57.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.8 tp10 -69.9 -20.81 63.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.51 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 97.1 m -87.05 -45.49 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.24 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.5 -18.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.668 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.2 -12.89 29.18 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 0.5 OUTLIER -121.6 -0.91 9.62 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.521 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.23 0.061 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -104.31 142.04 35.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.968 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.178 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.0 m -51.3 -29.38 14.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.421 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -72.59 -43.87 62.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.917 0.389 . . . . 0.0 110.113 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.547 HG22 HD11 ' A' ' 66' ' ' LEU . 13.6 mt -63.82 -44.96 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.61 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -45.11 85.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.949 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.444 ' HA ' HG23 ' A' ' 114' ' ' THR . 1.9 t-20 -58.98 -47.66 84.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.928 0.364 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -61.04 -20.16 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.104 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -86.88 -56.84 3.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.333 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 111' ' ' ASN . 9.7 t -61.99 -36.39 81.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 111.622 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -48.3 -45.44 34.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.169 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -40.27 16.74 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.472 ' HH ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -55.33 -35.1 64.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.689 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 58.1 mt -84.56 -17.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 0.0 110.252 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.74 -56.08 5.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 2.2 mptp? -85.23 -48.68 8.87 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.604 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -99.18 -10.02 23.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.42 -21.18 0.27 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.59 0.234 . . . . 0.0 110.937 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 121' ' ' LEU . 41.0 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 120.825 0.345 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.33 -44.81 62.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -53.98 -31.3 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.436 HG13 ' HG ' ' A' ' 123' ' ' SER . 54.5 t -88.73 -65.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.03 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.99 -62.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.99 -24.83 56.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HD3' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.08 -58.1 2.66 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.836 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -55.11 -30.67 60.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.689 0.281 . . . . 0.0 111.572 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.0 tpp -77.04 -52.5 9.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.403 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.62 -23.51 63.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 4.3 t80 -60.98 -36.06 78.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.127 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 18' ' ' ILE . 96.1 mt -142.34 38.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.129 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.482 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 9.0 tmm? -54.06 -51.01 81.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.083 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 15' ' ' MET . 60.5 Cg_endo -70.17 -8.67 24.17 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . 0.402 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 14.9 m-20 -106.71 -15.11 14.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 14' ' ' LEU . 70.5 mt -83.69 -44.2 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.884 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.505 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 25.0 mmt -53.46 -48.2 93.64 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 95.0 Cg_exo -42.96 -51.64 5.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.677 2.252 . . . . 0.0 112.749 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.457 ' O ' HD22 ' A' ' 50' ' ' LEU . 4.9 m -56.85 -42.04 78.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.13 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.28 -50.33 62.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.976 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.674 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.2 tpt . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 120.438 0.161 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.674 ' H ' ' HG3' ' A' ' 44' ' ' MET . 41.6 t -79.45 -44.53 21.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.063 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 tp60 -70.95 -39.96 72.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' H ' ' A' ' 44' ' ' MET . 2.3 tm? -68.56 -45.16 72.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.156 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HB1' ' A' ' 52' ' ' ALA . . . -55.4 -7.54 1.38 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.302 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.424 ' H ' ' C ' ' A' ' 47' ' ' LEU . 1.3 m -103.88 -60.9 1.5 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -53.94 -36.07 62.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.752 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HD3' HD22 ' A' ' 47' ' ' LEU . 13.6 tptt -80.65 -20.55 42.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.313 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -75.03 -23.86 58.22 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -26.17 68.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.419 HG21 HG12 ' A' ' 18' ' ' ILE . 21.3 t -77.72 -24.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.6 mtt -67.08 -55.03 16.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.623 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 45.1 mttm -58.27 -23.14 55.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -62.15 -36.51 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.895 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 pt -113.21 26.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.89 58.21 3.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.495 ' O ' ' HG2' ' A' ' 60' ' ' MET . 12.5 ttt -124.9 3.72 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 65' ' ' GLU . 33.9 tp -161.75 127.88 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.0 111.134 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -115.83 80.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.761 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 -72.74 0.92 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.754 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.3 p -139.55 29.46 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.89 0.376 . . . . 0.0 110.47 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HD13 ' A' ' 61' ' ' LEU . 7.0 tp10 -117.37 108.73 15.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.426 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.53 HD13 HG23 ' A' ' 109' ' ' ILE . 1.1 mm? -67.39 146.26 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.893 0.377 . . . . 0.0 111.418 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -142.33 155.41 45.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.501 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.65 5.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.736 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 38.0 mt-10 -59.5 -52.08 76.7 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -69.01 -28.87 28.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.171 1.914 . . . . 0.0 112.62 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 HG21 ' HE3' ' A' ' 60' ' ' MET . 21.5 t -63.94 -48.34 86.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.079 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.453 ' HA ' HD13 ' A' ' 75' ' ' ILE . 7.1 m-30 -51.47 -22.21 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.935 0.398 . . . . 0.0 110.422 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 39.9 tptt -83.22 -37.57 23.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.4 mtm -74.59 -43.85 53.6 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.35 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 72' ' ' TYR . 58.9 mt -48.87 -24.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.404 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 44.3 mt-10 -65.94 -59.26 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.328 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -80.96 -44.93 21.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 18.8 t -46.52 -40.79 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.266 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.452 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 78.8 m-70 -106.31 53.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.29 122.33 16.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.308 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.92 -76.14 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -96.04 144.42 26.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.31 -28.67 34.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.42 -26.79 38.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -58.36 -23.65 57.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.74 -32.76 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.447 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -75.57 -21.15 58.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.973 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.09 -55.46 4.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 HD22 ' A' ' 121' ' ' LEU . 58.5 t -56.11 -32.46 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -34.13 68.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.753 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.43 -27.12 33.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.375 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 121' ' ' LEU . 43.6 mm -69.06 -38.01 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -19.29 65.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -84.2 -29.79 26.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -27.38 62.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -22.16 54.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.39 -49.51 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.35 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.5 -40.8 80.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -57.85 -48.3 80.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.889 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.098 0.475 . . . . 0.0 110.971 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.7 0.286 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.2 t70 -91.65 142.66 27.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -55.18 -67.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.254 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.457 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 61.1 m -50.26 -35.35 26.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 39.7 t-20 -59.3 -50.42 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.53 HG23 HD13 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -59.17 -32.95 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.146 177.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 114' ' ' THR . . . -66.58 -57.17 10.51 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.419 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 3.7 t-20 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.653 0.263 . . . . 0.0 111.491 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.15 -30.75 19.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.864 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -82.69 -63.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 110' ' ' GLY . 10.1 t -53.68 -30.57 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.27 -59.61 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -49.84 -37.03 28.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.427 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 38.0 mm -82.27 -27.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.146 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.85 -59.57 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 116' ' ' CYS . 3.2 mptp? -86.85 -43.56 12.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 123' ' ' SER . 46.7 tp -99.66 -15.75 18.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.9 t80 67.83 -13.61 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.92 0.391 . . . . 0.0 110.911 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.55 ' H ' ' C ' ' A' ' 121' ' ' LEU . 48.2 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.319 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.71 -37.22 86.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.433 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 3.0 t -54.54 -29.35 50.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.89 -64.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.048 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.68 -62.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.17 -28.19 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.7 mmmt -88.48 -59.45 2.23 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.687 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -52.89 -20.52 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.202 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 78.9 mmm -85.54 -60.48 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.9 -28.19 69.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.704 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.07 -46.68 88.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.004 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 mt -123.12 34.79 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.092 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.464 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.4 tmm? -55.5 -50.62 85.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.665 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 15' ' ' MET . 74.0 Cg_endo -73.7 -4.19 15.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.065 1.844 . . . . 0.0 112.183 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.0 -14.93 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.11 -42.4 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.553 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 56.3 mtm -54.94 -48.78 95.03 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.326 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -53.32 -43.93 53.19 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.174 1.916 . . . . 0.0 112.568 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -57.87 -55.6 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.04 -42.03 37.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.671 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.455 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 16.1 ptp . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.1 p -53.17 -49.29 66.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.809 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.557 ' HG3' HD23 ' A' ' 50' ' ' LEU . 18.3 tp60 -87.83 -18.42 29.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.719 0.295 . . . . 0.0 111.157 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.45 ' C ' ' H ' ' A' ' 49' ' ' CYS . 10.5 mt -70.11 -28.29 65.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.99 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.482 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -71.52 10.99 3.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.486 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.45 ' H ' ' C ' ' A' ' 47' ' ' LEU . 3.9 m -134.59 -62.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.891 0.376 . . . . 0.0 110.594 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -50.76 -46.81 59.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.756 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.582 ' HZ2' ' HB3' ' A' ' 50' ' ' LEU . 0.9 OUTLIER -81.58 -20.63 39.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.634 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 55' ' ' MET . . . -69.4 -17.82 63.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.27 -46.24 70.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.751 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.91 -25.4 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.859 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.416 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 34.3 mtm -65.38 -46.43 80.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -67.95 -25.83 65.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.74 -38.17 86.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.73 17.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.26 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.22 59.85 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.7 ttp -124.12 5.47 8.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.262 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 67.7 tp -152.47 99.48 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.459 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -95.8 96.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.161 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . 47.51 60.13 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.762 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 63' ' ' GLY . 7.7 p 73.45 27.3 1.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.284 0.634 . . . . 0.0 111.819 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 43.3 mt-10 -114.4 113.06 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.0 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.564 HD23 HG22 ' A' ' 109' ' ' ILE . 91.9 mt -70.37 139.43 51.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.766 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -145.82 169.03 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.474 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.24 25.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.0 mt-10 -75.36 -50.66 3.56 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.4 Cg_endo -66.04 -44.07 8.02 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.039 1.826 . . . . 0.0 112.972 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.427 ' HA ' ' HG3' ' A' ' 74' ' ' MET . 14.1 m -57.49 -45.16 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -53.77 -22.94 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.644 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.0 tmtp? -85.37 -36.56 20.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.427 ' HG3' ' HA ' ' A' ' 71' ' ' VAL . 13.8 mtp -68.32 -48.0 66.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.397 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' HIS . 62.6 mt -48.32 -24.51 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HA ' HD12 ' A' ' 86' ' ' ILE . 43.7 mt-10 -60.65 -59.55 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 -36.26 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 9' ' ' LYS . 68.8 t -60.75 -7.74 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.103 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 78.7 m-70 -143.62 43.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 135.57 55.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.18 -60.49 0.54 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -117.84 150.12 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.44 -33.87 31.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.536 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 8.7 m-20 -81.27 -25.54 36.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.794 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 79' ' ' HIS . 36.6 t70 -58.76 -31.93 68.81 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 76' ' ' GLU . 95.7 mt -77.68 -29.64 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.134 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -77.01 -24.14 52.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.236 179.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.7 -49.35 18.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 75' ' ' ILE . 45.5 t -61.9 -34.08 61.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.782 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -35.41 75.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.78 -22.9 65.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.588 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 120' ' ' LYS . 51.4 mt -63.76 -41.72 93.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -62.35 -29.48 70.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -62.68 -41.04 98.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.249 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.96 -39.18 84.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.528 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 65.9 m -71.05 -37.68 72.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.792 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 93' ' ' ALA . 83.3 mt -65.74 -19.3 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -85.13 -32.8 22.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.2 p30 -96.35 -17.26 20.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.508 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.722 0.296 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.46 144.19 28.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -59.6 -67.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 54.2 m -52.75 -23.72 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.719 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.96 -43.38 54.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.562 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.564 HG22 HD23 ' A' ' 66' ' ' LEU . 1.5 mt -66.5 -41.66 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 110.691 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -71.17 -49.46 26.76 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.077 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.482 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.7 t-20 -51.68 -59.25 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.906 0.353 . . . . 0.0 110.927 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 10.3 mmpt? -54.0 -45.11 71.37 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 41.3 t80 -73.72 -65.9 0.77 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.3 p -50.55 -41.73 54.43 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 22.0 t70 -42.99 -67.31 0.28 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -55.95 -25.4 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -29.91 64.88 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.487 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -85.35 -25.94 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.3 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.16 -53.83 15.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.808 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HB2' HG22 ' A' ' 92' ' ' ILE . 71.8 mmtt -86.7 -58.06 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 123' ' ' SER . 49.6 tp -85.53 -10.72 55.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 3.9 t80 69.66 -19.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.555 0.217 . . . . 0.0 111.118 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.8 t . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -49.41 -43.27 44.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.39 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 2.1 t -54.17 -33.18 57.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.23 -65.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.32 -62.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.16 43.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.81 -59.32 2.26 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.905 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -54.54 -20.31 7.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.3 mmt -84.29 -57.39 3.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.2 -47.8 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.463 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -45.72 -34.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.742 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 18' ' ' ILE . 52.1 mt -138.54 46.07 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.317 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 49.1 ttp -71.92 -51.74 8.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.683 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.2 Cg_endo -69.71 -3.08 11.25 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.116 1.878 . . . . 0.0 112.117 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -103.21 -19.66 14.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 14' ' ' LEU . 75.9 mt -84.61 -37.1 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.537 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.47 -52.73 47.21 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -37.88 -52.87 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.017 2.478 . . . . 0.0 114.192 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -88.43 -42.33 12.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.586 0.231 . . . . 0.0 111.583 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 50' ' ' LEU . . . -64.05 -6.75 6.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.533 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -66.07 -57.6 7.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.593 0.235 . . . . 0.0 111.497 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 46' ' ' GLN . 12.2 mm100 -87.29 -13.1 44.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.549 HD21 HG22 ' A' ' 114' ' ' THR . 1.4 tt -57.67 -42.63 83.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.497 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -77.91 38.17 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.484 ' H ' ' C ' ' A' ' 47' ' ' LEU . 3.8 m -144.37 -79.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 110.556 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.577 HD11 ' HA ' ' A' ' 22' ' ' ALA . 4.6 mm? -52.6 -47.36 66.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.601 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -79.76 -30.6 40.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.782 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.3 4.69 29.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' CYS . 5.9 t -85.12 -30.25 24.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.015 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 51' ' ' LYS . 7.4 p -69.3 -20.19 24.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 60' ' ' MET . 59.8 mtt -66.09 -46.39 77.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.49 -16.9 41.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.341 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.41 -47.62 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.523 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 pt -92.06 33.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.723 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 54.25 30.2 11.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.4 tpt -91.55 -12.9 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -154.27 112.53 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.726 ' HG3' ' HH ' ' A' ' 67' ' ' TYR . 5.8 mmpt? -108.1 77.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.575 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.31 -70.21 2.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.004 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.6 p -143.2 18.46 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.574 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -102.72 110.82 22.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.053 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.6 mt -84.15 115.6 22.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.421 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.726 ' HH ' ' HG3' ' A' ' 62' ' ' LYS . 67.8 m-85 -96.4 -166.86 1.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.57 -15.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.54 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.1 mt-10 -60.79 -51.23 81.01 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 18.6 Cg_endo -60.95 -18.91 60.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.111 1.874 . . . . 0.0 112.539 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 75' ' ' ILE . 5.0 t -76.28 -49.2 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.514 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 24.6 m-85 -52.48 -22.27 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -78.74 -43.53 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.723 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.0 ptm -77.12 -36.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.546 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.595 HG21 HG21 ' A' ' 86' ' ' ILE . 88.2 mt -51.9 -25.49 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 110.193 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 86' ' ' ILE . 50.2 mt-10 -61.71 -59.42 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.825 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.82 -35.61 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.916 0.389 . . . . 0.0 111.545 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 25.1 t -57.53 -11.62 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 73.8 m-70 -134.11 49.15 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.407 . . . . 0.0 110.521 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.7 135.68 54.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.6 -55.84 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.9 m120 -128.01 129.07 46.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.04 68.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.0 m-20 -84.24 -25.29 29.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.8 t0 -59.11 -32.71 70.08 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.595 HG21 HG21 ' A' ' 75' ' ' ILE . 68.0 mt -76.17 -29.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.539 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -78.42 -26.5 46.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 92' ' ' ILE . 55.5 tp -67.39 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG21 HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.04 -28.97 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.489 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 72' ' ' TYR . 3.7 tptm -48.3 -46.62 36.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.74 -27.75 49.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 121' ' ' LEU . 49.3 mm -62.91 -31.13 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.38 -22.94 66.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.18 -36.24 22.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.408 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.62 -24.43 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 111.266 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.475 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 37.7 m -86.35 -31.53 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.45 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.52 -35.66 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.463 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.179 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.9 p30 -109.87 -14.41 14.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -179.655 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t70 -97.33 143.56 27.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 0.0 111.25 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.79 -69.05 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.602 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.1 m -51.69 -26.24 8.84 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.73 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 6.2 m120 -70.85 -39.71 72.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 109.917 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.15 -36.71 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.95 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.37 -53.71 27.44 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.583 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.497 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.4 t-20 -52.78 -58.12 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.539 0.209 . . . . 0.0 111.101 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.4 mmpt? -55.23 -21.19 13.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.273 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -86.76 -64.78 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.549 HG22 HD21 ' A' ' 47' ' ' LEU . 10.1 t -55.86 -31.04 62.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.93 -56.51 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -40.36 91.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.684 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -41.74 78.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 65.0 mt -77.73 -22.0 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -59.65 2.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.243 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -87.07 -54.23 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 123' ' ' SER . 38.0 tp -83.32 -10.21 58.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 11.0 t80 68.49 -9.55 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.707 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 121' ' ' LEU . 33.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.116 0.484 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -52.1 -47.42 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.787 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 79' ' ' HIS . 91.1 m -48.69 -37.0 17.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.143 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.86 -66.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.49 -62.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.34 -26.5 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 5' ' ' THR . 34.0 mmtp -89.51 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.77 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CE1' HG13 ' A' ' 78' ' ' VAL . 35.6 m-85 -55.47 -19.29 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.377 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.0 ttm -84.33 -59.23 2.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.71 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.354 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -64.88 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.374 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.57 47.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.262 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.493 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 31.4 ttm -64.71 -51.12 60.48 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.947 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 15' ' ' MET . 58.2 Cg_endo -69.89 -9.43 26.04 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.28 -17.16 20.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.79 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.504 HG12 HG23 ' A' ' 54' ' ' VAL . 73.5 mt -83.53 -48.25 17.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.475 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 59.7 mtt -43.61 -49.33 18.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.051 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 70.9 Cg_exo -40.12 -63.35 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.596 2.197 . . . . 0.0 113.494 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.0 m -72.1 -27.37 62.6 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' HD23 ' A' ' 50' ' ' LEU . . . -52.12 -42.4 63.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.84 0.352 . . . . 0.0 110.663 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.524 179.572 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.595 ' HE3' HD22 ' A' ' 111' ' ' ASN . 39.4 ttp . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.3 t -71.53 -58.34 3.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.594 0.235 . . . . 0.0 111.598 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.68 -13.25 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.839 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.606 ' HG ' ' HZ3' ' A' ' 51' ' ' LYS . 16.3 tp -67.78 -29.59 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.289 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -75.22 11.65 8.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.319 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.74 -71.26 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 111.674 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.541 HD23 ' HA ' ' A' ' 22' ' ' ALA . 3.4 tm? -48.75 -46.96 41.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HZ3' ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.6 -24.9 53.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.232 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.6 63.06 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.324 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.56 -41.4 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.504 HG23 HG12 ' A' ' 18' ' ' ILE . 40.5 t -61.89 -28.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.599 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.7 mtp -63.78 -56.14 17.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.538 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -66.72 -17.81 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.7 tpm_? -68.86 -31.3 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -113.23 31.48 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.602 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 58.94 13.64 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.607 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 tpt -77.98 -8.44 58.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.218 0.532 . . . . 0.0 110.622 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 66' ' ' LEU . 59.1 tp -156.86 103.55 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 76.7 10.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.36 -59.9 3.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.474 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -147.56 7.73 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.599 0.238 . . . . 0.0 111.137 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.6 tp10 -96.72 110.82 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.585 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.564 HD12 HD13 ' A' ' 61' ' ' LEU . 2.6 mm? -73.42 109.99 7.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.66 -167.81 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -169.38 -8.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.566 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.2 mp0 -73.44 -51.46 5.6 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 19.6 Cg_endo -58.46 -38.19 91.23 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.296 1.998 . . . . 0.0 113.011 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.54 ' HA ' ' HE2' ' A' ' 74' ' ' MET . 59.4 t -57.87 -43.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.439 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.473 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 9.1 m-30 -53.02 -32.91 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -74.28 -30.79 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.252 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.54 ' HE2' ' HA ' ' A' ' 71' ' ' VAL . 12.2 mtm -78.63 -46.6 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.404 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 86' ' ' ILE . 64.8 mt -50.77 -27.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 41.4 mt-10 -60.78 -59.17 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.86 -44.86 16.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.551 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 10' ' ' TYR . 55.5 t -49.99 -17.91 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.806 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.645 ' HA ' HG22 ' A' ' 5' ' ' THR . 50.5 m-70 -128.77 53.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.781 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 127.68 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -81.36 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.1 145.05 25.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.95 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.08 32.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.767 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.13 -28.47 35.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.706 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -56.82 -27.22 59.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 75' ' ' ILE . 79.7 mt -80.54 -31.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.988 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -78.16 -19.36 54.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.467 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.8 -59.18 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 92' ' ' ILE . 21.4 t -57.59 -23.59 20.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.94 0.4 . . . . 0.0 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 9.6 tptt -53.95 -48.48 70.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.182 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.2 58.77 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.074 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 89' ' ' VAL . 68.4 mt -60.63 -40.76 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.641 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.17 -26.98 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.685 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.68 -30.22 25.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 9.7 tp10 -57.3 -28.86 63.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 1.5 m -86.65 -45.32 11.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.197 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.7 mt -53.91 -37.91 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.69 0.281 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.77 -31.98 70.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.85 -7.16 19.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.383 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.475 -179.66 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.608 0.242 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 109' ' ' ILE . 23.1 t70 -76.35 119.29 20.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 109' ' ' ILE . 10.0 tp10 -48.96 -58.36 5.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.493 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.7 m -54.06 -24.95 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.4 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.94 -32.2 25.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.372 . . . . 0.0 110.55 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 105' ' ' ASP . 55.3 mt -70.12 -38.85 76.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.556 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 114' ' ' THR . . . -77.86 -51.65 5.77 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.7 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.595 HD22 ' HE3' ' A' ' 44' ' ' MET . 7.4 t-20 -49.93 -32.36 14.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.751 0.275 . . . . 0.0 111.083 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -80.02 -38.65 31.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 110.133 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -70.11 -64.68 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.776 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.49 ' HG1' HG12 ' A' ' 118' ' ' ILE . 14.9 t -49.53 -31.82 11.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.142 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 25.7 t70 -46.79 -71.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.66 -24.27 61.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.89 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.501 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -64.56 -58.59 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.656 0.265 . . . . 0.0 110.753 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.49 HG12 ' HG1' ' A' ' 114' ' ' THR . 46.6 mm -59.79 -16.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.141 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 10.1 tp10 -68.49 -59.67 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.248 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 1.4 mptp? -87.25 -40.96 14.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.683 0.277 . . . . 0.0 111.541 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 6.7 tt -58.6 -46.41 87.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.34 42.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.048 0.451 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.8 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 . . . . . 0 N--CA 1.46 0.05 0 CA-C-O 120.943 0.401 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.99 -44.23 15.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 51.9 p -56.96 -26.76 60.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . 0.407 HG22 ' HE1' ' A' ' 79' ' ' HIS . 62.0 t -89.96 -67.36 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.89 -62.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -22.63 67.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.6 mptm? -90.44 -56.79 3.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.228 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 21.5 m-85 -54.32 -50.25 67.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.99 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.9 tpp -56.08 -40.57 73.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -80.6 -24.7 38.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.039 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.49 ' HH ' ' HA ' ' A' ' 74' ' ' MET . 8.2 t80 -59.79 -29.01 67.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 0.0 111.192 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' HG13 ' A' ' 18' ' ' ILE . 97.4 mt -148.13 39.26 0.91 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.604 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.583 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 34.6 ttm -60.04 -51.17 82.43 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.292 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 23.7 Cg_exo -63.59 -22.84 70.49 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.088 1.859 . . . . 0.0 112.468 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.81 -10.62 53.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.393 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 14' ' ' LEU . 74.2 mt -87.95 -28.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.22 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.464 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 63.5 mtm -46.77 -48.79 49.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.6 Cg_exo -41.74 -56.51 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.61 2.207 . . . . 0.0 113.379 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -85.42 -18.52 33.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 111.144 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 19' ' ' MET . . . -69.75 -10.87 60.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.879 179.564 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.0 tpt . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.7 ' H ' ' HG3' ' A' ' 44' ' ' MET . 22.8 t -78.23 -52.23 8.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -79.94 -23.25 41.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.084 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.544 HD22 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -87.12 -39.1 15.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.06 -10.92 62.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -73.26 -67.45 0.58 Allowed 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 tp -51.7 -33.61 34.98 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 -28.62 61.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.546 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . -74.54 -24.73 58.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.154 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.3 t -60.67 -31.49 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.47 -24.5 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 57.4 mtt -70.32 -58.38 3.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.099 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.96 -19.14 28.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.533 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.4 tpm_? -72.91 -31.12 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.361 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.18 33.95 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.44 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 61.22 10.52 3.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.689 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.486 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -77.09 -6.95 54.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.027 0.442 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.57 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.1 tt -152.62 99.49 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.686 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 7.5 mmpt? -86.27 77.8 9.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.44 -60.44 4.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.0 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 p -153.52 11.85 0.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 13.6 mm-40 -100.21 109.26 21.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.771 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.603 HD23 ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -67.12 147.09 53.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.619 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 27.9 m-85 -136.51 165.63 25.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -140.26 -11.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mp0 -57.31 -53.64 63.26 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.401 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.8 Cg_endo -66.05 -25.21 51.63 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.992 1.795 . . . . 0.0 112.107 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 75' ' ' ILE . 17.6 t -68.86 -43.88 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -55.35 -22.29 18.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.981 0.42 . . . . 0.0 110.524 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -80.67 -48.99 11.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.49 ' HA ' ' HH ' ' A' ' 13' ' ' TYR . 7.1 ptp -68.56 -37.0 79.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.371 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 86' ' ' ILE . 95.0 mt -53.69 -21.94 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.286 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.39 -58.28 3.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.408 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.75 -39.79 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.77 -9.18 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.98 0.419 . . . . 0.0 111.661 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HE1' HG22 ' A' ' 6' ' ' VAL . 84.6 m-70 -130.49 40.86 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.3 122.84 14.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.411 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.11 -65.16 0.34 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.186 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -114.78 151.59 33.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.649 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.57 -20.74 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -84.81 -30.54 24.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 86' ' ' ILE . 4.2 p30 -59.09 -21.12 58.73 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HA ' HG22 ' A' ' 75' ' ' ILE . 68.8 mt -85.67 -30.02 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.119 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.24 -19.84 42.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.118 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.407 ' O ' HG12 ' A' ' 92' ' ' ILE . 64.3 tp -83.11 -63.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.329 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.501 HG11 HD23 ' A' ' 121' ' ' LEU . 46.5 t -52.27 -41.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.517 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 11.1 mttt -53.32 -32.39 48.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.549 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.57 -23.01 41.09 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.533 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 88' ' ' LEU . 39.6 mm -68.69 -37.83 78.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.01 66.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -79.22 -22.41 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.3 -18.9 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 -49.34 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.735 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mt -48.55 -24.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.91 -45.74 73.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.56 -21.31 32.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.603 ' HB1' HD23 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.343 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.664 0.269 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 108' ' ' ASN . 12.7 t70 -108.18 147.41 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.03 -68.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.827 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.403 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 23.3 m -57.74 -41.49 81.95 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.219 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -56.81 -42.88 80.34 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.497 HG12 ' HZ3' ' A' ' 112' ' ' LYS . 1.6 mt -63.06 -31.82 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.499 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.71 -45.13 78.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 7.3 t-20 -72.6 -45.74 57.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.64 ' HD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -56.28 -47.56 78.37 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.64 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -74.16 -42.93 59.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . 0.465 HG23 ' HA ' ' A' ' 111' ' ' ASN . 5.7 t -69.37 -23.41 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.05 -61.48 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.153 0.502 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -40.92 84.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -31.09 65.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.358 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 32.6 mm -83.76 -31.02 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.924 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 38.6 tt0 -68.76 -56.1 9.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.966 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 9.3 mptt -86.62 -48.65 8.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 123' ' ' SER . 45.9 tp -97.81 -14.61 20.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.0 t80 68.45 -13.08 0.32 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 121' ' ' LEU . 46.8 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.874 0.369 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.14 143.19 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.68 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.54 -34.62 64.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 109.91 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.81 -26.96 64.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.997 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -88.9 -23.45 22.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG12 HD13 ' A' ' 121' ' ' LEU . 48.2 t -71.82 -51.41 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.222 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.96 -30.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.24 -31.42 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.419 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -79.53 -55.73 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.297 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.467 ' HH ' HG12 ' A' ' 75' ' ' ILE . 21.6 m-85 -56.21 -28.25 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 111.225 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.8 ttm -81.29 -54.99 5.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.102 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.75 -23.61 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -70.24 -25.31 63.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -147.07 39.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.483 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 34.8 ttm -61.41 -51.86 74.49 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.362 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.6 Cg_endo -70.45 0.17 6.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.915 1.744 . . . . 0.0 111.944 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -112.26 -14.22 13.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.02 -31.61 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.652 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -62.3 -31.99 8.68 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD3' ' HG3' ' A' ' 19' ' ' MET . 15.1 Cg_exo -68.9 -35.49 15.33 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.768 1.645 . . . . 0.0 111.942 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.56 -52.7 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.405 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.42 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -55.39 -34.42 64.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.697 0.284 . . . . 0.0 111.502 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.71 -16.38 51.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.574 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.02 -54.14 49.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.977 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 HD11 HD23 ' A' ' 50' ' ' LEU . 36.2 mt -97.25 -41.57 8.22 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.622 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.589 ' HD1' HG23 ' A' ' 27' ' ' ILE . 23.2 t-80 176.67 -65.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.663 0.744 . . . . 0.0 111.008 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.589 HG23 ' HD1' ' A' ' 26' ' ' HIS . 7.2 pt -134.9 173.04 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.319 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.522 ' HA ' HD12 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -86.06 128.51 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.071 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.54 ' HG3' HD11 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -51.8 -20.17 2.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.335 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.535 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 21.7 t70 -73.76 -65.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.5 mt -70.03 -5.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.4 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -46.97 -35.84 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.435 ' O ' ' HA ' ' A' ' 42' ' ' ALA . 1.6 t -179.0 125.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.45 -82.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.592 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 21.2 pt -140.06 55.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.934 0.397 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -133.19 14.56 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.435 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . . . -85.08 -76.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 37' ' ' ALA . . . 175.93 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.457 ' HE2' HD22 ' A' ' 111' ' ' ASN . 12.9 mptt -48.7 -60.86 2.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.047 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -125.8 -1.94 7.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.827 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.592 ' HA3' ' HA ' ' A' ' 35' ' ' ILE . . . 102.5 -16.49 54.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.711 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . . . -85.73 -51.28 6.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.69 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.672 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 4.4 t70 -177.16 178.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.547 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.561 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 5.8 ttt -154.71 -59.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.634 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 m -65.07 -48.88 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -87.26 -12.73 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.638 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.672 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.1 tt -74.27 -39.89 62.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.415 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.86 4.93 2.06 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.725 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.446 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -135.77 -61.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.545 0.212 . . . . 0.0 111.347 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.54 HD11 ' HG3' ' A' ' 29' ' ' GLU . 3.0 tm? -48.2 -44.37 32.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HD3' HD23 ' A' ' 47' ' ' LEU . 43.2 tttm -84.05 -20.36 32.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.649 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.407 ' HB1' ' HA ' ' A' ' 49' ' ' CYS . . . -74.84 -15.91 60.71 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.121 0.486 . . . . 0.0 110.059 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.63 -33.3 75.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.432 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 t -69.21 -22.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.204 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.5 ' HB3' ' HE2' ' A' ' 60' ' ' MET . 48.8 mtt -75.38 -52.62 10.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.52 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -65.73 -16.42 63.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.592 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.0 tpm_? -70.93 -32.59 69.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 pt -102.37 23.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.228 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 60.95 49.83 5.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.559 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.5 ' HE2' ' HB3' ' A' ' 55' ' ' MET . 5.7 ttp -120.41 -18.33 7.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.446 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 19.1 tp -130.48 108.77 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.815 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.2 mmpt? -104.53 78.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.31 -70.71 2.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.038 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.0 p -137.35 9.7 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.18 103.34 15.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.93 114.62 23.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.452 . . . . 0.0 110.211 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -109.53 -167.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.968 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.477 ' HB ' HD13 ' A' ' 97' ' ' ILE . 10.6 p -163.1 -14.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.672 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 41.8 mt-10 -53.15 -54.37 45.35 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 10.8 Cg_endo -55.29 -29.4 67.26 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.006 1.804 . . . . 0.0 111.829 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 20.8 t -72.65 -39.44 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.352 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -57.48 -22.3 42.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -85.17 -37.11 20.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.105 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 11.9 ptm -80.4 -30.1 37.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.876 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.586 HG22 HG22 ' A' ' 86' ' ' ILE . 96.8 mt -59.39 -22.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 -54.72 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.266 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.01 -45.05 16.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -48.53 -27.19 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.271 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -118.54 54.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.609 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.92 51.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.97 -72.18 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.317 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.6 m120 -110.84 155.3 22.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 110.716 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -81.45 -37.44 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.52 -28.96 41.31 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.137 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -56.25 -31.88 63.96 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.586 HG22 HG22 ' A' ' 75' ' ' ILE . 87.9 mt -78.36 -32.92 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.08 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.412 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 13.2 mm100 -74.99 -19.8 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 tp -76.13 -55.58 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.618 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.521 ' HB ' HG23 ' A' ' 75' ' ' ILE . 38.8 t -55.59 -28.89 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.532 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -58.12 -49.06 78.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.618 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.9 -26.96 69.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.253 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 120' ' ' LYS . 58.3 mt -61.49 -45.09 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.61 69.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.569 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.6 tp10 -65.42 -27.33 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.2 m -80.1 -28.81 38.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.951 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.477 HD13 ' HB ' ' A' ' 68' ' ' VAL . 78.0 mt -77.15 -43.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.87 -14.92 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.51 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.542 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t30 -94.22 -43.78 8.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 101' ' ' LYS . . . -78.07 -19.97 53.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 110.625 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER 33.06 33.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.174 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.49 67.53 2.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -60.23 175.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 111.144 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -84.43 -47.65 10.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.27 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.1 t70 -77.94 139.94 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.935 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.65 -61.73 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.0 m -54.17 -27.69 35.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.472 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.5 t-20 -72.28 -44.05 63.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.65 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.52 -47.27 93.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.025 0.441 . . . . 0.0 110.673 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.33 -41.42 85.68 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.337 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.561 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 2.2 t-20 -58.08 -36.94 73.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.11 0.455 . . . . 0.0 110.824 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.542 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 11.0 mmpt? -78.39 -37.54 43.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.52 -27.18 58.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.552 HG23 HD22 ' A' ' 47' ' ' LEU . 11.1 t -79.71 -46.88 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 110.249 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -46.45 -60.26 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -40.58 70.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.797 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -27.41 67.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.236 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.579 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -84.68 -32.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -69.83 -44.71 69.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.027 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.569 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 71.0 mmtt -87.05 -58.56 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.491 ' O ' HD11 ' A' ' 121' ' ' LEU . 1.3 tm? -97.63 -15.73 20.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.579 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER 73.36 -19.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.592 0.234 . . . . 0.0 111.302 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.475 ' H ' ' C ' ' A' ' 121' ' ' LEU . 36.8 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.818 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . 0.401 ' H41' ' HE1' ' A' ' 55' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 5.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.746 0.308 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.83 133.63 46.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.677 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.81 -24.42 36.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -83.85 -55.89 4.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.195 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.42 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 81.0 p -52.03 -31.52 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.715 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.47 -64.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.822 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.13 -60.67 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.29 -31.18 42.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.97 -59.13 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.113 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -52.56 -23.46 6.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 111.366 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 tpp -80.48 -56.78 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.15 -23.61 67.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.139 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.04 -33.75 72.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.024 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.404 HD13 HG23 ' A' ' 58' ' ' ILE . 65.5 mt -146.9 50.91 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.451 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.2 tmm? -71.45 -50.57 10.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.409 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.451 ' HD2' ' N ' ' A' ' 15' ' ' MET . 73.7 Cg_endo -75.05 -24.7 12.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.232 1.955 . . . . 0.0 112.62 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.39 -9.95 59.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.329 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.13 -27.81 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.361 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 62.3 mtt -53.1 -48.58 91.52 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 33.2 Cg_exo -60.85 -36.13 85.25 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.396 2.064 . . . . 0.0 112.703 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.8 m -54.83 -46.27 74.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.866 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -55.98 -46.53 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.38 -15.88 59.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.13 -52.59 64.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.795 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.55 ' HB2' HD22 ' A' ' 50' ' ' LEU . 68.2 mt -108.82 -40.58 5.0 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 3.9 t60 177.84 -62.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.507 0.67 . . . . 0.0 111.806 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.567 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -150.17 131.04 4.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.034 -176.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.606 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 55.0 p -63.97 161.82 15.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.334 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' HB2' ' HD3' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -57.81 -22.35 47.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.102 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.19 -39.08 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.775 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.2 mt -100.68 -7.24 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.609 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.391 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.8 m -59.22 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.129 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.82 56.61 7.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 mt 58.54 52.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.021 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -146.43 113.58 6.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.365 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.729 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -72.6 -64.98 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.723 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 44' ' ' MET . . . 66.65 -93.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.452 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 8.8 tmtt? -104.03 -62.05 1.36 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.66 14.53 7.01 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.798 0.333 . . . . 0.0 111.561 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.729 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.69 -17.64 30.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.128 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.72 -71.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 110.426 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -177.89 170.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.217 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.42 ' HB2' HD22 ' A' ' 111' ' ' ASN . 5.0 ptt? -130.13 -41.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.575 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -65.39 -51.84 57.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.913 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.535 ' HB3' HD23 ' A' ' 50' ' ' LEU . 4.3 mm100 -87.15 -12.89 45.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HG ' HG23 ' A' ' 114' ' ' THR . 48.8 tp -66.51 -25.73 66.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -88.17 8.26 78.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.388 178.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . 13.6 m -137.01 -71.49 0.44 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.673 -0.263 . . . . 0.0 111.428 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 27' ' ' ILE . 0.4 OUTLIER -48.26 -39.72 22.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HZ3' ' H52' ' A' ' 124' ' ' TSD . 8.4 tptp -84.26 -23.76 30.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.601 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 49' ' ' CYS . . . -70.74 -16.86 62.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.45 -37.9 79.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.914 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 59.0 t -63.22 -30.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.452 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.493 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 54.6 mtt -70.56 -58.5 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -61.1 -19.36 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.56 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -72.44 -29.55 63.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.459 HD11 ' SD ' ' A' ' 60' ' ' MET . 49.3 pt -106.24 13.98 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.64 55.69 1.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.07 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 17.6 ptm -133.3 15.01 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 0.0 110.183 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 HD12 HD13 ' A' ' 66' ' ' LEU . 66.6 tp -164.57 109.77 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.507 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -108.56 77.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.14 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.41 -28.48 0.7 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.224 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.475 ' H ' ' C ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -175.54 -15.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -84.55 110.47 18.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD13 HD12 ' A' ' 61' ' ' LEU . 2.9 mm? -77.27 149.97 35.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 111.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 74.9 m-85 -147.07 136.04 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.9 15.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.841 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.8 mt-10 -67.64 -51.91 28.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 39.6 Cg_endo -70.77 -24.06 25.48 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.039 1.826 . . . . 0.0 112.564 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' O ' HG13 ' A' ' 75' ' ' ILE . 11.0 t -73.32 -50.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.253 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.508 ' HA ' HD12 ' A' ' 75' ' ' ILE . 5.7 m-30 -51.37 -22.16 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.643 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -78.85 -42.36 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -77.76 -36.84 50.21 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 121.338 -0.145 . . . . 0.0 110.875 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 72' ' ' TYR . 72.4 mt -51.45 -21.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.361 0.601 . . . . 0.0 109.918 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HA ' HD13 ' A' ' 86' ' ' ILE . 44.9 mt-10 -63.89 -59.31 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.376 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.4 -41.64 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.904 0.383 . . . . 0.0 110.896 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.1 t -47.54 -26.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.485 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -125.11 55.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.76 55.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.71 -79.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.341 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.08 133.64 44.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 111.013 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.6 66.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.71 -28.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.959 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.74 -29.21 64.59 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.49 HG23 HG22 ' A' ' 75' ' ' ILE . 82.7 mt -76.56 -30.72 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.111 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -81.5 -19.19 42.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.908 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -61.4 -32.48 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.808 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.53 -32.65 58.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.672 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.51 -23.32 43.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.04 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.6 mt -69.14 -30.74 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.411 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -64.39 -23.48 67.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.276 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -79.58 -33.56 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.15 -31.21 72.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 10.8 m -79.4 -21.45 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.411 HG13 ' O ' ' A' ' 93' ' ' ALA . 94.5 mt -76.12 -46.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 111.285 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.61 -30.16 70.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 4.7 t30 -80.51 -51.29 8.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.34 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.74 -20.63 57.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.744 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.539 ' HE3' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -72.62 137.29 46.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.539 ' H ' ' HE3' ' A' ' 101' ' ' LYS . . . 125.51 -0.35 8.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.165 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HB2' HG12 ' A' ' 109' ' ' ILE . 20.8 mm-40 -125.22 -179.37 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.777 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -135.16 -30.89 1.02 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.527 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 14.5 t70 -74.41 136.42 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -50.91 -68.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.92 -33.83 38.88 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.527 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 9.6 m120 -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.543 HG12 ' HB2' ' A' ' 103' ' ' GLU . 78.3 mt -74.01 -32.62 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.502 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.49 -56.44 9.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.976 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.42 HD22 ' HB2' ' A' ' 44' ' ' MET . 3.6 t-20 -48.95 -24.61 1.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.435 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 60.4 mtpt -86.6 -44.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.63 -59.32 4.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.059 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.502 HG22 ' O ' ' A' ' 110' ' ' GLY . 8.9 t -53.44 -46.14 69.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.207 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.584 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 16.6 t70 -42.28 -52.32 4.52 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.98 0.419 . . . . 0.0 111.264 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -44.32 93.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.06 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.285 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.535 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 40.6 mt -83.23 -20.46 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.76 -59.09 4.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.07 -54.9 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.502 ' C ' ' H ' ' A' ' 123' ' ' SER . 33.0 tp -86.32 -10.82 53.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.535 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 19.8 t80 67.21 -9.23 0.4 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 110.783 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 121' ' ' LEU . 60.7 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.801 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . 0.423 ' H52' ' HZ3' ' A' ' 51' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.532 HD11 HD11 ' A' ' 121' ' ' LEU . 49.7 pt . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -81.41 118.66 22.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.21 -17.93 65.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -74.31 -27.0 60.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.3 p -82.66 -20.69 35.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.681 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.37 -63.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.726 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.01 -51.94 60.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.48 -29.64 70.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.483 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.3 mmmt -88.27 -59.35 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.554 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -50.39 -20.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 0.0 111.019 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.7 mmm -85.39 -62.06 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.801 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.42 -51.9 32.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.772 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -52.87 -21.06 3.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.566 HD12 HG11 ' A' ' 54' ' ' VAL . 48.0 mt -133.92 26.03 3.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.596 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.565 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.6 ttp -71.95 -49.41 10.33 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 15' ' ' MET . 29.7 Cg_endo -61.8 -21.97 73.35 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.005 1.803 . . . . 0.0 112.649 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -102.03 -7.35 22.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.237 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.429 HD13 ' HZ1' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -85.09 -44.17 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.006 179.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.609 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 57.6 mtt -47.02 -49.83 48.54 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.52 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.609 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -57.89 -49.35 13.21 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.206 1.937 . . . . 0.0 112.671 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -56.55 -44.35 80.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.561 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -55.44 -47.17 76.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.166 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.09 -15.96 59.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.445 . . . . 0.0 110.332 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.03 -48.28 82.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.437 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.32 -41.56 5.49 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.325 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.528 ' HE2' ' HG2' ' A' ' 46' ' ' GLN . 0.1 OUTLIER 177.46 -59.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.56 0.695 . . . . 0.0 110.73 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.469 ' H ' ' CD2' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -147.72 164.27 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.438 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.605 ' HA ' HD11 ' A' ' 50' ' ' LEU . 59.7 p -85.23 147.66 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.647 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -59.42 -20.73 57.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.736 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.14 -56.71 4.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.329 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.41 ' H ' ' HG ' ' A' ' 28' ' ' SER . 36.0 mm -67.92 -8.34 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.343 0.592 . . . . 0.0 109.807 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.12 62.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.285 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -168.99 101.54 0.38 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.711 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.5 p30 38.69 75.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.928 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.4 mt 55.17 -87.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.041 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.415 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 3.2 tp-100 65.98 151.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.171 0.51 . . . . 0.0 110.55 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.7 -74.09 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.552 ' HB1' ' HG ' ' A' ' 47' ' ' LEU . . . -156.42 -103.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.647 0.26 . . . . 0.0 111.699 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 115' ' ' ASP . 59.0 pttt -68.56 -3.47 11.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.403 ' H ' ' C ' ' A' ' 38' ' ' ALA . 1.1 t-20 -82.33 27.12 0.51 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.758 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 43' ' ' ASP . . . 112.48 -5.24 26.44 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.827 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.415 ' HB1' ' HB3' ' A' ' 36' ' ' GLN . . . -82.96 25.71 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' H ' ' C ' ' A' ' 41' ' ' GLY . 15.8 t70 64.93 77.14 0.32 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.398 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.694 ' HG2' HD21 ' A' ' 111' ' ' ASN . 54.8 ttp -47.65 -37.64 13.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.02 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -49.07 -55.23 12.77 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.635 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -86.9 -12.43 47.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.552 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -64.91 -37.48 87.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.026 0.441 . . . . 0.0 110.045 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 5.04 20.63 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.147 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.406 ' HA ' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -135.34 -70.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 2.3 tm? -45.77 -51.39 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.647 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 1.6 tpmt? -74.4 -24.65 59.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.418 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HB1' ' HA ' ' A' ' 49' ' ' CYS . . . -74.0 -14.12 60.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 3.6 t -64.41 -39.23 93.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.566 HG11 HD12 ' A' ' 14' ' ' LEU . 63.2 t -68.13 -28.86 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.755 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 86.9 mtp -58.86 -41.27 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -79.82 -15.69 56.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.079 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.551 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.8 mmp_? -71.91 -42.6 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.096 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 pt -92.1 24.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.564 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 57.25 30.47 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.421 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.464 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 25.7 ttt -99.95 -0.87 38.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.039 0.447 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.531 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 64.1 tp -157.95 99.87 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.96 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.3 mmpt? -86.9 76.56 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.225 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.3 3.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.54 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -147.12 4.03 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.697 0.284 . . . . 0.0 111.155 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.531 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 37.4 mt-10 -96.63 120.77 37.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.624 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.487 HD22 HD13 ' A' ' 61' ' ' LEU . 36.4 mt -78.91 151.06 31.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.946 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.464 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 60.9 m-85 -143.15 148.57 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.637 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.09 7.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.57 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.454 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mm-40 -73.5 -49.17 6.72 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.79 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.454 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 71.8 Cg_endo -77.26 -23.74 9.99 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.105 1.87 . . . . 0.0 113.137 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.415 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 2.3 p -73.41 -44.91 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.642 0.258 . . . . 0.0 111.192 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.41 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 18.6 m-30 -60.04 -22.32 62.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.81 -44.05 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.882 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.415 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 25.5 ptm -72.47 -43.21 64.03 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.202 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.575 HG22 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -49.2 -23.58 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.408 ' HA ' HD13 ' A' ' 86' ' ' ILE . 30.8 mt-10 -60.38 -59.49 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.414 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.31 -34.88 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.21 0.529 . . . . 0.0 110.951 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.483 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 40.7 t -58.71 -8.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.087 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.563 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 92.6 m-70 -141.04 52.11 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.429 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.69 136.54 53.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.182 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.53 -67.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.158 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.534 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 3.5 m-20 -124.37 142.6 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.55 -28.52 69.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.526 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 5.6 m-20 -83.78 -25.83 30.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.287 . . . . 0.0 110.349 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.534 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.1 t70 -57.97 -30.06 65.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.575 HG23 HG22 ' A' ' 75' ' ' ILE . 79.5 mt -83.95 -26.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.616 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -79.71 -22.01 43.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.497 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 57.2 tp -78.23 -58.5 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.019 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.41 -36.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.41 ' HG2' ' CD1' ' A' ' 72' ' ' TYR . 1.7 mttm -60.66 -34.97 75.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.61 -25.14 54.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.39 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 120' ' ' LYS . 42.3 mm -69.71 -43.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.126 0.488 . . . . 0.0 111.109 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.36 -17.62 59.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.677 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.65 -22.67 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.973 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -82.54 -37.71 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.275 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.435 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 5.8 m -64.05 -27.65 69.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 62.0 mt -74.49 -34.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.608 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.1 p30 -91.42 -17.64 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 111.058 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -134.44 50.85 2.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.265 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.484 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -47.16 -31.39 3.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.68 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.484 ' N ' ' HD2' ' A' ' 101' ' ' LYS . . . 146.04 82.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.542 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.518 ' N ' HG12 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -62.29 -178.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.33 . . . . 0.0 110.983 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t -84.82 -40.98 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.45 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -92.26 123.56 35.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.482 ' HA ' HD11 ' A' ' 109' ' ' ILE . 9.9 tp10 -37.15 -65.58 0.29 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.934 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 96.0 m -46.76 -50.52 18.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.21 -36.14 68.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.518 HG12 ' N ' ' A' ' 103' ' ' GLU . 56.2 mt -67.15 -41.4 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.416 ' O ' HG21 ' A' ' 114' ' ' THR . . . -73.41 -45.37 30.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.147 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.694 HD21 ' HG2' ' A' ' 44' ' ' MET . 17.5 m120 -48.56 -60.78 2.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.883 0.341 . . . . 0.0 111.273 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 14.3 mmtm -54.49 -37.08 64.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.469 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -69.31 -64.07 0.94 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.227 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.449 HG22 HD13 ' A' ' 47' ' ' LEU . 4.1 t -47.3 -56.98 5.76 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.497 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 70.6 m-20 -35.32 -54.54 0.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -51.4 -48.04 62.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.872 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -34.5 65.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.452 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 3.6 mp -81.77 -27.82 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.262 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.49 -47.28 56.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.812 0.339 . . . . 0.0 111.271 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.595 ' HB3' HD12 ' A' ' 92' ' ' ILE . 71.6 mmtt -87.02 -58.33 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.532 HD11 HD11 ' A' ' 1' ' ' ILE . 26.1 tp -96.06 -10.18 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.545 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.74 -24.12 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.434 0.159 . . . . 0.0 110.602 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.505 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.444 HG13 HD12 ' A' ' 121' ' ' LEU . 31.9 mt . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -125.57 141.73 51.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' HG2' ' N ' ' A' ' 4' ' ' ASP . 11.0 pm0 -56.16 -37.24 69.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.406 ' N ' ' HG2' ' A' ' 3' ' ' GLN . 18.1 t70 -65.84 -54.86 21.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 53.5 p -57.36 -35.69 70.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.408 HG12 ' HA ' ' A' ' 123' ' ' SER . 57.6 t -87.22 -64.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.598 HG11 ' HE3' ' A' ' 11' ' ' MET . 41.4 t -58.78 -62.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.76 -25.78 42.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.2 mptm? -88.23 -54.6 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.714 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -57.88 -23.37 52.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.598 ' HE3' HG11 ' A' ' 7' ' ' VAL . 32.4 mtm -82.75 -56.13 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.84 -25.73 68.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.272 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -53.19 -46.26 68.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.263 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' O ' HG13 ' A' ' 18' ' ' ILE . 46.3 mt -152.1 45.11 0.74 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.766 0.317 . . . . 0.0 111.453 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.534 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 ttp -52.39 -50.25 80.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 15' ' ' MET . 33.4 Cg_endo -63.84 -32.33 66.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.051 1.834 . . . . 0.0 112.749 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -84.45 -9.66 58.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 14' ' ' LEU . 39.4 mt -86.37 -29.11 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.324 . . . . 0.0 110.855 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.476 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 25.5 mmt -54.75 -47.27 98.57 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.965 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 19' ' ' MET . 48.8 Cg_exo -37.83 -49.43 2.05 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.939 2.426 . . . . 0.0 113.475 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.9 m -85.01 -35.57 21.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.72 47.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -83.54 -50.47 8.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.67 -54.44 5.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.386 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' HB2' HD12 ' A' ' 50' ' ' LEU . 41.0 mt -86.17 38.72 0.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.4 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -63.09 75.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.338 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 pt -160.97 54.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.093 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.589 ' HA ' HD23 ' A' ' 50' ' ' LEU . 10.9 m -57.68 177.09 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.66 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.413 ' HG2' HD11 ' A' ' 47' ' ' LEU . 7.2 mt-10 -46.61 -21.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.523 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.46 -63.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.575 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 35.1 mm -73.05 -6.59 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB2' ' HB2' ' A' ' 43' ' ' ASP . . . -51.32 -55.15 19.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t 179.76 107.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -83.13 17.0 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.195 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.99 15.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.356 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.92 129.86 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.572 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -83.04 -40.57 19.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.538 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.98 -94.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.694 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -104.02 -62.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -127.13 30.43 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 105.29 -16.33 45.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.923 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.85 -142.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.514 ' HB2' ' HB2' ' A' ' 32' ' ' ALA . 18.3 t70 -108.94 -15.17 14.43 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.047 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.453 ' HG3' ' HB2' ' A' ' 39' ' ' LYS . 22.7 ttt 69.66 -72.14 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -48.03 -40.47 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.411 ' NE2' ' HB2' ' A' ' 49' ' ' CYS . 13.2 tp60 -87.43 -27.93 22.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.457 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 2.9 mp -66.81 -7.5 21.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.05 7.07 73.03 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.187 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.411 ' HB2' ' NE2' ' A' ' 46' ' ' GLN . 36.2 m -131.75 -70.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.227 . . . . 0.0 111.452 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.589 HD23 ' HA ' ' A' ' 28' ' ' SER . 42.7 tp -51.56 -55.07 21.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 1.4 tpmt? -64.68 -23.2 67.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.215 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.406 ' HA ' ' HE1' ' A' ' 55' ' ' MET . . . -79.17 -15.85 57.48 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.581 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.06 -25.45 66.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.081 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.31 -36.87 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.524 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.406 ' HE1' ' HA ' ' A' ' 52' ' ' ALA . 72.6 mtm -68.5 -40.42 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.464 ' HB2' ' HZ3' ' A' ' 56' ' ' LYS . 7.8 mtmp? -73.09 -20.02 61.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.458 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -86.06 -27.49 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.433 HG13 ' HB2' ' A' ' 60' ' ' MET . 48.5 pt -94.75 17.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.1 34.22 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.413 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.433 ' HB2' HG13 ' A' ' 58' ' ' ILE . 26.6 ttt -104.35 1.9 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.166 0.507 . . . . 0.0 110.544 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 66' ' ' LEU . 50.0 tp -153.18 98.79 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.757 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.3 mmpt? -104.67 104.67 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . 48.14 51.61 19.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.356 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 63' ' ' GLY . 8.8 p 73.66 34.55 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.242 0.617 . . . . 0.0 111.479 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.0 106.08 9.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.679 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.44 HD11 HD11 ' A' ' 61' ' ' LEU . 3.2 mm? -68.45 147.27 52.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.378 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.97 169.31 13.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.35 . . . . 0.0 111.223 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.06 -25.69 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.358 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.563 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 48.1 mt-10 -62.37 -47.96 88.18 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.115 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 36.9 Cg_endo -65.07 -42.46 13.95 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.275 1.983 . . . . 0.0 113.445 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG13 ' HD1' ' A' ' 72' ' ' TYR . 3.1 p -65.23 -46.51 90.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.592 0.234 . . . . 0.0 111.395 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' HD1' HG13 ' A' ' 71' ' ' VAL . 4.6 m-30 -59.29 -22.0 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.278 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.453 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 21.8 tptm -84.62 -45.56 12.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.2 ptp -70.84 -42.66 69.88 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.461 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.57 HG21 HG22 ' A' ' 86' ' ' ILE . 95.5 mt -48.73 -27.81 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.739 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 36.9 mt-10 -59.64 -59.22 5.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.716 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.5 -39.72 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.083 0.468 . . . . 0.0 110.811 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.77 -9.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.362 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 93.5 m-70 -143.47 56.75 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.9 137.54 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.11 -53.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.43 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -128.05 154.66 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.81 -29.4 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.351 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.532 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 4.1 p30 -83.52 -29.34 27.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.76 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -28.56 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.57 HG22 HG21 ' A' ' 75' ' ' ILE . 88.9 mt -83.33 -29.06 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.237 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.78 -22.4 53.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.357 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.425 ' O ' HG12 ' A' ' 92' ' ' ILE . 69.6 tp -75.94 -60.12 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.768 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.481 HG13 HD21 ' A' ' 121' ' ' LEU . 35.0 t -55.23 -35.97 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.93 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -33.96 60.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.25 -28.75 24.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.483 HG21 ' HB2' ' A' ' 120' ' ' LYS . 31.3 mm -65.39 -36.29 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.0 64.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -74.21 -40.99 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.611 ' HG2' ' HE2' ' A' ' 120' ' ' LYS . 8.2 tp10 -62.57 -18.14 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.529 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 57.9 m -86.18 -53.89 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.747 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.6 mt -51.07 -30.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 111.295 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.52 -51.94 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.804 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.529 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.5 p30 -81.74 -5.93 58.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.647 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.43 39.72 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.493 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -41.91 -34.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.843 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.488 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 150.85 73.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.403 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.484 ' HB2' HG13 ' A' ' 109' ' ' ILE . 7.9 mm-40 -61.73 150.14 37.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -74.25 -24.51 59.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.695 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -99.96 144.95 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.01 -70.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.0 m -50.02 -24.15 2.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.684 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -70.09 -58.18 4.1 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.706 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.484 HG13 ' HB2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -52.44 -41.66 36.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.87 -36.0 85.88 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.58 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.513 ' HA ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -68.62 -40.49 80.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.989 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -61.7 -27.15 68.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -59.32 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.001 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.513 HG22 ' HA ' ' A' ' 111' ' ' ASN . 8.7 t -46.76 -45.14 19.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.814 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -48.12 -61.72 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -49.27 73.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -36.91 42.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.4 mm -79.49 -28.66 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 110.93 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.426 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 37.9 tt0 -69.53 -53.13 20.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.611 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 11.3 mptt -85.13 -55.94 3.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 123' ' ' SER . 39.0 tp -95.56 -11.32 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.538 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER 69.14 -16.93 0.22 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.548 ' H ' ' C ' ' A' ' 121' ' ' LEU . 37.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . 0.446 ' D31' ' HD3' ' A' ' 51' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.24 129.12 34.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -78.87 -16.89 56.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.681 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -73.13 -26.7 61.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 69.4 p -81.54 -20.87 39.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 109.716 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.505 HG13 ' HB3' ' A' ' 123' ' ' SER . 87.0 t -82.38 -63.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.813 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.566 HG12 ' HE2' ' A' ' 11' ' ' MET . 24.4 t -65.13 -52.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -61.39 -27.98 68.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.05 -55.88 3.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.783 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -54.05 -24.24 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.566 ' HE2' HG12 ' A' ' 7' ' ' VAL . 32.4 mtm -79.23 -62.03 1.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.216 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.64 -23.62 67.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.792 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.472 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 5.2 t80 -56.56 -35.89 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.425 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.497 ' O ' HG13 ' A' ' 18' ' ' ILE . 41.4 mt -151.59 28.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.589 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 36.3 ttp -47.41 -50.44 49.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 21.5 Cg_exo -65.84 -30.7 49.12 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.213 1.942 . . . . 0.0 112.351 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.37 -7.55 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.425 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 14' ' ' LEU . 93.3 mt -83.95 -25.78 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.635 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.502 ' HA ' ' HE3' ' A' ' 19' ' ' MET . 32.4 mmt -49.11 -50.06 65.65 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.192 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.487 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 96.0 Cg_exo -41.93 -53.92 3.19 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.614 2.209 . . . . 0.0 113.251 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.0 m -82.29 -20.98 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.897 0.38 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -74.86 -2.73 28.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -83.65 -57.22 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.769 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -83.65 -47.86 10.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HB2' HD23 ' A' ' 50' ' ' LEU . 49.6 mt -90.65 39.09 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.443 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 26.8 p-80 -63.88 68.17 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.487 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.484 ' O ' ' HB1' ' A' ' 32' ' ' ALA . 1.3 pp -156.3 56.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -50.22 160.1 0.4 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.548 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -40.84 -32.46 0.23 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.59 -50.55 73.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.552 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 52.0 mt -94.28 -8.65 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.315 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' HB1' ' O ' ' A' ' 27' ' ' ILE . . . -76.64 -1.6 28.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.099 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 81.3 p -67.44 4.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' GLN . 42.9 t30 -59.56 138.38 57.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.598 0.237 . . . . 0.0 110.514 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -51.77 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.446 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' ASN . 55.0 mt-30 -122.97 -98.54 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.461 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 43' ' ' ASP . . . -85.45 -31.8 22.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 111.659 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 63.55 25.66 14.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.897 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 44' ' ' MET . 46.7 tptt -46.07 -59.95 2.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.47 24.01 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.26 57.82 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.191 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' HA ' ' HA ' ' A' ' 33' ' ' THR . . . -88.43 -81.87 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.688 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 10.9 t70 -178.14 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.458 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.701 ' H ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER 71.62 -34.26 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.34 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.441 ' H ' ' C ' ' A' ' 43' ' ' ASP . 64.3 m -52.41 -51.52 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 14.9 mm-40 -87.66 -28.5 21.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.766 -179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.701 HD12 ' H ' ' A' ' 44' ' ' MET . 6.5 mp -64.13 -21.85 66.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.77 -8.18 63.21 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.296 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -137.31 -62.47 0.62 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.577 HD23 ' HB2' ' A' ' 25' ' ' LEU . 1.9 tm? -48.42 -41.81 30.3 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 26.2 ttpp -82.3 -23.93 34.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' HB2' ' HA ' ' A' ' 49' ' ' CYS . . . -79.66 -6.62 57.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.273 0.558 . . . . 0.0 109.753 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.1 t -64.58 -28.19 69.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.722 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.405 HG12 HD12 ' A' ' 14' ' ' LEU . 59.0 t -70.17 -26.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.933 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.25 -56.63 7.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 46.1 mtmt -55.12 -26.7 40.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.505 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -72.1 -33.51 67.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.43 HG21 HD13 ' A' ' 14' ' ' LEU . 42.7 pt -100.2 22.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.477 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 58.26 29.29 17.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.416 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -97.43 -10.04 26.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.75 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 5.6 tt -149.15 114.66 5.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.415 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -107.82 77.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.58 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 -74.1 1.75 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -126.77 -1.57 6.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.503 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -91.0 156.16 18.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.605 HD23 HG13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -135.55 131.19 35.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.515 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.434 ' N ' HD12 ' A' ' 66' ' ' LEU . 31.3 m-85 -118.84 170.83 8.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 71' ' ' VAL . 31.4 m -137.72 -3.67 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 42.6 mt-10 -67.54 -49.51 40.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.1 Cg_endo -65.47 -28.23 53.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.101 1.867 . . . . 0.0 113.107 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -72.02 -41.63 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 111.083 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.6 m-30 -56.6 -22.06 31.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.263 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.82 -40.49 22.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.791 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.435 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 14.4 ptm -77.44 -38.44 49.47 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.101 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 71' ' ' VAL . 94.1 mt -50.97 -23.57 2.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.041 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -60.59 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.912 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.095 0.474 . . . . 0.0 110.983 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.482 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 34.0 t -64.14 -7.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -144.58 50.76 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.58 134.83 55.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.52 -68.51 0.48 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.559 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.06 147.53 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.36 -21.47 53.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.408 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.54 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 7.5 m-20 -84.14 -27.17 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.956 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.22 -27.22 63.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.44 HG21 HG21 ' A' ' 75' ' ' ILE . 83.5 mt -85.93 -26.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.475 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.54 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -81.26 -21.41 39.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.819 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 92' ' ' ILE . 42.6 tp -81.33 -57.78 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.426 HG22 HD12 ' A' ' 121' ' ' LEU . 87.5 t -54.27 -36.22 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -62.66 -31.42 72.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.975 179.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.26 47.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.221 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 88' ' ' LEU . 74.3 mt -73.06 -40.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.684 0.278 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.89 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.55 -26.07 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.487 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.7 tp10 -77.97 -19.64 54.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.043 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -86.28 -43.4 12.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.501 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.605 HG13 HD23 ' A' ' 66' ' ' LEU . 2.0 mp -58.89 -41.67 83.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.678 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.31 -14.46 61.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.7 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.538 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 6.4 t30 -98.66 -75.21 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.24 70.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.111 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? 67.64 -73.51 0.08 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.645 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 159.5 74.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.497 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.48 ' N ' HG12 ' A' ' 109' ' ' ILE . 11.4 mm-40 -61.3 -178.37 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.342 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t -84.61 -43.23 14.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.469 ' O ' HG13 ' A' ' 109' ' ' ILE . 24.0 t70 -87.93 122.84 32.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.55 0.214 . . . . 0.0 110.763 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.434 ' HA ' HD13 ' A' ' 109' ' ' ILE . 36.6 tt0 -42.07 -66.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.128 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.94 -36.13 16.62 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -67.46 -42.54 82.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG12 ' N ' ' A' ' 103' ' ' GLU . 50.6 mt -58.75 -50.75 78.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.491 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.445 ' O ' HG22 ' A' ' 114' ' ' THR . . . -64.82 -36.85 93.59 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.719 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -48.36 -38.36 19.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.011 0.405 . . . . 0.0 111.372 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.538 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 3.3 mptp? -86.43 -24.15 25.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.03 -64.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.445 HG22 ' O ' ' A' ' 110' ' ' GLY . 5.2 t -54.06 -28.51 39.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -53.36 -70.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.337 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -34.53 62.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.572 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -33.97 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 0.0 110.562 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.624 HD13 ' HE3' ' A' ' 44' ' ' MET . 75.1 mt -85.08 -17.14 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 110.271 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.21 -58.66 3.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.464 ' HD2' ' N ' ' A' ' 120' ' ' LYS . 2.8 mptp? -87.36 -49.15 7.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.542 ' C ' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -91.0 -12.02 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.064 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.595 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 71.54 -23.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -179.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.542 ' H ' ' C ' ' A' ' 121' ' ' LEU . 64.0 p . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.5 pt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.83 134.08 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.58 -24.85 67.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.94 -52.93 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.053 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.0 p -51.21 -29.98 15.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.128 0.49 . . . . 0.0 110.97 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 53.7 t -77.48 -63.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.589 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.05 -59.46 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.79 -35.91 15.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.411 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 31.1 mmmt -88.74 -59.42 2.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 13.7 m-85 -49.86 -29.1 7.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.31 . . . . 0.0 111.551 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.6 tpp -71.98 -55.46 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.69 -46.49 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.452 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 2.5 t80 -45.34 -39.87 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.352 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.447 ' HG ' ' HD1' ' A' ' 13' ' ' TYR . 26.3 mt -145.3 63.53 1.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.447 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.479 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 57.2 ttp -83.9 -52.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.599 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.479 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 71.6 Cg_endo -77.41 -27.31 6.52 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.968 1.779 . . . . 0.0 111.721 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 9.6 m-20 -72.38 -10.87 60.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.576 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 14' ' ' LEU . 2.8 mt -77.29 -39.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.594 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 17.0 mmt -48.54 -51.66 50.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.935 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 74.2 Cg_exo -49.57 -51.5 10.62 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.265 1.977 . . . . 0.0 112.746 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.44 -43.23 83.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.499 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.595 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -60.18 -44.08 95.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.77 -15.96 61.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.68 -54.37 47.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.7 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.518 HD13 HD23 ' A' ' 50' ' ' LEU . 10.8 mt -102.36 -41.07 6.46 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.166 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.0 t60 176.71 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 110.391 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.96 163.48 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.573 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.573 ' HA ' HD12 ' A' ' 50' ' ' LEU . 91.8 p -85.25 148.17 26.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.598 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -54.52 -22.7 13.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.242 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.55 -52.39 18.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.39 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.0 mt -79.75 -8.52 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.251 0.548 . . . . 0.0 110.067 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.33 6.01 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.46 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -60.04 -9.04 2.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.694 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.07 2.12 6.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 87.9 mt -118.91 -46.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 60.01 99.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.722 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . . . -85.38 -76.38 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 37' ' ' ALA . . . 170.4 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.293 0.371 . . . . 0.0 111.962 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.632 ' HB2' ' HB2' ' A' ' 44' ' ' MET . 2.0 tmtt? -59.63 -63.18 1.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.112 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.442 ' HB3' HG22 ' A' ' 118' ' ' ILE . 6.9 p30 -127.78 -4.14 5.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.45 43.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.922 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' HB2' ' O ' ' A' ' 29' ' ' GLU . . . -85.4 -79.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.568 0.223 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 62.7 t0 176.18 83.54 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.632 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 49.9 ttp -51.3 -39.54 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.376 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -51.98 -57.07 10.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.278 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -85.05 -12.33 53.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.483 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 16.5 tp -62.73 -39.74 95.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.084 0.468 . . . . 0.0 110.139 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.473 ' HA2' ' HA3' ' A' ' 110' ' ' GLY . . . -69.87 4.7 7.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.478 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 107' ' ' CYS . 1.8 m -131.48 -72.54 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.703 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.595 HD22 ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm? -47.32 -54.05 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.36 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.598 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 16.8 tptp -71.97 -23.5 61.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.596 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.12 -18.63 61.88 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.036 0.446 . . . . 0.0 110.092 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.92 -36.13 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.222 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.415 HG11 HD13 ' A' ' 14' ' ' LEU . 67.0 t -59.58 -27.53 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.2 mtt -65.65 -51.84 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.575 179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -66.09 -15.94 63.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.209 -179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.42 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 5.6 tpm_? -69.33 -45.81 68.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.403 HG13 ' HB2' ' A' ' 60' ' ' MET . 36.8 pt -91.55 29.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.442 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 55.33 29.94 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.425 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 ttt -94.34 -17.73 22.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.48 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 60.4 tp -144.13 101.94 3.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 5.9 mmpt? -84.16 77.45 9.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.945 0.402 . . . . 0.0 110.124 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.42 -57.09 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.2 p -153.52 9.32 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.48 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 28.7 mm-40 -94.5 108.18 20.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.51 HD12 HG12 ' A' ' 109' ' ' ILE . 7.6 mp -67.66 138.22 56.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 60' ' ' MET . 62.5 m-85 -139.31 159.75 41.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.26 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.444 HG11 ' HH ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -138.22 -10.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.363 -179.359 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.5 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.1 mt-10 -56.85 -50.27 89.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.8 -14.13 35.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.001 1.801 . . . . 0.0 112.001 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.5 t -78.76 -47.44 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.045 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.468 ' HB3' ' HZ3' ' A' ' 90' ' ' LYS . 13.8 m-85 -63.3 -27.35 69.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -76.56 -30.08 56.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.256 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.5 ptm -85.73 -43.94 12.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.35 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.53 HG22 HG21 ' A' ' 86' ' ' ILE . 93.7 mt -51.62 -33.84 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 110.549 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -53.8 -57.49 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.97 -24.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 111.171 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.411 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 6.3 t -67.61 -11.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.944 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.542 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 90.5 m-70 -134.05 49.96 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.467 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.23 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.55 -70.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.16 148.35 31.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.913 0.387 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.09 -35.84 36.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.719 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 -30.85 51.32 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.955 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -21.78 6.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.53 HG21 HG22 ' A' ' 75' ' ' ILE . 63.5 mt -85.93 -55.03 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.5 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.409 ' HA ' ' HG3' ' A' ' 90' ' ' LYS . 9.1 mm100 -52.81 -25.68 12.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.732 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.458 ' O ' HG12 ' A' ' 92' ' ' ILE . 63.8 tp -71.66 -46.55 58.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.588 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.44 HG12 HD21 ' A' ' 121' ' ' LEU . 43.0 t -69.15 -41.71 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.317 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.501 ' HD3' HG22 ' A' ' 86' ' ' ILE . 9.2 mtmt -55.11 -27.12 42.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.28 -24.52 36.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.356 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 88' ' ' LEU . 47.2 mm -61.87 -40.16 86.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.725 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -59.88 -30.1 68.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.72 -23.53 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.04 -38.65 31.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.411 ' HA ' ' OD1' ' A' ' 99' ' ' ASN . 72.9 m -74.13 -36.36 64.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.653 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 93' ' ' ALA . 93.4 mt -56.46 -27.35 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -52.35 7.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.196 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' C ' HD21 ' A' ' 99' ' ' ASN . 0.4 OUTLIER -70.78 -17.13 62.79 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.433 ' N ' HD21 ' A' ' 99' ' ' ASN . . . -81.58 -49.15 10.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.635 0.255 . . . . 0.0 111.272 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 61.13 -177.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.85 44.5 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.307 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.79 125.6 24.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -72.98 -26.58 61.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.503 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -72.87 134.73 44.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.35 -61.6 2.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.726 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 54.0 m -60.59 -10.3 4.99 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 42.1 t-20 -86.66 -53.61 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 110.243 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.51 HG12 HD12 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -51.31 -34.81 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.473 ' HA3' ' HA2' ' A' ' 48' ' ' GLY . . . -85.93 -51.47 3.58 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.891 -0.671 . . . . 0.0 114.296 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 2.3 t-20 -52.96 -23.86 8.16 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.7 0.75 . . . . 0.0 110.446 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -87.49 -40.82 13.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.923 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.15 -64.96 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.843 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 p -46.21 -45.57 17.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.988 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 14.7 t70 -43.9 -72.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.823 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.18 -32.32 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.822 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.438 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -56.18 -38.46 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 110.532 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.8 mt -83.45 -19.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 110.275 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.505 ' HB2' ' HZ3' ' A' ' 39' ' ' LYS . 10.3 tp10 -71.24 -60.11 2.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.153 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.43 ' HB3' HD11 ' A' ' 92' ' ' ILE . 67.2 mttm -87.17 -50.77 6.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.499 ' C ' ' H ' ' A' ' 123' ' ' SER . 57.0 tp -85.35 -11.87 53.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 6.3 t80 66.72 -6.03 0.58 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 0.0 110.504 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 121' ' ' LEU . 68.1 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.836 0.35 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.78 137.54 39.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -66.14 -7.94 20.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.6 -43.98 87.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.552 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.579 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 5.6 t -52.54 -25.48 10.56 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.8 t -87.67 -64.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.449 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.72 -61.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.03 -28.27 23.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.4 mmtm -88.62 -59.6 2.19 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.53 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -51.14 -21.29 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.8 mtt -83.31 -61.59 1.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.306 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -52.56 64.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 4.8 t80 -43.9 -33.82 1.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.447 ' HG ' ' HD1' ' A' ' 13' ' ' TYR . 90.9 mt -146.64 59.75 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.431 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 37.9 tpp -89.15 -51.28 0.37 Allowed Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.7 Cg_endo -72.69 -12.46 26.68 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.991 1.794 . . . . 0.0 111.685 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.01 -9.86 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.884 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 8.3 mt -89.21 -47.35 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.707 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.473 ' CG ' ' HD3' ' A' ' 20' ' ' PRO . 19.3 ptp -53.84 -34.05 18.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.473 ' HD3' ' CG ' ' A' ' 19' ' ' MET . 52.2 Cg_exo -54.48 -52.55 7.92 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.419 1.413 . . . . 0.0 112.978 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.463 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 11.3 m -72.84 -22.88 60.72 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.491 ' HA ' HD23 ' A' ' 50' ' ' LEU . . . -53.92 -42.17 68.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.646 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -83.95 -16.18 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.332 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 33.2 tt0 -61.5 -54.37 44.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.956 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 19.1 mt -90.23 -41.42 11.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 3.9 t60 176.5 -62.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.77 0.795 . . . . 0.0 110.658 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 1.2 pt -146.45 164.35 8.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.793 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.46 148.59 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.594 ' HB2' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.757 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.12 -53.38 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.481 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 36.5 mt -88.7 -6.7 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.211 179.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.498 ' HB1' ' HA ' ' A' ' 29' ' ' GLU . . . -72.36 -1.05 14.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 4.0 t -49.07 -51.62 30.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.583 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 42.46 42.16 2.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.286 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 mm 55.8 52.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -147.62 123.28 10.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.354 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.731 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -79.28 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.618 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 44' ' ' MET . . . 64.45 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.618 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -103.75 -61.39 1.43 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.446 HD21 ' H ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -127.06 4.32 6.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.852 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.731 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.49 -4.23 31.1 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.717 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.594 ' HB3' ' HB2' ' A' ' 29' ' ' GLU . . . -85.2 -69.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.592 0.234 . . . . 0.0 111.529 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 44' ' ' MET . 23.4 t70 -176.16 -30.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.577 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 10.2 ttt 74.59 -65.78 0.33 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.175 0.297 . . . . 0.0 111.047 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.7 p -59.05 -43.54 91.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.27 . . . . 0.0 110.703 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.441 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -87.81 -30.25 20.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.579 HD11 ' HB3' ' A' ' 51' ' ' LYS . 1.5 tm? -54.29 -44.9 72.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 110.054 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 6.49 1.59 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.807 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.456 ' H ' ' C ' ' A' ' 47' ' ' LEU . 3.6 m -134.3 -72.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 22' ' ' ALA . 1.2 tm? -46.56 -51.49 15.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.522 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.587 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 27.4 tptp -75.37 -22.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.37 -20.13 62.98 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.41 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.5 t -60.99 -34.23 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.5 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.86 -26.88 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.7 mtm -69.06 -51.98 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.826 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.437 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 30.7 pttt -75.82 -15.75 60.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.408 ' HA ' ' NE ' ' A' ' 57' ' ' ARG . 2.5 tpm_? -70.45 -30.15 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.751 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.9 pt -105.86 26.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.488 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 57.93 63.11 1.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -139.65 -10.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.53 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.537 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 30.0 tp -134.84 99.48 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.529 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -94.16 76.61 4.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.188 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.26 -58.73 3.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.285 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.9 p -148.25 4.26 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.714 0.292 . . . . 0.0 110.994 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt-10 -94.16 131.26 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.1 mt -113.74 113.83 25.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.139 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -106.15 177.85 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.61 25.49 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.541 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.439 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.7 mt-10 -79.19 -50.21 1.39 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.625 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 60.0 Cg_endo -74.44 -38.45 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.148 1.898 . . . . 0.0 113.067 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.429 ' HA ' ' HE1' ' A' ' 74' ' ' MET . 11.8 t -63.59 -46.1 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.633 0.254 . . . . 0.0 111.13 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -60.88 -21.81 63.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.371 . . . . 0.0 110.62 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -82.12 -48.01 11.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.743 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.429 ' HE1' ' HA ' ' A' ' 71' ' ' VAL . 14.7 ptt? -74.61 -35.43 62.94 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.91 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.667 HG23 HG22 ' A' ' 86' ' ' ILE . 9.6 mt -49.68 -26.15 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.076 0.465 . . . . 0.0 110.418 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -59.05 5.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.497 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.68 -24.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.198 0.523 . . . . 0.0 111.146 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 25.1 t -67.27 -7.39 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.458 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 88.9 m-70 -138.05 43.28 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.56 134.65 57.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.86 -60.92 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.408 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.634 ' HB3' ' HB2' ' A' ' 85' ' ' ASP . 30.3 t30 -116.87 132.16 56.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 110.514 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.87 67.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 -22.3 30.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 13.8 t70 -62.04 -24.18 66.92 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.667 HG22 HG23 ' A' ' 75' ' ' ILE . 93.3 mt -85.13 -29.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.661 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -81.48 -21.98 38.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.578 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.97 -60.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.24 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.538 HG11 HD13 ' A' ' 121' ' ' LEU . 24.3 m -54.93 -31.5 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -58.02 -41.95 84.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.648 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.7 -18.88 72.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.802 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.473 HD12 ' HA ' ' A' ' 89' ' ' VAL . 50.9 mt -67.54 -41.03 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.728 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.96 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.283 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.3 -48.81 39.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.259 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.9 -21.21 57.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.445 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 29.3 m -86.24 -39.39 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.696 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.502 HG23 ' HB2' ' A' ' 66' ' ' LEU . 93.2 mt -69.74 -42.04 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.808 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.98 -19.97 64.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.905 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.445 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 0.8 OUTLIER -109.33 -8.43 15.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.4 12.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HG2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -73.59 -177.64 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.975 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.572 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 75.89 -26.46 1.43 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.91 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.575 ' HB2' HG12 ' A' ' 109' ' ' ILE . 14.5 mm-40 -64.62 176.03 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.702 0.287 . . . . 0.0 110.72 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.1 p -123.77 -20.28 5.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.507 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.426 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -102.4 139.99 37.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.54 -65.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.415 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 64.9 m -50.34 -31.1 13.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -68.66 -40.36 80.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 103' ' ' GLU . 85.9 mt -69.41 -47.29 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.866 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -62.08 -52.3 50.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.909 -179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.577 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.0 t-20 -54.56 -39.47 67.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.078 0.439 . . . . 0.0 110.319 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -69.23 -25.65 64.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -83.72 -61.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.449 HG22 HD12 ' A' ' 47' ' ' LEU . 7.7 t -47.36 -47.93 25.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.375 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -44.93 -61.55 1.57 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.57 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -48.03 73.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -25.68 54.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.489 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.9 mm -85.12 -32.15 7.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.963 0.411 . . . . 0.0 111.171 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.23 -45.22 57.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.857 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt -86.64 -56.53 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.557 ' C ' ' H ' ' A' ' 123' ' ' SER . 28.9 tp -98.93 -11.84 21.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.534 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.0 OUTLIER 69.05 -16.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 110.862 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -99.08 104.46 16.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -58.74 -39.33 80.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.14 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -53.42 -50.5 65.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.416 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 40.3 p -64.91 -20.67 66.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.28 -63.18 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.09 -57.13 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.498 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.55 64.94 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.553 ' HB3' HG23 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.43 -59.29 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.959 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -51.49 -22.98 3.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 110.851 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.2 ttp -85.52 -62.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.346 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.6 -31.31 67.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.076 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -55.92 -45.22 78.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.437 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -141.03 40.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.56 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.486 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttp -58.34 -51.81 79.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.47 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 15' ' ' MET . 57.9 Cg_endo -70.83 -13.47 31.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.007 1.805 . . . . 0.0 112.218 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -101.96 -6.95 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.41 -43.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.509 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 84.8 mmm -53.02 -48.73 90.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 76.4 Cg_exo -43.79 -51.38 6.37 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.719 2.28 . . . . 0.0 113.149 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.3 -31.91 67.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.771 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.67 71.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.2 -15.97 59.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -60.7 -38.86 86.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.819 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -117.88 -39.58 3.09 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.417 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.579 ' HE2' ' HG3' ' A' ' 46' ' ' GLN . 0.1 OUTLIER 178.9 -58.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.205 0.526 . . . . 0.0 112.094 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.438 ' H ' ' HD2' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -143.56 178.37 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.295 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.459 ' C ' HD22 ' A' ' 50' ' ' LEU . 10.9 m -86.24 171.28 11.39 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.003 0.43 . . . . 0.0 110.851 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.1 tm-20 -68.67 -21.82 64.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.221 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.29 -47.08 9.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.223 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 18.1 mt -70.38 -7.0 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.608 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.65 -49.71 56.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 36' ' ' GLN . 8.2 m -152.57 -11.92 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.279 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 64.46 63.24 0.76 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 11.0 mt 52.83 46.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.832 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.533 ' HB2' HG22 ' A' ' 33' ' ' THR . 46.4 mt-30 -146.96 12.92 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.26 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.614 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -85.42 -72.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.46 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.45 -75.46 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.577 ' HZ3' ' HB ' ' A' ' 118' ' ' ILE . 12.8 ptmm? -89.68 -58.22 2.6 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.531 HD21 ' HZ1' ' A' ' 39' ' ' LYS . 8.8 p30 -122.19 -3.74 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.761 0.315 . . . . 0.0 111.248 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.614 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 102.73 0.63 49.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.199 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 44' ' ' MET . . . -85.32 -3.3 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 45' ' ' SER . 15.0 t70 70.94 -14.39 0.45 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.491 ' H ' ' C ' ' A' ' 42' ' ' ALA . 46.3 ttm 71.22 -27.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 43' ' ' ASP . 47.5 t -64.6 -57.43 9.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.498 0.189 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.579 ' HG3' ' HE2' ' A' ' 26' ' ' HIS . 0.9 OUTLIER -86.9 -12.14 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 0.0 110.776 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.408 ' C ' ' H ' ' A' ' 49' ' ' CYS . 55.4 tp -57.2 -41.99 80.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.909 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.411 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -74.54 13.61 4.88 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.504 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.538 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 5.1 m -147.3 -70.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 111.737 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 28' ' ' SER . 12.2 tp -44.35 -55.91 4.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.398 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.547 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 84.6 tttt -79.16 -22.18 45.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.41 ' HB2' ' HA ' ' A' ' 49' ' ' CYS . . . -76.15 -7.8 55.61 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.026 0.441 . . . . 0.0 110.626 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.0 t -72.15 -36.09 69.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.83 -22.22 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.0 mtt -69.84 -46.48 65.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.505 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 49.5 mttm -60.2 -18.8 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.432 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 4.4 tpm_? -67.59 -45.31 75.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.381 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.04 34.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.29 13.55 3.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.754 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.4 tpt -71.9 -14.3 61.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 31.9 tp -155.18 103.71 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -95.3 80.87 3.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 -70.56 1.61 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.893 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.7 p -145.54 27.19 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.21 110.53 21.08 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.413 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.583 HD22 HG23 ' A' ' 109' ' ' ILE . 86.0 mt -73.63 131.94 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.707 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -119.81 172.15 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.476 HG12 HD12 ' A' ' 97' ' ' ILE . 11.2 m -149.26 -17.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.547 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.3 mt-10 -58.61 -51.14 83.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.82 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 21.9 Cg_endo -61.21 -32.67 90.83 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.216 1.944 . . . . 0.0 112.625 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.462 HG12 HD13 ' A' ' 75' ' ' ILE . 46.2 t -72.94 -48.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.179 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -54.09 -24.71 18.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -86.0 -36.76 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.419 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 20.0 ptm -75.75 -39.57 56.96 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.508 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.534 HG22 HG22 ' A' ' 86' ' ' ILE . 90.3 mt -50.48 -23.64 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.053 0.454 . . . . 0.0 110.189 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' HD11 ' A' ' 86' ' ' ILE . 43.9 mt-10 -59.01 -58.82 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.464 HG11 ' HD2' ' A' ' 9' ' ' LYS . 21.2 t -88.05 -24.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.151 0.5 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.553 HG23 ' HB3' ' A' ' 9' ' ' LYS . 41.8 t -66.26 -8.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.941 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.432 ' NE2' HG22 ' A' ' 89' ' ' VAL . 92.0 m-70 -143.37 49.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.613 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.58 127.32 30.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -73.53 0.34 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.4 m-20 -104.6 136.69 43.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.688 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.5 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.613 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.07 -24.89 30.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.758 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.554 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.0 t70 -59.58 -26.56 65.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.534 HG22 HG22 ' A' ' 75' ' ' ILE . 81.1 mt -84.34 -27.73 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.475 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.83 -19.76 43.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.617 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.8 tp -78.25 -55.06 5.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.548 HG12 ' HG ' ' A' ' 121' ' ' LEU . 26.4 t -55.94 -36.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.572 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -61.83 -30.04 70.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.722 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.19 51.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.261 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.595 HG13 HD23 ' A' ' 121' ' ' LEU . 47.9 mm -74.38 -39.91 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 0.0 110.893 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -58.34 -23.72 57.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -75.48 -37.48 60.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' HG3' ' HZ1' ' A' ' 120' ' ' LYS . 2.7 tm-20 -56.64 -28.45 60.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.466 179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.531 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 59.8 m -80.68 -27.68 37.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.476 HD12 HG12 ' A' ' 68' ' ' VAL . 39.6 mt -74.15 -21.8 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.933 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.0 -29.44 55.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.531 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 3.9 p30 -97.51 -40.74 8.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.191 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.78 -46.09 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt 59.88 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.709 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 179.68 63.84 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.948 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.466 ' HB2' HG13 ' A' ' 109' ' ' ILE . 6.8 mm-40 -60.45 166.25 3.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.175 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.9 t -90.42 -20.87 22.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.735 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -96.03 143.34 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.303 . . . . 0.0 110.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.538 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 12.9 tp10 -65.41 -69.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.697 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 14.3 m -50.25 -24.11 2.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.516 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -76.81 -49.35 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.583 HG23 HD22 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -56.79 -43.82 80.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.5 -50.21 39.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.752 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.426 ' ND2' ' O ' ' A' ' 111' ' ' ASN . 1.7 t-20 -54.83 -33.78 62.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.08 -31.49 58.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.852 0.358 . . . . 0.0 111.014 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.96 -65.57 1.0 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.76 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -46.73 -42.9 17.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.142 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.426 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 17.0 t70 -46.0 -63.77 0.9 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.77 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.332 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.35 -51.21 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.898 0.38 . . . . 0.0 110.669 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.4 mt -78.17 -17.76 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.54 -60.01 3.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.602 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.426 ' HZ1' ' HG3' ' A' ' 95' ' ' GLU . 90.9 mttt -86.93 -55.96 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.595 HD23 HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -85.34 -11.32 54.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.607 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.32 -14.24 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 110.524 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.538 ' H ' ' C ' ' A' ' 121' ' ' LEU . 70.0 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.72 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.6 pt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 5' ' ' THR . 38.6 t0 -75.68 143.03 42.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.81 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.0 -4.24 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.997 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.52 -57.0 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 2' ' ' ASP . 15.3 t -49.8 -28.17 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.387 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -86.93 -64.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.844 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.89 -58.11 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.19 -29.49 22.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 mptp? -88.54 -59.09 2.33 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.517 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -51.28 -20.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.727 0.299 . . . . 0.0 111.362 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -85.0 -58.6 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.37 -23.48 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.55 -23.41 56.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.694 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.477 ' HB3' HG11 ' A' ' 54' ' ' VAL . 79.0 mt -135.02 15.98 3.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.482 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tmm? -58.27 -51.91 78.41 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.316 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 16.3 Cg_exo -69.86 -7.15 20.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.551 2.167 . . . . 0.0 112.321 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -104.75 -16.88 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.486 HG12 HG22 ' A' ' 54' ' ' VAL . 67.7 mt -89.21 -49.51 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.262 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.582 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 91.9 mmm -49.07 -49.65 67.88 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.7 Cg_exo -51.29 -52.18 9.6 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.242 1.961 . . . . 0.0 113.118 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.432 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -76.65 -22.14 54.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.531 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.509 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -54.82 -35.78 64.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.76 -16.54 44.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.432 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -59.95 -51.07 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.701 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 13.2 mt -96.52 -41.43 8.57 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.805 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.442 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 18.3 t60 176.26 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.903 0.859 . . . . 0.0 110.132 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.1 pt -149.2 171.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 113.899 -1.5 . . . . 0.0 110.35 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.0 p -81.88 151.43 27.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.468 ' HG3' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -61.35 -9.13 4.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.576 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.85 -42.73 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.287 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.7 mt -90.64 -6.7 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.177 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.83 6.5 6.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.09 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 9.4 t -63.37 -3.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.581 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.88 -10.76 59.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.7 mt -103.71 -44.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 90.8 mt-30 60.28 101.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 43' ' ' ASP . . . -85.66 -75.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.718 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 37' ' ' ALA . . . 172.05 -21.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.325 0.39 . . . . 0.0 112.049 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.52 -62.25 1.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.677 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.726 HD21 ' H ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -127.38 -1.99 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 0.0 111.237 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 36' ' ' GLN . . . 105.0 -11.1 48.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.262 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HB3' HD22 ' A' ' 40' ' ' ASN . . . -85.99 -77.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.597 0.237 . . . . 0.0 111.32 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.465 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 25.8 t0 174.38 96.11 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.398 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.566 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 11.3 ttm -46.3 -41.19 12.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.014 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.4 p -63.06 -57.06 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.28 -12.54 59.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.579 ' HG ' HG23 ' A' ' 114' ' ' THR . 30.3 tp -84.46 -30.92 24.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.13 14.94 63.19 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.28 -74.2 0.51 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.988 -0.606 . . . . 0.0 111.305 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.509 HD22 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -50.84 -45.67 59.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.351 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.468 ' HB2' ' HG3' ' A' ' 29' ' ' GLU . 58.3 tttm -74.65 -24.94 58.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.412 ' HB3' ' HA3' ' A' ' 110' ' ' GLY . . . -68.15 -22.11 64.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.3 0.571 . . . . 0.0 109.851 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.4 t -73.75 -37.84 64.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.277 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.486 HG22 HG12 ' A' ' 18' ' ' ILE . 5.7 t -63.55 -20.9 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.434 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 17.1 mmt -63.92 -51.94 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.647 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.601 ' HZ1' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.86 -16.19 48.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.17 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.2 mmp_? -73.08 -34.15 66.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.086 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.411 HD12 ' SD ' ' A' ' 60' ' ' MET . 33.1 pt -107.13 34.91 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 42.68 40.95 2.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.894 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.434 ' HG3' ' HB3' ' A' ' 55' ' ' MET . 18.2 ptm -112.02 8.97 20.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 110.091 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 44.4 tp -157.72 99.01 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 11.7 mmpt? -104.37 95.8 6.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.059 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.15 57.6 14.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.39 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p 73.03 22.85 2.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.038 0.535 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 20.3 mm-40 -115.75 104.94 12.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD21 ' HB3' ' A' ' 100' ' ' ALA . 5.7 mp -78.51 141.27 38.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -112.86 -178.48 3.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.51 HG11 HD12 ' A' ' 97' ' ' ILE . 30.6 m -129.18 -28.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm-40 -64.71 -52.86 48.21 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.933 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 12.7 Cg_endo -58.13 -13.76 16.94 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.054 1.836 . . . . 0.0 112.402 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.47 HG12 ' HE1' ' A' ' 74' ' ' MET . 16.7 t -91.53 -46.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -62.77 -22.25 66.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.213 179.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.515 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -82.35 -47.68 12.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.47 ' HE1' HG12 ' A' ' 71' ' ' VAL . 25.0 ptt? -71.59 -41.27 69.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.861 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.604 HD11 HG13 ' A' ' 89' ' ' VAL . 26.5 mt -49.37 -30.5 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.005 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -54.71 -59.53 4.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.814 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.57 -29.09 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 111.142 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.05 -7.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.873 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -139.05 33.35 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.38 56.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.319 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.15 -53.08 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.209 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.8 m120 -116.19 110.28 18.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.69 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.51 69.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.1 m-20 -79.71 -18.84 50.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.81 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.544 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 37.2 t0 -62.9 -34.09 76.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.455 ' O ' ' HB2' ' A' ' 90' ' ' LYS . 88.5 mt -76.42 -31.76 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.561 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.507 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -75.55 -30.95 59.89 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.779 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -83.75 -47.14 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.604 HG13 HD11 ' A' ' 75' ' ' ILE . 9.9 p -64.73 -32.88 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -52.69 -34.53 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.1 -30.44 31.28 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.38 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.55 HG13 HD21 ' A' ' 121' ' ' LEU . 34.8 mm -65.69 -35.64 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.36 -33.54 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.966 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.32 -21.73 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.29 -33.38 69.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.679 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.588 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 69.5 m -87.25 -53.65 4.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.47 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.51 HD12 HG11 ' A' ' 68' ' ' VAL . 65.1 mt -49.46 -28.8 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.63 -34.68 53.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.588 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.5 p30 -94.37 -3.88 49.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.443 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HB3' HD21 ' A' ' 66' ' ' LEU . . . -100.63 -33.68 10.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.832 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.54 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 25.5 -85.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.052 0.845 . . . . 0.0 113.048 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.54 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . -167.18 77.76 0.12 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.716 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.94 168.76 9.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.811 0.339 . . . . 0.0 110.94 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.404 ' HG1' ' N ' ' A' ' 105' ' ' ASP . 65.5 p -87.77 -43.12 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.404 ' N ' ' HG1' ' A' ' 104' ' ' THR . 11.1 t70 -79.83 131.23 35.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.835 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -49.16 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 83.4 m -56.58 -21.53 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -81.61 -31.19 32.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.013 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.401 HG13 ' O ' ' A' ' 105' ' ' ASP . 90.7 mt -66.74 -40.49 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.412 ' HA3' ' HB3' ' A' ' 52' ' ' ALA . . . -82.59 -37.03 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.368 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.566 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.6 t-20 -56.92 -48.31 78.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.674 0.273 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -53.59 -26.83 23.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.706 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.83 -65.8 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.917 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.579 HG23 ' HG ' ' A' ' 47' ' ' LEU . 9.7 t -53.19 -46.18 68.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 14.9 t70 -38.81 -58.44 1.08 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 p -76.81 -34.94 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.93 -32.5 66.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.876 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.583 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 54.3 mt -83.77 -20.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.224 0.535 . . . . 0.0 110.426 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.62 -58.26 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.0 -52.06 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.55 HD21 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -92.45 -11.44 34.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.583 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.19 -15.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.587 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 121' ' ' LEU . 58.8 m . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.496 HD12 HD13 ' A' ' 121' ' ' LEU . 44.7 pt . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.87 0.367 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.07 125.21 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.33 -38.38 71.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.81 -48.51 75.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.446 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.6 p -54.84 -24.52 23.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.484 HG11 ' HB2' ' A' ' 123' ' ' SER . 58.4 t -86.41 -63.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.592 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.41 -62.11 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.24 -28.65 19.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.7 mmpt? -87.72 -59.15 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.491 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -52.06 -29.03 19.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -76.95 -62.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.98 -23.65 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.53 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.411 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -63.72 -48.19 78.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.483 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.481 ' O ' HG13 ' A' ' 18' ' ' ILE . 80.4 mt -137.89 36.68 2.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.491 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.0 ttm -55.3 -50.89 84.1 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 15' ' ' MET . 70.0 Cg_endo -71.24 -8.44 23.45 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.215 1.943 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -100.29 -16.1 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' LEU . 78.3 mt -80.88 -49.87 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.454 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 87.8 mtp -48.4 -47.98 67.52 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.068 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 19' ' ' MET . 53.3 Cg_exo -38.51 -60.31 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.684 2.256 . . . . 0.0 113.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' O ' HD12 ' A' ' 25' ' ' LEU . 64.8 m -69.64 -26.49 64.43 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -52.53 -44.83 66.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.877 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.15 -15.95 45.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.207 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 7.9 tp10 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.621 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 21' ' ' CYS . 1.2 mp -88.29 -41.34 12.96 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.739 -0.785 . . . . 0.0 112.289 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 39.8 t60 177.19 -62.16 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.719 0.771 . . . . 0.0 111.033 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.415 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -149.58 163.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.938 -177.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.502 ' HA ' HD13 ' A' ' 50' ' ' LEU . 60.4 p -85.49 163.19 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.517 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -73.84 0.46 13.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.415 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' H ' ' HG ' ' A' ' 28' ' ' SER . 19.1 t70 -87.26 -37.88 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mm -101.64 -16.09 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.448 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -60.52 -18.71 53.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.349 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -82.11 34.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.046 0.45 . . . . 0.0 111.31 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.08 -6.09 39.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.444 ' N ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -120.98 -29.0 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.268 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 61.78 109.41 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -80.82 -74.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.658 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.22 -62.35 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -55.29 -61.37 2.37 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.666 HD21 ' H ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -126.39 -23.35 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.624 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.5 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 109.57 -14.2 32.62 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.583 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 44' ' ' MET . . . -83.48 -2.54 56.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.675 0.274 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 68.56 -3.8 1.29 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.543 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.455 ' HG2' HD21 ' A' ' 111' ' ' ASN . 20.6 ttm 59.79 9.71 1.78 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.263 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.9 t -86.5 -58.03 2.77 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 110.772 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.96 -16.38 36.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.058 0.456 . . . . 0.0 109.99 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.49 HD23 HD13 ' A' ' 118' ' ' ILE . 19.3 tp -71.59 -35.31 70.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.623 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.26 9.38 9.92 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.734 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.64 -62.99 0.3 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.502 HD13 ' HA ' ' A' ' 28' ' ' SER . 1.9 tm? -48.68 -42.68 35.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.517 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 81.2 tttt -81.16 -20.47 41.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.599 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.416 ' HA ' ' HE2' ' A' ' 55' ' ' MET . . . -70.53 -21.95 62.67 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.408 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 1.7 t -59.64 -31.44 69.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.02 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.97 -28.93 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.42 ' O ' ' HB3' ' A' ' 60' ' ' MET . 71.1 mtm -72.68 -65.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.16 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.527 ' HG2' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -58.07 -15.34 9.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.471 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.1 tpm_? -72.18 -34.26 68.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.175 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.461 HD11 HD11 ' A' ' 14' ' ' LEU . 40.2 pt -113.29 34.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.827 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 64.01 11.05 5.81 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.563 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.42 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.0 tpt -79.05 4.16 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.527 HD23 ' HG2' ' A' ' 56' ' ' LYS . 34.2 tp -166.81 99.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 2.5 mmpt? -85.93 78.33 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.452 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.7 -64.58 3.28 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.049 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.404 HG22 HD11 ' A' ' 109' ' ' ILE . 63.8 p -147.36 15.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.709 0.29 . . . . 0.0 110.835 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -108.83 110.22 21.53 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.68 135.01 49.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.33 178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -106.4 174.31 5.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.73 -25.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.346 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.2 mm-40 -56.54 -51.86 77.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.504 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -63.53 -13.67 37.79 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.969 1.779 . . . . 0.0 112.099 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.8 t -86.05 -50.37 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.274 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -56.86 -22.54 37.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.839 0.352 . . . . 0.0 110.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -85.33 -44.21 13.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.319 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.8 ptp -71.98 -41.71 67.36 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.697 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.551 HD12 HG22 ' A' ' 89' ' ' VAL . 89.0 mt -48.66 -28.52 2.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.01 -56.36 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.12 -24.73 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 75' ' ' ILE . 40.8 t -69.83 -8.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.856 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -144.67 45.53 1.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.652 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.77 119.91 10.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.61 -74.4 0.27 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.47 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.618 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.0 m120 -100.13 123.89 44.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.66 -25.27 67.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.024 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.485 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 9.5 m-20 -84.3 -24.98 29.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.436 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.618 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.8 t0 -56.68 -36.1 69.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.463 HG23 HG23 ' A' ' 75' ' ' ILE . 96.9 mt -74.39 -28.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.485 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.6 tp60 -81.66 -23.56 36.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tt -78.37 -62.11 1.79 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.285 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.551 HG22 HD12 ' A' ' 75' ' ' ILE . 28.5 m -58.85 -27.77 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.653 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.4 tttt -56.82 -35.91 69.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.713 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.46 -19.15 62.69 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' A' ' 89' ' ' VAL . 29.1 mm -73.87 -35.27 42.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 0.0 110.76 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.13 68.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -82.94 -27.15 30.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.608 ' HG2' ' HZ1' ' A' ' 120' ' ' LYS . 7.3 tp10 -69.86 -19.64 63.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.204 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.4 m -86.07 -42.3 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.48 -36.9 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.16 -36.93 76.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -5.06 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.605 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.97 50.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.601 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -44.78 -28.28 0.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.63 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.601 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . 132.32 91.62 0.51 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.929 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.447 ' N ' HG12 ' A' ' 109' ' ' ILE . 7.5 mm-40 -67.42 -179.14 0.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.0 110.705 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t -93.91 -27.75 16.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.72 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.414 ' O ' HG13 ' A' ' 109' ' ' ILE . 26.3 t70 -102.52 140.47 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.36 -69.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.666 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.9 m -53.82 -16.81 1.94 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.896 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 26.3 t-20 -87.06 -35.13 18.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.447 HG12 ' N ' ' A' ' 103' ' ' GLU . 84.6 mt -69.88 -55.57 14.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 114' ' ' THR . . . -61.25 -43.34 99.5 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.613 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.455 HD21 ' HG2' ' A' ' 44' ' ' MET . 26.5 t-20 -50.92 -30.39 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.6 -25.79 23.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.976 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -86.29 -63.47 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.735 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.6 t -49.3 -43.1 43.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -45.92 -38.54 7.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.59 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.22 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.339 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.51 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 0.0 111.584 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.554 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 61.4 mt -77.86 -21.23 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 110.718 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.57 -57.0 4.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.568 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.608 ' HZ1' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -87.2 -44.6 11.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 123' ' ' SER . 42.9 tp -99.9 -10.54 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.554 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER 72.79 -22.93 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.277 . . . . 0.0 110.968 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 121' ' ' LEU . 57.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.778 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.403 HD12 HD22 ' A' ' 121' ' ' LEU . 44.2 pt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.799 0.333 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -65.61 137.15 57.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.766 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -72.99 -5.67 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.1 -48.44 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 6.6 t -59.32 -24.96 63.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.08 -64.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.008 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.89 -59.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -27.58 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB2' ' O ' ' A' ' 5' ' ' THR . 13.5 mptt -88.42 -59.4 2.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.585 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.531 ' HH ' ' HE1' ' A' ' 74' ' ' MET . 3.8 m-85 -50.22 -24.7 3.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 -179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.418 ' O ' ' HB2' ' A' ' 15' ' ' MET . 0.7 OUTLIER -81.75 -62.21 1.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.99 -54.52 17.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -51.68 -23.41 4.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.459 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.582 ' HB3' HG12 ' A' ' 54' ' ' VAL . 96.3 mt -139.86 62.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.519 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.604 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 50.7 ttp -110.01 -51.45 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.366 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.604 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 31.3 Cg_exo -58.89 -14.79 24.02 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.989 1.793 . . . . 0.0 111.806 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -94.56 -19.86 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 38.9 mt -81.09 -36.91 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.561 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 58.5 mtt -45.57 -50.27 32.4 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 77.1 Cg_exo -50.19 -52.41 9.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.272 1.982 . . . . 0.0 113.302 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.3 m -85.29 -15.04 44.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.661 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.33 -7.84 21.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.138 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.88 -52.75 6.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.63 -19.16 31.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.391 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' HB2' HD11 ' A' ' 50' ' ' LEU . 71.4 mt -125.47 40.44 3.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.028 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -63.73 67.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.516 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.448 ' HA ' ' HB ' ' A' ' 31' ' ' ILE . 1.2 pp -159.2 55.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 122.818 0.447 . . . . 0.0 110.33 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.532 ' C ' ' H ' ' A' ' 30' ' ' ASP . 8.9 p -56.71 -176.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.871 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -66.82 10.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.667 0.27 . . . . 0.0 111.272 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' H ' ' C ' ' A' ' 28' ' ' SER . 19.6 t70 -106.73 -28.28 10.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.386 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.448 ' HB ' ' HA ' ' A' ' 27' ' ' ILE . 46.5 mm -106.34 -40.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.795 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.69 1.08 1.94 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.982 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.446 ' HA ' ' HB3' ' A' ' 42' ' ' ALA . 12.4 t -119.64 49.99 1.31 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.757 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.409 ' N ' ' ND2' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -49.55 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 12.7 mm 61.08 60.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.893 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 4.7 mm-40 -167.54 176.76 6.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' A' ' 40' ' ' ASN . . . -87.93 -68.56 0.75 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.473 ' C ' ' H ' ' A' ' 40' ' ' ASN . . . -156.58 -146.51 0.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.374 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.514 ' C ' ' H ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -46.3 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.043 0.449 . . . . 0.0 110.383 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.551 HD22 ' HB1' ' A' ' 37' ' ' ALA . 7.6 p30 -71.63 34.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.071 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.514 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . 115.84 19.14 5.75 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.676 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 33' ' ' THR . . . -85.87 -50.18 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.548 ' C ' ' H ' ' A' ' 45' ' ' SER . 21.8 t70 -172.3 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.536 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.52 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 27.6 ttt 61.25 -5.66 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.548 ' H ' ' C ' ' A' ' 43' ' ' ASP . 32.6 t -92.41 -57.35 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -88.06 -27.41 22.01 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.501 ' C ' ' H ' ' A' ' 49' ' ' CYS . 4.6 tt -49.77 -46.78 51.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -76.02 29.65 1.35 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.65 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.501 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -132.71 -73.0 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.557 HD11 ' HB2' ' A' ' 25' ' ' LEU . 56.1 tp -51.99 -45.46 64.49 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -74.44 -25.27 59.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.485 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' HB2' ' HE1' ' A' ' 55' ' ' MET . . . -78.83 -16.75 56.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 40.0 t -70.21 -33.39 71.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.582 HG12 ' HB3' ' A' ' 14' ' ' LEU . 15.2 t -68.28 -24.99 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.985 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.442 ' HE1' ' HB2' ' A' ' 52' ' ' ALA . 51.3 mtm -60.79 -45.83 92.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 2.0 pttm -75.51 -15.84 60.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.615 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.519 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.9 mmp_? -76.94 -23.16 52.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 pt -113.01 26.08 3.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.81 63.21 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -139.31 -20.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.544 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 13.6 tp -124.93 99.99 6.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.559 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 10.4 mmpt? -124.14 87.57 2.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.14 59.44 10.03 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.367 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.1 p 72.29 8.84 5.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.27 0.628 . . . . 0.0 111.171 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.412 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 42.8 mt-10 -92.91 122.51 35.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.21 113.85 25.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.958 0.409 . . . . 0.0 110.926 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.73 178.43 8.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.778 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 -12.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.754 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 36.6 mt-10 -70.65 -49.76 14.61 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.607 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 33.8 Cg_endo -66.6 -29.28 44.05 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.917 1.745 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.542 ' O ' ' HG3' ' A' ' 74' ' ' MET . 22.0 t -64.21 -53.64 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.926 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -55.26 -21.69 15.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -85.21 -38.43 18.96 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.13 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.542 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -72.92 -42.99 62.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.349 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.442 HG21 HG23 ' A' ' 86' ' ' ILE . 76.4 mt -51.91 -27.75 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 0.0 110.749 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -57.58 -58.22 9.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.855 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -86.35 -25.79 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.184 0.516 . . . . 0.0 110.835 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.61 -8.15 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.644 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.42 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 90.0 m-70 -145.21 43.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 132.12 48.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.185 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.65 -62.26 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -126.72 147.57 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -65.93 -33.6 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -82.91 -30.19 28.65 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.548 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -53.02 -30.73 37.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.442 HG23 HG21 ' A' ' 75' ' ' ILE . 95.0 mt -83.29 -34.56 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.412 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 15.0 mm100 -71.27 -19.76 62.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -78.06 -44.68 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.432 HG22 HD12 ' A' ' 121' ' ' LEU . 21.3 t -70.43 -29.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.78 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.58 -35.9 54.99 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.408 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.83 -31.32 32.86 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.193 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.514 HD11 ' HB3' ' A' ' 120' ' ' LYS . 34.6 mm -60.18 -35.36 61.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 -19.07 57.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -74.67 -42.04 59.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.343 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.95 -18.27 62.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -85.15 -38.03 19.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.471 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.76 -35.63 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.379 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.8 -13.27 62.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.299 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -106.75 -49.18 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.131 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.96 43.64 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.216 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.491 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -41.67 -28.34 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.064 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.491 ' N ' ' HD2' ' A' ' 101' ' ' LYS . . . 143.85 92.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.585 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.42 ' N ' HG12 ' A' ' 109' ' ' ILE . 16.7 mm-40 -66.32 -178.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.951 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -91.78 -32.59 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 19.5 t70 -95.15 139.78 31.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -45.47 -64.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.908 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -56.3 -43.6 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.588 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.73 -37.98 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 105' ' ' ASP . 97.5 mt -60.12 -41.49 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -86.33 -29.22 25.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.17 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.533 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 21.3 m120 -58.15 -36.66 73.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.177 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.39 -38.26 30.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -68.65 -24.68 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.592 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 11.1 t -88.0 -42.81 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 110.25 179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.449 ' HA ' ' HG3' ' A' ' 39' ' ' LYS . 17.7 t70 -43.17 -68.97 0.15 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.46 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 p -54.26 -39.62 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.022 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.42 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.2 OUTLIER -54.34 -37.01 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.524 ' HA ' ' N ' ' A' ' 123' ' ' SER . 87.8 mt -85.29 -35.88 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.068 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.15 -46.25 72.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.931 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.514 ' HB3' HD11 ' A' ' 92' ' ' ILE . 12.3 mptt -86.14 -44.97 11.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.622 ' O ' ' HB3' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -100.16 -53.93 3.01 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.622 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 135.74 -6.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.254 1.422 . . . . 0.0 111.02 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.524 ' N ' ' HA ' ' A' ' 118' ' ' ILE . 89.9 p . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.2 139.17 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -59.89 -15.41 21.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.6 -44.6 33.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.485 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 79' ' ' HIS . 25.9 m -47.49 -41.93 21.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.44 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.11 -62.43 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.18 -26.25 11.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.439 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.6 OUTLIER -89.37 -59.34 2.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.875 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -56.5 -23.77 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.716 0.293 . . . . 0.0 111.479 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.3 ttt -84.49 -56.02 3.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.63 -23.86 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.65 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.511 ' HB3' HD12 ' A' ' 14' ' ' LEU . 1.2 t80 -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 13' ' ' TYR . 4.5 mp -137.97 32.45 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 ttp -50.43 -51.67 62.05 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.608 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 15' ' ' MET . 42.5 Cg_endo -67.14 -33.3 31.78 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.889 1.726 . . . . 0.0 112.112 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.425 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 m-20 -78.78 0.72 25.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.464 HD11 ' HA ' ' A' ' 15' ' ' MET . 37.8 mt -89.42 -43.42 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.432 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 26.9 ptt? -57.87 -33.32 17.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 19' ' ' MET . 78.6 Cg_exo -50.37 -51.9 10.08 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.684 1.589 . . . . 0.0 112.68 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.441 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 66.0 m -74.68 -28.99 61.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.559 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.473 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.54 -40.53 62.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -84.48 -16.38 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 37.6 tt0 -61.11 -54.68 41.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.01 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 20.8 mt -91.06 -40.66 11.5 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.274 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 12.0 t60 177.25 -60.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 0.8 OUTLIER -145.94 175.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.307 -178.19 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.635 ' HA ' HD13 ' A' ' 50' ' ' LEU . 68.7 p -85.81 178.83 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.062 0.458 . . . . 0.0 111.233 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -67.62 -19.84 65.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.39 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.04 -36.43 12.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.165 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.523 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 35.0 mm -83.42 -6.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.191 0.519 . . . . 0.0 110.201 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.07 -55.64 7.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.657 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -151.46 -35.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.577 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 45.41 25.12 0.2 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.062 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.551 ' HB ' ' NE2' ' A' ' 36' ' ' GLN . 95.2 mt -138.74 -36.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.272 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.551 ' NE2' ' HB ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -97.16 97.67 9.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.502 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -74.17 -61.2 1.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 57.44 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.243 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -103.19 -60.23 1.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.682 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.84 -20.89 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.449 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.502 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.71 -16.94 30.86 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.643 ' HB1' HD12 ' A' ' 47' ' ' LEU . . . -86.91 -0.34 56.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.472 ' C ' ' H ' ' A' ' 45' ' ' SER . 18.7 t70 70.02 -3.07 1.86 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.925 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.413 ' HG2' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER 61.83 -3.22 0.24 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.472 ' H ' ' C ' ' A' ' 43' ' ' ASP . 78.8 p -78.11 -58.75 3.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.686 0.279 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.518 ' HA ' ' NE2' ' A' ' 46' ' ' GLN . 9.9 mm100 -88.74 -13.52 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.305 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.659 HD21 ' HB3' ' A' ' 51' ' ' LYS . 2.6 tt -60.04 -43.26 95.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.065 0.46 . . . . 0.0 109.845 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.48 9.3 6.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.037 179.589 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' H ' ' C ' ' A' ' 47' ' ' LEU . 1.2 m -138.91 -78.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.232 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.635 HD13 ' HA ' ' A' ' 28' ' ' SER . 3.1 tm? -48.64 -52.62 22.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.659 ' HB3' HD21 ' A' ' 47' ' ' LEU . 5.3 tmtt? -73.55 -22.87 59.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.48 ' HA ' ' HE1' ' A' ' 55' ' ' MET . . . -76.06 -10.39 59.38 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.341 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.432 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.1 t -60.7 -35.71 76.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.753 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.99 -28.83 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.122 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 52' ' ' ALA . 39.5 mtt -65.18 -49.02 71.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.171 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HB2' ' HZ3' ' A' ' 56' ' ' LYS . 7.9 mtmp? -64.38 -27.3 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.795 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.3 -30.42 66.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.519 HD11 ' HG2' ' A' ' 60' ' ' MET . 49.1 pt -96.45 15.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.828 0.347 . . . . 0.0 111.216 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 58.41 45.45 16.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.668 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.53 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 2.8 ppp? -121.11 -8.96 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.088 0.47 . . . . 0.0 110.447 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 58.6 tp -139.47 99.87 3.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.471 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.25 77.84 3.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.35 -63.73 3.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.741 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -147.23 15.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.641 0.257 . . . . 0.0 110.659 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.45 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -107.5 111.2 23.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.739 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.547 HD11 HG22 ' A' ' 109' ' ' ILE . 95.7 mt -84.23 139.14 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.53 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 6.4 m-85 -111.67 -172.55 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.57 -15.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.608 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 47.0 mt-10 -72.95 -47.33 8.41 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 50.0 Cg_exo -52.65 -51.42 11.16 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.274 1.983 . . . . 0.0 112.834 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.481 ' HA ' ' HE3' ' A' ' 74' ' ' MET . 20.5 t -55.89 -44.38 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.764 -179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -55.51 -23.7 27.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.945 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -85.46 -34.79 21.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.22 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.481 ' HE3' ' HA ' ' A' ' 71' ' ' VAL . 18.7 mtm -71.6 -50.49 30.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.555 -179.41 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.42 HG22 HG21 ' A' ' 86' ' ' ILE . 70.0 mt -49.35 -22.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.59 -59.71 3.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.427 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.8 -32.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG12 ' HB2' ' A' ' 9' ' ' LYS . 37.6 t -61.08 -11.93 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.83 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.414 ' HA ' HG22 ' A' ' 5' ' ' THR . 89.6 m-70 -139.09 53.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.93 109.19 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.48 -67.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.359 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -107.11 153.18 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 0.0 110.648 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 -46.72 14.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.89 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.45 -26.46 61.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.925 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.45 -32.53 67.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.42 HG21 HG22 ' A' ' 75' ' ' ILE . 93.8 mt -75.71 -29.79 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.123 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -81.34 -19.42 42.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.448 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -61.39 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.551 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.472 HG12 ' HH ' ' A' ' 117' ' ' TYR . 22.1 t -58.64 -30.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -60.0 -32.95 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.823 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.53 -24.96 37.36 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.604 HG13 HD23 ' A' ' 121' ' ' LEU . 38.7 mm -69.25 -35.77 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 110.977 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.46 -15.89 63.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.98 -27.68 57.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.492 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.8 tp10 -69.9 -20.81 63.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.51 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 97.1 m -87.05 -45.49 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.24 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.5 -18.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.668 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.2 -12.89 29.18 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 0.5 OUTLIER -121.6 -0.91 9.62 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.4 -22.22 12.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.48 ' O ' ' HE3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.69 -167.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.453 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.405 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 54.42 11.7 2.74 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.47 178.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -96.35 178.07 5.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.877 0.339 . . . . 0.0 110.696 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -133.33 -17.47 2.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.647 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -104.31 142.04 35.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.968 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.178 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.0 m -51.3 -29.38 14.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.421 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -72.59 -43.87 62.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.917 0.389 . . . . 0.0 110.113 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.547 HG22 HD11 ' A' ' 66' ' ' LEU . 13.6 mt -63.82 -44.96 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.61 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -45.11 85.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.949 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.444 ' HA ' HG23 ' A' ' 114' ' ' THR . 1.9 t-20 -58.98 -47.66 84.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.928 0.364 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -61.04 -20.16 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.104 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -86.88 -56.84 3.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.333 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.444 HG23 ' HA ' ' A' ' 111' ' ' ASN . 9.7 t -61.99 -36.39 81.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 111.622 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -48.3 -45.44 34.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.169 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -40.27 16.74 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.472 ' HH ' HG12 ' A' ' 89' ' ' VAL . 0.2 OUTLIER -55.33 -35.1 64.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.689 -179.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 58.1 mt -84.56 -17.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 0.0 110.252 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.74 -56.08 5.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.492 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 2.2 mptp? -85.23 -48.68 8.87 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.604 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -99.18 -10.02 23.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.42 -21.18 0.27 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.59 0.234 . . . . 0.0 110.937 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 121' ' ' LEU . 41.0 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.923 0.392 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.46 120.39 10.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -53.62 -37.22 62.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.184 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.33 -44.81 62.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -53.98 -31.3 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.436 HG13 ' HG ' ' A' ' 123' ' ' SER . 54.5 t -88.73 -65.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.03 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.99 -62.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.99 -24.83 56.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HD3' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.08 -58.1 2.66 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.836 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -55.11 -30.67 60.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.689 0.281 . . . . 0.0 111.572 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.0 tpp -77.04 -52.5 9.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.403 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.62 -23.51 63.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 4.3 t80 -60.98 -36.06 78.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.127 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.426 ' O ' HG13 ' A' ' 18' ' ' ILE . 96.1 mt -142.34 38.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.129 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.482 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 9.0 tmm? -54.06 -51.01 81.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.083 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 15' ' ' MET . 60.5 Cg_endo -70.17 -8.67 24.17 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . 0.402 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 14.9 m-20 -106.71 -15.11 14.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 14' ' ' LEU . 70.5 mt -83.69 -44.2 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.884 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.505 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 25.0 mmt -53.46 -48.2 93.64 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 95.0 Cg_exo -42.96 -51.64 5.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.677 2.252 . . . . 0.0 112.749 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.457 ' O ' HD22 ' A' ' 50' ' ' LEU . 4.9 m -56.85 -42.04 78.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.13 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.548 ' HB1' ' HB2' ' A' ' 28' ' ' SER . . . -52.28 -50.33 62.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.83 -16.12 58.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 6.3 tp10 -63.31 -50.68 69.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.504 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 HD11 ' HG ' ' A' ' 50' ' ' LEU . 11.0 mt -106.6 -43.17 4.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.67 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.47 ' HE2' ' HG3' ' A' ' 46' ' ' GLN . 0.1 OUTLIER 176.96 -61.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.619 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 2.3 pt -148.06 138.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.855 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.548 ' HB2' ' HB1' ' A' ' 22' ' ' ALA . 29.3 t -85.61 -176.64 6.14 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.334 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 13.7 tt0 -57.48 -17.73 14.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.283 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.431 ' OD1' ' HB3' ' A' ' 28' ' ' SER . 8.6 p-10 -74.47 -30.92 62.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.014 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.619 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 39.2 mt -112.15 -7.62 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.535 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.28 70.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.276 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -86.25 41.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.17 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.584 ' N ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -71.25 -33.9 70.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.171 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.431 ' H ' ' ND2' ' A' ' 34' ' ' ASN . 38.8 pt -142.51 28.62 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.263 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.7 126.96 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.087 0.47 . . . . 0.0 110.774 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.648 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -85.19 -75.56 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.64 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.501 ' HB1' ' SD ' ' A' ' 44' ' ' MET . . . -179.93 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.427 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 24.4 mmmt -51.49 -64.7 0.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.093 0.473 . . . . 0.0 110.844 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.528 HD22 ' HB2' ' A' ' 43' ' ' ASP . 2.2 p30 -128.94 5.12 5.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.649 0.738 . . . . 0.0 109.238 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.648 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 81.11 -21.07 6.08 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.21 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . . . -92.55 -42.04 9.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.261 0.553 . . . . 0.0 110.826 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HB2' HD22 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -106.42 153.88 21.62 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.197 -178.26 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.674 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.2 tpt -175.53 -143.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.295 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.674 ' H ' ' HG3' ' A' ' 44' ' ' MET . 41.6 t -79.45 -44.53 21.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.063 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.47 ' HG3' ' HE2' ' A' ' 26' ' ' HIS . 5.5 tp60 -70.95 -39.96 72.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.617 ' HB3' ' H ' ' A' ' 44' ' ' MET . 2.3 tm? -68.56 -45.16 72.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.156 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' O ' ' HB1' ' A' ' 52' ' ' ALA . . . -55.4 -7.54 1.38 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.302 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.424 ' H ' ' C ' ' A' ' 47' ' ' LEU . 1.3 m -103.88 -60.9 1.5 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.492 ' HG ' HD11 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -53.94 -36.07 62.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.752 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' HD3' HD22 ' A' ' 47' ' ' LEU . 13.6 tptt -80.65 -20.55 42.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.313 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 48' ' ' GLY . . . -75.03 -23.86 58.22 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -26.17 68.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.419 HG21 HG12 ' A' ' 18' ' ' ILE . 21.3 t -77.72 -24.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.6 mtt -67.08 -55.03 16.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.623 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 45.1 mttm -58.27 -23.14 55.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.537 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -62.15 -36.51 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.895 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 pt -113.21 26.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.89 58.21 3.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.495 ' O ' ' HG2' ' A' ' 60' ' ' MET . 12.5 ttt -124.9 3.72 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 65' ' ' GLU . 33.9 tp -161.75 127.88 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.0 111.134 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -115.83 80.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.761 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 -72.74 0.92 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.754 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.3 p -139.55 29.46 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.89 0.376 . . . . 0.0 110.47 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.443 ' O ' HD13 ' A' ' 61' ' ' LEU . 7.0 tp10 -117.37 108.73 15.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.426 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD13 HG23 ' A' ' 109' ' ' ILE . 1.1 mm? -67.39 146.26 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.893 0.377 . . . . 0.0 111.418 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -142.33 155.41 45.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.501 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.65 5.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.736 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 38.0 mt-10 -59.5 -52.08 76.7 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.476 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -69.01 -28.87 28.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.171 1.914 . . . . 0.0 112.62 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 HG21 ' HE3' ' A' ' 60' ' ' MET . 21.5 t -63.94 -48.34 86.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.079 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.453 ' HA ' HD13 ' A' ' 75' ' ' ILE . 7.1 m-30 -51.47 -22.21 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.935 0.398 . . . . 0.0 110.422 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.404 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 39.9 tptt -83.22 -37.57 23.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.4 mtm -74.59 -43.85 53.6 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.35 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.453 HD13 ' HA ' ' A' ' 72' ' ' TYR . 58.9 mt -48.87 -24.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 44.3 mt-10 -65.94 -59.26 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.328 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -80.96 -44.93 21.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.603 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 18.8 t -46.52 -40.79 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.266 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.452 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 78.8 m-70 -106.31 53.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.29 122.33 16.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.308 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.92 -76.14 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -96.04 144.42 26.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.31 -28.67 34.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.42 -26.79 38.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -58.36 -23.65 57.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 73.5 mt -86.74 -32.76 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.447 178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -75.57 -21.15 58.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.973 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.09 -55.46 4.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.439 HG13 HD22 ' A' ' 121' ' ' LEU . 58.5 t -56.11 -32.46 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -34.13 68.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.753 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.43 -27.12 33.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.375 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.458 HG21 ' HB2' ' A' ' 121' ' ' LEU . 43.6 mm -69.06 -38.01 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -19.29 65.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -84.2 -29.79 26.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -27.38 62.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -22.16 54.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.39 -49.51 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.35 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.5 -40.8 80.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -57.85 -48.3 80.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.889 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -77.07 -14.08 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.098 0.475 . . . . 0.0 110.971 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HD2' ' O ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER 35.11 30.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.948 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.08 72.61 0.57 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.984 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HB2' HG13 ' A' ' 109' ' ' ILE . 13.7 mm-40 -61.77 166.28 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -77.5 -39.92 44.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.634 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.2 t70 -91.65 142.66 27.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -55.18 -67.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.254 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.457 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 61.1 m -50.26 -35.35 26.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 39.7 t-20 -59.3 -50.42 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.53 HG23 HD13 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -59.17 -32.95 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.146 177.663 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 114' ' ' THR . . . -66.58 -57.17 10.51 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.419 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.606 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 3.7 t-20 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.653 0.263 . . . . 0.0 111.491 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.15 -30.75 19.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.864 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -82.69 -63.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.443 HG21 ' O ' ' A' ' 110' ' ' GLY . 10.1 t -53.68 -30.57 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.27 -59.61 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.449 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -49.84 -37.03 28.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.427 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 38.0 mm -82.27 -27.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.146 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.85 -59.57 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.449 ' HD2' ' O ' ' A' ' 116' ' ' CYS . 3.2 mptp? -86.85 -43.56 12.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.55 ' C ' ' H ' ' A' ' 123' ' ' SER . 46.7 tp -99.66 -15.75 18.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.9 t80 67.83 -13.61 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.92 0.391 . . . . 0.0 110.911 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.55 ' H ' ' C ' ' A' ' 121' ' ' LEU . 48.2 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.319 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . 0.439 HG12 HG21 ' A' ' 5' ' ' THR . 9.1 tp . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -71.77 142.54 49.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.78 -14.77 35.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.471 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.71 -37.22 86.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.439 HG21 HG12 ' A' ' 1' ' ' ILE . 3.0 t -54.54 -29.35 50.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.89 -64.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.048 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.68 -62.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.17 -28.19 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.47 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.7 mmmt -88.48 -59.45 2.23 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.687 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -52.89 -20.52 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.202 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 78.9 mmm -85.54 -60.48 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.9 -28.19 69.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.704 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -62.07 -46.68 88.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.004 -179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 mt -123.12 34.79 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.092 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.464 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.4 tmm? -55.5 -50.62 85.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.665 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 15' ' ' MET . 74.0 Cg_endo -73.7 -4.19 15.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.065 1.844 . . . . 0.0 112.183 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.0 -14.93 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.11 -42.4 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.553 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 56.3 mtm -54.94 -48.78 95.03 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.326 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -53.32 -43.93 53.19 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.174 1.916 . . . . 0.0 112.568 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -57.87 -55.6 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.04 -42.03 37.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -83.42 -16.55 45.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -60.42 -54.25 47.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.57 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.511 HD12 HD21 ' A' ' 50' ' ' LEU . 53.0 mt -96.14 -42.21 8.33 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.326 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 3.2 t-80 176.19 -64.19 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.302 0.572 . . . . 0.0 112.467 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.518 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -151.76 145.94 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.935 -175.506 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.6 p -85.41 -177.8 6.55 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.111 178.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.601 ' N ' ' HZ3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.31 -17.84 64.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.88 -55.07 8.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . 0.473 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 27.4 mm -75.84 -16.93 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.1 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.09 -41.48 64.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.028 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.521 ' HB ' ' HB2' ' A' ' 36' ' ' GLN . 24.0 m -161.56 118.46 2.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.229 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.516 HD21 ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -54.92 -9.84 0.41 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.241 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.516 ' N ' HD21 ' A' ' 34' ' ' ASN . 2.2 pp -127.42 41.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.062 0.458 . . . . 0.0 111.517 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.521 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 83.8 mm-40 -148.66 126.76 12.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.763 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.27 -57.06 3.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.577 ' C ' ' H ' ' A' ' 40' ' ' ASN . . . -147.61 -141.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.619 0.247 . . . . 0.0 111.316 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.684 ' HD2' ' H ' ' A' ' 39' ' ' LYS . 7.9 mptt -59.27 0.62 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.223 0.535 . . . . 0.0 110.187 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.577 ' H ' ' C ' ' A' ' 38' ' ' ALA . 1.8 t-20 -77.68 32.68 0.16 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.954 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.49 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . 114.35 5.09 21.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.967 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.447 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . . . -86.47 28.58 0.84 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.161 0.481 . . . . 0.0 110.088 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.468 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.3 m-20 66.06 72.7 0.39 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.455 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 16.1 ptp -49.59 -22.01 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.521 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.1 p -53.17 -49.29 66.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.809 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.557 ' HG3' HD23 ' A' ' 50' ' ' LEU . 18.3 tp60 -87.83 -18.42 29.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.719 0.295 . . . . 0.0 111.157 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.535 ' HB3' ' HE3' ' A' ' 39' ' ' LYS . 10.5 mt -70.11 -28.29 65.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.99 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.482 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -71.52 10.99 3.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.486 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.45 ' H ' ' C ' ' A' ' 47' ' ' LEU . 3.9 m -134.59 -62.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.891 0.376 . . . . 0.0 110.594 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.582 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -50.76 -46.81 59.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.756 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.601 ' HZ3' ' N ' ' A' ' 29' ' ' GLU . 0.9 OUTLIER -81.58 -20.63 39.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.634 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.416 ' HA ' ' HG3' ' A' ' 55' ' ' MET . . . -69.4 -17.82 63.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.27 -46.24 70.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.751 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.91 -25.4 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.859 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.416 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 34.3 mtm -65.38 -46.43 80.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -67.95 -25.83 65.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.495 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.74 -38.17 86.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.73 17.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.26 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.22 59.85 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.7 ttp -124.12 5.47 8.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.262 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.484 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 67.7 tp -152.47 99.48 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.459 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.538 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -95.8 96.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.161 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.409 ' O ' ' OG1' ' A' ' 64' ' ' THR . . . 47.51 60.13 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.762 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 63' ' ' GLY . 7.7 p 73.45 27.3 1.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.284 0.634 . . . . 0.0 111.819 179.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 43.3 mt-10 -114.4 113.06 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.0 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.564 HD23 HG22 ' A' ' 109' ' ' ILE . 91.9 mt -70.37 139.43 51.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.766 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -145.82 169.03 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.474 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.24 25.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.0 mt-10 -75.36 -50.66 3.56 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.4 Cg_endo -66.04 -44.07 8.02 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.039 1.826 . . . . 0.0 112.972 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.427 ' HA ' ' HG3' ' A' ' 74' ' ' MET . 14.1 m -57.49 -45.16 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -53.77 -22.94 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.644 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.463 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.0 tmtp? -85.37 -36.56 20.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.427 ' HG3' ' HA ' ' A' ' 71' ' ' VAL . 13.8 mtp -68.32 -48.0 66.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.397 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 79' ' ' HIS . 62.6 mt -48.32 -24.51 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HA ' HD12 ' A' ' 86' ' ' ILE . 43.7 mt-10 -60.65 -59.55 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 -36.26 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HB3' ' A' ' 9' ' ' LYS . 68.8 t -60.75 -7.74 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.103 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 78.7 m-70 -143.62 43.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 135.57 55.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.18 -60.49 0.54 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -117.84 150.12 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.44 -33.87 31.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.536 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.524 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 8.7 m-20 -81.27 -25.54 36.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.794 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.405 ' OD2' ' HB3' ' A' ' 79' ' ' HIS . 36.6 t70 -58.76 -31.93 68.81 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.4 HD12 ' HA ' ' A' ' 76' ' ' GLU . 95.7 mt -77.68 -29.64 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.134 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.524 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -77.01 -24.14 52.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.236 179.606 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.7 -49.35 18.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.446 ' HB ' HG21 ' A' ' 75' ' ' ILE . 45.5 t -61.9 -34.08 61.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.782 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -35.41 75.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.78 -22.9 65.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.588 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.544 HG22 ' HB2' ' A' ' 120' ' ' LYS . 51.4 mt -63.76 -41.72 93.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.409 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -62.35 -29.48 70.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -62.68 -41.04 98.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.249 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.96 -39.18 84.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.528 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 65.9 m -71.05 -37.68 72.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.792 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 93' ' ' ALA . 83.3 mt -65.74 -19.3 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -85.13 -32.8 22.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.2 p30 -96.35 -17.26 20.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.434 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -101.32 -19.75 15.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.508 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.572 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 29.9 -88.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.436 0.694 . . . . 0.0 112.689 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.572 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . -167.48 76.56 0.12 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.506 ' HB2' HG13 ' A' ' 109' ' ' ILE . 10.4 mm-40 -70.5 147.34 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.3 p -76.91 -18.76 58.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.598 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.46 144.19 28.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -59.6 -67.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 54.2 m -52.75 -23.72 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.719 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.96 -43.38 54.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.562 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.564 HG22 HD23 ' A' ' 66' ' ' LEU . 1.5 mt -66.5 -41.66 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 110.691 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.419 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -71.17 -49.46 26.76 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.077 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.482 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.7 t-20 -51.68 -59.25 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.906 0.353 . . . . 0.0 110.927 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 10.3 mmpt? -54.0 -45.11 71.37 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 41.3 t80 -73.72 -65.9 0.77 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.488 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 32.3 p -50.55 -41.73 54.43 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 22.0 t70 -42.99 -67.31 0.28 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -55.95 -25.4 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.803 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -29.91 64.88 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.487 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.593 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -85.35 -25.94 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.3 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.16 -53.83 15.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.808 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.544 ' HB2' HG22 ' A' ' 92' ' ' ILE . 71.8 mmtt -86.7 -58.06 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.537 ' C ' ' H ' ' A' ' 123' ' ' SER . 49.6 tp -85.53 -10.72 55.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.593 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 3.9 t80 69.66 -19.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.555 0.217 . . . . 0.0 111.118 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.537 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.8 t . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.8 pt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.413 ' O ' HG22 ' A' ' 5' ' ' THR . 6.6 m-20 -77.27 137.84 39.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.118 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -56.73 -32.45 65.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.934 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -49.41 -43.27 44.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.39 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.484 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 2.1 t -54.17 -33.18 57.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.23 -65.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.32 -62.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.72 -26.16 43.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.81 -59.32 2.26 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.905 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -54.54 -20.31 7.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.3 mmt -84.29 -57.39 3.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.2 -47.8 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.463 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -45.72 -34.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.742 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 18' ' ' ILE . 52.1 mt -138.54 46.07 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.317 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.478 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 49.1 ttp -71.92 -51.74 8.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.683 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.2 Cg_endo -69.71 -3.08 11.25 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.116 1.878 . . . . 0.0 112.117 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -103.21 -19.66 14.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 14' ' ' LEU . 75.9 mt -84.61 -37.1 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.537 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -49.47 -52.73 47.21 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -37.88 -52.87 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.017 2.478 . . . . 0.0 114.192 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -88.43 -42.33 12.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.586 0.231 . . . . 0.0 111.583 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.577 ' HA ' HD11 ' A' ' 50' ' ' LEU . . . -64.05 -6.75 6.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.533 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.11 -29.76 24.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -85.66 -54.7 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.607 ' HB2' HD23 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -112.18 44.52 1.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.364 -178.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 39.4 t60 -56.18 82.56 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 112.155 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 25' ' ' LEU . 43.0 pt -140.46 49.88 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.95 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 30' ' ' ASP . 48.4 t -50.82 -179.74 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.562 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.535 ' HG2' ' HB2' ' A' ' 42' ' ' ALA . 9.0 mt-10 -43.18 -18.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.774 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 28' ' ' SER . 11.7 m-20 -84.66 -68.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mt -73.94 -14.48 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.839 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.23 -49.96 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 110.492 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 36' ' ' GLN . 3.1 m -171.17 118.18 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.787 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 7.8 p-10 -36.82 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.282 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.47 ' H ' ' CG ' ' A' ' 34' ' ' ASN . 11.1 pt -151.6 32.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.554 ' HB3' HG23 ' A' ' 33' ' ' THR . 8.7 tt0 -70.84 -68.72 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.804 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.39 85.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.954 0.407 . . . . 0.0 110.743 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.62 1.15 1.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.582 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -53.7 -61.16 2.48 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.178 0.513 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.5 ' HB3' HG22 ' A' ' 118' ' ' ILE . 1.9 m-80 -127.48 9.9 6.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.194 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -16.91 60.12 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.023 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.535 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . . . -88.05 -152.07 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.959 0.409 . . . . 0.0 111.448 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 45' ' ' SER . 26.1 t0 -107.82 -27.7 10.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.41 -33.1 0.23 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.63 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 51.0 m -66.07 -57.6 7.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.593 0.235 . . . . 0.0 111.497 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.485 ' HA ' ' NE2' ' A' ' 46' ' ' GLN . 12.2 mm100 -87.29 -13.1 44.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.549 HD21 HG22 ' A' ' 114' ' ' THR . 1.4 tt -57.67 -42.63 83.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.497 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -77.91 38.17 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.484 ' H ' ' C ' ' A' ' 47' ' ' LEU . 3.8 m -144.37 -79.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 110.556 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.607 HD23 ' HB2' ' A' ' 25' ' ' LEU . 4.6 mm? -52.6 -47.36 66.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.601 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -79.76 -30.6 40.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.782 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.3 4.69 29.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' CYS . 5.9 t -85.12 -30.25 24.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.015 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 51' ' ' LYS . 7.4 p -69.3 -20.19 24.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 60' ' ' MET . 59.8 mtt -66.09 -46.39 77.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.49 -16.9 41.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.341 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.41 -47.62 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.523 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.2 pt -92.06 33.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.723 -179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 54.25 30.2 11.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.448 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.4 tpt -91.55 -12.9 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -154.27 112.53 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.726 ' HG3' ' HH ' ' A' ' 67' ' ' TYR . 5.8 mmpt? -108.1 77.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.575 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.31 -70.21 2.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.004 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.6 p -143.2 18.46 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.574 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -102.72 110.82 22.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.053 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.6 mt -84.15 115.6 22.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.421 179.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.726 ' HH ' ' HG3' ' A' ' 62' ' ' LYS . 67.8 m-85 -96.4 -166.86 1.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.57 -15.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.54 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.1 mt-10 -60.79 -51.23 81.01 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 18.6 Cg_endo -60.95 -18.91 60.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.111 1.874 . . . . 0.0 112.539 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 75' ' ' ILE . 5.0 t -76.28 -49.2 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.514 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 24.6 m-85 -52.48 -22.27 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -78.74 -43.53 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.723 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.0 ptm -77.12 -36.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.546 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.595 HG21 HG21 ' A' ' 86' ' ' ILE . 88.2 mt -51.9 -25.49 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 110.193 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' HA ' HD12 ' A' ' 86' ' ' ILE . 50.2 mt-10 -61.71 -59.42 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.825 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.82 -35.61 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.916 0.389 . . . . 0.0 111.545 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.427 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 25.1 t -57.53 -11.62 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.484 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 73.8 m-70 -134.11 49.15 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.407 . . . . 0.0 110.521 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.7 135.68 54.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.6 -55.84 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.9 m120 -128.01 129.07 46.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.04 68.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.0 m-20 -84.24 -25.29 29.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.505 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.8 t0 -59.11 -32.71 70.08 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.595 HG21 HG21 ' A' ' 75' ' ' ILE . 68.0 mt -76.17 -29.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.539 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -78.42 -26.5 46.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.41 ' O ' HG12 ' A' ' 92' ' ' ILE . 55.5 tp -67.39 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG21 HD11 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.04 -28.97 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.489 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.514 ' HE2' ' HB3' ' A' ' 72' ' ' TYR . 3.7 tptm -48.3 -46.62 36.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.74 -27.75 49.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 121' ' ' LEU . 49.3 mm -62.91 -31.13 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.38 -22.94 66.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.18 -36.24 22.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.408 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.62 -24.43 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 111.266 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.475 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 37.7 m -86.35 -31.53 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.45 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.52 -35.66 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.463 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.179 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.475 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.9 p30 -109.87 -14.41 14.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.55 -18.37 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.503 ' HG2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -66.63 179.69 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.876 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.503 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 65.29 4.19 15.77 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.024 -0.607 . . . . 0.0 113.031 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -89.88 162.6 15.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t -119.76 -22.21 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.907 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.53 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t70 -97.33 143.56 27.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 0.0 111.25 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.79 -69.05 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.602 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.1 m -51.69 -26.24 8.84 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.73 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.53 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 6.2 m120 -70.85 -39.71 72.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 109.917 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.2 mt -69.15 -36.71 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.95 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.37 -53.71 27.44 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.583 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.497 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.4 t-20 -52.78 -58.12 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.539 0.209 . . . . 0.0 111.101 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.527 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.4 mmpt? -55.23 -21.19 13.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.273 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -86.76 -64.78 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.549 HG22 HD21 ' A' ' 47' ' ' LEU . 10.1 t -55.86 -31.04 62.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.93 -56.51 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -40.36 91.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.684 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -41.74 78.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.565 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 65.0 mt -77.73 -22.0 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -59.65 2.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.243 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -87.07 -54.23 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.506 ' C ' ' H ' ' A' ' 123' ' ' SER . 38.0 tp -83.32 -10.21 58.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.565 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 11.0 t80 68.49 -9.55 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.707 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 121' ' ' LEU . 33.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.06 135.63 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -51.0 -35.45 33.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.443 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -52.1 -47.42 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.787 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.645 HG22 ' HA ' ' A' ' 79' ' ' HIS . 91.1 m -48.69 -37.0 17.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.143 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.86 -66.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.49 -62.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.34 -26.5 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 5' ' ' THR . 34.0 mmtp -89.51 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.77 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.43 ' CE1' HG13 ' A' ' 78' ' ' VAL . 35.6 m-85 -55.47 -19.29 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.377 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.0 ttm -84.33 -59.23 2.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.71 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.354 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -64.88 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.374 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.57 47.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.262 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.493 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 31.4 ttm -64.71 -51.12 60.48 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.947 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 15' ' ' MET . 58.2 Cg_endo -69.89 -9.43 26.04 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.28 -17.16 20.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.79 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.504 HG12 HG23 ' A' ' 54' ' ' VAL . 73.5 mt -83.53 -48.25 17.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.475 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 59.7 mtt -43.61 -49.33 18.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.051 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 70.9 Cg_exo -40.12 -63.35 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.596 2.197 . . . . 0.0 113.494 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 39.0 m -72.1 -27.37 62.6 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.541 ' HA ' HD23 ' A' ' 50' ' ' LEU . . . -52.12 -42.4 63.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.84 0.352 . . . . 0.0 110.663 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.13 -16.67 42.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.524 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 8.4 tp10 -59.64 -54.63 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.924 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.546 HD13 HD21 ' A' ' 50' ' ' LEU . 19.3 mt -90.06 -41.05 11.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.676 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.43 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 12.9 t-80 176.44 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.765 0.793 . . . . 0.0 110.841 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.9 pt -145.66 168.14 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.343 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.549 ' HA ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -86.02 125.94 33.78 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.484 ' H ' HD13 ' A' ' 50' ' ' LEU . 1.5 mm-40 -52.87 -41.42 64.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.842 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.29 -26.9 68.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.909 0.385 . . . . 0.0 110.956 -179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.6 mt -104.62 -8.03 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.42 -45.2 65.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.612 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.52 113.58 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -39.74 -74.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.481 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.418 ' H ' ' NE2' ' A' ' 36' ' ' GLN . 23.1 pt -145.32 48.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.504 HE21 ' N ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -122.1 9.31 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.064 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.32 -75.34 0.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.645 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -177.24 -77.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -70.34 -61.07 1.91 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.599 HD21 HG21 ' A' ' 118' ' ' ILE . 6.0 p30 -125.04 -11.64 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.37 -16.59 31.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.053 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -85.9 4.99 34.95 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.582 -0.364 . . . . 0.0 111.401 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t70 60.74 171.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.595 ' HE3' HD22 ' A' ' 111' ' ' ASN . 39.4 ttp -122.97 -10.09 8.22 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.3 t -71.53 -58.34 3.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.594 0.235 . . . . 0.0 111.598 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.413 ' OE1' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.68 -13.25 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.839 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.606 ' HG ' ' HZ3' ' A' ' 51' ' ' LYS . 16.3 tp -67.78 -29.59 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.289 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -75.22 11.65 8.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.319 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -140.74 -71.26 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 111.674 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 28' ' ' SER . 3.4 tm? -48.75 -46.96 41.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HZ3' ' HG ' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.6 -24.9 53.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.232 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.16 -14.6 63.06 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.324 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.56 -41.4 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.504 HG23 HG12 ' A' ' 18' ' ' ILE . 40.5 t -61.89 -28.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.599 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 64.7 mtp -63.78 -56.14 17.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.538 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -66.72 -17.81 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.508 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.7 tpm_? -68.86 -31.3 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -113.23 31.48 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.602 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 58.94 13.64 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.607 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 10.8 tpt -77.98 -8.44 58.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.218 0.532 . . . . 0.0 110.622 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.564 HD13 HD12 ' A' ' 66' ' ' LEU . 59.1 tp -156.86 103.55 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 76.7 10.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.36 -59.9 3.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.474 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -147.56 7.73 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.599 0.238 . . . . 0.0 111.137 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.6 tp10 -96.72 110.82 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.585 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.564 HD12 HD13 ' A' ' 61' ' ' LEU . 2.6 mm? -73.42 109.99 7.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.66 -167.81 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -169.38 -8.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.566 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.2 mp0 -73.44 -51.46 5.6 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 19.6 Cg_endo -58.46 -38.19 91.23 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.296 1.998 . . . . 0.0 113.011 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.54 ' HA ' ' HE2' ' A' ' 74' ' ' MET . 59.4 t -57.87 -43.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.439 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.473 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 9.1 m-30 -53.02 -32.91 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -74.28 -30.79 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.252 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.54 ' HE2' ' HA ' ' A' ' 71' ' ' VAL . 12.2 mtm -78.63 -46.6 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.404 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 86' ' ' ILE . 64.8 mt -50.77 -27.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 41.4 mt-10 -60.78 -59.17 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.86 -44.86 16.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.551 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 HG13 ' CE1' ' A' ' 10' ' ' TYR . 55.5 t -49.99 -17.91 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.806 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.645 ' HA ' HG22 ' A' ' 5' ' ' THR . 50.5 m-70 -128.77 53.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.781 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 127.68 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -81.36 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.1 145.05 25.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.95 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.08 32.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.767 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.13 -28.47 35.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.706 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -56.82 -27.22 59.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.489 HG23 HG23 ' A' ' 75' ' ' ILE . 79.7 mt -80.54 -31.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.988 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -78.16 -19.36 54.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.467 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.8 -59.18 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.58 ' HA ' HD13 ' A' ' 92' ' ' ILE . 21.4 t -57.59 -23.59 20.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.94 0.4 . . . . 0.0 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 9.6 tptt -53.95 -48.48 70.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.182 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.2 58.77 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.074 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.58 HD13 ' HA ' ' A' ' 89' ' ' VAL . 68.4 mt -60.63 -40.76 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.641 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.17 -26.98 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.685 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.68 -30.22 25.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 9.7 tp10 -57.3 -28.86 63.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 1.5 m -86.65 -45.32 11.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.197 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.7 mt -53.91 -37.91 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.69 0.281 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.77 -31.98 70.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.85 -7.16 19.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.383 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 101' ' ' LYS . . . -103.18 -3.45 25.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.475 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.513 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 21.99 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.068 0.855 . . . . 0.0 112.829 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . 178.51 70.2 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.823 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.494 ' HG2' ' HE3' ' A' ' 101' ' ' LYS . 16.7 mm-40 -60.69 172.44 0.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.878 0.37 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.7 p -91.97 -45.47 8.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.217 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 109' ' ' ILE . 23.1 t70 -76.35 119.29 20.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.421 ' HA ' HD11 ' A' ' 109' ' ' ILE . 10.0 tp10 -48.96 -58.36 5.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.493 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.7 m -54.06 -24.95 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.4 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.94 -32.2 25.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.372 . . . . 0.0 110.55 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.479 HG13 ' O ' ' A' ' 105' ' ' ASP . 55.3 mt -70.12 -38.85 76.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.556 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.427 ' O ' HG21 ' A' ' 114' ' ' THR . . . -77.86 -51.65 5.77 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.7 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.595 HD22 ' HE3' ' A' ' 44' ' ' MET . 7.4 t-20 -49.93 -32.36 14.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.751 0.275 . . . . 0.0 111.083 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -80.02 -38.65 31.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 110.133 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -70.11 -64.68 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.776 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.49 ' HG1' HG12 ' A' ' 118' ' ' ILE . 14.9 t -49.53 -31.82 11.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.142 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.415 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 25.7 t70 -46.79 -71.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.66 -24.27 61.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.89 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.501 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -64.56 -58.59 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.656 0.265 . . . . 0.0 110.753 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.599 HG21 HD21 ' A' ' 40' ' ' ASN . 46.6 mm -59.79 -16.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.141 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 10.1 tp10 -68.49 -59.67 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.248 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 1.4 mptp? -87.25 -40.96 14.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.683 0.277 . . . . 0.0 111.541 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.431 ' HB3' ' O ' ' A' ' 117' ' ' TYR . 6.7 tt -58.6 -46.41 87.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.34 42.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.048 0.451 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.423 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.8 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . 0.438 ' H62' ' HE3' ' A' ' 74' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 34.0 pt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -83.82 143.09 30.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.312 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -13.95 62.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.99 -44.23 15.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.546 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 51.9 p -56.96 -26.76 60.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . 0.407 HG22 ' HE1' ' A' ' 79' ' ' HIS . 62.0 t -89.96 -67.36 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.89 -62.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -22.63 67.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.6 mptm? -90.44 -56.79 3.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.228 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.401 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 21.5 m-85 -54.32 -50.25 67.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.99 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.9 tpp -56.08 -40.57 73.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -80.6 -24.7 38.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.039 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.49 ' HH ' ' HA ' ' A' ' 74' ' ' MET . 8.2 t80 -59.79 -29.01 67.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 0.0 111.192 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.458 ' O ' HG13 ' A' ' 18' ' ' ILE . 97.4 mt -148.13 39.26 0.91 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.604 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.583 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 34.6 ttm -60.04 -51.17 82.43 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.292 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 23.7 Cg_exo -63.59 -22.84 70.49 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.088 1.859 . . . . 0.0 112.468 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.81 -10.62 53.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.393 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 14' ' ' LEU . 74.2 mt -87.95 -28.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.22 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.464 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 63.5 mtm -46.77 -48.79 49.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.464 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.6 Cg_exo -41.74 -56.51 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.61 2.207 . . . . 0.0 113.379 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -85.42 -18.52 33.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 111.144 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.435 ' HB1' ' HA ' ' A' ' 19' ' ' MET . . . -69.75 -10.87 60.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -83.77 -56.47 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.879 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.97 -50.33 9.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.006 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.438 ' O ' HD23 ' A' ' 50' ' ' LEU . 51.9 mt -90.17 40.08 0.99 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.444 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -62.3 72.06 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.489 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.649 HG22 ' HA ' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -153.4 45.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.013 178.791 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.0 p -47.73 156.57 0.31 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.255 -179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.416 ' HG2' ' C ' ' A' ' 42' ' ' ALA . 10.4 mt-10 -41.23 -26.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.254 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.81 -66.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.18 -5.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.211 0.529 . . . . 0.0 110.756 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.649 ' HA ' HG22 ' A' ' 27' ' ' ILE . . . -64.2 -10.25 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.392 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.8 m -49.84 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 70.72 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.501 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.423 HG22 ' O ' ' A' ' 35' ' ' ILE . 4.5 tt -166.31 22.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.299 0.571 . . . . 0.0 111.443 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -132.9 109.04 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.059 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -62.19 -7.93 4.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.79 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.511 ' HB3' ' SD ' ' A' ' 44' ' ' MET . . . 37.27 -108.24 0.06 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.457 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -93.66 -60.37 1.78 Allowed 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.668 HD21 ' H ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -126.73 4.63 6.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.122 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 93.68 -18.03 57.36 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' H ' ' ND2' ' A' ' 40' ' ' ASN . . . -89.48 -59.55 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HA ' ' HB2' ' A' ' 47' ' ' LEU . 1.7 p-10 -111.37 162.2 15.29 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' MET . . . . . 0.7 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.0 tpt -176.06 -142.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.65 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.7 ' H ' ' HG3' ' A' ' 44' ' ' MET . 22.8 t -78.23 -52.23 8.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -79.94 -23.25 41.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.084 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.708 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -87.12 -39.1 15.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.06 -10.92 62.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -73.26 -67.45 0.58 Allowed 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 25' ' ' LEU . 16.4 tp -51.7 -33.61 34.98 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 -28.62 61.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.546 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' N ' ' O ' ' A' ' 49' ' ' CYS . . . -74.54 -24.73 58.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.154 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.3 t -60.67 -31.49 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.47 -24.5 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.776 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 57.4 mtt -70.32 -58.38 3.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.099 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.57 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.96 -19.14 28.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.533 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.443 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.4 tpm_? -72.91 -31.12 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.361 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.18 33.95 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.44 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 61.22 10.52 3.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.689 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.486 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -77.09 -6.95 54.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.027 0.442 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.57 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 7.1 tt -152.62 99.49 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.686 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.475 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 7.5 mmpt? -86.27 77.8 9.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.44 -60.44 4.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.0 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 p -153.52 11.85 0.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.433 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 13.6 mm-40 -100.21 109.26 21.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.771 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.603 HD23 ' HB1' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -67.12 147.09 53.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.619 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . 0.486 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 27.9 m-85 -136.51 165.63 25.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -140.26 -11.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mp0 -57.31 -53.64 63.26 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.401 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.8 Cg_endo -66.05 -25.21 51.63 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.992 1.795 . . . . 0.0 112.107 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' O ' HG13 ' A' ' 75' ' ' ILE . 17.6 t -68.86 -43.88 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -55.35 -22.29 18.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.981 0.42 . . . . 0.0 110.524 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -80.67 -48.99 11.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.49 ' HA ' ' HH ' ' A' ' 13' ' ' TYR . 7.1 ptp -68.56 -37.0 79.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.371 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.453 HG22 ' HA ' ' A' ' 86' ' ' ILE . 95.0 mt -53.69 -21.94 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.286 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.39 -58.28 3.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.408 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.75 -39.79 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.77 -9.18 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.98 0.419 . . . . 0.0 111.661 -179.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.407 ' HE1' HG22 ' A' ' 6' ' ' VAL . 84.6 m-70 -130.49 40.86 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.3 122.84 14.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.411 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.11 -65.16 0.34 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.186 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -114.78 151.59 33.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.649 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.57 -20.74 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -84.81 -30.54 24.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.444 ' OD1' HG13 ' A' ' 86' ' ' ILE . 4.2 p30 -59.09 -21.12 58.73 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.453 ' HA ' HG22 ' A' ' 75' ' ' ILE . 68.8 mt -85.67 -30.02 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.119 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.24 -19.84 42.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.118 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.407 ' O ' HG12 ' A' ' 92' ' ' ILE . 64.3 tp -83.11 -63.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.329 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.501 HG11 HD23 ' A' ' 121' ' ' LEU . 46.5 t -52.27 -41.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.517 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.426 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 11.1 mttt -53.32 -32.39 48.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.549 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.57 -23.01 41.09 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.533 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.407 HG12 ' O ' ' A' ' 88' ' ' LEU . 39.6 mm -68.69 -37.83 78.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.01 66.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -79.22 -22.41 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.3 -18.9 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 -49.34 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.735 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mt -48.55 -24.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.91 -45.74 73.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.56 -21.31 32.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.603 ' HB1' HD23 ' A' ' 66' ' ' LEU . . . -71.88 -40.63 68.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.343 -179.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.57 35.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.96 68.82 1.49 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.462 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.46 ' HB2' HG13 ' A' ' 109' ' ' ILE . 12.4 mm-40 -68.57 160.1 30.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.583 0.23 . . . . 0.0 110.449 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -107.77 4.12 25.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.629 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 108' ' ' ASN . 12.7 t70 -108.18 147.41 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.03 -68.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.827 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.403 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 23.3 m -57.74 -41.49 81.95 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.219 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -56.81 -42.88 80.34 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.497 HG12 ' HZ3' ' A' ' 112' ' ' LYS . 1.6 mt -63.06 -31.82 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.499 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.71 -45.13 78.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 7.3 t-20 -72.6 -45.74 57.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.64 ' HD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -56.28 -47.56 78.37 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.64 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -74.16 -42.93 59.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.228 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . 0.508 HG21 ' HB2' ' A' ' 43' ' ' ASP . 5.7 t -69.37 -23.41 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.05 -61.48 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.153 0.502 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -40.92 84.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -31.09 65.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.358 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 32.6 mm -83.76 -31.02 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.924 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 38.6 tt0 -68.76 -56.1 9.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.966 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . 0.413 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 9.3 mptt -86.62 -48.65 8.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 123' ' ' SER . 45.9 tp -97.81 -14.61 20.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.469 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.0 t80 68.45 -13.08 0.32 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.518 ' H ' ' C ' ' A' ' 121' ' ' LEU . 46.8 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.874 0.369 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.303 0.573 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.81 -26.96 64.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.997 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -88.9 -23.45 22.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 121' ' ' LEU . 48.2 t -71.82 -51.41 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.222 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.96 -30.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.24 -31.42 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.419 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -79.53 -55.73 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.297 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -56.21 -28.25 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 111.225 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.8 ttm -81.29 -54.99 5.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.102 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.75 -23.61 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -70.24 -25.31 63.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -147.07 39.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 34.8 ttm -61.41 -51.86 74.49 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.362 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.6 Cg_endo -70.45 0.17 6.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.915 1.744 . . . . 0.0 111.944 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 20' ' ' PRO . 10.3 m-20 -112.26 -14.22 13.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.02 -31.61 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.652 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -62.3 -31.99 8.68 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD3' ' HG3' ' A' ' 19' ' ' MET . 15.1 Cg_exo -68.9 -35.49 15.33 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.768 1.645 . . . . 0.0 111.942 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.56 -52.7 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.405 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -55.39 -34.42 64.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.697 0.284 . . . . 0.0 111.502 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.574 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.42 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 5.8 ttt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 m -65.07 -48.88 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -87.26 -12.73 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.638 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD21 ' HD3' ' A' ' 51' ' ' LYS . 5.1 tt -74.27 -39.89 62.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.415 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.86 4.93 2.06 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.725 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -135.77 -61.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.545 0.212 . . . . 0.0 111.347 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.473 HD13 ' O ' ' A' ' 50' ' ' LEU . 3.0 tm? -48.2 -44.37 32.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' HD21 ' A' ' 47' ' ' LEU . 43.2 tttm -84.05 -20.36 32.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.649 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.84 -15.91 60.71 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.121 0.486 . . . . 0.0 110.059 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.63 -33.3 75.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.432 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 t -69.21 -22.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.204 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.444 ' HB3' ' HE2' ' A' ' 60' ' ' MET . 48.8 mtt -75.38 -52.62 10.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.52 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' H ' ' A' ' 61' ' ' LEU . 5.8 ptpp? -65.73 -16.42 63.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.0 tpm_? -70.93 -32.59 69.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 pt -102.37 23.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.228 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 60.95 49.83 5.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.559 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.507 ' HG3' ' HG2' ' A' ' 70' ' ' PRO . 5.7 ttp -120.41 -18.33 7.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.446 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 56' ' ' LYS . 19.1 tp -130.48 108.77 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.815 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.2 mmpt? -104.53 78.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.31 -70.71 2.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.038 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.0 p -137.35 9.7 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.18 103.34 15.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.93 114.62 23.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.452 . . . . 0.0 110.211 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -109.53 -167.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.968 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' A' ' 97' ' ' ILE . 10.6 p -163.1 -14.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.672 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 41.8 mt-10 -53.15 -54.37 45.35 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 60' ' ' MET . 10.8 Cg_endo -55.29 -29.4 67.26 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.006 1.804 . . . . 0.0 111.829 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 20.8 t -72.65 -39.44 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.352 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -57.48 -22.3 42.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -85.17 -37.11 20.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.105 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 11.9 ptm -80.4 -30.1 37.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.876 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.731 HG22 HG23 ' A' ' 86' ' ' ILE . 96.8 mt -59.39 -22.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 -54.72 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.266 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.01 -45.05 16.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -48.53 -27.19 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.271 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.408 ' CD2' HG23 ' A' ' 75' ' ' ILE . 85.4 m-70 -118.54 54.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.609 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.92 51.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.97 -72.18 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.317 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.6 m120 -110.84 155.3 22.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 110.716 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -81.45 -37.44 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.52 -28.96 41.31 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.137 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -56.25 -31.88 63.96 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 75' ' ' ILE . 87.9 mt -78.36 -32.92 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.08 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 80.5 mm-40 -74.99 -19.8 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 tp -76.13 -55.58 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.618 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HD12 ' A' ' 92' ' ' ILE . 38.8 t -55.59 -28.89 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -58.12 -49.06 78.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.618 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.9 -26.96 69.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.253 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 120' ' ' LYS . 58.3 mt -61.49 -45.09 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.61 69.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.598 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.6 tp10 -65.42 -27.33 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.2 m -80.1 -28.81 38.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.951 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD11 ' HB ' ' A' ' 68' ' ' VAL . 78.0 mt -77.15 -43.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.87 -14.92 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.51 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 112' ' ' LYS . 8.1 t-20 -94.22 -43.78 8.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 110.625 179.737 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.766 0.317 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.1 t70 -77.94 139.94 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.935 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.65 -61.73 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.0 m -54.17 -27.69 35.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.5 t-20 -72.28 -44.05 63.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.65 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.52 -47.27 93.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.025 0.441 . . . . 0.0 110.673 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.33 -41.42 85.68 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.337 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.42 ' OD1' ' HG3' ' A' ' 44' ' ' MET . 16.2 t30 -58.08 -36.94 73.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.11 0.455 . . . . 0.0 110.824 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.0 mmpt? -78.39 -37.54 43.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.52 -27.18 58.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.603 HG21 HD22 ' A' ' 47' ' ' LEU . 11.1 t -79.71 -46.88 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 110.249 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 114' ' ' THR . 26.3 t70 -46.45 -60.26 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -40.58 70.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.797 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -27.41 67.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.236 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -84.68 -32.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -69.83 -44.71 69.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.027 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 71.0 mmtt -87.05 -58.56 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.3 tm? -97.63 -15.73 20.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER 73.36 -19.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.592 0.234 . . . . 0.0 111.302 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 121' ' ' LEU . 36.8 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.818 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.875 0.369 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.8 m-20 -83.85 -55.89 4.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.195 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 81.0 p -52.03 -31.52 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.715 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.47 -64.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.822 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.13 -60.67 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -53.29 -31.18 42.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.97 -59.13 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.113 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -52.56 -23.46 6.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 111.366 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 tpp -80.48 -56.78 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.15 -23.61 67.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.139 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.04 -33.75 72.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.024 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 58' ' ' ILE . 65.5 mt -146.9 50.91 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.2 tmm? -71.45 -50.57 10.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.409 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 15' ' ' MET . 73.7 Cg_endo -75.05 -24.7 12.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.232 1.955 . . . . 0.0 112.62 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.39 -9.95 59.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.329 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.13 -27.81 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.361 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 62.3 mtt -53.1 -48.58 91.52 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 33.2 Cg_exo -60.85 -36.13 85.25 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.396 2.064 . . . . 0.0 112.703 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.8 m -54.83 -46.27 74.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.866 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.98 -46.53 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.148 179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 5.0 ptt? . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.776 0.322 . . . . 0.0 110.575 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -65.39 -51.84 57.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.913 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 50' ' ' LEU . 4.3 mm100 -87.15 -12.89 45.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HG ' HG21 ' A' ' 114' ' ' THR . 48.8 tp -66.51 -25.73 66.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -88.17 8.26 78.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.388 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 13.6 m -137.01 -71.49 0.44 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.673 -0.263 . . . . 0.0 111.428 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -48.26 -39.72 22.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB2' HD12 ' A' ' 47' ' ' LEU . 8.4 tptp -84.26 -23.76 30.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.601 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.74 -16.86 62.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.45 -37.9 79.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.914 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 14' ' ' LEU . 59.0 t -63.22 -30.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.452 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 54.6 mtt -70.56 -58.5 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -61.1 -19.36 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.589 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -72.44 -29.55 63.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.479 HD11 ' SD ' ' A' ' 60' ' ' MET . 49.3 pt -106.24 13.98 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.64 55.69 1.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.07 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 17.6 ptm -133.3 15.01 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 0.0 110.183 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 66' ' ' LEU . 66.6 tp -164.57 109.77 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.507 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -108.56 77.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.14 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.41 -28.48 0.7 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.224 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -175.54 -15.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -84.55 110.47 18.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.9 mm? -77.27 149.97 35.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 111.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 74.9 m-85 -147.07 136.04 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.9 15.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.841 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.8 mt-10 -67.64 -51.91 28.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 39.6 Cg_endo -70.77 -24.06 25.48 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.039 1.826 . . . . 0.0 112.564 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG12 HD11 ' A' ' 75' ' ' ILE . 11.0 t -73.32 -50.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.253 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.52 ' HA ' HD12 ' A' ' 75' ' ' ILE . 5.7 m-30 -51.37 -22.16 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.643 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -78.85 -42.36 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -77.76 -36.84 50.21 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 121.338 -0.145 . . . . 0.0 110.875 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.555 HG22 HG23 ' A' ' 86' ' ' ILE . 72.4 mt -51.45 -21.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.361 0.601 . . . . 0.0 109.918 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 44.9 mt-10 -63.89 -59.31 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.376 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.4 -41.64 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.904 0.383 . . . . 0.0 110.896 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 9' ' ' LYS . 25.1 t -47.54 -26.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.485 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.594 ' CE1' HG11 ' A' ' 89' ' ' VAL . 71.2 m80 -125.11 55.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.76 55.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.71 -79.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.341 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.08 133.64 44.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 111.013 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.6 66.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.71 -28.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.959 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.74 -29.21 64.59 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.555 HG23 HG22 ' A' ' 75' ' ' ILE . 82.7 mt -76.56 -30.72 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.111 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.5 -19.19 42.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.908 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.594 HG11 ' CE1' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -61.4 -32.48 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.808 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.53 -32.65 58.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.672 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.51 -23.32 43.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.04 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.6 mt -69.14 -30.74 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -64.39 -23.48 67.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.276 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -79.58 -33.56 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.15 -31.21 72.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 10.8 m -79.4 -21.45 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 93' ' ' ALA . 94.5 mt -76.12 -46.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 111.285 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.61 -30.16 70.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.51 -51.29 8.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.34 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.744 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.569 0.223 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 14.5 t70 -74.41 136.42 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -50.91 -68.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.92 -33.83 38.88 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 9.6 m120 -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -74.01 -32.62 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.49 -56.44 9.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.976 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.408 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 30.6 t30 -48.95 -24.61 1.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.6 -44.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.63 -59.32 4.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.059 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 110' ' ' GLY . 8.9 t -53.44 -46.14 69.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.207 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.459 ' N ' HG23 ' A' ' 114' ' ' THR . 16.6 t70 -42.28 -52.32 4.52 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.98 0.419 . . . . 0.0 111.264 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -44.32 93.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.06 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.285 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 40.6 mt -83.23 -20.46 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.76 -59.09 4.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.07 -54.9 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 123' ' ' SER . 33.0 tp -86.32 -10.82 53.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 19.8 t80 67.21 -9.23 0.4 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 110.783 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 121' ' ' LEU . 60.7 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.801 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 2.7 p30 -74.31 -27.0 60.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.3 p -82.66 -20.69 35.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.681 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.37 -63.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.726 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.01 -51.94 60.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.48 -29.64 70.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.3 mmmt -88.27 -59.35 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.554 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -50.39 -20.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 0.0 111.019 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.7 mmm -85.39 -62.06 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.801 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.42 -51.9 32.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.772 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -52.87 -21.06 3.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD13 HG11 ' A' ' 54' ' ' VAL . 48.0 mt -133.92 26.03 3.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.596 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.6 ttp -71.95 -49.41 10.33 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 15' ' ' MET . 29.7 Cg_endo -61.8 -21.97 73.35 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.005 1.803 . . . . 0.0 112.649 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 14' ' ' LEU . 2.2 p30 -102.03 -7.35 22.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -44.17 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.006 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 57.6 mtt -47.02 -49.83 48.54 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.52 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -57.89 -49.35 13.21 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.206 1.937 . . . . 0.0 112.671 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -56.55 -44.35 80.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.474 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -55.44 -47.17 76.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.166 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.445 . . . . 0.0 110.332 179.897 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 54.8 ttp . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -49.07 -55.23 12.77 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 3.5 tp-100 -86.9 -12.43 47.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -64.91 -37.48 87.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.026 0.441 . . . . 0.0 110.045 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 5.04 20.63 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.147 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -135.34 -70.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 2.3 tm? -45.77 -51.39 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.6 tpmt? -74.4 -24.65 59.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.418 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.0 -14.12 60.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 3.6 t -64.41 -39.23 93.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 14' ' ' LEU . 63.2 t -68.13 -28.86 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.755 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 86.9 mtp -58.86 -41.27 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -79.82 -15.69 56.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.079 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.8 mmp_? -71.91 -42.6 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.096 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 pt -92.1 24.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.564 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 57.25 30.47 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.421 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 25.7 ttt -99.95 -0.87 38.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.039 0.447 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 64.1 tp -157.95 99.87 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.96 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.3 mmpt? -86.9 76.56 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.225 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.3 3.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.54 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -147.12 4.03 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.697 0.284 . . . . 0.0 111.155 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 37.4 mt-10 -96.63 120.77 37.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.624 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 100' ' ' ALA . 36.4 mt -78.91 151.06 31.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.946 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.496 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 60.9 m-85 -143.15 148.57 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.637 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.09 7.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.57 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mm-40 -73.5 -49.17 6.72 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.79 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 71.8 Cg_endo -77.26 -23.74 9.99 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.105 1.87 . . . . 0.0 113.137 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 2.3 p -73.41 -44.91 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.642 0.258 . . . . 0.0 111.192 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 18.6 m-30 -60.04 -22.32 62.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.81 -44.05 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.882 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 25.5 ptm -72.47 -43.21 64.03 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.202 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -49.2 -23.58 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 86' ' ' ILE . 30.8 mt-10 -60.38 -59.49 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.414 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.31 -34.88 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.21 0.529 . . . . 0.0 110.951 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.494 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 40.7 t -58.71 -8.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.087 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 71.0 m80 -141.04 52.11 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.429 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.69 136.54 53.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.182 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.53 -67.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.158 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 3.5 m-20 -124.37 142.6 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.55 -28.52 69.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 5.6 m-20 -83.78 -25.83 30.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.287 . . . . 0.0 110.349 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.1 t70 -57.97 -30.06 65.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.604 HG23 HG22 ' A' ' 75' ' ' ILE . 79.5 mt -83.95 -26.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.616 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.6 OUTLIER -79.71 -22.01 43.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.497 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 92' ' ' ILE . 57.2 tp -78.23 -58.5 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.019 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.41 -36.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 72' ' ' TYR . 1.7 mttm -60.66 -34.97 75.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.61 -25.14 54.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.39 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.644 HD12 ' HB3' ' A' ' 120' ' ' LYS . 42.3 mm -69.71 -43.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.126 0.488 . . . . 0.0 111.109 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.36 -17.62 59.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.677 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.65 -22.67 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.973 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -82.54 -37.71 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.275 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 5.8 m -64.05 -27.65 69.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.506 HG23 HD12 ' A' ' 66' ' ' LEU . 62.0 mt -74.49 -34.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.608 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.1 p30 -91.42 -17.64 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 111.058 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' O ' HD11 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.265 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -92.26 123.56 35.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp10 -37.15 -65.58 0.29 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.934 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 96.0 m -46.76 -50.52 18.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.21 -36.14 68.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 106' ' ' GLU . 56.2 mt -67.15 -41.4 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 114' ' ' THR . . . -73.41 -45.37 30.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.147 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -48.56 -60.78 2.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.883 0.341 . . . . 0.0 111.273 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 14.3 mmtm -54.49 -37.08 64.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -69.31 -64.07 0.94 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.227 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 4.1 t -47.3 -56.98 5.76 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.509 ' H ' HG23 ' A' ' 114' ' ' THR . 70.6 m-20 -35.32 -54.54 0.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -51.4 -48.04 62.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.872 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -34.5 65.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.452 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 3.6 mp -81.77 -27.82 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.262 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.49 -47.28 56.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.812 0.339 . . . . 0.0 111.271 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.644 ' HB3' HD12 ' A' ' 92' ' ' ILE . 71.6 mmtt -87.02 -58.33 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 123' ' ' SER . 26.1 tp -96.06 -10.18 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.74 -24.12 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.434 0.159 . . . . 0.0 110.602 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.978 HE21 ' N ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 121.048 0.451 . . . . 0.0 110.911 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 18.1 t70 -65.84 -54.86 21.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 53.5 p -57.36 -35.69 70.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 123' ' ' SER . 57.6 t -87.22 -64.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -58.78 -62.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.76 -25.78 42.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.2 mptm? -88.23 -54.6 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.714 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -57.88 -23.37 52.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -82.75 -56.13 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.84 -25.73 68.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.272 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -53.19 -46.26 68.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.263 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -152.1 45.11 0.74 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.766 0.317 . . . . 0.0 111.453 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.546 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 ttp -52.39 -50.25 80.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 15' ' ' MET . 33.4 Cg_endo -63.84 -32.33 66.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.051 1.834 . . . . 0.0 112.749 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 m-20 -84.45 -9.66 58.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 mt -86.37 -29.11 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.324 . . . . 0.0 110.855 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 25.5 mmt -54.75 -47.27 98.57 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.965 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 19' ' ' MET . 48.8 Cg_exo -37.83 -49.43 2.05 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.939 2.426 . . . . 0.0 113.475 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.9 m -85.01 -35.57 21.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.72 47.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 179.654 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.42 ' CA ' HD21 ' A' ' 111' ' ' ASN . 22.7 ttt . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -48.03 -40.47 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -87.43 -27.93 22.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 2.9 mp -66.81 -7.5 21.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -94.05 7.07 73.03 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.187 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 36.2 m -131.75 -70.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.227 . . . . 0.0 111.452 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.7 tp -51.56 -55.07 21.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 1.4 tpmt? -64.68 -23.2 67.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.215 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.17 -15.85 57.48 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.581 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.06 -25.45 66.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.081 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.31 -36.87 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.524 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.408 ' HB2' ' HE3' ' A' ' 55' ' ' MET . 72.6 mtm -68.5 -40.42 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -73.09 -20.02 61.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -86.06 -27.49 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' A' ' 60' ' ' MET . 48.5 pt -94.75 17.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.1 34.22 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.413 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.447 ' HB2' HG13 ' A' ' 58' ' ' ILE . 26.6 ttt -104.35 1.9 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.166 0.507 . . . . 0.0 110.544 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 66' ' ' LEU . 50.0 tp -153.18 98.79 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.757 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.3 mmpt? -104.67 104.67 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 48.14 51.61 19.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.356 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 109' ' ' ILE . 8.8 p 73.66 34.55 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.242 0.617 . . . . 0.0 111.479 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.0 106.08 9.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.679 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.2 mm? -68.45 147.27 52.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.378 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.97 169.31 13.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.35 . . . . 0.0 111.223 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.06 -25.69 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.358 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 48.1 mt-10 -62.37 -47.96 88.18 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.115 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 36.9 Cg_endo -65.07 -42.46 13.95 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.275 1.983 . . . . 0.0 113.445 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.544 HG13 ' HD1' ' A' ' 72' ' ' TYR . 3.1 p -65.23 -46.51 90.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.592 0.234 . . . . 0.0 111.395 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HD1' HG13 ' A' ' 71' ' ' VAL . 4.6 m-30 -59.29 -22.0 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.278 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 21.8 tptm -84.62 -45.56 12.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.4 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 1.2 ptp -70.84 -42.66 69.88 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.461 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.599 HG22 HG23 ' A' ' 86' ' ' ILE . 95.5 mt -48.73 -27.81 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.739 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 36.9 mt-10 -59.64 -59.22 5.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.716 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.5 -39.72 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.083 0.468 . . . . 0.0 110.811 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.77 -9.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.362 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 73.6 m80 -143.47 56.75 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.9 137.54 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.11 -53.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.43 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -128.05 154.66 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.81 -29.4 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.351 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 4.1 p30 -83.52 -29.34 27.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.76 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -28.56 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 75' ' ' ILE . 88.9 mt -83.33 -29.06 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.237 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -76.78 -22.4 53.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.357 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 92' ' ' ILE . 69.6 tp -75.94 -60.12 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.768 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 121' ' ' LEU . 35.0 t -55.23 -35.97 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.93 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -33.96 60.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.25 -28.75 24.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 120' ' ' LYS . 31.3 mm -65.39 -36.29 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.0 64.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -74.21 -40.99 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.634 ' HG2' ' HE2' ' A' ' 120' ' ' LYS . 8.2 tp10 -62.57 -18.14 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.544 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 57.9 m -86.18 -53.89 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.747 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.6 mt -51.07 -30.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 111.295 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.52 -51.94 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.804 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.5 p30 -81.74 -5.93 58.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.647 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.863 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.689 0.281 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 108' ' ' ASN . 15.1 t70 -99.96 144.95 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.01 -70.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.0 m -50.02 -24.15 2.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.684 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.406 ' CG ' ' HB3' ' A' ' 105' ' ' ASP . 5.5 m-20 -70.09 -58.18 4.1 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -52.44 -41.66 36.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.87 -36.0 85.88 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.58 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.579 ' HA ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -68.62 -40.49 80.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.989 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -61.7 -27.15 68.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -59.32 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.001 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 111' ' ' ASN . 8.7 t -46.76 -45.14 19.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.814 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 114' ' ' THR . 13.7 t70 -48.12 -61.72 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -49.27 73.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -36.91 42.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.4 mm -79.49 -28.66 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 110.93 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 37.9 tt0 -69.53 -53.13 20.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 11.3 mptt -85.13 -55.94 3.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 HG13 ' A' ' 89' ' ' VAL . 39.0 tp -95.56 -11.32 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER 69.14 -16.93 0.22 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 121' ' ' LEU . 37.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.92 0.39 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 9.6 m-20 -73.13 -26.7 61.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 69.4 p -81.54 -20.87 39.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 109.716 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 123' ' ' SER . 87.0 t -82.38 -63.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.813 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -65.13 -52.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.39 -27.98 68.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.05 -55.88 3.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.783 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -54.05 -24.24 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -79.23 -62.03 1.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.64 -23.62 67.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.792 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 5.2 t80 -56.56 -35.89 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.425 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.544 HD12 HG13 ' A' ' 54' ' ' VAL . 41.4 mt -151.59 28.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.6 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 36.3 ttp -47.41 -50.44 49.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 21.5 Cg_exo -65.84 -30.7 49.12 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.213 1.942 . . . . 0.0 112.351 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.37 -7.55 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.425 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 14' ' ' LEU . 93.3 mt -83.95 -25.78 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.635 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.519 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.4 mmt -49.11 -50.06 65.65 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.192 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 96.0 Cg_exo -41.93 -53.92 3.19 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.614 2.209 . . . . 0.0 113.251 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.0 m -82.29 -20.98 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.897 0.38 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -74.86 -2.73 28.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.769 179.6 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.87 ' HA ' HD22 ' A' ' 111' ' ' ASN . 64.3 m -52.41 -51.52 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.1 mm100 -87.66 -28.5 21.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.766 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 44' ' ' MET . 6.5 mp -64.13 -21.85 66.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.77 -8.18 63.21 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.296 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -137.31 -62.47 0.62 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' HD22 ' A' ' 50' ' ' LEU . 1.9 tm? -48.42 -41.81 30.3 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 26.2 ttpp -82.3 -23.93 34.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.622 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.66 -6.62 57.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.273 0.558 . . . . 0.0 109.753 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.1 t -64.58 -28.19 69.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.722 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 HD12 ' A' ' 14' ' ' LEU . 59.0 t -70.17 -26.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.933 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.25 -56.63 7.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 46.1 mtmt -55.12 -26.7 40.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -72.1 -33.51 67.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 14' ' ' LEU . 42.7 pt -100.2 22.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.477 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 58.26 29.29 17.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -97.43 -10.04 26.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.75 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 5.6 tt -149.15 114.66 5.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -107.82 77.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.58 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 -74.1 1.75 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -126.77 -1.57 6.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.503 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -91.0 156.16 18.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.638 HD21 HG13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -135.55 131.19 35.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.515 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' HD12 ' A' ' 66' ' ' LEU . 31.3 m-85 -118.84 170.83 8.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.4 m -137.72 -3.67 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 42.6 mt-10 -67.54 -49.51 40.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.1 Cg_endo -65.47 -28.23 53.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.101 1.867 . . . . 0.0 113.107 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -72.02 -41.63 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 111.083 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 21.6 m-30 -56.6 -22.06 31.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.263 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.82 -40.49 22.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.791 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 14.4 ptm -77.44 -38.44 49.47 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.101 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 86' ' ' ILE . 94.1 mt -50.97 -23.57 2.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.041 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 37.1 mt-10 -60.59 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.912 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.095 0.474 . . . . 0.0 110.983 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 34.0 t -64.14 -7.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' NE2' HG21 ' A' ' 89' ' ' VAL . 94.6 m-70 -144.58 50.76 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.58 134.83 55.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.52 -68.51 0.48 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.559 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.06 147.53 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.36 -21.47 53.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.408 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.547 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 7.5 m-20 -84.14 -27.17 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.956 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.22 -27.22 63.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 75' ' ' ILE . 83.5 mt -85.93 -26.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.475 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -81.26 -21.41 39.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.819 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 92' ' ' ILE . 42.6 tp -81.33 -57.78 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 121' ' ' LEU . 87.5 t -54.27 -36.22 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 72' ' ' TYR . 9.2 mttt -62.66 -31.42 72.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.975 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.26 47.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.221 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 88' ' ' LEU . 74.3 mt -73.06 -40.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.684 0.278 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.89 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.55 -26.07 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.487 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.7 tp10 -77.97 -19.64 54.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.043 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -86.28 -43.4 12.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.501 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.638 HG13 HD21 ' A' ' 66' ' ' LEU . 2.0 mp -58.89 -41.67 83.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.678 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.31 -14.46 61.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.7 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.66 -75.21 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.111 179.637 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 109' ' ' ILE . 24.0 t70 -87.93 122.84 32.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.55 0.214 . . . . 0.0 110.763 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.6 tt0 -42.07 -66.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.128 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.94 -36.13 16.62 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -67.46 -42.54 82.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 105' ' ' ASP . 50.6 mt -58.75 -50.75 78.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.491 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 114' ' ' THR . . . -64.82 -36.85 93.59 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.719 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.87 HD22 ' HA ' ' A' ' 45' ' ' SER . 4.9 m-80 -48.36 -38.36 19.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.011 0.405 . . . . 0.0 111.372 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.43 -24.15 25.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.888 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.03 -64.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 110' ' ' GLY . 5.2 t -54.06 -28.51 39.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -53.36 -70.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.337 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -34.53 62.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.572 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -33.97 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 0.0 110.562 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 75.1 mt -85.08 -17.14 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 110.271 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.21 -58.66 3.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' A' ' 120' ' ' LYS . 2.8 mptp? -87.36 -49.15 7.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -91.0 -12.02 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.064 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 71.54 -23.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -179.0 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.551 ' HB3' HG11 ' A' ' 6' ' ' VAL . 64.0 p . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.996 0.427 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.94 -52.93 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.053 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.0 p -51.21 -29.98 15.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.128 0.49 . . . . 0.0 110.97 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 53.7 t -77.48 -63.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.589 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.05 -59.46 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.79 -35.91 15.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.1 mmmt -88.74 -59.42 2.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 13.7 m-85 -49.86 -29.1 7.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.31 . . . . 0.0 111.551 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.6 tpp -71.98 -55.46 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.69 -46.49 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.452 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.448 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 2.5 t80 -45.34 -39.87 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.352 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 54' ' ' VAL . 26.3 mt -145.3 63.53 1.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.447 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.495 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 57.2 ttp -83.9 -52.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.599 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 71.6 Cg_endo -77.41 -27.31 6.52 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.968 1.779 . . . . 0.0 111.721 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 9.6 m-20 -72.38 -10.87 60.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.576 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 14' ' ' LEU . 2.8 mt -77.29 -39.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.604 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 17.0 mmt -48.54 -51.66 50.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.935 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 74.2 Cg_exo -49.57 -51.5 10.62 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.265 1.977 . . . . 0.0 112.746 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.44 -43.23 83.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.499 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.617 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -60.18 -44.08 95.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 49.9 ttp . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.304 . . . . 0.0 111.376 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -51.98 -57.07 10.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.278 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -85.05 -12.33 53.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.483 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 16.5 tp -62.73 -39.74 95.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.084 0.468 . . . . 0.0 110.139 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 110' ' ' GLY . . . -69.87 4.7 7.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.478 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 107' ' ' CYS . 1.8 m -131.48 -72.54 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.703 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm? -47.32 -54.05 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.36 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 16.8 tptp -71.97 -23.5 61.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.596 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.12 -18.63 61.88 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.036 0.446 . . . . 0.0 110.092 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.92 -36.13 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.222 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 14' ' ' LEU . 67.0 t -59.58 -27.53 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 60' ' ' MET . 56.2 mtt -65.65 -51.84 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.575 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 56' ' ' LYS . 47.2 mttt -66.09 -15.94 63.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.209 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 5.6 tpm_? -69.33 -45.81 68.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 60' ' ' MET . 36.8 pt -91.55 29.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.442 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 55.33 29.94 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 ttt -94.34 -17.73 22.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 60.4 tp -144.13 101.94 3.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 5.9 mmpt? -84.16 77.45 9.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.945 0.402 . . . . 0.0 110.124 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.42 -57.09 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.2 p -153.52 9.32 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 28.7 mm-40 -94.5 108.18 20.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 HG12 ' A' ' 109' ' ' ILE . 7.6 mp -67.66 138.22 56.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 60' ' ' MET . 62.5 m-85 -139.31 159.75 41.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.26 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.22 -10.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.363 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.1 mt-10 -56.85 -50.27 89.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.8 -14.13 35.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.001 1.801 . . . . 0.0 112.001 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 HD11 ' A' ' 75' ' ' ILE . 24.5 t -78.76 -47.44 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.045 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -63.3 -27.35 69.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -76.56 -30.08 56.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.256 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.5 ptm -85.73 -43.94 12.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.35 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.726 HG22 HG23 ' A' ' 86' ' ' ILE . 93.7 mt -51.62 -33.84 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 110.549 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' HA ' HD13 ' A' ' 86' ' ' ILE . 29.5 mt-10 -53.8 -57.49 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.97 -24.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 111.171 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 9' ' ' LYS . 6.3 t -67.61 -11.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.944 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 90.5 m-70 -134.05 49.96 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.467 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.23 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.55 -70.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.16 148.35 31.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.913 0.387 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.09 -35.84 36.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.719 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 -30.85 51.32 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.955 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -21.78 6.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.726 HG23 HG22 ' A' ' 75' ' ' ILE . 63.5 mt -85.93 -55.03 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.5 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 90' ' ' LYS . 9.1 mm100 -52.81 -25.68 12.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.732 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 92' ' ' ILE . 63.8 tp -71.66 -46.55 58.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.588 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 75' ' ' ILE . 43.0 t -69.15 -41.71 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.317 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 86' ' ' ILE . 9.2 mtmt -55.11 -27.12 42.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.28 -24.52 36.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.356 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 121' ' ' LEU . 47.2 mm -61.87 -40.16 86.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.725 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -59.88 -30.1 68.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.72 -23.53 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.04 -38.65 31.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.624 ' HA ' HD22 ' A' ' 99' ' ' ASN . 72.9 m -74.13 -36.36 64.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.653 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 93' ' ' ALA . 93.4 mt -56.46 -27.35 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -52.35 7.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.196 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.624 HD22 ' HA ' ' A' ' 96' ' ' CYS . 23.2 p30 -70.78 -17.13 62.79 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.635 0.255 . . . . 0.0 111.272 -179.477 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.753 0.311 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.6 t70 -72.87 134.73 44.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.35 -61.6 2.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.726 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 54.0 m -60.59 -10.3 4.99 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.1 t-20 -86.66 -53.61 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 110.243 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.553 HG12 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -51.31 -34.81 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 48' ' ' GLY . . . -85.93 -51.47 3.58 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.891 -0.671 . . . . 0.0 114.296 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 14.5 t30 -52.96 -23.86 8.16 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.7 0.75 . . . . 0.0 110.446 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -87.49 -40.82 13.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.923 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.15 -64.96 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.843 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 p -46.21 -45.57 17.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.988 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 14.7 t70 -43.9 -72.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.823 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.18 -32.32 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.822 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -56.18 -38.46 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 110.532 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.8 mt -83.45 -19.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 110.275 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -71.24 -60.11 2.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 92' ' ' ILE . 67.2 mttm -87.17 -50.77 6.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.5 HD22 HG13 ' A' ' 89' ' ' VAL . 57.0 tp -85.35 -11.87 53.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 6.3 t80 66.72 -6.03 0.58 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 0.0 110.504 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 121' ' ' LEU . 68.1 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.832 0.348 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.6 -43.98 87.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.552 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 5.6 t -52.54 -25.48 10.56 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.8 t -87.67 -64.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.449 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.72 -61.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.03 -28.27 23.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.4 mmtm -88.62 -59.6 2.19 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.53 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -51.14 -21.29 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.8 mtt -83.31 -61.59 1.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.306 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -52.56 64.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 4.8 t80 -43.9 -33.82 1.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.46 HD11 HG21 ' A' ' 58' ' ' ILE . 90.9 mt -146.64 59.75 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.452 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 37.9 tpp -89.15 -51.28 0.37 Allowed Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.7 Cg_endo -72.69 -12.46 26.68 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.991 1.794 . . . . 0.0 111.685 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.01 -9.86 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.884 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 mt -89.21 -47.35 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.707 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.483 ' CG ' ' HD3' ' A' ' 20' ' ' PRO . 19.3 ptp -53.84 -34.05 18.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HD3' ' CG ' ' A' ' 19' ' ' MET . 52.2 Cg_exo -54.48 -52.55 7.92 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.419 1.413 . . . . 0.0 112.978 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.84 -22.88 60.72 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.514 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -53.92 -42.17 68.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.646 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.332 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.587 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 10.2 ttt . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.558 0.218 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.7 p -59.05 -43.54 91.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.27 . . . . 0.0 110.703 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 4.1 tp-100 -87.81 -30.25 20.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.5 tm? -54.29 -44.9 72.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 110.054 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 110' ' ' GLY . . . -66.15 6.49 1.59 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.807 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.6 m -134.3 -72.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.2 tm? -46.56 -51.49 15.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.522 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB3' HD13 ' A' ' 47' ' ' LEU . 27.4 tptp -75.37 -22.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.37 -20.13 62.98 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.5 t -60.99 -34.23 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.5 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.86 -26.88 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.7 mtm -69.06 -51.98 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.826 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 30.7 pttt -75.82 -15.75 60.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.5 tpm_? -70.45 -30.15 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.751 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 14' ' ' LEU . 45.9 pt -105.86 26.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.488 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 57.93 63.11 1.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -139.65 -10.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.53 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 30.0 tp -134.84 99.48 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.54 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -94.16 76.61 4.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.188 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.26 -58.73 3.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.285 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.9 p -148.25 4.26 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.714 0.292 . . . . 0.0 110.994 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt-10 -94.16 131.26 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.1 mt -113.74 113.83 25.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.139 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -106.15 177.85 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.61 25.49 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.541 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 43.7 mt-10 -79.19 -50.21 1.39 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.625 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 60.0 Cg_endo -74.44 -38.45 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.148 1.898 . . . . 0.0 113.067 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG13 ' HE3' ' A' ' 74' ' ' MET . 11.8 t -63.59 -46.1 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.633 0.254 . . . . 0.0 111.13 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -60.88 -21.81 63.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.371 . . . . 0.0 110.62 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -82.12 -48.01 11.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.743 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.58 ' HE3' HG13 ' A' ' 71' ' ' VAL . 14.7 ptt? -74.61 -35.43 62.94 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.91 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.692 HG22 HG23 ' A' ' 86' ' ' ILE . 9.6 mt -49.68 -26.15 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.076 0.465 . . . . 0.0 110.418 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -59.05 5.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.497 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.68 -24.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.198 0.523 . . . . 0.0 111.146 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 25.1 t -67.27 -7.39 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 79.9 m80 -138.05 43.28 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.56 134.65 57.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.86 -60.92 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.408 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.681 ' HB3' ' HB2' ' A' ' 85' ' ' ASP . 30.3 t30 -116.87 132.16 56.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 110.514 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.87 67.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 -22.3 30.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.681 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 13.8 t70 -62.04 -24.18 66.92 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.692 HG23 HG22 ' A' ' 75' ' ' ILE . 93.3 mt -85.13 -29.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.661 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -81.48 -21.98 38.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.578 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.97 -60.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.24 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.666 HG12 HD13 ' A' ' 121' ' ' LEU . 24.3 m -54.93 -31.5 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -58.02 -41.95 84.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.648 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.7 -18.88 72.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.802 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 89' ' ' VAL . 50.9 mt -67.54 -41.03 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.728 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.96 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.283 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.3 -48.81 39.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.259 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.9 -21.21 57.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 29.3 m -86.24 -39.39 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.696 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 66' ' ' LEU . 93.2 mt -69.74 -42.04 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.808 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.98 -19.97 64.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.905 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.33 -8.43 15.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.72 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.592 0.234 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -102.4 139.99 37.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.54 -65.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.415 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 64.9 m -50.34 -31.1 13.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -68.66 -40.36 80.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 105' ' ' ASP . 85.9 mt -69.41 -47.29 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.866 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 114' ' ' THR . . . -62.08 -52.3 50.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.909 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.587 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.0 t-20 -54.56 -39.47 67.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.078 0.439 . . . . 0.0 110.319 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -69.23 -25.65 64.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -83.72 -61.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 47' ' ' LEU . 7.7 t -47.36 -47.93 25.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.375 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.473 ' N ' HG23 ' A' ' 114' ' ' THR . 4.8 t70 -44.93 -61.55 1.57 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.57 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -48.03 73.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -25.68 54.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.489 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.9 mm -85.12 -32.15 7.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.963 0.411 . . . . 0.0 111.171 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.23 -45.22 57.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.857 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 92' ' ' ILE . 73.0 mmtt -86.64 -56.53 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 89' ' ' VAL . 28.9 tp -98.93 -11.84 21.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.0 OUTLIER 69.05 -16.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 110.862 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.228 -0.033 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -53.42 -50.5 65.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.416 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 40.3 p -64.91 -20.67 66.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.28 -63.18 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.09 -57.13 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.498 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.55 64.94 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.43 -59.29 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.959 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -51.49 -22.98 3.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 110.851 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.2 ttp -85.52 -62.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.346 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.6 -31.31 67.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.076 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -55.92 -45.22 78.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.437 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -141.03 40.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.56 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttp -58.34 -51.81 79.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.47 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 15' ' ' MET . 57.9 Cg_endo -70.83 -13.47 31.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.007 1.805 . . . . 0.0 112.218 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -101.96 -6.95 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.41 -43.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.512 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 84.8 mmm -53.02 -48.73 90.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 76.4 Cg_exo -43.79 -51.38 6.37 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.719 2.28 . . . . 0.0 113.149 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.3 -31.91 67.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.771 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.67 71.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 179.501 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 46.3 ttm . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -64.6 -57.43 9.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.498 0.189 . . . . 0.0 111.359 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.468 ' HA ' ' NE2' ' A' ' 46' ' ' GLN . 0.9 OUTLIER -86.9 -12.14 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 0.0 110.776 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.2 -41.99 80.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -74.54 13.61 4.88 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.504 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.558 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 5.1 m -147.3 -70.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 111.737 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' GLN . 12.2 tp -44.35 -55.91 4.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.398 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.16 -22.18 45.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -76.15 -7.8 55.61 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.026 0.441 . . . . 0.0 110.626 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.0 t -72.15 -36.09 69.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.83 -22.22 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.0 mtt -69.84 -46.48 65.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.505 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 49.5 mttm -60.2 -18.8 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 4.4 tpm_? -67.59 -45.31 75.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.381 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.04 34.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.29 13.55 3.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.754 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.4 tpt -71.9 -14.3 61.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 31.9 tp -155.18 103.71 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -95.3 80.87 3.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 -70.56 1.61 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.893 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.7 p -145.54 27.19 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.21 110.53 21.08 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.413 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 109' ' ' ILE . 86.0 mt -73.63 131.94 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.707 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -119.81 172.15 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 97' ' ' ILE . 11.2 m -149.26 -17.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.3 mt-10 -58.61 -51.14 83.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.82 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 21.9 Cg_endo -61.21 -32.67 90.83 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.216 1.944 . . . . 0.0 112.625 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 75' ' ' ILE . 46.2 t -72.94 -48.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.179 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -54.09 -24.71 18.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -86.0 -36.76 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 20.0 ptm -75.75 -39.57 56.96 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.508 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.631 HG22 HG23 ' A' ' 86' ' ' ILE . 90.3 mt -50.48 -23.64 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.053 0.454 . . . . 0.0 110.189 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.481 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.9 mt-10 -59.01 -58.82 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 9' ' ' LYS . 21.2 t -88.05 -24.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.151 0.5 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 9' ' ' LYS . 41.8 t -66.26 -8.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.941 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' NE2' HG21 ' A' ' 89' ' ' VAL . 92.0 m-70 -143.37 49.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.613 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.58 127.32 30.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -73.53 0.34 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.595 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.4 m-20 -104.6 136.69 43.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.688 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.5 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.613 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.07 -24.89 30.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.758 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.0 t70 -59.58 -26.56 65.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.631 HG23 HG22 ' A' ' 75' ' ' ILE . 81.1 mt -84.34 -27.73 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.475 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.83 -19.76 43.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.617 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.8 tp -78.25 -55.06 5.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.582 HG13 ' HG ' ' A' ' 121' ' ' LEU . 26.4 t -55.94 -36.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.572 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -61.83 -30.04 70.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.722 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.19 51.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.261 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.609 HG13 HD23 ' A' ' 121' ' ' LEU . 47.9 mm -74.38 -39.91 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 0.0 110.893 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -58.34 -23.72 57.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -75.48 -37.48 60.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -56.64 -28.45 60.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.546 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 59.8 m -80.68 -27.68 37.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD11 HG11 ' A' ' 68' ' ' VAL . 39.6 mt -74.15 -21.8 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.933 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.0 -29.44 55.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 3.9 p30 -97.51 -40.74 8.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.191 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 179.854 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.231 0.115 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -96.03 143.34 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.303 . . . . 0.0 110.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.558 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 12.9 tp10 -65.41 -69.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.697 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 14.3 m -50.25 -24.11 2.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.516 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -76.81 -49.35 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.655 HG23 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -56.79 -43.82 80.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.5 -50.21 39.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.752 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.5 t30 -54.83 -33.78 62.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.08 -31.49 58.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.852 0.358 . . . . 0.0 111.014 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.96 -65.57 1.0 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.76 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -46.73 -42.9 17.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.142 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 17.0 t70 -46.0 -63.77 0.9 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.77 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.332 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.35 -51.21 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.898 0.38 . . . . 0.0 110.669 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.4 mt -78.17 -17.76 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.54 -60.01 3.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.602 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.93 -55.96 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.609 HD23 HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -85.34 -11.32 54.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.32 -14.24 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 110.524 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 121' ' ' LEU . 70.0 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.72 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.941 0.4 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.52 -57.0 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 15.3 t -49.8 -28.17 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.387 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -86.93 -64.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.844 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.89 -58.11 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.19 -29.49 22.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 mptp? -88.54 -59.09 2.33 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.517 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -51.28 -20.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.727 0.299 . . . . 0.0 111.362 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -85.0 -58.6 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.37 -23.48 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.55 -23.41 56.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.694 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HB3' HG11 ' A' ' 54' ' ' VAL . 79.0 mt -135.02 15.98 3.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tmm? -58.27 -51.91 78.41 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.316 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 16.3 Cg_exo -69.86 -7.15 20.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.551 2.167 . . . . 0.0 112.321 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -104.75 -16.88 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 HG21 ' A' ' 54' ' ' VAL . 67.7 mt -89.21 -49.51 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.262 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.594 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 91.9 mmm -49.07 -49.65 67.88 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.7 Cg_exo -51.29 -52.18 9.6 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.242 1.961 . . . . 0.0 113.118 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -22.14 54.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.531 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.569 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -54.82 -35.78 64.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.561 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.408 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 11.3 ttm . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.4 p -63.06 -57.06 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.28 -12.54 59.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.648 ' HG ' HG21 ' A' ' 114' ' ' THR . 30.3 tp -84.46 -30.92 24.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -92.13 14.94 63.19 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -132.28 -74.2 0.51 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.988 -0.606 . . . . 0.0 111.305 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -50.84 -45.67 59.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.351 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 58.3 tttm -74.65 -24.94 58.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -68.15 -22.11 64.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.3 0.571 . . . . 0.0 109.851 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.4 t -73.75 -37.84 64.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.277 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.533 HG21 HG12 ' A' ' 18' ' ' ILE . 5.7 t -63.55 -20.9 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.46 ' HE2' ' HG2' ' A' ' 51' ' ' LYS . 17.1 mmt -63.92 -51.94 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.647 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.86 -16.19 48.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.17 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.2 mmp_? -73.08 -34.15 66.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.086 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.447 HD11 ' SD ' ' A' ' 60' ' ' MET . 33.1 pt -107.13 34.91 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 42.68 40.95 2.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.894 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 55' ' ' MET . 18.2 ptm -112.02 8.97 20.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 110.091 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 56' ' ' LYS . 44.4 tp -157.72 99.01 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 11.7 mmpt? -104.37 95.8 6.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.059 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.15 57.6 14.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.39 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p 73.03 22.85 2.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.038 0.535 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 20.3 mm-40 -115.75 104.94 12.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 100' ' ' ALA . 5.7 mp -78.51 141.27 38.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -112.86 -178.48 3.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 HD13 ' A' ' 97' ' ' ILE . 30.6 m -129.18 -28.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm-40 -64.71 -52.86 48.21 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.933 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 12.7 Cg_endo -58.13 -13.76 16.94 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.054 1.836 . . . . 0.0 112.402 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.7 t -91.53 -46.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.4 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.9 m-85 -62.77 -22.25 66.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.213 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -82.35 -47.68 12.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -71.59 -41.27 69.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.861 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 89' ' ' VAL . 26.5 mt -49.37 -30.5 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.005 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 48.0 mt-10 -54.71 -59.53 4.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.814 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.57 -29.09 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 111.142 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 35.5 t -65.05 -7.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -139.05 33.35 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.38 56.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.319 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.15 -53.08 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.209 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.8 m120 -116.19 110.28 18.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.69 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.51 69.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.1 m-20 -79.71 -18.84 50.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.81 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 37.2 t0 -62.9 -34.09 76.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 75' ' ' ILE . 88.5 mt -76.42 -31.76 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.561 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.9 tp60 -75.55 -30.95 59.89 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -83.75 -47.14 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 ' HG ' ' A' ' 121' ' ' LEU . 9.9 p -64.73 -32.88 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -52.69 -34.53 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.1 -30.44 31.28 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.38 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.591 HG13 HD23 ' A' ' 121' ' ' LEU . 34.8 mm -65.69 -35.64 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.36 -33.54 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.966 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.32 -21.73 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.29 -33.38 69.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.679 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.614 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 69.5 m -87.25 -53.65 4.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.47 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.57 HD13 HG12 ' A' ' 68' ' ' VAL . 65.1 mt -49.46 -28.8 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.63 -34.68 53.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.5 p30 -94.37 -3.88 49.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.443 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.832 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 109' ' ' ILE . 11.1 t70 -79.83 131.23 35.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.835 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -49.16 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 83.4 m -56.58 -21.53 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -81.61 -31.19 32.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.013 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 105' ' ' ASP . 90.7 mt -66.74 -40.49 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -82.59 -37.03 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.368 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.413 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 51.9 t30 -56.92 -48.31 78.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.674 0.273 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -53.59 -26.83 23.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.706 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.83 -65.8 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.917 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.648 HG21 ' HG ' ' A' ' 47' ' ' LEU . 9.7 t -53.19 -46.18 68.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.454 ' N ' HG23 ' A' ' 114' ' ' THR . 14.9 t70 -38.81 -58.44 1.08 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 p -76.81 -34.94 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.93 -32.5 66.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.876 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 54.3 mt -83.77 -20.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.224 0.535 . . . . 0.0 110.426 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.62 -58.26 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.0 -52.06 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.591 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -92.45 -11.44 34.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.19 -15.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.587 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 121' ' ' LEU . 58.8 m . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.81 -48.51 75.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.446 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.6 p -54.84 -24.52 23.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 123' ' ' SER . 58.4 t -86.41 -63.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.592 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.41 -62.11 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.24 -28.65 19.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.7 mmpt? -87.72 -59.15 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.491 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -52.06 -29.03 19.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -76.95 -62.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.98 -23.65 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.53 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -63.72 -48.19 78.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.483 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 58' ' ' ILE . 80.4 mt -137.89 36.68 2.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.0 ttm -55.3 -50.89 84.1 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 15' ' ' MET . 70.0 Cg_endo -71.24 -8.44 23.45 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.215 1.943 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 7.1 m-20 -100.29 -16.1 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 14' ' ' LEU . 78.3 mt -80.88 -49.87 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.471 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 87.8 mtp -48.4 -47.98 67.52 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.068 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 19' ' ' MET . 53.3 Cg_exo -38.51 -60.31 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.684 2.256 . . . . 0.0 113.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m -69.64 -26.49 64.43 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.53 -44.83 66.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.877 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.207 179.465 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 20.6 ttm . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.9 t -86.5 -58.03 2.77 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 110.772 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -86.96 -16.38 36.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.058 0.456 . . . . 0.0 109.99 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 118' ' ' ILE . 19.3 tp -71.59 -35.31 70.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.623 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.26 9.38 9.92 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.734 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -146.64 -62.99 0.3 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.9 tm? -48.68 -42.68 35.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -81.16 -20.47 41.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.599 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.53 -21.95 62.67 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 1.7 t -59.64 -31.44 69.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.02 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.97 -28.93 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' MET . 71.1 mtm -72.68 -65.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.16 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HG2' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -58.07 -15.34 9.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.471 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.1 tpm_? -72.18 -34.26 68.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.175 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 14' ' ' LEU . 40.2 pt -113.29 34.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.827 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 64.01 11.05 5.81 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.563 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.0 tpt -79.05 4.16 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 56' ' ' LYS . 34.2 tp -166.81 99.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 2.5 mmpt? -85.93 78.33 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.452 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.7 -64.58 3.28 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.049 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 109' ' ' ILE . 63.8 p -147.36 15.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.709 0.29 . . . . 0.0 110.835 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -108.83 110.22 21.53 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.6 mm? -69.68 135.01 49.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.33 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 2.6 m-85 -106.4 174.31 5.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.73 -25.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.346 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.2 mm-40 -56.54 -51.86 77.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.504 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -63.53 -13.67 37.79 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.969 1.779 . . . . 0.0 112.099 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 75' ' ' ILE . 2.8 t -86.05 -50.37 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -56.86 -22.54 37.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.839 0.352 . . . . 0.0 110.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -85.33 -44.21 13.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.319 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 24.8 ptp -71.98 -41.71 67.36 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.697 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.572 HD13 HG23 ' A' ' 89' ' ' VAL . 89.0 mt -48.66 -28.52 2.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.01 -56.36 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.12 -24.73 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 75' ' ' ILE . 40.8 t -69.83 -8.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.856 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -144.67 45.53 1.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.652 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.77 119.91 10.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.61 -74.4 0.27 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.47 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.0 m120 -100.13 123.89 44.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.66 -25.27 67.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.024 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 9.5 m-20 -84.3 -24.98 29.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.436 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.8 t0 -56.68 -36.1 69.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 75' ' ' ILE . 96.9 mt -74.39 -28.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.6 tp60 -81.66 -23.56 36.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tt -78.37 -62.11 1.79 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.285 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 75' ' ' ILE . 28.5 m -58.85 -27.77 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.653 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.4 tttt -56.82 -35.91 69.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.713 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.46 -19.15 62.69 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 89' ' ' VAL . 29.1 mm -73.87 -35.27 42.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 0.0 110.76 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.13 68.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -82.94 -27.15 30.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.86 -19.64 63.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.4 m -86.07 -42.3 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.48 -36.9 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.16 -36.93 76.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 -5.06 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.605 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.853 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.232 0.155 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 26.3 t70 -102.52 140.47 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.36 -69.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.666 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.9 m -53.82 -16.81 1.94 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.896 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 26.3 t-20 -87.06 -35.13 18.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 64' ' ' THR . 84.6 mt -69.88 -55.57 14.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 114' ' ' THR . . . -61.25 -43.34 99.5 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.613 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -50.92 -30.39 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.6 -25.79 23.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.976 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -86.29 -63.47 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.735 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.6 t -49.3 -43.1 43.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 114' ' ' THR . 12.7 t70 -45.92 -38.54 7.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.59 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.22 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.339 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.51 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 0.0 111.584 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 61.4 mt -77.86 -21.23 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 110.718 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.57 -57.0 4.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.568 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -44.6 11.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.507 HD13 HG12 ' A' ' 89' ' ' VAL . 42.9 tp -99.9 -10.54 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER 72.79 -22.93 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.277 . . . . 0.0 110.968 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.516 ' HB2' HG11 ' A' ' 6' ' ' VAL . 57.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.778 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 C--O 1.229 0.026 0 CA-C-O 120.751 0.31 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.1 -48.44 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 6.6 t -59.32 -24.96 63.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.08 -64.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.008 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.89 -59.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -27.58 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 5' ' ' THR . 13.5 mptt -88.42 -59.4 2.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.585 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -50.22 -24.7 3.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 15' ' ' MET . 0.7 OUTLIER -81.75 -62.21 1.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.99 -54.52 17.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -51.68 -23.41 4.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.459 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' HG11 ' A' ' 54' ' ' VAL . 96.3 mt -139.86 62.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.519 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.616 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 50.7 ttp -110.01 -51.45 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.366 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 31.3 Cg_exo -58.89 -14.79 24.02 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.989 1.793 . . . . 0.0 111.806 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -94.56 -19.86 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 22' ' ' ALA . 38.9 mt -81.09 -36.91 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 58.5 mtt -45.57 -50.27 32.4 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 77.1 Cg_exo -50.19 -52.41 9.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.272 1.982 . . . . 0.0 113.302 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.3 m -85.29 -15.04 44.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.661 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -66.33 -7.84 21.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 179.492 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.382 0.134 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.6 t -92.41 -57.35 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -88.06 -27.41 22.01 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.6 tt -49.77 -46.78 51.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -76.02 29.65 1.35 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.65 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -132.71 -73.0 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 tp -51.99 -45.46 64.49 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -74.44 -25.27 59.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.485 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -78.83 -16.75 56.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 40.0 t -70.21 -33.39 71.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 14' ' ' LEU . 15.2 t -68.28 -24.99 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.985 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.79 -45.83 92.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 2.0 pttm -75.51 -15.84 60.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.615 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.9 mmp_? -76.94 -23.16 52.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 pt -113.01 26.08 3.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.81 63.21 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -139.31 -20.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 13.6 tp -124.93 99.99 6.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.559 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.597 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 10.4 mmpt? -124.14 87.57 2.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.14 59.44 10.03 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.367 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 109' ' ' ILE . 6.1 p 72.29 8.84 5.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.27 0.628 . . . . 0.0 111.171 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 42.8 mt-10 -92.91 122.51 35.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.21 113.85 25.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.958 0.409 . . . . 0.0 110.926 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.73 178.43 8.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.778 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 -12.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.754 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 36.6 mt-10 -70.65 -49.76 14.61 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.607 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 33.8 Cg_endo -66.6 -29.28 44.05 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.917 1.745 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 74' ' ' MET . 22.0 t -64.21 -53.64 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.926 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -55.26 -21.69 15.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -85.21 -38.43 18.96 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.13 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -72.92 -42.99 62.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.349 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.51 HG22 HG23 ' A' ' 86' ' ' ILE . 76.4 mt -51.91 -27.75 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 0.0 110.749 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 86' ' ' ILE . 47.4 mt-10 -57.58 -58.22 9.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.855 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -86.35 -25.79 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.184 0.516 . . . . 0.0 110.835 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.61 -8.15 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.644 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.425 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 72.9 m80 -145.21 43.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 132.12 48.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.185 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.65 -62.26 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -126.72 147.57 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -65.93 -33.6 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -82.91 -30.19 28.65 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.548 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -53.02 -30.73 37.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 HG22 ' A' ' 75' ' ' ILE . 95.0 mt -83.29 -34.56 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.412 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 81.4 mm-40 -71.27 -19.76 62.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -78.06 -44.68 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 75' ' ' ILE . 21.3 t -70.43 -29.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.78 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.58 -35.9 54.99 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.408 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.83 -31.32 32.86 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.193 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 120' ' ' LYS . 34.6 mm -60.18 -35.36 61.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 -19.07 57.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.67 -42.04 59.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.343 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.95 -18.27 62.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -85.15 -38.03 19.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.471 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.76 -35.63 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.379 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.8 -13.27 62.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.299 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -106.75 -49.18 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.131 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.216 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 109' ' ' ILE . 19.5 t70 -95.15 139.78 31.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -45.47 -64.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.908 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -56.3 -43.6 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.588 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.73 -37.98 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 105' ' ' ASP . 97.5 mt -60.12 -41.49 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -86.33 -29.22 25.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.17 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 78.0 m-20 -58.15 -36.66 73.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.177 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.39 -38.26 30.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -68.65 -24.68 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.592 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 115' ' ' ASP . 11.1 t -88.0 -42.81 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 110.25 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 114' ' ' THR . 17.7 t70 -43.17 -68.97 0.15 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.46 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 p -54.26 -39.62 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.022 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.42 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.2 OUTLIER -54.34 -37.01 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 123' ' ' SER . 87.8 mt -85.29 -35.88 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.068 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.15 -46.25 72.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.931 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 92' ' ' ILE . 12.3 mptt -86.14 -44.97 11.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -100.16 -53.93 3.01 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 135.74 -6.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.254 1.422 . . . . 0.0 111.02 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.535 ' HA ' HG12 ' A' ' 118' ' ' ILE . 89.9 p . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.782 0.325 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.4 m-20 -76.6 -44.6 33.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.485 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 79' ' ' HIS . 25.9 m -47.49 -41.93 21.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.44 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.11 -62.43 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -52.18 -26.25 11.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -89.37 -59.34 2.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.875 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -56.5 -23.77 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.716 0.293 . . . . 0.0 111.479 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.3 ttt -84.49 -56.02 3.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.63 -23.86 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.65 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.506 ' HB3' HD12 ' A' ' 14' ' ' LEU . 1.2 t80 -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 13' ' ' TYR . 4.5 mp -137.97 32.45 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 ttp -50.43 -51.67 62.05 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.608 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 15' ' ' MET . 42.5 Cg_endo -67.14 -33.3 31.78 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.889 1.726 . . . . 0.0 112.112 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.443 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 m-20 -78.78 0.72 25.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 15' ' ' MET . 37.8 mt -89.42 -43.42 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.432 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 26.9 ptt? -57.87 -33.32 17.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 19' ' ' MET . 78.6 Cg_exo -50.37 -51.9 10.08 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.684 1.589 . . . . 0.0 112.68 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.0 m -74.68 -28.99 61.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.559 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.54 -40.53 62.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.729 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -78.11 -58.75 3.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.686 0.279 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 50' ' ' LEU . 52.9 mm-40 -88.74 -13.52 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.305 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.613 HD23 ' HB3' ' A' ' 51' ' ' LYS . 2.6 tt -60.04 -43.26 95.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.065 0.46 . . . . 0.0 109.845 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -72.48 9.3 6.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.037 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.91 -78.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.232 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -48.64 -52.62 22.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.613 ' HB3' HD23 ' A' ' 47' ' ' LEU . 5.3 tmtt? -73.55 -22.87 59.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.39 59.38 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.341 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.1 t -60.7 -35.71 76.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.753 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.99 -28.83 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.122 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.448 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 39.5 mtt -65.18 -49.02 71.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.171 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 53' ' ' CYS . 7.9 mtmp? -64.38 -27.3 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.795 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.3 -30.42 66.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' A' ' 60' ' ' MET . 49.1 pt -96.45 15.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.828 0.347 . . . . 0.0 111.216 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 58.41 45.45 16.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.668 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 2.8 ppp? -121.11 -8.96 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.088 0.47 . . . . 0.0 110.447 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 58.6 tp -139.47 99.87 3.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.471 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.25 77.84 3.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.35 -63.73 3.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.741 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -147.23 15.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.641 0.257 . . . . 0.0 110.659 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -107.5 111.2 23.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.739 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.583 HD11 HG23 ' A' ' 109' ' ' ILE . 95.7 mt -84.23 139.14 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 6.4 m-85 -111.67 -172.55 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.57 -15.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.608 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 47.0 mt-10 -72.95 -47.33 8.41 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 50.0 Cg_exo -52.65 -51.42 11.16 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.274 1.983 . . . . 0.0 112.834 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.89 -44.38 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.764 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -55.51 -23.7 27.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.945 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -85.46 -34.79 21.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.22 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.7 mtm -71.6 -50.49 30.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.555 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 86' ' ' ILE . 70.0 mt -49.35 -22.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.59 -59.71 3.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.427 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.8 -32.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 9' ' ' LYS . 37.6 t -61.08 -11.93 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.83 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HA ' HG23 ' A' ' 5' ' ' THR . 89.6 m-70 -139.09 53.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.93 109.19 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.48 -67.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.359 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.7 m-20 -107.11 153.18 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 -46.72 14.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.89 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.45 -26.46 61.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.925 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.2 t70 -57.45 -32.53 67.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 75' ' ' ILE . 93.8 mt -75.71 -29.79 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.123 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -81.34 -19.42 42.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.448 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -61.39 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.551 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -58.64 -30.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -60.0 -32.95 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.823 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.53 -24.96 37.36 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.633 HG13 HD23 ' A' ' 121' ' ' LEU . 38.7 mm -69.25 -35.77 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 110.977 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.46 -15.89 63.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.98 -27.68 57.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.8 tp10 -69.9 -20.81 63.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.576 ' HA ' HD22 ' A' ' 99' ' ' ASN . 97.1 m -87.05 -45.49 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.24 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.5 -18.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.668 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.2 -12.89 29.18 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 96' ' ' CYS . 0.5 OUTLIER -121.6 -0.91 9.62 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.521 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.23 0.061 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -104.31 142.04 35.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.968 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.178 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.0 m -51.3 -29.38 14.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.421 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -72.59 -43.87 62.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.917 0.389 . . . . 0.0 110.113 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.583 HG23 HD11 ' A' ' 66' ' ' LEU . 13.6 mt -63.82 -44.96 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.61 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -45.11 85.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.949 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HA ' HG22 ' A' ' 114' ' ' THR . 1.9 t-20 -58.98 -47.66 84.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.928 0.364 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -61.04 -20.16 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.104 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -86.88 -56.84 3.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.333 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 111' ' ' ASN . 9.7 t -61.99 -36.39 81.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 111.622 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -48.3 -45.44 34.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.169 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -40.27 16.74 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.33 -35.1 64.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 58.1 mt -84.56 -17.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 0.0 110.252 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.74 -56.08 5.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 2.2 mptp? -85.23 -48.68 8.87 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -99.18 -10.02 23.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.42 -21.18 0.27 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.59 0.234 . . . . 0.0 110.937 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 121' ' ' LEU . 41.0 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 120.825 0.345 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.33 -44.81 62.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -53.98 -31.3 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' SER . 54.5 t -88.73 -65.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.03 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.99 -62.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.99 -24.83 56.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.08 -58.1 2.66 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.836 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -55.11 -30.67 60.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.689 0.281 . . . . 0.0 111.572 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.0 tpp -77.04 -52.5 9.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.403 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.62 -23.51 63.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 4.3 t80 -60.98 -36.06 78.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.127 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 18' ' ' ILE . 96.1 mt -142.34 38.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.129 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 9.0 tmm? -54.06 -51.01 81.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.083 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 15' ' ' MET . 60.5 Cg_endo -70.17 -8.67 24.17 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 14.9 m-20 -106.71 -15.11 14.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' LEU . 70.5 mt -83.69 -44.2 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.884 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.525 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 25.0 mmt -53.46 -48.2 93.64 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 95.0 Cg_exo -42.96 -51.64 5.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.677 2.252 . . . . 0.0 112.749 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 50' ' ' LEU . 4.9 m -56.85 -42.04 78.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.13 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.28 -50.33 62.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.976 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.683 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.2 tpt . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 120.438 0.161 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.683 ' H ' ' HG3' ' A' ' 44' ' ' MET . 41.6 t -79.45 -44.53 21.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.063 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -70.95 -39.96 72.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.525 HD21 ' HD3' ' A' ' 51' ' ' LYS . 2.3 tm? -68.56 -45.16 72.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.156 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -55.4 -7.54 1.38 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.302 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m -103.88 -60.9 1.5 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -53.94 -36.07 62.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.752 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HD3' HD21 ' A' ' 47' ' ' LEU . 13.6 tptt -80.65 -20.55 42.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.313 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -75.03 -23.86 58.22 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -26.17 68.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 18' ' ' ILE . 21.3 t -77.72 -24.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.6 mtt -67.08 -55.03 16.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.623 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HE2' HD23 ' A' ' 61' ' ' LEU . 45.1 mttm -58.27 -23.14 55.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -62.15 -36.51 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.895 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 pt -113.21 26.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.89 58.21 3.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.502 ' O ' ' HG2' ' A' ' 60' ' ' MET . 12.5 ttt -124.9 3.72 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 65' ' ' GLU . 33.9 tp -161.75 127.88 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.0 111.134 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -115.83 80.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.761 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 -72.74 0.92 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.754 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.3 p -139.55 29.46 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.89 0.376 . . . . 0.0 110.47 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 61' ' ' LEU . 7.0 tp10 -117.37 108.73 15.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.426 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -67.39 146.26 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.893 0.377 . . . . 0.0 111.418 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -142.33 155.41 45.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.501 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.65 5.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.736 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 38.0 mt-10 -59.5 -52.08 76.7 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -69.01 -28.87 28.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.171 1.914 . . . . 0.0 112.62 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 75' ' ' ILE . 21.5 t -63.94 -48.34 86.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.079 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HA ' HD12 ' A' ' 75' ' ' ILE . 7.1 m-30 -51.47 -22.21 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.935 0.398 . . . . 0.0 110.422 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 39.9 tptt -83.22 -37.57 23.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.4 mtm -74.59 -43.85 53.6 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.35 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 72' ' ' TYR . 58.9 mt -48.87 -24.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 44.3 mt-10 -65.94 -59.26 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.328 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -80.96 -44.93 21.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 18.8 t -46.52 -40.79 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.266 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.522 ' CE1' HG21 ' A' ' 89' ' ' VAL . 79.9 m80 -106.31 53.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.29 122.33 16.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.308 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.92 -76.14 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -96.04 144.42 26.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.31 -28.67 34.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.42 -26.79 38.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.8 m-20 -58.36 -23.65 57.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 75' ' ' ILE . 73.5 mt -86.74 -32.76 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.447 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -75.57 -21.15 58.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.973 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.09 -55.46 4.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 79' ' ' HIS . 58.5 t -56.11 -32.46 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -34.13 68.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.753 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.43 -27.12 33.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.375 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' A' ' 121' ' ' LEU . 43.6 mm -69.06 -38.01 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -19.29 65.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -84.2 -29.79 26.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -27.38 62.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -22.16 54.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.39 -49.51 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.35 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.5 -40.8 80.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -57.85 -48.3 80.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.889 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.098 0.475 . . . . 0.0 110.971 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.7 0.286 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.2 t70 -91.65 142.66 27.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.6 tp10 -55.18 -67.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.254 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.479 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 61.1 m -50.26 -35.35 26.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 39.7 t-20 -59.3 -50.42 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -59.17 -32.95 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.146 177.663 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 114' ' ' THR . . . -66.58 -57.17 10.51 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.419 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 54.8 t30 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.653 0.263 . . . . 0.0 111.491 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.15 -30.75 19.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.864 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -82.69 -63.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 110' ' ' GLY . 10.1 t -53.68 -30.57 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.27 -59.61 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -49.84 -37.03 28.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.427 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 38.0 mm -82.27 -27.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.146 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.85 -59.57 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 116' ' ' CYS . 3.2 mptp? -86.85 -43.56 12.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 46.7 tp -99.66 -15.75 18.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.9 t80 67.83 -13.61 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.92 0.391 . . . . 0.0 110.911 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 121' ' ' LEU . 48.2 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.319 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.71 -37.22 86.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 3.0 t -54.54 -29.35 50.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.89 -64.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.048 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.68 -62.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.17 -28.19 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.7 mmmt -88.48 -59.45 2.23 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.687 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -52.89 -20.52 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.202 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 78.9 mmm -85.54 -60.48 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.9 -28.19 69.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.704 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -62.07 -46.68 88.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.004 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 mt -123.12 34.79 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.092 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.481 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.4 tmm? -55.5 -50.62 85.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.665 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 15' ' ' MET . 74.0 Cg_endo -73.7 -4.19 15.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.065 1.844 . . . . 0.0 112.183 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.0 -14.93 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.11 -42.4 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 56.3 mtm -54.94 -48.78 95.03 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.326 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -53.32 -43.93 53.19 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.174 1.916 . . . . 0.0 112.568 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -57.87 -55.6 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.04 -42.03 37.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.671 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 ptp . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.1 p -53.17 -49.29 66.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.809 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' HD23 ' A' ' 50' ' ' LEU . 6.1 tp-100 -87.83 -18.42 29.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.719 0.295 . . . . 0.0 111.157 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 10.5 mt -70.11 -28.29 65.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.99 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -71.52 10.99 3.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.486 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.9 m -134.59 -62.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.891 0.376 . . . . 0.0 110.594 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD23 ' HG3' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -50.76 -46.81 59.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.756 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.526 ' HE2' ' H ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -81.58 -20.63 39.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.634 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -69.4 -17.82 63.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.27 -46.24 70.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.751 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.91 -25.4 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.859 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 34.3 mtm -65.38 -46.43 80.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -67.95 -25.83 65.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.74 -38.17 86.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.73 17.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.26 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.22 59.85 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.7 ttp -124.12 5.47 8.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.262 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 67.7 tp -152.47 99.48 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.459 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -95.8 96.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.161 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.51 60.13 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.7 p 73.45 27.3 1.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.284 0.634 . . . . 0.0 111.819 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 43.3 mt-10 -114.4 113.06 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.0 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.633 HD21 HG23 ' A' ' 109' ' ' ILE . 91.9 mt -70.37 139.43 51.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.766 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -145.82 169.03 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.474 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.24 25.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.0 mt-10 -75.36 -50.66 3.56 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.4 Cg_endo -66.04 -44.07 8.02 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.039 1.826 . . . . 0.0 112.972 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HG3' ' A' ' 74' ' ' MET . 14.1 m -57.49 -45.16 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -53.77 -22.94 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.644 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.0 tmtp? -85.37 -36.56 20.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 71' ' ' VAL . 13.8 mtp -68.32 -48.0 66.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.397 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' HIS . 62.6 mt -48.32 -24.51 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.7 mt-10 -60.65 -59.55 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 -36.26 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 9' ' ' LYS . 68.8 t -60.75 -7.74 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.103 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 74.2 m80 -143.62 43.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 135.57 55.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.18 -60.49 0.54 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.4 m120 -117.84 150.12 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.44 -33.87 31.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.536 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 8.7 m-20 -81.27 -25.54 36.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.794 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.6 t70 -58.76 -31.93 68.81 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 76' ' ' GLU . 95.7 mt -77.68 -29.64 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.134 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.2 tp60 -77.01 -24.14 52.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.236 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.7 -49.35 18.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.491 ' HB ' HG21 ' A' ' 75' ' ' ILE . 45.5 t -61.9 -34.08 61.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.782 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -60.01 -35.41 75.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.319 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.78 -22.9 65.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.588 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.634 HG23 ' HB2' ' A' ' 120' ' ' LYS . 51.4 mt -63.76 -41.72 93.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -62.35 -29.48 70.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -62.68 -41.04 98.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.249 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.96 -39.18 84.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.545 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 65.9 m -71.05 -37.68 72.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.792 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 93' ' ' ALA . 83.3 mt -65.74 -19.3 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -85.13 -32.8 22.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.2 p30 -96.35 -17.26 20.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.508 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.722 0.296 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.46 144.19 28.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -59.6 -67.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 54.2 m -52.75 -23.72 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.719 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.96 -43.38 54.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.562 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.633 HG23 HD21 ' A' ' 66' ' ' LEU . 1.5 mt -66.5 -41.66 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 110.691 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -71.17 -49.46 26.76 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.077 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.5 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 11.3 t30 -51.68 -59.25 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.906 0.353 . . . . 0.0 110.927 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 10.3 mmpt? -54.0 -45.11 71.37 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 41.3 t80 -73.72 -65.9 0.77 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.3 p -50.55 -41.73 54.43 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 22.0 t70 -42.99 -67.31 0.28 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -55.95 -25.4 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -29.91 64.88 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.487 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -85.35 -25.94 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.3 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.16 -53.83 15.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.808 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HB2' HG23 ' A' ' 92' ' ' ILE . 71.8 mmtt -86.7 -58.06 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 123' ' ' SER . 49.6 tp -85.53 -10.72 55.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 3.9 t80 69.66 -19.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.555 0.217 . . . . 0.0 111.118 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.8 t . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 12.2 t70 -49.41 -43.27 44.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.39 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 2.1 t -54.17 -33.18 57.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.23 -65.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.32 -62.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.72 -26.16 43.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.81 -59.32 2.26 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.905 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -54.54 -20.31 7.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.3 mmt -84.29 -57.39 3.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.2 -47.8 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.463 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -45.72 -34.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.742 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 18' ' ' ILE . 52.1 mt -138.54 46.07 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.317 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 49.1 ttp -71.92 -51.74 8.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.683 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.2 Cg_endo -69.71 -3.08 11.25 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.116 1.878 . . . . 0.0 112.117 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -103.21 -19.66 14.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 14' ' ' LEU . 75.9 mt -84.61 -37.1 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.537 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -49.47 -52.73 47.21 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 19' ' ' MET . 59.7 Cg_exo -37.88 -52.87 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.017 2.478 . . . . 0.0 114.192 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -88.43 -42.33 12.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.586 0.231 . . . . 0.0 111.583 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.05 -6.75 6.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.533 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -66.07 -57.6 7.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.593 0.235 . . . . 0.0 111.497 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.48 ' HA ' ' SG ' ' A' ' 49' ' ' CYS . 64.0 mm-40 -87.29 -13.1 44.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 114' ' ' THR . 1.4 tt -57.67 -42.63 83.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -77.91 38.17 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 46' ' ' GLN . 3.8 m -144.37 -79.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 110.556 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 22' ' ' ALA . 4.6 mm? -52.6 -47.36 66.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.601 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -79.76 -30.6 40.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.782 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.3 4.69 29.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' CYS . 5.9 t -85.12 -30.25 24.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.015 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 51' ' ' LYS . 7.4 p -69.3 -20.19 24.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 60' ' ' MET . 59.8 mtt -66.09 -46.39 77.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.49 -16.9 41.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.341 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.41 -47.62 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.523 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 60' ' ' MET . 46.2 pt -92.06 33.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.723 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 54.25 30.2 11.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.4 tpt -91.55 -12.9 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -154.27 112.53 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -108.1 77.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.575 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.31 -70.21 2.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.004 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.6 p -143.2 18.46 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.574 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -102.72 110.82 22.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.053 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD11 HG23 ' A' ' 109' ' ' ILE . 18.6 mt -84.15 115.6 22.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.421 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -96.4 -166.86 1.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.57 -15.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.1 mt-10 -60.79 -51.23 81.01 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 18.6 Cg_endo -60.95 -18.91 60.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.111 1.874 . . . . 0.0 112.539 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 75' ' ' ILE . 5.0 t -76.28 -49.2 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 24.6 m-85 -52.48 -22.27 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -78.74 -43.53 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.723 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.0 ptm -77.12 -36.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.546 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 86' ' ' ILE . 88.2 mt -51.9 -25.49 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 110.193 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 86' ' ' ILE . 50.2 mt-10 -61.71 -59.42 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.825 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.82 -35.61 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.916 0.389 . . . . 0.0 111.545 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.461 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 25.1 t -57.53 -11.62 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 73.8 m-70 -134.11 49.15 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.407 . . . . 0.0 110.521 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.7 135.68 54.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.6 -55.84 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.9 m120 -128.01 129.07 46.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.04 68.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.0 m-20 -84.24 -25.29 29.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.8 t0 -59.11 -32.71 70.08 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 75' ' ' ILE . 68.0 mt -76.17 -29.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.539 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -78.42 -26.5 46.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 92' ' ' ILE . 55.5 tp -67.39 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.545 HG22 HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.04 -28.97 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.489 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.526 ' HE2' ' HB3' ' A' ' 72' ' ' TYR . 3.7 tptm -48.3 -46.62 36.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.74 -27.75 49.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 121' ' ' LEU . 49.3 mm -62.91 -31.13 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.38 -22.94 66.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.18 -36.24 22.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.408 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.62 -24.43 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 111.266 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 37.7 m -86.35 -31.53 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.45 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.52 -35.66 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.463 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.179 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -14.41 14.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -179.655 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t70 -97.33 143.56 27.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 0.0 111.25 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.79 -69.05 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.602 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.1 m -51.69 -26.24 8.84 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.73 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 6.2 m120 -70.85 -39.71 72.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 109.917 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 66' ' ' LEU . 7.2 mt -69.15 -36.71 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.95 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.37 -53.71 27.44 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.583 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.515 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 12.5 t30 -52.78 -58.12 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.539 0.209 . . . . 0.0 111.101 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.4 mmpt? -55.23 -21.19 13.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.273 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -86.76 -64.78 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.601 HG21 HD22 ' A' ' 47' ' ' LEU . 10.1 t -55.86 -31.04 62.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.93 -56.51 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -40.36 91.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.684 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -41.74 78.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 65.0 mt -77.73 -22.0 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -59.65 2.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.243 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -87.07 -54.23 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 92' ' ' ILE . 38.0 tp -83.32 -10.21 58.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 11.0 t80 68.49 -9.55 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.707 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 121' ' ' LEU . 33.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.116 0.484 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -52.1 -47.42 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.787 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 79' ' ' HIS . 91.1 m -48.69 -37.0 17.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.143 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.86 -66.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.49 -62.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.34 -26.5 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' THR . 34.0 mmtp -89.51 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.77 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 35.6 m-85 -55.47 -19.29 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.377 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.0 ttm -84.33 -59.23 2.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.71 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.354 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -64.88 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.374 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.57 47.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.262 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.51 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 31.4 ttm -64.71 -51.12 60.48 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.947 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 15' ' ' MET . 58.2 Cg_endo -69.89 -9.43 26.04 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.28 -17.16 20.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.79 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 54' ' ' VAL . 73.5 mt -83.53 -48.25 17.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.501 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 59.7 mtt -43.61 -49.33 18.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.051 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 70.9 Cg_exo -40.12 -63.35 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.596 2.197 . . . . 0.0 113.494 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.0 m -72.1 -27.37 62.6 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.553 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.12 -42.4 63.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.84 0.352 . . . . 0.0 110.663 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.524 179.572 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.423 ' HG3' HG23 ' A' ' 114' ' ' THR . 39.4 ttp . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.3 t -71.53 -58.34 3.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.594 0.235 . . . . 0.0 111.598 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.68 -13.25 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.839 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 51' ' ' LYS . 16.3 tp -67.78 -29.59 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.289 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -75.22 11.65 8.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.319 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -140.74 -71.26 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 111.674 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.4 tm? -48.75 -46.96 41.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -76.6 -24.9 53.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.232 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -67.16 -14.6 63.06 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.324 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.56 -41.4 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG21 HG12 ' A' ' 18' ' ' ILE . 40.5 t -61.89 -28.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.599 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' MET . 64.7 mtp -63.78 -56.14 17.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.538 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -66.72 -17.81 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.7 tpm_? -68.86 -31.3 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -113.23 31.48 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.602 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 58.94 13.64 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.607 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 55' ' ' MET . 10.8 tpt -77.98 -8.44 58.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.218 0.532 . . . . 0.0 110.622 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 66' ' ' LEU . 59.1 tp -156.86 103.55 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 76.7 10.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.36 -59.9 3.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.474 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -147.56 7.73 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.599 0.238 . . . . 0.0 111.137 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.6 tp10 -96.72 110.82 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.585 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 61' ' ' LEU . 2.6 mm? -73.42 109.99 7.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.66 -167.81 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -169.38 -8.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.2 mp0 -73.44 -51.46 5.6 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 19.6 Cg_endo -58.46 -38.19 91.23 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.296 1.998 . . . . 0.0 113.011 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' ILE . 59.4 t -57.87 -43.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.439 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 9.1 m-30 -53.02 -32.91 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -74.28 -30.79 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.252 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.2 mtm -78.63 -46.6 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.404 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.525 HG22 HG23 ' A' ' 86' ' ' ILE . 64.8 mt -50.77 -27.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 41.4 mt-10 -60.78 -59.17 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.86 -44.86 16.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.551 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 10' ' ' TYR . 55.5 t -49.99 -17.91 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.806 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.675 ' HA ' HG23 ' A' ' 5' ' ' THR . 50.5 m-70 -128.77 53.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.781 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 127.68 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -81.36 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.1 145.05 25.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.95 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.08 32.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.767 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.13 -28.47 35.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.706 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -56.82 -27.22 59.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 75' ' ' ILE . 79.7 mt -80.54 -31.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.988 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -78.16 -19.36 54.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.467 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.8 -59.18 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 92' ' ' ILE . 21.4 t -57.59 -23.59 20.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.94 0.4 . . . . 0.0 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 9.6 tptt -53.95 -48.48 70.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.182 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.2 58.77 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.074 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 89' ' ' VAL . 68.4 mt -60.63 -40.76 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.641 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.17 -26.98 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.685 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.68 -30.22 25.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 9.7 tp10 -57.3 -28.86 63.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 1.5 m -86.65 -45.32 11.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.197 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.7 mt -53.91 -37.91 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.69 0.281 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.77 -31.98 70.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.85 -7.16 19.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.383 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.475 -179.66 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.608 0.242 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 109' ' ' ILE . 23.1 t70 -76.35 119.29 20.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.0 tp10 -48.96 -58.36 5.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.493 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.7 m -54.06 -24.95 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.4 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.94 -32.2 25.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.372 . . . . 0.0 110.55 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 105' ' ' ASP . 55.3 mt -70.12 -38.85 76.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.556 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 114' ' ' THR . . . -77.86 -51.65 5.77 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.7 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.484 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 3.9 t30 -49.93 -32.36 14.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.751 0.275 . . . . 0.0 111.083 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -80.02 -38.65 31.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 110.133 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -70.11 -64.68 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.776 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.9 t -49.53 -31.82 11.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.142 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 25.7 t70 -46.79 -71.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.66 -24.27 61.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.89 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.501 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -64.56 -58.59 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.656 0.265 . . . . 0.0 110.753 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.6 mm -59.79 -16.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.141 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 10.1 tp10 -68.49 -59.67 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.248 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 1.4 mptp? -87.25 -40.96 14.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.683 0.277 . . . . 0.0 111.541 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 6.7 tt -58.6 -46.41 87.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.34 42.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.048 0.451 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 . . . . . 0 N--CA 1.46 0.05 0 CA-C-O 120.943 0.401 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.99 -44.23 15.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 51.9 p -56.96 -26.76 60.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG22 ' HE1' ' A' ' 79' ' ' HIS . 62.0 t -89.96 -67.36 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.89 -62.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -22.63 67.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HB3' HG22 ' A' ' 78' ' ' VAL . 1.6 mptm? -90.44 -56.79 3.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.228 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -54.32 -50.25 67.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.99 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.9 tpp -56.08 -40.57 73.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -80.6 -24.7 38.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.039 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.79 -29.01 67.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 0.0 111.192 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 18' ' ' ILE . 97.4 mt -148.13 39.26 0.91 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.604 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.587 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 34.6 ttm -60.04 -51.17 82.43 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.292 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 23.7 Cg_exo -63.59 -22.84 70.49 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.088 1.859 . . . . 0.0 112.468 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.81 -10.62 53.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.393 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 14' ' ' LEU . 74.2 mt -87.95 -28.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.22 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.494 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 63.5 mtm -46.77 -48.79 49.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.6 Cg_exo -41.74 -56.51 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.61 2.207 . . . . 0.0 113.379 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -85.42 -18.52 33.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 111.144 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -69.75 -10.87 60.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.879 179.564 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 44' ' ' MET . . . . . 0.691 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.0 tpt . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.691 ' H ' ' HG3' ' A' ' 44' ' ' MET . 22.8 t -78.23 -52.23 8.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -79.94 -23.25 41.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.084 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.597 ' N ' HD23 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -87.12 -39.1 15.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -69.06 -10.92 62.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -73.26 -67.45 0.58 Allowed 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 tp -51.7 -33.61 34.98 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 -28.62 61.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.546 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -74.54 -24.73 58.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.154 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.3 t -60.67 -31.49 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 18' ' ' ILE . 4.0 t -68.47 -24.5 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.776 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 57.4 mtt -70.32 -58.38 3.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.099 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.96 -19.14 28.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.533 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 6.4 tpm_? -72.91 -31.12 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.361 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.18 33.95 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.44 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 61.22 10.52 3.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.689 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -77.09 -6.95 54.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.027 0.442 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.605 HD11 HG21 ' A' ' 109' ' ' ILE . 7.1 tt -152.62 99.49 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.686 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 7.5 mmpt? -86.27 77.8 9.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.44 -60.44 4.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.0 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 p -153.52 11.85 0.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 13.6 mm-40 -100.21 109.26 21.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.771 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.682 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -67.12 147.09 53.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.619 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 27.9 m-85 -136.51 165.63 25.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -140.26 -11.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mp0 -57.31 -53.64 63.26 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.401 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.8 Cg_endo -66.05 -25.21 51.63 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.992 1.795 . . . . 0.0 112.107 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 75' ' ' ILE . 17.6 t -68.86 -43.88 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.401 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 19.3 m-30 -55.35 -22.29 18.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.981 0.42 . . . . 0.0 110.524 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -80.67 -48.99 11.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 7.1 ptp -68.56 -37.0 79.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.371 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 86' ' ' ILE . 95.0 mt -53.69 -21.94 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.286 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.39 -58.28 3.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.408 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.75 -39.79 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -56.77 -9.18 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.98 0.419 . . . . 0.0 111.661 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HE1' HG22 ' A' ' 6' ' ' VAL . 84.6 m-70 -130.49 40.86 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.3 122.84 14.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.411 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.11 -65.16 0.34 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.186 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -114.78 151.59 33.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.649 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.57 -20.74 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -84.81 -30.54 24.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 86' ' ' ILE . 4.2 p30 -59.09 -21.12 58.73 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 75' ' ' ILE . 68.8 mt -85.67 -30.02 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.119 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.24 -19.84 42.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.118 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 92' ' ' ILE . 64.3 tp -83.11 -63.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.329 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.549 HG13 HD22 ' A' ' 121' ' ' LEU . 46.5 t -52.27 -41.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.517 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 11.1 mttt -53.32 -32.39 48.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.549 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.57 -23.01 41.09 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.533 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 88' ' ' LEU . 39.6 mm -68.69 -37.83 78.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.01 66.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -79.22 -22.41 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.3 -18.9 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 -49.34 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.735 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mt -48.55 -24.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.91 -45.74 73.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.56 -21.31 32.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.343 -179.575 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.664 0.269 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 108' ' ' ASN . 12.7 t70 -108.18 147.41 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.03 -68.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.827 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 23.3 m -57.74 -41.49 81.95 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.219 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 10.7 t-20 -56.81 -42.88 80.34 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.605 HG21 HD11 ' A' ' 61' ' ' LEU . 1.6 mt -63.06 -31.82 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.499 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.71 -45.13 78.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.558 ' HA ' HG22 ' A' ' 114' ' ' THR . 50.4 t30 -72.6 -45.74 57.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -56.28 -47.56 78.37 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.652 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -74.16 -42.93 59.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.228 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 111' ' ' ASN . 5.7 t -69.37 -23.41 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.05 -61.48 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.153 0.502 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -40.92 84.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -31.09 65.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.358 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 114' ' ' THR . 32.6 mm -83.76 -31.02 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.924 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 38.6 tt0 -68.76 -56.1 9.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.966 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 9.3 mptt -86.62 -48.65 8.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.549 HD22 HG13 ' A' ' 89' ' ' VAL . 45.9 tp -97.81 -14.61 20.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.0 t80 68.45 -13.08 0.32 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 121' ' ' LEU . 46.8 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.874 0.369 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.14 143.19 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.68 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.54 -34.62 64.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 109.91 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.81 -26.96 64.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.997 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -88.9 -23.45 22.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 121' ' ' LEU . 48.2 t -71.82 -51.41 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.222 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.96 -30.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.24 -31.42 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.419 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -79.53 -55.73 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.297 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -56.21 -28.25 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 111.225 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.8 ttm -81.29 -54.99 5.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.102 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.75 -23.61 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -70.24 -25.31 63.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -147.07 39.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 34.8 ttm -61.41 -51.86 74.49 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.362 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.6 Cg_endo -70.45 0.17 6.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.915 1.744 . . . . 0.0 111.944 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 20' ' ' PRO . 10.3 m-20 -112.26 -14.22 13.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.02 -31.61 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.652 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -62.3 -31.99 8.68 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD3' ' HG3' ' A' ' 19' ' ' MET . 15.1 Cg_exo -68.9 -35.49 15.33 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.768 1.645 . . . . 0.0 111.942 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.56 -52.7 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.405 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -55.39 -34.42 64.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.697 0.284 . . . . 0.0 111.502 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.71 -16.38 51.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.574 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.02 -54.14 49.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.977 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 50' ' ' LEU . 36.2 mt -97.25 -41.57 8.22 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.622 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 23.2 t-80 176.67 -65.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.663 0.744 . . . . 0.0 111.008 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.2 pt -134.9 173.04 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.319 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.422 ' HA ' HD11 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -86.06 128.51 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.071 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HG3' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -51.8 -20.17 2.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.335 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 21.7 t70 -73.76 -65.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 31' ' ' ILE . 23.5 mt -70.03 -5.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.4 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -46.97 -35.84 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 41' ' ' GLY . 1.6 t -179.0 125.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.45 -82.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.613 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 21.2 pt -140.06 55.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.934 0.397 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 15.0 tm0? -133.19 14.56 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . -85.08 -76.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ALA . . . 175.93 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -48.7 -60.86 2.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.047 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -125.8 -1.94 7.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.827 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 35' ' ' ILE . . . 102.5 -16.49 54.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.711 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 30' ' ' ASP . . . -85.73 -51.28 6.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.69 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 4.4 t70 -177.16 178.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.547 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.42 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 5.8 ttt -154.71 -59.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.634 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 m -65.07 -48.88 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.1 tp-100 -87.26 -12.73 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.638 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.1 tt -74.27 -39.89 62.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.415 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.86 4.93 2.06 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.725 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -135.77 -61.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.545 0.212 . . . . 0.0 111.347 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD12 ' HG3' ' A' ' 29' ' ' GLU . 3.0 tm? -48.2 -44.37 32.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' HD21 ' A' ' 47' ' ' LEU . 43.2 tttm -84.05 -20.36 32.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.649 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.84 -15.91 60.71 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.121 0.486 . . . . 0.0 110.059 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.63 -33.3 75.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.432 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 t -69.21 -22.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.204 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.444 ' HB3' ' HE2' ' A' ' 60' ' ' MET . 48.8 mtt -75.38 -52.62 10.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.52 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' H ' ' A' ' 61' ' ' LEU . 5.8 ptpp? -65.73 -16.42 63.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.0 tpm_? -70.93 -32.59 69.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 pt -102.37 23.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.228 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 60.95 49.83 5.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.559 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.507 ' HG3' ' HG2' ' A' ' 70' ' ' PRO . 5.7 ttp -120.41 -18.33 7.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.446 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 56' ' ' LYS . 19.1 tp -130.48 108.77 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.815 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.2 mmpt? -104.53 78.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.31 -70.71 2.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.038 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.0 p -137.35 9.7 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.18 103.34 15.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.93 114.62 23.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.452 . . . . 0.0 110.211 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -109.53 -167.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.968 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' A' ' 97' ' ' ILE . 10.6 p -163.1 -14.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.672 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 41.8 mt-10 -53.15 -54.37 45.35 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 60' ' ' MET . 10.8 Cg_endo -55.29 -29.4 67.26 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.006 1.804 . . . . 0.0 111.829 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 20.8 t -72.65 -39.44 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.352 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -57.48 -22.3 42.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -85.17 -37.11 20.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.105 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 11.9 ptm -80.4 -30.1 37.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.876 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.731 HG22 HG23 ' A' ' 86' ' ' ILE . 96.8 mt -59.39 -22.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 -54.72 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.266 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.01 -45.05 16.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -48.53 -27.19 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.271 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.408 ' CD2' HG23 ' A' ' 75' ' ' ILE . 85.4 m-70 -118.54 54.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.609 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.92 51.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.97 -72.18 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.317 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.6 m120 -110.84 155.3 22.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 110.716 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -81.45 -37.44 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.52 -28.96 41.31 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.137 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -56.25 -31.88 63.96 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 75' ' ' ILE . 87.9 mt -78.36 -32.92 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.08 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 80.5 mm-40 -74.99 -19.8 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 tp -76.13 -55.58 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.618 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HD12 ' A' ' 92' ' ' ILE . 38.8 t -55.59 -28.89 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -58.12 -49.06 78.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.618 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.9 -26.96 69.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.253 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 120' ' ' LYS . 58.3 mt -61.49 -45.09 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.61 69.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.598 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.6 tp10 -65.42 -27.33 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.2 m -80.1 -28.81 38.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.951 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD11 ' HB ' ' A' ' 68' ' ' VAL . 78.0 mt -77.15 -43.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.87 -14.92 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.51 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 112' ' ' LYS . 8.1 t-20 -94.22 -43.78 8.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 101' ' ' LYS . . . -78.07 -19.97 53.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 110.625 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER 33.06 33.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.174 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.49 67.53 2.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 109' ' ' ILE . 13.3 mm-40 -60.23 175.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 111.144 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -84.43 -47.65 10.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.27 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.1 t70 -77.94 139.94 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.935 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.65 -61.73 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.0 m -54.17 -27.69 35.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.5 t-20 -72.28 -44.05 63.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.65 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.408 HG12 ' N ' ' A' ' 103' ' ' GLU . 98.3 mt -60.52 -47.27 93.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.025 0.441 . . . . 0.0 110.673 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.33 -41.42 85.68 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.337 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.42 ' OD1' ' HG3' ' A' ' 44' ' ' MET . 16.2 t30 -58.08 -36.94 73.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.11 0.455 . . . . 0.0 110.824 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.419 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.0 mmpt? -78.39 -37.54 43.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.52 -27.18 58.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.603 HG21 HD22 ' A' ' 47' ' ' LEU . 11.1 t -79.71 -46.88 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 110.249 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 114' ' ' THR . 26.3 t70 -46.45 -60.26 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -40.58 70.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.797 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -27.41 67.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.236 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -84.68 -32.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -69.83 -44.71 69.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.027 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 71.0 mmtt -87.05 -58.56 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 121' ' ' LEU . 1.3 tm? -97.63 -15.73 20.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER 73.36 -19.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.592 0.234 . . . . 0.0 111.302 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 121' ' ' LEU . 36.8 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.818 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 1' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.746 0.308 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.83 133.63 46.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.677 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.81 -24.42 36.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.8 m-20 -83.85 -55.89 4.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.195 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 81.0 p -52.03 -31.52 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.715 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.47 -64.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.822 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.13 -60.67 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -53.29 -31.18 42.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.97 -59.13 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.113 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -52.56 -23.46 6.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 111.366 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 tpp -80.48 -56.78 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.15 -23.61 67.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.139 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.04 -33.75 72.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.024 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 58' ' ' ILE . 65.5 mt -146.9 50.91 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.2 tmm? -71.45 -50.57 10.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.409 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 15' ' ' MET . 73.7 Cg_endo -75.05 -24.7 12.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.232 1.955 . . . . 0.0 112.62 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.39 -9.95 59.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.329 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.13 -27.81 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.361 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 62.3 mtt -53.1 -48.58 91.52 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 33.2 Cg_exo -60.85 -36.13 85.25 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.396 2.064 . . . . 0.0 112.703 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.8 m -54.83 -46.27 74.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.866 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -55.98 -46.53 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.38 -15.88 59.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.13 -52.59 64.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.795 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.79 HD12 HD22 ' A' ' 50' ' ' LEU . 68.2 mt -108.82 -40.58 5.0 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 28.8 t-80 177.84 -62.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.507 0.67 . . . . 0.0 111.806 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -150.17 131.04 4.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.034 -176.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 55.0 p -63.97 161.82 15.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.334 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HG2' HD13 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -57.81 -22.35 47.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.102 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.19 -39.08 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.775 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.2 mt -100.68 -7.24 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.609 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . . . -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.391 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.8 m -59.22 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.129 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 64.5 t30 50.82 56.61 7.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 mt 58.54 52.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.021 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -146.43 113.58 6.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.365 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -72.6 -64.98 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.723 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 44' ' ' MET . . . 66.65 -93.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.452 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 8.8 tmtt? -104.03 -62.05 1.36 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.66 14.53 7.01 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.798 0.333 . . . . 0.0 111.561 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.757 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.69 -17.64 30.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.128 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.72 -71.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 110.426 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -177.89 170.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.217 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.451 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 5.0 ptt? -130.13 -41.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.575 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -65.39 -51.84 57.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.913 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 50' ' ' LEU . 4.3 mm100 -87.15 -12.89 45.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HG ' HG21 ' A' ' 114' ' ' THR . 48.8 tp -66.51 -25.73 66.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -88.17 8.26 78.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.388 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 13.6 m -137.01 -71.49 0.44 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.673 -0.263 . . . . 0.0 111.428 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.79 HD22 HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -48.26 -39.72 22.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB2' HD12 ' A' ' 47' ' ' LEU . 8.4 tptp -84.26 -23.76 30.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.601 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.74 -16.86 62.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.45 -37.9 79.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.914 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 14' ' ' LEU . 59.0 t -63.22 -30.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.452 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 54.6 mtt -70.56 -58.5 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -61.1 -19.36 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.589 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -72.44 -29.55 63.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.479 HD11 ' SD ' ' A' ' 60' ' ' MET . 49.3 pt -106.24 13.98 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.64 55.69 1.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.07 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 17.6 ptm -133.3 15.01 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 0.0 110.183 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 66' ' ' LEU . 66.6 tp -164.57 109.77 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.507 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -108.56 77.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.14 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.41 -28.48 0.7 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.224 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -175.54 -15.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -84.55 110.47 18.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 66' ' ' LEU . 2.9 mm? -77.27 149.97 35.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 111.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 74.9 m-85 -147.07 136.04 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.9 15.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.841 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.8 mt-10 -67.64 -51.91 28.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 39.6 Cg_endo -70.77 -24.06 25.48 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.039 1.826 . . . . 0.0 112.564 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG12 HD11 ' A' ' 75' ' ' ILE . 11.0 t -73.32 -50.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.253 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.52 ' HA ' HD12 ' A' ' 75' ' ' ILE . 5.7 m-30 -51.37 -22.16 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.643 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -78.85 -42.36 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -77.76 -36.84 50.21 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 121.338 -0.145 . . . . 0.0 110.875 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.555 HG22 HG23 ' A' ' 86' ' ' ILE . 72.4 mt -51.45 -21.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.361 0.601 . . . . 0.0 109.918 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 44.9 mt-10 -63.89 -59.31 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.376 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.4 -41.64 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.904 0.383 . . . . 0.0 110.896 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 9' ' ' LYS . 25.1 t -47.54 -26.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.485 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.594 ' CE1' HG11 ' A' ' 89' ' ' VAL . 71.2 m80 -125.11 55.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.76 55.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.71 -79.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.341 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.08 133.64 44.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 111.013 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.6 66.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.71 -28.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.959 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.74 -29.21 64.59 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.555 HG23 HG22 ' A' ' 75' ' ' ILE . 82.7 mt -76.56 -30.72 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.111 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -81.5 -19.19 42.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.908 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.594 HG11 ' CE1' ' A' ' 79' ' ' HIS . 0.2 OUTLIER -61.4 -32.48 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.808 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.53 -32.65 58.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.672 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.51 -23.32 43.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.04 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.6 mt -69.14 -30.74 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -64.39 -23.48 67.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.276 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -79.58 -33.56 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.15 -31.21 72.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 10.8 m -79.4 -21.45 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 93' ' ' ALA . 94.5 mt -76.12 -46.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 111.285 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.61 -30.16 70.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -80.51 -51.29 8.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.34 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.74 -20.63 57.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.744 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HE3' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -72.62 137.29 46.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.538 ' H ' ' HE3' ' A' ' 101' ' ' LYS . . . 125.51 -0.35 8.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.165 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.585 ' HB2' HG12 ' A' ' 109' ' ' ILE . 20.8 mm-40 -125.22 -179.37 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.777 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -135.16 -30.89 1.02 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 14.5 t70 -74.41 136.42 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -50.91 -68.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.92 -33.83 38.88 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 9.6 m120 -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 103' ' ' GLU . 78.3 mt -74.01 -32.62 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.49 -56.44 9.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.976 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.408 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 30.6 t30 -48.95 -24.61 1.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -86.6 -44.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.63 -59.32 4.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.059 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 110' ' ' GLY . 8.9 t -53.44 -46.14 69.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.207 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.615 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 16.6 t70 -42.28 -52.32 4.52 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.98 0.419 . . . . 0.0 111.264 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -44.32 93.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.06 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.285 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 40.6 mt -83.23 -20.46 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.76 -59.09 4.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.07 -54.9 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 123' ' ' SER . 33.0 tp -86.32 -10.82 53.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 19.8 t80 67.21 -9.23 0.4 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 110.783 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 121' ' ' LEU . 60.7 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.801 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.569 HD13 HD11 ' A' ' 121' ' ' LEU . 49.7 pt . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 4' ' ' ASP . 9.1 m-20 -81.41 118.66 22.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.21 -17.93 65.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 2.7 p30 -74.31 -27.0 60.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.3 p -82.66 -20.69 35.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.681 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.37 -63.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.726 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.01 -51.94 60.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.48 -29.64 70.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.3 mmmt -88.27 -59.35 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.554 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -50.39 -20.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 0.0 111.019 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.7 mmm -85.39 -62.06 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.801 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.42 -51.9 32.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.772 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -52.87 -21.06 3.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD13 HG11 ' A' ' 54' ' ' VAL . 48.0 mt -133.92 26.03 3.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.596 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.6 ttp -71.95 -49.41 10.33 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 15' ' ' MET . 29.7 Cg_endo -61.8 -21.97 73.35 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.005 1.803 . . . . 0.0 112.649 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 14' ' ' LEU . 2.2 p30 -102.03 -7.35 22.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -44.17 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.006 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 57.6 mtt -47.02 -49.83 48.54 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.52 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -57.89 -49.35 13.21 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.206 1.937 . . . . 0.0 112.671 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -56.55 -44.35 80.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -55.44 -47.17 76.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.166 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.09 -15.96 59.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.445 . . . . 0.0 110.332 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.03 -48.28 82.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.437 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.32 -41.56 5.49 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.325 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.48 ' CD2' ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER 177.46 -59.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.56 0.695 . . . . 0.0 110.73 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' H ' ' CD2' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -147.72 164.27 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.438 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.685 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 59.7 p -85.23 147.66 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -59.42 -20.73 57.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.736 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.14 -56.71 4.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.329 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.405 ' O ' HG22 ' A' ' 31' ' ' ILE . 36.0 mm -67.92 -8.34 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.343 0.592 . . . . 0.0 109.807 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.12 62.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.285 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -168.99 101.54 0.38 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.711 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 38.69 75.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.928 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.4 mt 55.17 -87.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.041 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.533 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 3.2 tp-100 65.98 151.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.171 0.51 . . . . 0.0 110.55 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.7 -74.09 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 47' ' ' LEU . . . -156.42 -103.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.647 0.26 . . . . 0.0 111.699 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 115' ' ' ASP . 59.0 pttt -68.56 -3.47 11.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.33 27.12 0.51 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.758 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.48 -5.24 26.44 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.827 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . . . -82.96 25.71 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 64.93 77.14 0.32 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.398 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 54.8 ttp -47.65 -37.64 13.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.02 178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -49.07 -55.23 12.77 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 3.5 tp-100 -86.9 -12.43 47.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -64.91 -37.48 87.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.026 0.441 . . . . 0.0 110.045 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 5.04 20.63 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.147 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -135.34 -70.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 2.3 tm? -45.77 -51.39 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 1.6 tpmt? -74.4 -24.65 59.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.418 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.0 -14.12 60.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 3.6 t -64.41 -39.23 93.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 14' ' ' LEU . 63.2 t -68.13 -28.86 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.755 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 86.9 mtp -58.86 -41.27 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -79.82 -15.69 56.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.079 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.8 mmp_? -71.91 -42.6 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.096 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 pt -92.1 24.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.564 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 57.25 30.47 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.421 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 25.7 ttt -99.95 -0.87 38.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.039 0.447 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 64.1 tp -157.95 99.87 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.96 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 9.3 mmpt? -86.9 76.56 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.225 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.3 3.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.54 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -147.12 4.03 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.697 0.284 . . . . 0.0 111.155 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 37.4 mt-10 -96.63 120.77 37.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.624 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 100' ' ' ALA . 36.4 mt -78.91 151.06 31.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.946 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.496 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 60.9 m-85 -143.15 148.57 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.637 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.09 7.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.57 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mm-40 -73.5 -49.17 6.72 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.79 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 71.8 Cg_endo -77.26 -23.74 9.99 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.105 1.87 . . . . 0.0 113.137 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 2.3 p -73.41 -44.91 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.642 0.258 . . . . 0.0 111.192 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 18.6 m-30 -60.04 -22.32 62.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.81 -44.05 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.882 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 25.5 ptm -72.47 -43.21 64.03 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.202 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -49.2 -23.58 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 86' ' ' ILE . 30.8 mt-10 -60.38 -59.49 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.414 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.31 -34.88 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.21 0.529 . . . . 0.0 110.951 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.494 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 40.7 t -58.71 -8.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.087 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 71.0 m80 -141.04 52.11 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.429 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.69 136.54 53.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.182 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.53 -67.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.158 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 3.5 m-20 -124.37 142.6 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.55 -28.52 69.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 5.6 m-20 -83.78 -25.83 30.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.287 . . . . 0.0 110.349 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.1 t70 -57.97 -30.06 65.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.604 HG23 HG22 ' A' ' 75' ' ' ILE . 79.5 mt -83.95 -26.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.616 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.6 OUTLIER -79.71 -22.01 43.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.497 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 92' ' ' ILE . 57.2 tp -78.23 -58.5 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.019 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.41 -36.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 72' ' ' TYR . 1.7 mttm -60.66 -34.97 75.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.61 -25.14 54.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.39 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.644 HD12 ' HB3' ' A' ' 120' ' ' LYS . 42.3 mm -69.71 -43.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.126 0.488 . . . . 0.0 111.109 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.36 -17.62 59.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.677 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.65 -22.67 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.973 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -82.54 -37.71 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.275 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 5.8 m -64.05 -27.65 69.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.506 HG23 HD12 ' A' ' 66' ' ' LEU . 62.0 mt -74.49 -34.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.608 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.1 p30 -91.42 -17.64 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 111.058 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -134.44 50.85 2.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.265 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -47.16 -31.39 3.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.68 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 101' ' ' LYS . . . 146.04 82.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.542 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -62.29 -178.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.33 . . . . 0.0 110.983 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t -84.82 -40.98 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -92.26 123.56 35.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp10 -37.15 -65.58 0.29 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.934 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 96.0 m -46.76 -50.52 18.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.21 -36.14 68.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.53 HG12 ' N ' ' A' ' 103' ' ' GLU . 56.2 mt -67.15 -41.4 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 114' ' ' THR . . . -73.41 -45.37 30.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.147 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 50.9 m-80 -48.56 -60.78 2.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.883 0.341 . . . . 0.0 111.273 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 14.3 mmtm -54.49 -37.08 64.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -69.31 -64.07 0.94 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.227 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 4.1 t -47.3 -56.98 5.76 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.509 ' H ' HG23 ' A' ' 114' ' ' THR . 70.6 m-20 -35.32 -54.54 0.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -51.4 -48.04 62.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.872 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -34.5 65.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.452 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 3.6 mp -81.77 -27.82 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.262 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.49 -47.28 56.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.812 0.339 . . . . 0.0 111.271 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.644 ' HB3' HD12 ' A' ' 92' ' ' ILE . 71.6 mmtt -87.02 -58.33 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 1' ' ' ILE . 26.1 tp -96.06 -10.18 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.74 -24.12 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.434 0.159 . . . . 0.0 110.602 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 121' ' ' LEU . 31.9 mt . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -125.57 141.73 51.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -56.16 -37.24 69.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 18.1 t70 -65.84 -54.86 21.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 53.5 p -57.36 -35.69 70.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 123' ' ' SER . 57.6 t -87.22 -64.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -58.78 -62.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.76 -25.78 42.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.2 mptm? -88.23 -54.6 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.714 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -57.88 -23.37 52.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -82.75 -56.13 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.84 -25.73 68.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.272 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -53.19 -46.26 68.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.263 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -152.1 45.11 0.74 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.766 0.317 . . . . 0.0 111.453 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.546 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 ttp -52.39 -50.25 80.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 15' ' ' MET . 33.4 Cg_endo -63.84 -32.33 66.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.051 1.834 . . . . 0.0 112.749 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 m-20 -84.45 -9.66 58.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 mt -86.37 -29.11 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.324 . . . . 0.0 110.855 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 25.5 mmt -54.75 -47.27 98.57 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.965 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 19' ' ' MET . 48.8 Cg_exo -37.83 -49.43 2.05 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.939 2.426 . . . . 0.0 113.475 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.9 m -85.01 -35.57 21.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.72 47.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -83.54 -50.47 8.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.67 -54.44 5.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.386 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.629 ' HB2' HD13 ' A' ' 50' ' ' LEU . 41.0 mt -86.17 38.72 0.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.4 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' HG23 ' A' ' 27' ' ' ILE . 37.0 t60 -63.09 75.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.338 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 26' ' ' HIS . 1.7 pt -160.97 54.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.093 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.581 ' HA ' HD23 ' A' ' 50' ' ' LEU . 10.9 m -57.68 177.09 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.66 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 29' ' ' GLU . 7.2 mt-10 -46.61 -21.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.523 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.46 -63.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.575 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.434 ' O ' HG22 ' A' ' 31' ' ' ILE . 35.1 mm -73.05 -6.59 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 43' ' ' ASP . . . -51.32 -55.15 19.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t 179.76 107.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -83.13 17.0 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.195 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.99 15.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.356 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 -149.92 129.86 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -83.04 -40.57 19.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.538 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.98 -94.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.694 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.641 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -104.02 -62.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -127.13 30.43 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 105.29 -16.33 45.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.923 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.85 -142.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.596 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 18.3 t70 -108.94 -15.17 14.43 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.047 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.443 ' HG3' ' HB2' ' A' ' 39' ' ' LYS . 22.7 ttt 69.66 -72.14 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -48.03 -40.47 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -87.43 -27.93 22.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 2.9 mp -66.81 -7.5 21.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -94.05 7.07 73.03 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.187 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 36.2 m -131.75 -70.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.227 . . . . 0.0 111.452 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' ' 25' ' ' LEU . 42.7 tp -51.56 -55.07 21.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 1.4 tpmt? -64.68 -23.2 67.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.215 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.17 -15.85 57.48 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.581 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.06 -25.45 66.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.081 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.31 -36.87 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.524 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.408 ' HB2' ' HE3' ' A' ' 55' ' ' MET . 72.6 mtm -68.5 -40.42 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -73.09 -20.02 61.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -86.06 -27.49 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' A' ' 60' ' ' MET . 48.5 pt -94.75 17.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.1 34.22 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.413 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.447 ' HB2' HG13 ' A' ' 58' ' ' ILE . 26.6 ttt -104.35 1.9 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.166 0.507 . . . . 0.0 110.544 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 66' ' ' LEU . 50.0 tp -153.18 98.79 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.757 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.3 mmpt? -104.67 104.67 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 48.14 51.61 19.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.356 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 109' ' ' ILE . 8.8 p 73.66 34.55 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.242 0.617 . . . . 0.0 111.479 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.0 106.08 9.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.679 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.2 mm? -68.45 147.27 52.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.378 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.97 169.31 13.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.35 . . . . 0.0 111.223 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.06 -25.69 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.358 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 48.1 mt-10 -62.37 -47.96 88.18 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.115 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 36.9 Cg_endo -65.07 -42.46 13.95 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.275 1.983 . . . . 0.0 113.445 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.544 HG13 ' HD1' ' A' ' 72' ' ' TYR . 3.1 p -65.23 -46.51 90.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.592 0.234 . . . . 0.0 111.395 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HD1' HG13 ' A' ' 71' ' ' VAL . 4.6 m-30 -59.29 -22.0 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.278 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 21.8 tptm -84.62 -45.56 12.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.4 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 1.2 ptp -70.84 -42.66 69.88 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.461 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.599 HG22 HG23 ' A' ' 86' ' ' ILE . 95.5 mt -48.73 -27.81 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.739 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 36.9 mt-10 -59.64 -59.22 5.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.716 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.5 -39.72 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.083 0.468 . . . . 0.0 110.811 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.77 -9.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.362 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 93.5 m-70 -143.47 56.75 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.9 137.54 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.11 -53.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.43 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -128.05 154.66 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.81 -29.4 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.351 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 4.1 p30 -83.52 -29.34 27.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.76 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -28.56 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 75' ' ' ILE . 88.9 mt -83.33 -29.06 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.237 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -76.78 -22.4 53.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.357 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 92' ' ' ILE . 69.6 tp -75.94 -60.12 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.768 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 121' ' ' LEU . 35.0 t -55.23 -35.97 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.93 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -33.96 60.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.25 -28.75 24.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 120' ' ' LYS . 31.3 mm -65.39 -36.29 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.0 64.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -74.21 -40.99 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.634 ' HG2' ' HE2' ' A' ' 120' ' ' LYS . 8.2 tp10 -62.57 -18.14 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.544 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 57.9 m -86.18 -53.89 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.747 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.6 mt -51.07 -30.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 111.295 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.52 -51.94 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.804 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.5 p30 -81.74 -5.93 58.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.647 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.43 39.72 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -41.91 -34.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.843 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 150.85 73.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.403 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HB2' HG13 ' A' ' 109' ' ' ILE . 7.9 mm-40 -61.73 150.14 37.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -74.25 -24.51 59.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.695 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 108' ' ' ASN . 15.1 t70 -99.96 144.95 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.01 -70.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.0 m -50.02 -24.15 2.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.684 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.406 ' CG ' ' HB3' ' A' ' 105' ' ' ASP . 5.5 m-20 -70.09 -58.18 4.1 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.51 HG13 ' HB2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -52.44 -41.66 36.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.87 -36.0 85.88 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.58 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.579 ' HA ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -68.62 -40.49 80.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.989 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -61.7 -27.15 68.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -59.32 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.001 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 111' ' ' ASN . 8.7 t -46.76 -45.14 19.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.814 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 114' ' ' THR . 13.7 t70 -48.12 -61.72 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -49.27 73.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -36.91 42.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.4 mm -79.49 -28.66 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 110.93 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 37.9 tt0 -69.53 -53.13 20.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 11.3 mptt -85.13 -55.94 3.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 HG13 ' A' ' 89' ' ' VAL . 39.0 tp -95.56 -11.32 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER 69.14 -16.93 0.22 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 121' ' ' LEU . 37.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.24 129.12 34.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -78.87 -16.89 56.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.681 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 9.6 m-20 -73.13 -26.7 61.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 69.4 p -81.54 -20.87 39.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 109.716 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 123' ' ' SER . 87.0 t -82.38 -63.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.813 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -65.13 -52.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.39 -27.98 68.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.05 -55.88 3.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.783 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -54.05 -24.24 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -79.23 -62.03 1.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.64 -23.62 67.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.792 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 5.2 t80 -56.56 -35.89 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.425 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.544 HD12 HG13 ' A' ' 54' ' ' VAL . 41.4 mt -151.59 28.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.6 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 36.3 ttp -47.41 -50.44 49.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 21.5 Cg_exo -65.84 -30.7 49.12 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.213 1.942 . . . . 0.0 112.351 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.37 -7.55 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.425 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 14' ' ' LEU . 93.3 mt -83.95 -25.78 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.635 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.519 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.4 mmt -49.11 -50.06 65.65 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.192 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 96.0 Cg_exo -41.93 -53.92 3.19 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.614 2.209 . . . . 0.0 113.251 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.0 m -82.29 -20.98 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.897 0.38 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -74.86 -2.73 28.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -83.65 -57.22 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.769 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -83.65 -47.86 10.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.685 ' HB2' HD23 ' A' ' 50' ' ' LEU . 49.6 mt -90.65 39.09 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 26.8 p-80 -63.88 68.17 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.487 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.3 pp -156.3 56.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -50.22 160.1 0.4 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -40.84 -32.46 0.23 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.59 -50.55 73.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.552 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.412 ' O ' HG22 ' A' ' 31' ' ' ILE . 52.0 mt -94.28 -8.65 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.315 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 27' ' ' ILE . . . -76.64 -1.6 28.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.099 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 81.3 p -67.44 4.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' GLN . 42.9 t30 -59.56 138.38 57.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.598 0.237 . . . . 0.0 110.514 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -51.77 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.446 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' ASN . 55.0 mt-30 -122.97 -98.54 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.461 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 43' ' ' ASP . . . -85.45 -31.8 22.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 111.659 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 63.55 25.66 14.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.897 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 44' ' ' MET . 46.7 tptt -46.07 -59.95 2.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -125.47 24.01 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.26 57.82 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.191 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' THR . . . -88.43 -81.87 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.688 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 10.9 t70 -178.14 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.458 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.907 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER 71.62 -34.26 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.34 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.87 ' HA ' HD22 ' A' ' 111' ' ' ASN . 64.3 m -52.41 -51.52 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -87.66 -28.5 21.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.766 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.907 HD13 ' H ' ' A' ' 44' ' ' MET . 6.5 mp -64.13 -21.85 66.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.77 -8.18 63.21 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.296 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -137.31 -62.47 0.62 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 25' ' ' LEU . 1.9 tm? -48.42 -41.81 30.3 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 26.2 ttpp -82.3 -23.93 34.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.622 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.66 -6.62 57.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.273 0.558 . . . . 0.0 109.753 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.1 t -64.58 -28.19 69.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.722 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 HD12 ' A' ' 14' ' ' LEU . 59.0 t -70.17 -26.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.933 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.25 -56.63 7.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 46.1 mtmt -55.12 -26.7 40.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -72.1 -33.51 67.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 14' ' ' LEU . 42.7 pt -100.2 22.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.477 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 58.26 29.29 17.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -97.43 -10.04 26.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.75 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 5.6 tt -149.15 114.66 5.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HA ' ' HE3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -107.82 77.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.58 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 -74.1 1.75 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -126.77 -1.57 6.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.503 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -91.0 156.16 18.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.638 HD21 HG13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -135.55 131.19 35.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.515 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' HD12 ' A' ' 66' ' ' LEU . 31.3 m-85 -118.84 170.83 8.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.4 m -137.72 -3.67 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 42.6 mt-10 -67.54 -49.51 40.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.1 Cg_endo -65.47 -28.23 53.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.101 1.867 . . . . 0.0 113.107 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 75' ' ' ILE . 0.3 OUTLIER -72.02 -41.63 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 111.083 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 21.6 m-30 -56.6 -22.06 31.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.263 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.82 -40.49 22.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.791 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 14.4 ptm -77.44 -38.44 49.47 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.101 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 86' ' ' ILE . 94.1 mt -50.97 -23.57 2.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.041 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 37.1 mt-10 -60.59 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.912 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.095 0.474 . . . . 0.0 110.983 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 34.0 t -64.14 -7.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.608 ' CE1' HG21 ' A' ' 89' ' ' VAL . 74.2 m80 -144.58 50.76 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.58 134.83 55.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.52 -68.51 0.48 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.559 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.06 147.53 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.36 -21.47 53.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.408 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.547 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 7.5 m-20 -84.14 -27.17 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.956 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.22 -27.22 63.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 75' ' ' ILE . 83.5 mt -85.93 -26.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.475 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -81.26 -21.41 39.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.819 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 92' ' ' ILE . 42.6 tp -81.33 -57.78 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.608 HG21 ' CE1' ' A' ' 79' ' ' HIS . 87.5 t -54.27 -36.22 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 72' ' ' TYR . 9.2 mttt -62.66 -31.42 72.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.975 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.26 47.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.221 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 88' ' ' LEU . 74.3 mt -73.06 -40.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.684 0.278 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.89 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.55 -26.07 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.487 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.7 tp10 -77.97 -19.64 54.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.043 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -86.28 -43.4 12.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.501 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.638 HG13 HD21 ' A' ' 66' ' ' LEU . 2.0 mp -58.89 -41.67 83.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.678 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.31 -14.46 61.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.7 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -98.66 -75.21 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.861 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.24 70.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.111 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? 67.64 -73.51 0.08 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.645 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 159.5 74.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.497 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 109' ' ' ILE . 11.4 mm-40 -61.3 -178.37 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.342 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t -84.61 -43.23 14.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 109' ' ' ILE . 24.0 t70 -87.93 122.84 32.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.55 0.214 . . . . 0.0 110.763 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.6 tt0 -42.07 -66.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.128 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.94 -36.13 16.62 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -67.46 -42.54 82.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.487 HG12 ' N ' ' A' ' 103' ' ' GLU . 50.6 mt -58.75 -50.75 78.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.491 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 114' ' ' THR . . . -64.82 -36.85 93.59 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.719 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.87 HD22 ' HA ' ' A' ' 45' ' ' SER . 4.9 m-80 -48.36 -38.36 19.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.011 0.405 . . . . 0.0 111.372 -179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.3 mptp? -86.43 -24.15 25.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.888 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.03 -64.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 110' ' ' GLY . 5.2 t -54.06 -28.51 39.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -53.36 -70.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.337 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -34.53 62.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.572 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -33.97 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 0.0 110.562 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 75.1 mt -85.08 -17.14 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 110.271 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.21 -58.66 3.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.493 ' H ' ' HD2' ' A' ' 120' ' ' LYS . 2.8 mptp? -87.36 -49.15 7.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -91.0 -12.02 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.064 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 71.54 -23.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -179.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.551 ' HB3' HG11 ' A' ' 6' ' ' VAL . 64.0 p . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.5 pt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.83 134.08 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.58 -24.85 67.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.94 -52.93 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.053 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.0 p -51.21 -29.98 15.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.128 0.49 . . . . 0.0 110.97 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 53.7 t -77.48 -63.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.589 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.05 -59.46 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.79 -35.91 15.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.1 mmmt -88.74 -59.42 2.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 13.7 m-85 -49.86 -29.1 7.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.31 . . . . 0.0 111.551 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.6 tpp -71.98 -55.46 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.69 -46.49 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.452 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 2.5 t80 -45.34 -39.87 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.352 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 54' ' ' VAL . 26.3 mt -145.3 63.53 1.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.447 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.495 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 57.2 ttp -83.9 -52.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.599 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 71.6 Cg_endo -77.41 -27.31 6.52 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.968 1.779 . . . . 0.0 111.721 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 9.6 m-20 -72.38 -10.87 60.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.576 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 14' ' ' LEU . 2.8 mt -77.29 -39.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.604 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 17.0 mmt -48.54 -51.66 50.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.935 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 74.2 Cg_exo -49.57 -51.5 10.62 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.265 1.977 . . . . 0.0 112.746 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.44 -43.23 83.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.499 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -60.18 -44.08 95.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.77 -15.96 61.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.68 -54.37 47.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.7 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 50' ' ' LEU . 10.8 mt -102.36 -41.07 6.46 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.166 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 62.8 t-80 176.71 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 110.391 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.96 163.48 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.573 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 91.8 p -85.25 148.17 26.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.641 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -54.52 -22.7 13.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.242 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.55 -52.39 18.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.39 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 31' ' ' ILE . 51.0 mt -79.75 -8.52 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.251 0.548 . . . . 0.0 110.067 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.33 6.01 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.46 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -60.04 -9.04 2.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.694 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.07 2.12 6.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 87.9 mt -118.91 -46.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 60.01 99.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.722 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . . . -85.38 -76.38 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 37' ' ' ALA . . . 170.4 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.293 0.371 . . . . 0.0 111.962 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.653 ' HB2' ' HB2' ' A' ' 44' ' ' MET . 2.0 tmtt? -59.63 -63.18 1.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.112 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.471 ' HB3' HG21 ' A' ' 118' ' ' ILE . 6.9 p30 -127.78 -4.14 5.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.45 43.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.922 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -85.4 -79.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.568 0.223 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 62.7 t0 176.18 83.54 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.653 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 49.9 ttp -51.3 -39.54 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.376 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -51.98 -57.07 10.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.278 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.538 ' OE1' HD13 ' A' ' 25' ' ' LEU . 12.8 mm-40 -85.05 -12.33 53.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.483 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 16.5 tp -62.73 -39.74 95.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.084 0.468 . . . . 0.0 110.139 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 110' ' ' GLY . . . -69.87 4.7 7.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.478 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 107' ' ' CYS . 1.8 m -131.48 -72.54 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.703 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm? -47.32 -54.05 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.36 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.641 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 16.8 tptp -71.97 -23.5 61.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.596 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.12 -18.63 61.88 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.036 0.446 . . . . 0.0 110.092 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.92 -36.13 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.222 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 14' ' ' LEU . 67.0 t -59.58 -27.53 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 60' ' ' MET . 56.2 mtt -65.65 -51.84 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.575 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 56' ' ' LYS . 47.2 mttt -66.09 -15.94 63.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.209 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 5.6 tpm_? -69.33 -45.81 68.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 60' ' ' MET . 36.8 pt -91.55 29.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.442 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 55.33 29.94 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 ttt -94.34 -17.73 22.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 60.4 tp -144.13 101.94 3.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 5.9 mmpt? -84.16 77.45 9.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.945 0.402 . . . . 0.0 110.124 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.42 -57.09 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.2 p -153.52 9.32 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 28.7 mm-40 -94.5 108.18 20.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 HG12 ' A' ' 109' ' ' ILE . 7.6 mp -67.66 138.22 56.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 60' ' ' MET . 62.5 m-85 -139.31 159.75 41.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.26 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.22 -10.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.363 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.1 mt-10 -56.85 -50.27 89.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.8 -14.13 35.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.001 1.801 . . . . 0.0 112.001 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 HD11 ' A' ' 75' ' ' ILE . 24.5 t -78.76 -47.44 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.045 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -63.3 -27.35 69.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -76.56 -30.08 56.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.256 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.5 ptm -85.73 -43.94 12.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.35 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.726 HG22 HG23 ' A' ' 86' ' ' ILE . 93.7 mt -51.62 -33.84 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 110.549 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' HA ' HD13 ' A' ' 86' ' ' ILE . 29.5 mt-10 -53.8 -57.49 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.97 -24.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 111.171 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 9' ' ' LYS . 6.3 t -67.61 -11.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.944 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 90.5 m-70 -134.05 49.96 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.467 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.23 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.55 -70.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.16 148.35 31.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.913 0.387 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.09 -35.84 36.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.719 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 -30.85 51.32 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.955 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -21.78 6.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.726 HG23 HG22 ' A' ' 75' ' ' ILE . 63.5 mt -85.93 -55.03 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.5 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 90' ' ' LYS . 9.1 mm100 -52.81 -25.68 12.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.732 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 92' ' ' ILE . 63.8 tp -71.66 -46.55 58.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.588 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 75' ' ' ILE . 43.0 t -69.15 -41.71 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.317 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 86' ' ' ILE . 9.2 mtmt -55.11 -27.12 42.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.28 -24.52 36.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.356 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 121' ' ' LEU . 47.2 mm -61.87 -40.16 86.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.725 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -59.88 -30.1 68.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.72 -23.53 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.04 -38.65 31.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.624 ' HA ' HD22 ' A' ' 99' ' ' ASN . 72.9 m -74.13 -36.36 64.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.653 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 93' ' ' ALA . 93.4 mt -56.46 -27.35 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -52.35 7.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.196 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.624 HD22 ' HA ' ' A' ' 96' ' ' CYS . 23.2 p30 -70.78 -17.13 62.79 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.58 -49.15 10.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.635 0.255 . . . . 0.0 111.272 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 61.13 -177.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.85 44.5 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.307 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.79 125.6 24.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -72.98 -26.58 61.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.503 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.6 t70 -72.87 134.73 44.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.35 -61.6 2.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.726 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 54.0 m -60.59 -10.3 4.99 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.1 t-20 -86.66 -53.61 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 110.243 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.553 HG12 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -51.31 -34.81 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 48' ' ' GLY . . . -85.93 -51.47 3.58 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.891 -0.671 . . . . 0.0 114.296 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 14.5 t30 -52.96 -23.86 8.16 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.7 0.75 . . . . 0.0 110.446 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -87.49 -40.82 13.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.923 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.15 -64.96 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.843 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 p -46.21 -45.57 17.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.988 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 14.7 t70 -43.9 -72.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.823 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.18 -32.32 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.822 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -56.18 -38.46 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 110.532 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.8 mt -83.45 -19.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 110.275 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -71.24 -60.11 2.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 92' ' ' ILE . 67.2 mttm -87.17 -50.77 6.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.5 HD22 HG13 ' A' ' 89' ' ' VAL . 57.0 tp -85.35 -11.87 53.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 6.3 t80 66.72 -6.03 0.58 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 0.0 110.504 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 121' ' ' LEU . 68.1 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.836 0.35 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.78 137.54 39.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -66.14 -7.94 20.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.6 -43.98 87.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.552 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 5.6 t -52.54 -25.48 10.56 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.8 t -87.67 -64.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.449 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.72 -61.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.03 -28.27 23.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.4 mmtm -88.62 -59.6 2.19 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.53 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -51.14 -21.29 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.8 mtt -83.31 -61.59 1.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.306 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -52.56 64.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 4.8 t80 -43.9 -33.82 1.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.46 HD11 HG21 ' A' ' 58' ' ' ILE . 90.9 mt -146.64 59.75 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.452 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 37.9 tpp -89.15 -51.28 0.37 Allowed Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.7 Cg_endo -72.69 -12.46 26.68 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.991 1.794 . . . . 0.0 111.685 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.01 -9.86 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.884 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 mt -89.21 -47.35 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.707 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.483 ' CG ' ' HD3' ' A' ' 20' ' ' PRO . 19.3 ptp -53.84 -34.05 18.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HD3' ' CG ' ' A' ' 19' ' ' MET . 52.2 Cg_exo -54.48 -52.55 7.92 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.419 1.413 . . . . 0.0 112.978 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 11.3 m -72.84 -22.88 60.72 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.514 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -53.92 -42.17 68.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.646 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -83.95 -16.18 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.332 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 33.2 tt0 -61.5 -54.37 44.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.956 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 19.1 mt -90.23 -41.42 11.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 21.5 t-80 176.5 -62.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.77 0.795 . . . . 0.0 110.658 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 1.2 pt -146.45 164.35 8.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.793 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.46 148.59 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.631 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.757 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.12 -53.38 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.481 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.407 ' O ' HG22 ' A' ' 31' ' ' ILE . 36.5 mt -88.7 -6.7 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.211 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.558 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . . . -72.36 -1.05 14.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 34' ' ' ASN . 4.0 t -49.07 -51.62 30.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.583 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 33' ' ' THR . 13.3 t-20 42.46 42.16 2.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.286 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 mm 55.8 52.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -147.62 123.28 10.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.354 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -79.28 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.618 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 44' ' ' MET . . . 64.45 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -103.75 -61.39 1.43 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -127.06 4.32 6.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.852 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.756 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.49 -4.23 31.1 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.717 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 29' ' ' GLU . . . -85.2 -69.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.592 0.234 . . . . 0.0 111.529 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 44' ' ' MET . 23.4 t70 -176.16 -30.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.587 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 10.2 ttt 74.59 -65.78 0.33 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.175 0.297 . . . . 0.0 111.047 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.7 p -59.05 -43.54 91.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.27 . . . . 0.0 110.703 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 4.1 tp-100 -87.81 -30.25 20.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.5 tm? -54.29 -44.9 72.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 110.054 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 110' ' ' GLY . . . -66.15 6.49 1.59 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.807 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.6 m -134.3 -72.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.2 tm? -46.56 -51.49 15.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.522 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 27.4 tptp -75.37 -22.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.37 -20.13 62.98 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.5 t -60.99 -34.23 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.5 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.86 -26.88 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.7 mtm -69.06 -51.98 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.826 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 30.7 pttt -75.82 -15.75 60.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.5 tpm_? -70.45 -30.15 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.751 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 14' ' ' LEU . 45.9 pt -105.86 26.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.488 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 57.93 63.11 1.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -139.65 -10.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.53 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 30.0 tp -134.84 99.48 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.54 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -94.16 76.61 4.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.188 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.26 -58.73 3.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.285 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.9 p -148.25 4.26 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.714 0.292 . . . . 0.0 110.994 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt-10 -94.16 131.26 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.1 mt -113.74 113.83 25.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.139 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -106.15 177.85 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.61 25.49 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.541 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 43.7 mt-10 -79.19 -50.21 1.39 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.625 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 60.0 Cg_endo -74.44 -38.45 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.148 1.898 . . . . 0.0 113.067 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG13 ' HE3' ' A' ' 74' ' ' MET . 11.8 t -63.59 -46.1 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.633 0.254 . . . . 0.0 111.13 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -60.88 -21.81 63.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.371 . . . . 0.0 110.62 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -82.12 -48.01 11.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.743 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.58 ' HE3' HG13 ' A' ' 71' ' ' VAL . 14.7 ptt? -74.61 -35.43 62.94 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.91 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.692 HG22 HG23 ' A' ' 86' ' ' ILE . 9.6 mt -49.68 -26.15 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.076 0.465 . . . . 0.0 110.418 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -59.05 5.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.497 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.68 -24.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.198 0.523 . . . . 0.0 111.146 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 25.1 t -67.27 -7.39 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 79.9 m80 -138.05 43.28 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.56 134.65 57.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.86 -60.92 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.408 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.681 ' HB3' ' HB2' ' A' ' 85' ' ' ASP . 30.3 t30 -116.87 132.16 56.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 110.514 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.87 67.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 -22.3 30.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.681 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 13.8 t70 -62.04 -24.18 66.92 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.692 HG23 HG22 ' A' ' 75' ' ' ILE . 93.3 mt -85.13 -29.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.661 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -81.48 -21.98 38.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.578 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.97 -60.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.24 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.666 HG12 HD13 ' A' ' 121' ' ' LEU . 24.3 m -54.93 -31.5 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -58.02 -41.95 84.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.648 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.7 -18.88 72.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.802 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 89' ' ' VAL . 50.9 mt -67.54 -41.03 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.728 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.96 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.283 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.3 -48.81 39.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.259 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.9 -21.21 57.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 29.3 m -86.24 -39.39 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.696 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 66' ' ' LEU . 93.2 mt -69.74 -42.04 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.808 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.98 -19.97 64.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.905 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -109.33 -8.43 15.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.4 12.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HG2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -73.59 -177.64 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.975 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.552 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 75.89 -26.46 1.43 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.91 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.618 ' HB2' HG12 ' A' ' 109' ' ' ILE . 14.5 mm-40 -64.62 176.03 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.702 0.287 . . . . 0.0 110.72 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.1 p -123.77 -20.28 5.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.507 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -102.4 139.99 37.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.54 -65.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.415 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 64.9 m -50.34 -31.1 13.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -68.66 -40.36 80.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 103' ' ' GLU . 85.9 mt -69.41 -47.29 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.866 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 114' ' ' THR . . . -62.08 -52.3 50.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.909 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.587 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.0 t-20 -54.56 -39.47 67.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.078 0.439 . . . . 0.0 110.319 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -69.23 -25.65 64.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -83.72 -61.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 47' ' ' LEU . 7.7 t -47.36 -47.93 25.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.375 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.473 ' N ' HG23 ' A' ' 114' ' ' THR . 4.8 t70 -44.93 -61.55 1.57 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.57 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -48.03 73.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -25.68 54.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.489 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.9 mm -85.12 -32.15 7.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.963 0.411 . . . . 0.0 111.171 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.23 -45.22 57.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.857 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 92' ' ' ILE . 73.0 mmtt -86.64 -56.53 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 89' ' ' VAL . 28.9 tp -98.93 -11.84 21.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.0 OUTLIER 69.05 -16.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 110.862 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 6' ' ' VAL . 10.9 m-20 -99.08 104.46 16.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -58.74 -39.33 80.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.14 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -53.42 -50.5 65.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.416 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 40.3 p -64.91 -20.67 66.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 2' ' ' ASP . 87.9 t -83.28 -63.18 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.09 -57.13 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.498 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.55 64.94 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.43 -59.29 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.959 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -51.49 -22.98 3.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 110.851 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.2 ttp -85.52 -62.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.346 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.6 -31.31 67.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.076 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -55.92 -45.22 78.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.437 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -141.03 40.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.56 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttp -58.34 -51.81 79.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.47 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 15' ' ' MET . 57.9 Cg_endo -70.83 -13.47 31.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.007 1.805 . . . . 0.0 112.218 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -101.96 -6.95 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.41 -43.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.512 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 84.8 mmm -53.02 -48.73 90.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 76.4 Cg_exo -43.79 -51.38 6.37 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.719 2.28 . . . . 0.0 113.149 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 78.9 m -58.3 -31.91 67.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.771 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.67 71.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.2 -15.97 59.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 3.0 mm-40 -60.7 -38.86 86.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.819 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 HD22 ' OE1' ' A' ' 46' ' ' GLN . 0.9 OUTLIER -117.88 -39.58 3.09 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.417 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.47 ' HD2' ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER 178.9 -58.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.205 0.526 . . . . 0.0 112.094 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.47 ' H ' ' HD2' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -143.56 178.37 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.295 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.602 ' C ' HD21 ' A' ' 50' ' ' LEU . 10.9 m -86.24 171.28 11.39 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.003 0.43 . . . . 0.0 110.851 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.1 tm-20 -68.67 -21.82 64.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.221 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.29 -47.08 9.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.223 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 18.1 mt -70.38 -7.0 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.608 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.65 -49.71 56.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 36' ' ' GLN . 8.2 m -152.57 -11.92 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.279 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 64.46 63.24 0.76 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 11.0 mt 52.83 46.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.832 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.564 ' HB2' HG22 ' A' ' 33' ' ' THR . 46.4 mt-30 -146.96 12.92 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.26 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.709 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -85.42 -72.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.46 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.45 -75.46 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.436 ' HD2' ' HE2' ' A' ' 44' ' ' MET . 12.8 ptmm? -89.68 -58.22 2.6 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.745 HD22 ' HB2' ' A' ' 42' ' ' ALA . 2.8 p-10 -122.19 -3.74 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.761 0.315 . . . . 0.0 111.248 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.709 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 102.73 0.63 49.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.199 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.745 ' HB2' HD22 ' A' ' 40' ' ' ASN . . . -85.32 -3.3 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 15.0 t70 70.94 -14.39 0.45 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.453 ' H ' ' C ' ' A' ' 42' ' ' ALA . 46.3 ttm 71.22 -27.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 43' ' ' ASP . 47.5 t -64.6 -57.43 9.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.498 0.189 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.468 ' HA ' ' NE2' ' A' ' 46' ' ' GLN . 0.9 OUTLIER -86.9 -12.14 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 0.0 110.776 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.2 -41.99 80.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -74.54 13.61 4.88 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.504 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.558 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 5.1 m -147.3 -70.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 111.737 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.602 HD21 ' C ' ' A' ' 28' ' ' SER . 12.2 tp -44.35 -55.91 4.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.398 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 84.6 tttt -79.16 -22.18 45.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -76.15 -7.8 55.61 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.026 0.441 . . . . 0.0 110.626 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.0 t -72.15 -36.09 69.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.83 -22.22 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.0 mtt -69.84 -46.48 65.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.505 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 49.5 mttm -60.2 -18.8 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 4.4 tpm_? -67.59 -45.31 75.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.381 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.04 34.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.29 13.55 3.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.754 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.4 tpt -71.9 -14.3 61.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 31.9 tp -155.18 103.71 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -95.3 80.87 3.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 -70.56 1.61 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.893 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.7 p -145.54 27.19 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.21 110.53 21.08 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.413 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 109' ' ' ILE . 86.0 mt -73.63 131.94 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.707 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -119.81 172.15 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 97' ' ' ILE . 11.2 m -149.26 -17.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.3 mt-10 -58.61 -51.14 83.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.82 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 21.9 Cg_endo -61.21 -32.67 90.83 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.216 1.944 . . . . 0.0 112.625 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 75' ' ' ILE . 46.2 t -72.94 -48.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.179 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -54.09 -24.71 18.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -86.0 -36.76 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 20.0 ptm -75.75 -39.57 56.96 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.508 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.631 HG22 HG23 ' A' ' 86' ' ' ILE . 90.3 mt -50.48 -23.64 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.053 0.454 . . . . 0.0 110.189 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.481 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.9 mt-10 -59.01 -58.82 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 9' ' ' LYS . 21.2 t -88.05 -24.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.151 0.5 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 9' ' ' LYS . 41.8 t -66.26 -8.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.941 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' NE2' HG21 ' A' ' 89' ' ' VAL . 92.0 m-70 -143.37 49.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.613 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.58 127.32 30.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -73.53 0.34 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.595 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.4 m-20 -104.6 136.69 43.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.688 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.5 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.613 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.07 -24.89 30.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.758 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.0 t70 -59.58 -26.56 65.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.631 HG23 HG22 ' A' ' 75' ' ' ILE . 81.1 mt -84.34 -27.73 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.475 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.83 -19.76 43.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.617 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.8 tp -78.25 -55.06 5.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.582 HG13 ' HG ' ' A' ' 121' ' ' LEU . 26.4 t -55.94 -36.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.572 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -61.83 -30.04 70.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.722 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.19 51.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.261 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.609 HG13 HD23 ' A' ' 121' ' ' LEU . 47.9 mm -74.38 -39.91 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 0.0 110.893 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -58.34 -23.72 57.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -75.48 -37.48 60.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -56.64 -28.45 60.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.546 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 59.8 m -80.68 -27.68 37.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD11 HG11 ' A' ' 68' ' ' VAL . 39.6 mt -74.15 -21.8 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.933 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.0 -29.44 55.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 3.9 p30 -97.51 -40.74 8.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.191 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.78 -46.09 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt 59.88 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.709 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 179.68 63.84 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.948 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HB2' HG13 ' A' ' 109' ' ' ILE . 6.8 mm-40 -60.45 166.25 3.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.175 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.9 t -90.42 -20.87 22.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.735 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -96.03 143.34 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.303 . . . . 0.0 110.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.558 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 12.9 tp10 -65.41 -69.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.697 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 14.3 m -50.25 -24.11 2.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.516 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -76.81 -49.35 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.655 HG23 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -56.79 -43.82 80.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.5 -50.21 39.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.752 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 13.5 t30 -54.83 -33.78 62.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.08 -31.49 58.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.852 0.358 . . . . 0.0 111.014 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.96 -65.57 1.0 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.76 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -46.73 -42.9 17.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.142 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 17.0 t70 -46.0 -63.77 0.9 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.77 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.332 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.35 -51.21 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.898 0.38 . . . . 0.0 110.669 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.4 mt -78.17 -17.76 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.54 -60.01 3.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.602 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.93 -55.96 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.609 HD23 HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -85.34 -11.32 54.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.32 -14.24 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 110.524 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 121' ' ' LEU . 70.0 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.72 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.473 HG21 ' OD1' ' A' ' 85' ' ' ASP . 45.6 pt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 5' ' ' THR . 38.6 t0 -75.68 143.03 42.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.81 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.0 -4.24 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.997 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.52 -57.0 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 2' ' ' ASP . 15.3 t -49.8 -28.17 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.387 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -86.93 -64.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.844 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.89 -58.11 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.19 -29.49 22.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 mptp? -88.54 -59.09 2.33 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.517 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -51.28 -20.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.727 0.299 . . . . 0.0 111.362 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -85.0 -58.6 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.37 -23.48 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.55 -23.41 56.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.694 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HB3' HG11 ' A' ' 54' ' ' VAL . 79.0 mt -135.02 15.98 3.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tmm? -58.27 -51.91 78.41 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.316 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 16.3 Cg_exo -69.86 -7.15 20.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.551 2.167 . . . . 0.0 112.321 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -104.75 -16.88 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 HG21 ' A' ' 54' ' ' VAL . 67.7 mt -89.21 -49.51 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.262 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.594 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 91.9 mmm -49.07 -49.65 67.88 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.7 Cg_exo -51.29 -52.18 9.6 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.242 1.961 . . . . 0.0 113.118 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -76.65 -22.14 54.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.531 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.569 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -54.82 -35.78 64.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.76 -16.54 44.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -59.95 -51.07 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.701 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 50' ' ' LEU . 13.2 mt -96.52 -41.43 8.57 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.805 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 45.5 t-80 176.26 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.903 0.859 . . . . 0.0 110.132 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.1 pt -149.2 171.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 113.899 -1.5 . . . . 0.0 110.35 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.0 p -81.88 151.43 27.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HG3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.35 -9.13 4.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.576 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.85 -42.73 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.287 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.7 mt -90.64 -6.7 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.177 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.83 6.5 6.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.09 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 9.4 t -63.37 -3.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.581 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -69.88 -10.76 59.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.7 mt -103.71 -44.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 90.8 mt-30 60.28 101.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . . . -85.66 -75.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.718 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' ALA . . . 172.05 -21.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.325 0.39 . . . . 0.0 112.049 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.52 -62.25 1.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.677 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.495 ' HB3' HD13 ' A' ' 118' ' ' ILE . 27.9 p-10 -127.38 -1.99 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 0.0 111.237 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 36' ' ' GLN . . . 105.0 -11.1 48.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.262 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 43' ' ' ASP . . . -85.99 -77.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.597 0.237 . . . . 0.0 111.32 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 25.8 t0 174.38 96.11 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.398 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.408 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 11.3 ttm -46.3 -41.19 12.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.014 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.4 p -63.06 -57.06 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.28 -12.54 59.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.648 ' HG ' HG21 ' A' ' 114' ' ' THR . 30.3 tp -84.46 -30.92 24.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -92.13 14.94 63.19 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -132.28 -74.2 0.51 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.988 -0.606 . . . . 0.0 111.305 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -50.84 -45.67 59.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.351 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 58.3 tttm -74.65 -24.94 58.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -68.15 -22.11 64.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.3 0.571 . . . . 0.0 109.851 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.4 t -73.75 -37.84 64.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.277 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.533 HG21 HG12 ' A' ' 18' ' ' ILE . 5.7 t -63.55 -20.9 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.46 ' HE2' ' HG2' ' A' ' 51' ' ' LYS . 17.1 mmt -63.92 -51.94 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.647 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' HB2' ' NZ ' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.86 -16.19 48.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.17 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.2 mmp_? -73.08 -34.15 66.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.086 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.447 HD11 ' SD ' ' A' ' 60' ' ' MET . 33.1 pt -107.13 34.91 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 42.68 40.95 2.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.894 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 55' ' ' MET . 18.2 ptm -112.02 8.97 20.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 110.091 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 56' ' ' LYS . 44.4 tp -157.72 99.01 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 11.7 mmpt? -104.37 95.8 6.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.059 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.15 57.6 14.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.39 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p 73.03 22.85 2.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.038 0.535 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 20.3 mm-40 -115.75 104.94 12.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 100' ' ' ALA . 5.7 mp -78.51 141.27 38.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -112.86 -178.48 3.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 HD13 ' A' ' 97' ' ' ILE . 30.6 m -129.18 -28.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm-40 -64.71 -52.86 48.21 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.933 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 12.7 Cg_endo -58.13 -13.76 16.94 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.054 1.836 . . . . 0.0 112.402 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.7 t -91.53 -46.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.4 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.9 m-85 -62.77 -22.25 66.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.213 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -82.35 -47.68 12.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -71.59 -41.27 69.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.861 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 89' ' ' VAL . 26.5 mt -49.37 -30.5 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.005 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 48.0 mt-10 -54.71 -59.53 4.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.814 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.57 -29.09 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 111.142 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 35.5 t -65.05 -7.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -139.05 33.35 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.38 56.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.319 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.15 -53.08 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.209 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.8 m120 -116.19 110.28 18.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.69 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.51 69.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.1 m-20 -79.71 -18.84 50.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.81 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 37.2 t0 -62.9 -34.09 76.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 75' ' ' ILE . 88.5 mt -76.42 -31.76 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.561 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.9 tp60 -75.55 -30.95 59.89 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.779 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -83.75 -47.14 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 ' HG ' ' A' ' 121' ' ' LEU . 9.9 p -64.73 -32.88 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -52.69 -34.53 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.1 -30.44 31.28 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.38 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.591 HG13 HD23 ' A' ' 121' ' ' LEU . 34.8 mm -65.69 -35.64 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.36 -33.54 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.966 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.32 -21.73 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.29 -33.38 69.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.679 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.614 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 69.5 m -87.25 -53.65 4.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.47 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.57 HD13 HG12 ' A' ' 68' ' ' VAL . 65.1 mt -49.46 -28.8 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.63 -34.68 53.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.5 p30 -94.37 -3.88 49.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.443 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 66' ' ' LEU . . . -100.63 -33.68 10.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.832 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 25.5 -85.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.052 0.845 . . . . 0.0 113.048 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.543 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . -167.18 77.76 0.12 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.716 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.94 168.76 9.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.811 0.339 . . . . 0.0 110.94 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.5 p -87.77 -43.12 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 109' ' ' ILE . 11.1 t70 -79.83 131.23 35.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.835 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -49.16 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 83.4 m -56.58 -21.53 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -81.61 -31.19 32.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.013 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 105' ' ' ASP . 90.7 mt -66.74 -40.49 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -82.59 -37.03 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.368 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 51.9 t30 -56.92 -48.31 78.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.674 0.273 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -53.59 -26.83 23.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.706 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.83 -65.8 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.917 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.648 HG21 ' HG ' ' A' ' 47' ' ' LEU . 9.7 t -53.19 -46.18 68.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 14.9 t70 -38.81 -58.44 1.08 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 p -76.81 -34.94 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.93 -32.5 66.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.876 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 54.3 mt -83.77 -20.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.224 0.535 . . . . 0.0 110.426 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.62 -58.26 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.0 -52.06 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.591 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -92.45 -11.44 34.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.19 -15.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.587 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 121' ' ' LEU . 58.8 m . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 121' ' ' LEU . 44.7 pt . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.87 0.367 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.07 125.21 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.33 -38.38 71.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.81 -48.51 75.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.446 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.6 p -54.84 -24.52 23.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 123' ' ' SER . 58.4 t -86.41 -63.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.592 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.41 -62.11 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.24 -28.65 19.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.7 mmpt? -87.72 -59.15 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.491 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -52.06 -29.03 19.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -76.95 -62.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.98 -23.65 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.53 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -63.72 -48.19 78.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.483 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 58' ' ' ILE . 80.4 mt -137.89 36.68 2.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.0 ttm -55.3 -50.89 84.1 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 15' ' ' MET . 70.0 Cg_endo -71.24 -8.44 23.45 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.215 1.943 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 7.1 m-20 -100.29 -16.1 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 14' ' ' LEU . 78.3 mt -80.88 -49.87 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.471 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 87.8 mtp -48.4 -47.98 67.52 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.068 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 19' ' ' MET . 53.3 Cg_exo -38.51 -60.31 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.684 2.256 . . . . 0.0 113.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' O ' HD12 ' A' ' 25' ' ' LEU . 64.8 m -69.64 -26.49 64.43 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.53 -44.83 66.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.877 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.15 -15.95 45.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.207 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 7.9 tp10 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.621 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 21' ' ' CYS . 1.2 mp -88.29 -41.34 12.96 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.739 -0.785 . . . . 0.0 112.289 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 7.7 t-80 177.19 -62.16 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.719 0.771 . . . . 0.0 111.033 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -149.58 163.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.938 -177.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 60.4 p -85.49 163.19 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -73.84 0.46 13.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.415 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.26 -37.88 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mm -101.64 -16.09 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.448 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 27' ' ' ILE . . . -60.52 -18.71 53.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.349 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -82.11 34.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.046 0.45 . . . . 0.0 111.31 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -72.08 -6.09 39.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.442 HD13 ' H ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -120.98 -29.0 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.268 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 61.78 109.41 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -80.82 -74.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.658 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.22 -62.35 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -55.29 -61.37 2.37 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.688 HD22 ' HB3' ' A' ' 42' ' ' ALA . 24.7 p-10 -126.39 -23.35 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.624 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 109.57 -14.2 32.62 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.583 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.688 ' HB3' HD22 ' A' ' 40' ' ' ASN . . . -83.48 -2.54 56.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.675 0.274 . . . . 0.0 110.922 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 68.56 -3.8 1.29 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.543 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 20.6 ttm 59.79 9.71 1.78 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.263 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.9 t -86.5 -58.03 2.77 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 110.772 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -86.96 -16.38 36.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.058 0.456 . . . . 0.0 109.99 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.554 HD22 HD22 ' A' ' 40' ' ' ASN . 19.3 tp -71.59 -35.31 70.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.623 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.26 9.38 9.92 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.734 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -146.64 -62.99 0.3 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.9 tm? -48.68 -42.68 35.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 81.2 tttt -81.16 -20.47 41.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.599 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.53 -21.95 62.67 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 1.7 t -59.64 -31.44 69.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.02 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.97 -28.93 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' MET . 71.1 mtm -72.68 -65.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.16 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HG2' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -58.07 -15.34 9.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.471 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.1 tpm_? -72.18 -34.26 68.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.175 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 14' ' ' LEU . 40.2 pt -113.29 34.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.827 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 64.01 11.05 5.81 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.563 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.0 tpt -79.05 4.16 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 56' ' ' LYS . 34.2 tp -166.81 99.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 2.5 mmpt? -85.93 78.33 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.452 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.7 -64.58 3.28 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.049 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 109' ' ' ILE . 63.8 p -147.36 15.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.709 0.29 . . . . 0.0 110.835 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -108.83 110.22 21.53 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.436 HD22 ' N ' ' A' ' 66' ' ' LEU . 3.6 mm? -69.68 135.01 49.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.33 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 2.6 m-85 -106.4 174.31 5.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.73 -25.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.346 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.2 mm-40 -56.54 -51.86 77.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.504 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -63.53 -13.67 37.79 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.969 1.779 . . . . 0.0 112.099 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 75' ' ' ILE . 2.8 t -86.05 -50.37 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -56.86 -22.54 37.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.839 0.352 . . . . 0.0 110.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -85.33 -44.21 13.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.319 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 24.8 ptp -71.98 -41.71 67.36 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.697 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.572 HD13 HG23 ' A' ' 89' ' ' VAL . 89.0 mt -48.66 -28.52 2.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.01 -56.36 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.12 -24.73 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 75' ' ' ILE . 40.8 t -69.83 -8.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.856 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 74.8 m80 -144.67 45.53 1.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.652 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.77 119.91 10.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.61 -74.4 0.27 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.47 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.0 m120 -100.13 123.89 44.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.66 -25.27 67.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.024 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 9.5 m-20 -84.3 -24.98 29.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.436 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.8 t0 -56.68 -36.1 69.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 75' ' ' ILE . 96.9 mt -74.39 -28.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.6 tp60 -81.66 -23.56 36.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tt -78.37 -62.11 1.79 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.285 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 75' ' ' ILE . 28.5 m -58.85 -27.77 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.653 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.4 tttt -56.82 -35.91 69.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.713 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.46 -19.15 62.69 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 89' ' ' VAL . 29.1 mm -73.87 -35.27 42.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 0.0 110.76 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.13 68.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -82.94 -27.15 30.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.86 -19.64 63.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.4 m -86.07 -42.3 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.48 -36.9 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.16 -36.93 76.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.5 -5.06 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.605 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.97 50.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.601 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -44.78 -28.28 0.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.63 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.601 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . 132.32 91.62 0.51 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.929 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 109' ' ' ILE . 7.5 mm-40 -67.42 -179.14 0.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.0 110.705 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t -93.91 -27.75 16.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.72 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 26.3 t70 -102.52 140.47 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.36 -69.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.666 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.9 m -53.82 -16.81 1.94 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.896 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 26.3 t-20 -87.06 -35.13 18.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.464 HG12 ' N ' ' A' ' 103' ' ' GLU . 84.6 mt -69.88 -55.57 14.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 114' ' ' THR . . . -61.25 -43.34 99.5 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.613 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -50.92 -30.39 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.6 -25.79 23.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.976 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -86.29 -63.47 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.735 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.6 t -49.3 -43.1 43.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 114' ' ' THR . 12.7 t70 -45.92 -38.54 7.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.59 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.22 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.339 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.51 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 0.0 111.584 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 61.4 mt -77.86 -21.23 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 110.718 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.57 -57.0 4.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.568 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -44.6 11.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.549 HD11 HD11 ' A' ' 1' ' ' ILE . 42.9 tp -99.9 -10.54 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER 72.79 -22.93 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.277 . . . . 0.0 110.968 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.516 ' HB2' HG11 ' A' ' 6' ' ' VAL . 57.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.778 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 121' ' ' LEU . 44.2 pt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.799 0.333 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 5' ' ' THR . 8.9 m-20 -65.61 137.15 57.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.766 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -72.99 -5.67 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.1 -48.44 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 6.6 t -59.32 -24.96 63.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.08 -64.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.008 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.89 -59.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -27.58 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 5' ' ' THR . 13.5 mptt -88.42 -59.4 2.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.585 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -50.22 -24.7 3.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 15' ' ' MET . 0.7 OUTLIER -81.75 -62.21 1.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.99 -54.52 17.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -51.68 -23.41 4.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.459 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' HG11 ' A' ' 54' ' ' VAL . 96.3 mt -139.86 62.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.519 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.616 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 50.7 ttp -110.01 -51.45 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.366 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 31.3 Cg_exo -58.89 -14.79 24.02 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.989 1.793 . . . . 0.0 111.806 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -94.56 -19.86 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 22' ' ' ALA . 38.9 mt -81.09 -36.91 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 58.5 mtt -45.57 -50.27 32.4 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 77.1 Cg_exo -50.19 -52.41 9.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.272 1.982 . . . . 0.0 113.302 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.3 m -85.29 -15.04 44.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.661 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -66.33 -7.84 21.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.88 -52.75 6.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.63 -19.16 31.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.391 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.627 ' HB2' HD13 ' A' ' 50' ' ' LEU . 71.4 mt -125.47 40.44 3.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.028 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -63.73 67.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.516 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.2 pp -159.2 55.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 122.818 0.447 . . . . 0.0 110.33 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.57 ' HA ' HD23 ' A' ' 50' ' ' LEU . 8.9 p -56.71 -176.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.871 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -66.82 10.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.667 0.27 . . . . 0.0 111.272 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 28' ' ' SER . 19.6 t70 -106.73 -28.28 10.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.386 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 27' ' ' ILE . 46.5 mm -106.34 -40.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.795 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 27' ' ' ILE . . . -66.69 1.08 1.94 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.982 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.519 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 12.4 t -119.64 49.99 1.31 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.757 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -49.55 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 12.7 mm 61.08 60.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.893 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 5.0 mm100 -167.54 176.76 6.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.827 ' HB3' HD22 ' A' ' 40' ' ' ASN . . . -87.93 -68.56 0.75 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' C ' ' N ' ' A' ' 40' ' ' ASN . . . -156.58 -146.51 0.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.374 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -46.3 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.043 0.449 . . . . 0.0 110.383 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.827 HD22 ' HB3' ' A' ' 37' ' ' ALA . 2.5 p-10 -71.63 34.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.071 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . 115.84 19.14 5.75 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.676 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 33' ' ' THR . . . -85.87 -50.18 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 45' ' ' SER . 21.8 t70 -172.3 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.536 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 27.6 ttt 61.25 -5.66 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 43' ' ' ASP . 32.6 t -92.41 -57.35 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HB3' HD13 ' A' ' 27' ' ' ILE . 65.1 mm-40 -88.06 -27.41 22.01 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' HD23 ' A' ' 47' ' ' LEU . 4.6 tt -49.77 -46.78 51.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -76.02 29.65 1.35 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.65 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -132.71 -73.0 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 25' ' ' LEU . 56.1 tp -51.99 -45.46 64.49 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -74.44 -25.27 59.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.485 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -78.83 -16.75 56.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 40.0 t -70.21 -33.39 71.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 14' ' ' LEU . 15.2 t -68.28 -24.99 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.985 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.79 -45.83 92.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 2.0 pttm -75.51 -15.84 60.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.615 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 2.9 mmp_? -76.94 -23.16 52.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 pt -113.01 26.08 3.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.81 63.21 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -139.31 -20.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 13.6 tp -124.93 99.99 6.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.559 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.597 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 10.4 mmpt? -124.14 87.57 2.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.14 59.44 10.03 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.367 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 109' ' ' ILE . 6.1 p 72.29 8.84 5.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.27 0.628 . . . . 0.0 111.171 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 42.8 mt-10 -92.91 122.51 35.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.21 113.85 25.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.958 0.409 . . . . 0.0 110.926 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.73 178.43 8.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.778 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 -12.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.754 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 36.6 mt-10 -70.65 -49.76 14.61 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.607 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 33.8 Cg_endo -66.6 -29.28 44.05 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.917 1.745 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 74' ' ' MET . 22.0 t -64.21 -53.64 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.926 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -55.26 -21.69 15.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -85.21 -38.43 18.96 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.13 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -72.92 -42.99 62.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.349 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.51 HG22 HG23 ' A' ' 86' ' ' ILE . 76.4 mt -51.91 -27.75 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 0.0 110.749 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 86' ' ' ILE . 47.4 mt-10 -57.58 -58.22 9.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.855 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -86.35 -25.79 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.184 0.516 . . . . 0.0 110.835 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.7 t -72.61 -8.15 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.644 179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.425 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 72.9 m80 -145.21 43.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 132.12 48.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.185 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.65 -62.26 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -126.72 147.57 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -65.93 -33.6 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -82.91 -30.19 28.65 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.548 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -53.02 -30.73 37.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 HG22 ' A' ' 75' ' ' ILE . 95.0 mt -83.29 -34.56 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.412 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 81.4 mm-40 -71.27 -19.76 62.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -78.06 -44.68 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 75' ' ' ILE . 21.3 t -70.43 -29.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.78 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.58 -35.9 54.99 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.408 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.83 -31.32 32.86 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.193 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 120' ' ' LYS . 34.6 mm -60.18 -35.36 61.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 -19.07 57.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -74.67 -42.04 59.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.343 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.95 -18.27 62.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -85.15 -38.03 19.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.471 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.76 -35.63 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.379 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.8 -13.27 62.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.299 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -106.75 -49.18 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.131 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.96 43.64 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.216 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -41.67 -28.34 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.064 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 101' ' ' LYS . . . 143.85 92.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.585 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 109' ' ' ILE . 16.7 mm-40 -66.32 -178.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.951 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -91.78 -32.59 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 109' ' ' ILE . 19.5 t70 -95.15 139.78 31.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -45.47 -64.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.908 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -56.3 -43.6 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.588 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.73 -37.98 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 105' ' ' ASP . 97.5 mt -60.12 -41.49 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -86.33 -29.22 25.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.17 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 78.0 m-20 -58.15 -36.66 73.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.177 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.39 -38.26 30.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -68.65 -24.68 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.592 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 115' ' ' ASP . 11.1 t -88.0 -42.81 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 110.25 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.44 ' HA ' ' HG3' ' A' ' 39' ' ' LYS . 17.7 t70 -43.17 -68.97 0.15 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.46 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 p -54.26 -39.62 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.022 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.42 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.2 OUTLIER -54.34 -37.01 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.535 HG12 ' HA ' ' A' ' 123' ' ' SER . 87.8 mt -85.29 -35.88 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.068 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.15 -46.25 72.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.931 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 92' ' ' ILE . 12.3 mptt -86.14 -44.97 11.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -100.16 -53.93 3.01 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 135.74 -6.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.254 1.422 . . . . 0.0 111.02 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.535 ' HA ' HG12 ' A' ' 118' ' ' ILE . 89.9 p . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.2 139.17 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -59.89 -15.41 21.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.4 m-20 -76.6 -44.6 33.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.485 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 79' ' ' HIS . 25.9 m -47.49 -41.93 21.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.44 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.11 -62.43 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -52.18 -26.25 11.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -89.37 -59.34 2.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.875 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -56.5 -23.77 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.716 0.293 . . . . 0.0 111.479 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.3 ttt -84.49 -56.02 3.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.63 -23.86 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.65 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.506 ' HB3' HD12 ' A' ' 14' ' ' LEU . 1.2 t80 -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 13' ' ' TYR . 4.5 mp -137.97 32.45 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 ttp -50.43 -51.67 62.05 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.608 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 15' ' ' MET . 42.5 Cg_endo -67.14 -33.3 31.78 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.889 1.726 . . . . 0.0 112.112 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.443 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 m-20 -78.78 0.72 25.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 15' ' ' MET . 37.8 mt -89.42 -43.42 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.432 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 26.9 ptt? -57.87 -33.32 17.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 19' ' ' MET . 78.6 Cg_exo -50.37 -51.9 10.08 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.684 1.589 . . . . 0.0 112.68 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 66.0 m -74.68 -28.99 61.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.559 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.54 -40.53 62.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -84.48 -16.38 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 37.6 tt0 -61.11 -54.68 41.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.01 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 50' ' ' LEU . 20.8 mt -91.06 -40.66 11.5 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.274 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 35.4 t-80 177.25 -60.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 0.8 OUTLIER -145.94 175.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.307 -178.19 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.61 ' HA ' HD11 ' A' ' 50' ' ' LEU . 68.7 p -85.81 178.83 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.062 0.458 . . . . 0.0 111.233 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 42' ' ' ALA . 1.5 tm-20 -67.62 -19.84 65.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.39 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.04 -36.43 12.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.165 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 35.0 mm -83.42 -6.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.191 0.519 . . . . 0.0 110.201 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.07 -55.64 7.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.657 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -151.46 -35.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.577 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 45.41 25.12 0.2 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.062 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.4 ' HB ' ' OE1' ' A' ' 36' ' ' GLN . 95.2 mt -138.74 -36.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.272 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' OE1' ' HB ' ' A' ' 35' ' ' ILE . 0.7 OUTLIER -97.16 97.67 9.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.541 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -74.17 -61.2 1.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 57.44 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.243 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -103.19 -60.23 1.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.682 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.84 -20.89 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.449 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.71 -16.94 30.86 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.695 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -86.91 -0.34 56.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 45' ' ' SER . 18.7 t70 70.02 -3.07 1.86 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.925 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER 61.83 -3.22 0.24 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 43' ' ' ASP . 78.8 p -78.11 -58.75 3.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.686 0.279 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 50' ' ' LEU . 52.9 mm-40 -88.74 -13.52 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.305 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 42' ' ' ALA . 2.6 tt -60.04 -43.26 95.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.065 0.46 . . . . 0.0 109.845 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -72.48 9.3 6.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.037 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.91 -78.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.232 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD11 ' HA ' ' A' ' 28' ' ' SER . 3.1 tm? -48.64 -52.62 22.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.613 ' HB3' HD23 ' A' ' 47' ' ' LEU . 5.3 tmtt? -73.55 -22.87 59.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.39 59.38 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.341 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.1 t -60.7 -35.71 76.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.753 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.99 -28.83 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.122 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.448 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 39.5 mtt -65.18 -49.02 71.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.171 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 53' ' ' CYS . 7.9 mtmp? -64.38 -27.3 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.795 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.3 -30.42 66.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' A' ' 60' ' ' MET . 49.1 pt -96.45 15.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.828 0.347 . . . . 0.0 111.216 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 58.41 45.45 16.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.668 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 2.8 ppp? -121.11 -8.96 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.088 0.47 . . . . 0.0 110.447 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 58.6 tp -139.47 99.87 3.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.471 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.25 77.84 3.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.35 -63.73 3.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.741 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -147.23 15.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.641 0.257 . . . . 0.0 110.659 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -107.5 111.2 23.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.739 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.583 HD11 HG23 ' A' ' 109' ' ' ILE . 95.7 mt -84.23 139.14 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 6.4 m-85 -111.67 -172.55 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.57 -15.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.608 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 47.0 mt-10 -72.95 -47.33 8.41 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 50.0 Cg_exo -52.65 -51.42 11.16 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.274 1.983 . . . . 0.0 112.834 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.89 -44.38 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.764 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -55.51 -23.7 27.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.945 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -85.46 -34.79 21.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.22 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.7 mtm -71.6 -50.49 30.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.555 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 86' ' ' ILE . 70.0 mt -49.35 -22.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.59 -59.71 3.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.427 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.8 -32.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 9' ' ' LYS . 37.6 t -61.08 -11.93 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.83 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HA ' HG23 ' A' ' 5' ' ' THR . 89.6 m-70 -139.09 53.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.93 109.19 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.48 -67.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.359 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.7 m-20 -107.11 153.18 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 -46.72 14.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.89 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.45 -26.46 61.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.925 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.2 t70 -57.45 -32.53 67.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 75' ' ' ILE . 93.8 mt -75.71 -29.79 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.123 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -81.34 -19.42 42.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.448 179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -61.39 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.551 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -58.64 -30.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -60.0 -32.95 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.823 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.53 -24.96 37.36 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.633 HG13 HD23 ' A' ' 121' ' ' LEU . 38.7 mm -69.25 -35.77 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 110.977 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.46 -15.89 63.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.98 -27.68 57.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.8 tp10 -69.9 -20.81 63.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.576 ' HA ' HD22 ' A' ' 99' ' ' ASN . 97.1 m -87.05 -45.49 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.24 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.5 -18.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.668 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.2 -12.89 29.18 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 96' ' ' CYS . 0.5 OUTLIER -121.6 -0.91 9.62 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.4 -22.22 12.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.69 -167.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.453 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.42 11.7 2.74 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.47 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HB2' HG13 ' A' ' 109' ' ' ILE . 16.1 mm-40 -96.35 178.07 5.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.877 0.339 . . . . 0.0 110.696 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -133.33 -17.47 2.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.647 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -104.31 142.04 35.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.968 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.178 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.0 m -51.3 -29.38 14.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.421 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -72.59 -43.87 62.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.917 0.389 . . . . 0.0 110.113 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.583 HG23 HD11 ' A' ' 66' ' ' LEU . 13.6 mt -63.82 -44.96 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.61 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -45.11 85.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.949 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HA ' HG22 ' A' ' 114' ' ' THR . 1.9 t-20 -58.98 -47.66 84.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.928 0.364 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -61.04 -20.16 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.104 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -86.88 -56.84 3.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.333 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 111' ' ' ASN . 9.7 t -61.99 -36.39 81.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 111.622 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -48.3 -45.44 34.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.169 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -40.27 16.74 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.33 -35.1 64.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 58.1 mt -84.56 -17.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 0.0 110.252 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.74 -56.08 5.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 2.2 mptp? -85.23 -48.68 8.87 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -99.18 -10.02 23.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.42 -21.18 0.27 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.59 0.234 . . . . 0.0 110.937 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 121' ' ' LEU . 41.0 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.923 0.392 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.46 120.39 10.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' H ' ' CD ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -53.62 -37.22 62.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.184 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.33 -44.81 62.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -53.98 -31.3 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' SER . 54.5 t -88.73 -65.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.03 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.99 -62.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.99 -24.83 56.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.08 -58.1 2.66 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.836 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -55.11 -30.67 60.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.689 0.281 . . . . 0.0 111.572 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.0 tpp -77.04 -52.5 9.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.403 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.62 -23.51 63.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 4.3 t80 -60.98 -36.06 78.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.127 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 18' ' ' ILE . 96.1 mt -142.34 38.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.129 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 9.0 tmm? -54.06 -51.01 81.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.083 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 15' ' ' MET . 60.5 Cg_endo -70.17 -8.67 24.17 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 14.9 m-20 -106.71 -15.11 14.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' LEU . 70.5 mt -83.69 -44.2 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.884 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.525 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 25.0 mmt -53.46 -48.2 93.64 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 95.0 Cg_exo -42.96 -51.64 5.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.677 2.252 . . . . 0.0 112.749 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -56.85 -42.04 78.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.13 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.703 ' HB2' ' HB2' ' A' ' 28' ' ' SER . . . -52.28 -50.33 62.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.83 -16.12 58.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 6.3 tp10 -63.31 -50.68 69.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.504 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' HG ' ' A' ' 50' ' ' LEU . 11.0 mt -106.6 -43.17 4.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.67 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.436 ' CD2' ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER 176.96 -61.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 2.3 pt -148.06 138.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.855 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.703 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 29.3 t -85.61 -176.64 6.14 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.334 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.607 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 13.7 tt0 -57.48 -17.73 14.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.283 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 28' ' ' SER . 8.6 p-10 -74.47 -30.92 62.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.014 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 39.2 mt -112.15 -7.62 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.535 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.28 70.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.276 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -86.25 41.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.17 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -71.25 -33.9 70.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.171 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.8 pt -142.51 28.62 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.263 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 64.7 126.96 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.087 0.47 . . . . 0.0 110.774 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.685 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -85.19 -75.56 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.64 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.617 ' HB3' ' SD ' ' A' ' 44' ' ' MET . . . -179.93 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 24.4 mmmt -51.49 -64.7 0.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.093 0.473 . . . . 0.0 110.844 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.553 HD21 ' HB2' ' A' ' 43' ' ' ASP . 2.2 p30 -128.94 5.12 5.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.649 0.738 . . . . 0.0 109.238 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.685 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 81.11 -21.07 6.08 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.21 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . . . -92.55 -42.04 9.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.261 0.553 . . . . 0.0 110.826 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.553 ' HB2' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -106.42 153.88 21.62 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.197 -178.26 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.683 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.2 tpt -175.53 -143.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.295 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.683 ' H ' ' HG3' ' A' ' 44' ' ' MET . 41.6 t -79.45 -44.53 21.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.063 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -70.95 -39.96 72.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.624 ' HB3' ' H ' ' A' ' 44' ' ' MET . 2.3 tm? -68.56 -45.16 72.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.156 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -55.4 -7.54 1.38 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.302 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m -103.88 -60.9 1.5 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.658 ' HG ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -53.94 -36.07 62.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.752 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HD3' HD21 ' A' ' 47' ' ' LEU . 13.6 tptt -80.65 -20.55 42.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.313 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -75.03 -23.86 58.22 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -26.17 68.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 18' ' ' ILE . 21.3 t -77.72 -24.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.6 mtt -67.08 -55.03 16.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.623 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HE2' HD23 ' A' ' 61' ' ' LEU . 45.1 mttm -58.27 -23.14 55.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.561 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -62.15 -36.51 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.895 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 pt -113.21 26.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.89 58.21 3.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.502 ' O ' ' HG2' ' A' ' 60' ' ' MET . 12.5 ttt -124.9 3.72 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 65' ' ' GLU . 33.9 tp -161.75 127.88 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.0 111.134 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 8.1 mmpt? -115.83 80.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.761 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 -72.74 0.92 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.754 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.3 p -139.55 29.46 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.89 0.376 . . . . 0.0 110.47 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 61' ' ' LEU . 7.0 tp10 -117.37 108.73 15.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.426 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -67.39 146.26 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.893 0.377 . . . . 0.0 111.418 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -142.33 155.41 45.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.501 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.65 5.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.736 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 38.0 mt-10 -59.5 -52.08 76.7 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -69.01 -28.87 28.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.171 1.914 . . . . 0.0 112.62 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 75' ' ' ILE . 21.5 t -63.94 -48.34 86.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.079 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HA ' HD12 ' A' ' 75' ' ' ILE . 7.1 m-30 -51.47 -22.21 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.935 0.398 . . . . 0.0 110.422 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 39.9 tptt -83.22 -37.57 23.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.4 mtm -74.59 -43.85 53.6 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.35 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 72' ' ' TYR . 58.9 mt -48.87 -24.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 44.3 mt-10 -65.94 -59.26 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.328 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -80.96 -44.93 21.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 18.8 t -46.52 -40.79 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.266 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.522 ' CE1' HG21 ' A' ' 89' ' ' VAL . 79.9 m80 -106.31 53.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.29 122.33 16.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.308 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.92 -76.14 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -96.04 144.42 26.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.31 -28.67 34.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.42 -26.79 38.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.8 m-20 -58.36 -23.65 57.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 75' ' ' ILE . 73.5 mt -86.74 -32.76 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.447 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -75.57 -21.15 58.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.973 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.09 -55.46 4.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.522 HG21 ' CE1' ' A' ' 79' ' ' HIS . 58.5 t -56.11 -32.46 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -34.13 68.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.753 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.43 -27.12 33.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.375 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' A' ' 121' ' ' LEU . 43.6 mm -69.06 -38.01 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -19.29 65.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -84.2 -29.79 26.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -27.38 62.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -22.16 54.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.39 -49.51 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.35 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.5 -40.8 80.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -57.85 -48.3 80.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.889 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -77.07 -14.08 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.098 0.475 . . . . 0.0 110.971 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER 35.11 30.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.948 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.08 72.61 0.57 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.984 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.555 ' HB2' HG13 ' A' ' 109' ' ' ILE . 13.7 mm-40 -61.77 166.28 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -77.5 -39.92 44.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.634 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.2 t70 -91.65 142.66 27.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.6 tp10 -55.18 -67.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.254 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.479 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 61.1 m -50.26 -35.35 26.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 39.7 t-20 -59.3 -50.42 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -59.17 -32.95 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.146 177.663 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 114' ' ' THR . . . -66.58 -57.17 10.51 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.419 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.574 ' HB2' ' HA ' ' A' ' 45' ' ' SER . 54.8 t30 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.653 0.263 . . . . 0.0 111.491 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.15 -30.75 19.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.864 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -82.69 -63.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 110' ' ' GLY . 10.1 t -53.68 -30.57 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.27 -59.61 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -49.84 -37.03 28.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.427 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 38.0 mm -82.27 -27.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.146 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.85 -59.57 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 116' ' ' CYS . 3.2 mptp? -86.85 -43.56 12.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 46.7 tp -99.66 -15.75 18.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.9 t80 67.83 -13.61 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.92 0.391 . . . . 0.0 110.911 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 121' ' ' LEU . 48.2 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.319 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 5' ' ' THR . 9.1 tp . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -71.77 142.54 49.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.78 -14.77 35.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.471 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.71 -37.22 86.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.445 HG21 HG12 ' A' ' 1' ' ' ILE . 3.0 t -54.54 -29.35 50.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.89 -64.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.048 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.68 -62.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.17 -28.19 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.7 mmmt -88.48 -59.45 2.23 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.687 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -52.89 -20.52 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.202 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 78.9 mmm -85.54 -60.48 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.9 -28.19 69.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.704 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -62.07 -46.68 88.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.004 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 mt -123.12 34.79 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.092 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.481 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.4 tmm? -55.5 -50.62 85.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.665 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 15' ' ' MET . 74.0 Cg_endo -73.7 -4.19 15.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.065 1.844 . . . . 0.0 112.183 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.0 -14.93 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.11 -42.4 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 56.3 mtm -54.94 -48.78 95.03 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.326 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -53.32 -43.93 53.19 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.174 1.916 . . . . 0.0 112.568 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -57.87 -55.6 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -49.04 -42.03 37.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -83.42 -16.55 45.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -60.42 -54.25 47.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.57 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.71 HD12 HD22 ' A' ' 50' ' ' LEU . 53.0 mt -96.14 -42.21 8.33 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.326 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 3.2 t-80 176.19 -64.19 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.302 0.572 . . . . 0.0 112.467 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -151.76 145.94 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.935 -175.506 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.501 ' HA ' ' HZ3' ' A' ' 51' ' ' LYS . 68.6 p -85.41 -177.8 6.55 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.111 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.31 -17.84 64.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.88 -55.07 8.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 27.4 mm -75.84 -16.93 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.1 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.09 -41.48 64.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.028 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 35' ' ' ILE . 24.0 m -161.56 118.46 2.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.229 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -54.92 -9.84 0.41 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 33' ' ' THR . 2.2 pp -127.42 41.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.062 0.458 . . . . 0.0 111.517 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.527 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 83.8 mm-40 -148.66 126.76 12.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.763 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.27 -57.06 3.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 40' ' ' ASN . . . -147.61 -141.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.619 0.247 . . . . 0.0 111.316 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.768 ' HD2' ' H ' ' A' ' 39' ' ' LYS . 7.9 mptt -59.27 0.62 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.223 0.535 . . . . 0.0 110.187 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 38' ' ' ALA . 52.3 t30 -77.68 32.68 0.16 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.954 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . 114.35 5.09 21.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.967 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . . . -86.47 28.58 0.84 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.161 0.481 . . . . 0.0 110.088 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.3 m-20 66.06 72.7 0.39 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 16.1 ptp -49.59 -22.01 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.521 179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.1 p -53.17 -49.29 66.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.809 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' HD23 ' A' ' 50' ' ' LEU . 6.1 tp-100 -87.83 -18.42 29.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.719 0.295 . . . . 0.0 111.157 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD12 ' HG3' ' A' ' 39' ' ' LYS . 10.5 mt -70.11 -28.29 65.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.99 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -71.52 10.99 3.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.486 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.9 m -134.59 -62.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.891 0.376 . . . . 0.0 110.594 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.71 HD22 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.76 -46.81 59.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.756 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.526 ' HE2' ' H ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -81.58 -20.63 39.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.634 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -69.4 -17.82 63.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.27 -46.24 70.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.751 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.91 -25.4 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.859 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 34.3 mtm -65.38 -46.43 80.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -67.95 -25.83 65.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.74 -38.17 86.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.73 17.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.26 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.22 59.85 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.7 ttp -124.12 5.47 8.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.262 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 67.7 tp -152.47 99.48 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.459 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HE3' ' N ' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -95.8 96.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.161 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.51 60.13 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.7 p 73.45 27.3 1.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.284 0.634 . . . . 0.0 111.819 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 43.3 mt-10 -114.4 113.06 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.0 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.633 HD21 HG23 ' A' ' 109' ' ' ILE . 91.9 mt -70.37 139.43 51.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.766 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -145.82 169.03 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.474 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.24 25.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.0 mt-10 -75.36 -50.66 3.56 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.4 Cg_endo -66.04 -44.07 8.02 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.039 1.826 . . . . 0.0 112.972 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HG3' ' A' ' 74' ' ' MET . 14.1 m -57.49 -45.16 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -53.77 -22.94 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.644 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 4.0 tmtp? -85.37 -36.56 20.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 71' ' ' VAL . 13.8 mtp -68.32 -48.0 66.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.397 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' HIS . 62.6 mt -48.32 -24.51 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.7 mt-10 -60.65 -59.55 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 -36.26 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 9' ' ' LYS . 68.8 t -60.75 -7.74 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.103 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 74.2 m80 -143.62 43.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 135.57 55.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.18 -60.49 0.54 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.4 m120 -117.84 150.12 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.44 -33.87 31.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.536 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 8.7 m-20 -81.27 -25.54 36.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.794 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.6 t70 -58.76 -31.93 68.81 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 76' ' ' GLU . 95.7 mt -77.68 -29.64 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.134 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.2 tp60 -77.01 -24.14 52.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.236 179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.7 -49.35 18.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.491 ' HB ' HG21 ' A' ' 75' ' ' ILE . 45.5 t -61.9 -34.08 61.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.782 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -60.01 -35.41 75.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.319 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.78 -22.9 65.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.588 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.634 HG23 ' HB2' ' A' ' 120' ' ' LYS . 51.4 mt -63.76 -41.72 93.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -62.35 -29.48 70.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -62.68 -41.04 98.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.249 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.96 -39.18 84.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.545 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 65.9 m -71.05 -37.68 72.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.792 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 93' ' ' ALA . 83.3 mt -65.74 -19.3 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -85.13 -32.8 22.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.2 p30 -96.35 -17.26 20.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -101.32 -19.75 15.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.508 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.591 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 29.9 -88.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.436 0.694 . . . . 0.0 112.689 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.591 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . -167.48 76.56 0.12 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HB2' HG13 ' A' ' 109' ' ' ILE . 10.4 mm-40 -70.5 147.34 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.3 p -76.91 -18.76 58.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.598 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.46 144.19 28.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -59.6 -67.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 54.2 m -52.75 -23.72 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.719 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.96 -43.38 54.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.562 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.633 HG23 HD21 ' A' ' 66' ' ' LEU . 1.5 mt -66.5 -41.66 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 110.691 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -71.17 -49.46 26.76 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.077 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.5 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 11.3 t30 -51.68 -59.25 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.906 0.353 . . . . 0.0 110.927 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 10.3 mmpt? -54.0 -45.11 71.37 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 41.3 t80 -73.72 -65.9 0.77 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.476 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 32.3 p -50.55 -41.73 54.43 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 22.0 t70 -42.99 -67.31 0.28 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -55.95 -25.4 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -29.91 64.88 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.487 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -85.35 -25.94 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.3 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.16 -53.83 15.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.808 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HB2' HG23 ' A' ' 92' ' ' ILE . 71.8 mmtt -86.7 -58.06 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 123' ' ' SER . 49.6 tp -85.53 -10.72 55.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 3.9 t80 69.66 -19.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.555 0.217 . . . . 0.0 111.118 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.8 t . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.8 pt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 5' ' ' THR . 6.6 m-20 -77.27 137.84 39.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.118 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -56.73 -32.45 65.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.934 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 12.2 t70 -49.41 -43.27 44.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.39 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 2' ' ' ASP . 2.1 t -54.17 -33.18 57.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.23 -65.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.32 -62.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.72 -26.16 43.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.81 -59.32 2.26 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.905 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -54.54 -20.31 7.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.3 mmt -84.29 -57.39 3.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.2 -47.8 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.463 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -45.72 -34.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.742 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 18' ' ' ILE . 52.1 mt -138.54 46.07 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.317 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 49.1 ttp -71.92 -51.74 8.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.683 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.2 Cg_endo -69.71 -3.08 11.25 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.116 1.878 . . . . 0.0 112.117 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -103.21 -19.66 14.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 14' ' ' LEU . 75.9 mt -84.61 -37.1 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.537 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -49.47 -52.73 47.21 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 19' ' ' MET . 59.7 Cg_exo -37.88 -52.87 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.017 2.478 . . . . 0.0 114.192 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -88.43 -42.33 12.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.586 0.231 . . . . 0.0 111.583 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.05 -6.75 6.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.533 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.11 -29.76 24.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -85.66 -54.7 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -112.18 44.52 1.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.364 -178.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 39.4 t60 -56.18 82.56 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 112.155 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 25' ' ' LEU . 43.0 pt -140.46 49.88 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.95 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 30' ' ' ASP . 48.4 t -50.82 -179.74 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.562 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' HG2' ' HB2' ' A' ' 42' ' ' ALA . 9.0 mt-10 -43.18 -18.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.774 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 28' ' ' SER . 11.7 m-20 -84.66 -68.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mt -73.94 -14.48 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.839 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.23 -49.96 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 110.492 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.568 HG21 ' HB3' ' A' ' 36' ' ' GLN . 3.1 m -171.17 118.18 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.787 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 7.8 p-10 -36.82 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.282 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' H ' ' CG ' ' A' ' 34' ' ' ASN . 11.1 pt -151.6 32.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' HG21 ' A' ' 33' ' ' THR . 50.2 tt0 -70.84 -68.72 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.804 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.39 85.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.954 0.407 . . . . 0.0 110.743 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.62 1.15 1.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.582 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -53.7 -61.16 2.48 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.178 0.513 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.502 ' HB3' HG21 ' A' ' 118' ' ' ILE . 1.9 m-80 -127.48 9.9 6.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.194 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -16.91 60.12 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.023 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . . . -88.05 -152.07 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.959 0.409 . . . . 0.0 111.448 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 45' ' ' SER . 26.1 t0 -107.82 -27.7 10.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.41 -33.1 0.23 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.63 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 51.0 m -66.07 -57.6 7.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.593 0.235 . . . . 0.0 111.497 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.48 ' HA ' ' SG ' ' A' ' 49' ' ' CYS . 64.0 mm-40 -87.29 -13.1 44.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 114' ' ' THR . 1.4 tt -57.67 -42.63 83.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -77.91 38.17 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 46' ' ' GLN . 3.8 m -144.37 -79.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 110.556 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 25' ' ' LEU . 4.6 mm? -52.6 -47.36 66.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.601 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -79.76 -30.6 40.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.782 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.3 4.69 29.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' CYS . 5.9 t -85.12 -30.25 24.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.015 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 51' ' ' LYS . 7.4 p -69.3 -20.19 24.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 60' ' ' MET . 59.8 mtt -66.09 -46.39 77.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.49 -16.9 41.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.341 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.41 -47.62 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.523 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 60' ' ' MET . 46.2 pt -92.06 33.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.723 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 54.25 30.2 11.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.4 tpt -91.55 -12.9 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -154.27 112.53 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -108.1 77.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.575 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.31 -70.21 2.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.004 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.6 p -143.2 18.46 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.574 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -102.72 110.82 22.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.053 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD11 HG23 ' A' ' 109' ' ' ILE . 18.6 mt -84.15 115.6 22.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.421 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -96.4 -166.86 1.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.57 -15.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.1 mt-10 -60.79 -51.23 81.01 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 18.6 Cg_endo -60.95 -18.91 60.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.111 1.874 . . . . 0.0 112.539 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 75' ' ' ILE . 5.0 t -76.28 -49.2 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 24.6 m-85 -52.48 -22.27 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -78.74 -43.53 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.723 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.0 ptm -77.12 -36.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.546 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 86' ' ' ILE . 88.2 mt -51.9 -25.49 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 110.193 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 86' ' ' ILE . 50.2 mt-10 -61.71 -59.42 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.825 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.82 -35.61 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.916 0.389 . . . . 0.0 111.545 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.461 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 25.1 t -57.53 -11.62 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 73.8 m-70 -134.11 49.15 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.407 . . . . 0.0 110.521 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.7 135.68 54.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.6 -55.84 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.9 m120 -128.01 129.07 46.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.04 68.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.0 m-20 -84.24 -25.29 29.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.8 t0 -59.11 -32.71 70.08 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 75' ' ' ILE . 68.0 mt -76.17 -29.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.539 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -78.42 -26.5 46.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 92' ' ' ILE . 55.5 tp -67.39 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.545 HG22 HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.04 -28.97 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.489 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.526 ' HE2' ' HB3' ' A' ' 72' ' ' TYR . 3.7 tptm -48.3 -46.62 36.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.74 -27.75 49.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 121' ' ' LEU . 49.3 mm -62.91 -31.13 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.38 -22.94 66.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.18 -36.24 22.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.408 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.62 -24.43 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 111.266 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 37.7 m -86.35 -31.53 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.45 -179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.52 -35.66 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.463 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.179 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.87 -14.41 14.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.55 -18.37 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -66.63 179.69 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.876 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.505 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 65.29 4.19 15.77 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.024 -0.607 . . . . 0.0 113.031 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -89.88 162.6 15.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t -119.76 -22.21 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.907 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t70 -97.33 143.56 27.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 0.0 111.25 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.79 -69.05 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.602 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.1 m -51.69 -26.24 8.84 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.73 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 6.2 m120 -70.85 -39.71 72.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 109.917 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 66' ' ' LEU . 7.2 mt -69.15 -36.71 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.95 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.37 -53.71 27.44 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.583 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.515 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 12.5 t30 -52.78 -58.12 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.539 0.209 . . . . 0.0 111.101 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.4 mmpt? -55.23 -21.19 13.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.273 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -86.76 -64.78 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.601 HG21 HD22 ' A' ' 47' ' ' LEU . 10.1 t -55.86 -31.04 62.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.93 -56.51 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -40.36 91.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.684 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -41.74 78.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 65.0 mt -77.73 -22.0 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -59.65 2.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.243 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -87.07 -54.23 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 92' ' ' ILE . 38.0 tp -83.32 -10.21 58.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 11.0 t80 68.49 -9.55 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.707 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 121' ' ' LEU . 33.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.06 135.63 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -51.0 -35.45 33.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.443 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -52.1 -47.42 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.787 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 79' ' ' HIS . 91.1 m -48.69 -37.0 17.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.143 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.86 -66.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.49 -62.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.34 -26.5 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' THR . 34.0 mmtp -89.51 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.77 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 35.6 m-85 -55.47 -19.29 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.377 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.0 ttm -84.33 -59.23 2.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.71 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.354 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -64.88 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.374 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.57 47.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.262 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.51 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 31.4 ttm -64.71 -51.12 60.48 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.947 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 15' ' ' MET . 58.2 Cg_endo -69.89 -9.43 26.04 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.28 -17.16 20.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.79 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 54' ' ' VAL . 73.5 mt -83.53 -48.25 17.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.501 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 59.7 mtt -43.61 -49.33 18.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.051 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 70.9 Cg_exo -40.12 -63.35 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.596 2.197 . . . . 0.0 113.494 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 39.0 m -72.1 -27.37 62.6 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.553 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.12 -42.4 63.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.84 0.352 . . . . 0.0 110.663 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.13 -16.67 42.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.524 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 8.4 tp10 -59.64 -54.63 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.924 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 50' ' ' LEU . 19.3 mt -90.06 -41.05 11.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.676 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 12.9 t-80 176.44 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.765 0.793 . . . . 0.0 110.841 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.9 pt -145.66 168.14 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.343 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.49 ' HA ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -86.02 125.94 33.78 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.597 ' H ' HD12 ' A' ' 50' ' ' LEU . 1.5 mm-40 -52.87 -41.42 64.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.842 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 8.8 m-20 -61.29 -26.9 68.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.909 0.385 . . . . 0.0 110.956 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.6 mt -104.62 -8.03 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.42 -45.2 65.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.612 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -150.52 113.58 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 73.7 m-20 -39.74 -74.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.481 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 23.1 pt -145.32 48.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 18.3 mp0 -122.1 9.31 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.064 -179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . . . -85.32 -75.34 0.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -177.24 -77.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -70.34 -61.07 1.91 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.644 HD22 HG21 ' A' ' 118' ' ' ILE . 6.0 p30 -125.04 -11.64 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . 109.37 -16.59 31.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.053 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . . . -85.9 4.99 34.95 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.582 -0.364 . . . . 0.0 111.401 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t70 60.74 171.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.423 ' HG3' HG23 ' A' ' 114' ' ' THR . 39.4 ttp -122.97 -10.09 8.22 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.3 t -71.53 -58.34 3.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.594 0.235 . . . . 0.0 111.598 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.68 -13.25 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.839 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 51' ' ' LYS . 16.3 tp -67.78 -29.59 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.289 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -75.22 11.65 8.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.319 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -140.74 -71.26 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 111.674 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.597 HD12 ' H ' ' A' ' 29' ' ' GLU . 3.4 tm? -48.75 -46.96 41.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -76.6 -24.9 53.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.232 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -67.16 -14.6 63.06 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.324 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.56 -41.4 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG21 HG12 ' A' ' 18' ' ' ILE . 40.5 t -61.89 -28.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.599 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' MET . 64.7 mtp -63.78 -56.14 17.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.538 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -66.72 -17.81 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 3.7 tpm_? -68.86 -31.3 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -113.23 31.48 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.602 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 58.94 13.64 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.607 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 55' ' ' MET . 10.8 tpt -77.98 -8.44 58.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.218 0.532 . . . . 0.0 110.622 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 66' ' ' LEU . 59.1 tp -156.86 103.55 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 76.7 10.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.36 -59.9 3.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.474 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -147.56 7.73 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.599 0.238 . . . . 0.0 111.137 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.6 tp10 -96.72 110.82 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.585 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 61' ' ' LEU . 2.6 mm? -73.42 109.99 7.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.66 -167.81 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -169.38 -8.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.2 mp0 -73.44 -51.46 5.6 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 19.6 Cg_endo -58.46 -38.19 91.23 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.296 1.998 . . . . 0.0 113.011 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' ILE . 59.4 t -57.87 -43.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.439 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 9.1 m-30 -53.02 -32.91 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -74.28 -30.79 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.252 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.2 mtm -78.63 -46.6 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.404 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.525 HG22 HG23 ' A' ' 86' ' ' ILE . 64.8 mt -50.77 -27.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 41.4 mt-10 -60.78 -59.17 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.86 -44.86 16.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.551 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 10' ' ' TYR . 55.5 t -49.99 -17.91 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.806 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.675 ' HA ' HG23 ' A' ' 5' ' ' THR . 50.5 m-70 -128.77 53.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.781 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 127.68 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -81.36 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.1 145.05 25.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.95 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.08 32.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.767 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.13 -28.47 35.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.706 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -56.82 -27.22 59.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 75' ' ' ILE . 79.7 mt -80.54 -31.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.988 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -78.16 -19.36 54.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.467 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.8 -59.18 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 92' ' ' ILE . 21.4 t -57.59 -23.59 20.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.94 0.4 . . . . 0.0 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 9.6 tptt -53.95 -48.48 70.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.182 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.2 58.77 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.074 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 89' ' ' VAL . 68.4 mt -60.63 -40.76 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.641 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.17 -26.98 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.685 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.68 -30.22 25.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 9.7 tp10 -57.3 -28.86 63.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 1.5 m -86.65 -45.32 11.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.197 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.7 mt -53.91 -37.91 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.69 0.281 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.77 -31.98 70.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.85 -7.16 19.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.383 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 101' ' ' LYS . . . -103.18 -3.45 25.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.475 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 21.99 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.068 0.855 . . . . 0.0 112.829 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . 178.51 70.2 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.823 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.506 ' HG2' ' HE3' ' A' ' 101' ' ' LYS . 16.7 mm-40 -60.69 172.44 0.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.878 0.37 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.7 p -91.97 -45.47 8.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.217 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 109' ' ' ILE . 23.1 t70 -76.35 119.29 20.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.0 tp10 -48.96 -58.36 5.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.493 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.7 m -54.06 -24.95 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.4 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.94 -32.2 25.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.372 . . . . 0.0 110.55 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 103' ' ' GLU . 55.3 mt -70.12 -38.85 76.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.556 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 114' ' ' THR . . . -77.86 -51.65 5.77 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.7 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.484 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 3.9 t30 -49.93 -32.36 14.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.751 0.275 . . . . 0.0 111.083 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -80.02 -38.65 31.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 110.133 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -70.11 -64.68 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.776 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.9 t -49.53 -31.82 11.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.142 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 25.7 t70 -46.79 -71.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.66 -24.27 61.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.89 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.501 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -64.56 -58.59 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.656 0.265 . . . . 0.0 110.753 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.644 HG21 HD22 ' A' ' 40' ' ' ASN . 46.6 mm -59.79 -16.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.141 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 10.1 tp10 -68.49 -59.67 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.248 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 1.4 mptp? -87.25 -40.96 14.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.683 0.277 . . . . 0.0 111.541 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 6.7 tt -58.6 -46.41 87.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.34 42.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.048 0.451 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 34.0 pt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -83.82 143.09 30.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.312 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -13.95 62.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.99 -44.23 15.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 51.9 p -56.96 -26.76 60.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG22 ' HE1' ' A' ' 79' ' ' HIS . 62.0 t -89.96 -67.36 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.89 -62.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -22.63 67.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HB3' HG22 ' A' ' 78' ' ' VAL . 1.6 mptm? -90.44 -56.79 3.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.228 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -54.32 -50.25 67.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.99 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.9 tpp -56.08 -40.57 73.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -80.6 -24.7 38.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.039 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.79 -29.01 67.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 0.0 111.192 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 18' ' ' ILE . 97.4 mt -148.13 39.26 0.91 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.604 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.587 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 34.6 ttm -60.04 -51.17 82.43 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.292 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 23.7 Cg_exo -63.59 -22.84 70.49 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.088 1.859 . . . . 0.0 112.468 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.81 -10.62 53.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.393 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 14' ' ' LEU . 74.2 mt -87.95 -28.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.22 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.494 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 63.5 mtm -46.77 -48.79 49.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.6 Cg_exo -41.74 -56.51 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.61 2.207 . . . . 0.0 113.379 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -85.42 -18.52 33.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 111.144 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -69.75 -10.87 60.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -83.77 -56.47 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.879 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.97 -50.33 9.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.006 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.69 ' O ' HD22 ' A' ' 50' ' ' LEU . 51.9 mt -90.17 40.08 0.99 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.444 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -62.3 72.06 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.489 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.704 HG22 ' HA ' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -153.4 45.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.013 178.791 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 50' ' ' LEU . 3.0 p -47.73 156.57 0.31 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.255 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.432 ' HG2' ' C ' ' A' ' 42' ' ' ALA . 10.4 mt-10 -41.23 -26.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.254 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.81 -66.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.18 -5.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.211 0.529 . . . . 0.0 110.756 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.704 ' HA ' HG22 ' A' ' 27' ' ' ILE . . . -64.2 -10.25 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.392 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.8 m -49.84 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 70.72 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.501 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 35' ' ' ILE . 4.5 tt -166.31 22.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.299 0.571 . . . . 0.0 111.443 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -132.9 109.04 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.059 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -62.19 -7.93 4.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.79 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HB1' ' SD ' ' A' ' 44' ' ' MET . . . 37.27 -108.24 0.06 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.457 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -93.66 -60.37 1.78 Allowed 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.9 p-10 -126.73 4.63 6.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.122 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 93.68 -18.03 57.36 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' C ' ' HG2' ' A' ' 29' ' ' GLU . . . -89.48 -59.55 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.766 ' HA ' ' HB2' ' A' ' 47' ' ' LEU . 1.7 p-10 -111.37 162.2 15.29 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' MET . . . . . 0.691 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.0 tpt -176.06 -142.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.65 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.691 ' H ' ' HG3' ' A' ' 44' ' ' MET . 22.8 t -78.23 -52.23 8.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -79.94 -23.25 41.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.084 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -87.12 -39.1 15.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -69.06 -10.92 62.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -73.26 -67.45 0.58 Allowed 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 25' ' ' LEU . 16.4 tp -51.7 -33.61 34.98 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 -28.62 61.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.546 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -74.54 -24.73 58.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.154 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.3 t -60.67 -31.49 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 18' ' ' ILE . 4.0 t -68.47 -24.5 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.776 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 57.4 mtt -70.32 -58.38 3.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.099 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.96 -19.14 28.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.533 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HE ' ' HA ' ' A' ' 57' ' ' ARG . 6.4 tpm_? -72.91 -31.12 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.361 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.18 33.95 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.44 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 61.22 10.52 3.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.689 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -77.09 -6.95 54.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.027 0.442 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.605 HD11 HG21 ' A' ' 109' ' ' ILE . 7.1 tt -152.62 99.49 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.686 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.51 ' HE2' ' HA ' ' A' ' 62' ' ' LYS . 7.5 mmpt? -86.27 77.8 9.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.44 -60.44 4.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.0 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 p -153.52 11.85 0.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 13.6 mm-40 -100.21 109.26 21.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.771 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.682 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -67.12 147.09 53.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.619 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 27.9 m-85 -136.51 165.63 25.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -140.26 -11.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mp0 -57.31 -53.64 63.26 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.401 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.8 Cg_endo -66.05 -25.21 51.63 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.992 1.795 . . . . 0.0 112.107 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 75' ' ' ILE . 17.6 t -68.86 -43.88 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.401 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 19.3 m-30 -55.35 -22.29 18.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.981 0.42 . . . . 0.0 110.524 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -80.67 -48.99 11.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 7.1 ptp -68.56 -37.0 79.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.371 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 86' ' ' ILE . 95.0 mt -53.69 -21.94 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.286 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.39 -58.28 3.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.408 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.75 -39.79 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -56.77 -9.18 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.98 0.419 . . . . 0.0 111.661 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HE1' HG22 ' A' ' 6' ' ' VAL . 84.6 m-70 -130.49 40.86 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.3 122.84 14.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.411 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.11 -65.16 0.34 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.186 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -114.78 151.59 33.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.649 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.57 -20.74 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -84.81 -30.54 24.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 86' ' ' ILE . 4.2 p30 -59.09 -21.12 58.73 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 75' ' ' ILE . 68.8 mt -85.67 -30.02 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.119 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.24 -19.84 42.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.118 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 92' ' ' ILE . 64.3 tp -83.11 -63.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.329 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.549 HG13 HD22 ' A' ' 121' ' ' LEU . 46.5 t -52.27 -41.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.517 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 11.1 mttt -53.32 -32.39 48.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.549 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.57 -23.01 41.09 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.533 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 88' ' ' LEU . 39.6 mm -68.69 -37.83 78.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.01 66.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -79.22 -22.41 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.3 -18.9 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 -49.34 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.735 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mt -48.55 -24.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.91 -45.74 73.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -83.56 -21.31 32.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.88 -40.63 68.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.343 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.57 35.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.96 68.82 1.49 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.462 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.499 ' HB2' HG13 ' A' ' 109' ' ' ILE . 12.4 mm-40 -68.57 160.1 30.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.583 0.23 . . . . 0.0 110.449 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -107.77 4.12 25.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.629 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 108' ' ' ASN . 12.7 t70 -108.18 147.41 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.03 -68.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.827 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 23.3 m -57.74 -41.49 81.95 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.219 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 10.7 t-20 -56.81 -42.88 80.34 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.605 HG21 HD11 ' A' ' 61' ' ' LEU . 1.6 mt -63.06 -31.82 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.499 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.71 -45.13 78.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.558 ' HA ' HG22 ' A' ' 114' ' ' THR . 50.4 t30 -72.6 -45.74 57.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -56.28 -47.56 78.37 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.652 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -74.16 -42.93 59.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.228 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 43' ' ' ASP . 5.7 t -69.37 -23.41 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.05 -61.48 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.153 0.502 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -40.92 84.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -31.09 65.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.358 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 114' ' ' THR . 32.6 mm -83.76 -31.02 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.924 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 38.6 tt0 -68.76 -56.1 9.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.966 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 9.3 mptt -86.62 -48.65 8.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.549 HD22 HG13 ' A' ' 89' ' ' VAL . 45.9 tp -97.81 -14.61 20.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.0 t80 68.45 -13.08 0.32 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 121' ' ' LEU . 46.8 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.874 0.369 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.303 0.573 . . . . 0.0 109.91 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.81 -26.96 64.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.997 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -88.9 -23.45 22.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 121' ' ' LEU . 48.2 t -71.82 -51.41 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.222 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.96 -30.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.24 -31.42 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.419 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -79.53 -55.73 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.297 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -56.21 -28.25 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 111.225 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.8 ttm -81.29 -54.99 5.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.102 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.75 -23.61 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -70.24 -25.31 63.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -147.07 39.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 34.8 ttm -61.41 -51.86 74.49 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.362 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.6 Cg_endo -70.45 0.17 6.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.915 1.744 . . . . 0.0 111.944 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 20' ' ' PRO . 10.3 m-20 -112.26 -14.22 13.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.02 -31.61 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.652 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -62.3 -31.99 8.68 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD3' ' HG3' ' A' ' 19' ' ' MET . 15.1 Cg_exo -68.9 -35.49 15.33 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.768 1.645 . . . . 0.0 111.942 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.56 -52.7 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.405 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -55.39 -34.42 64.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.697 0.284 . . . . 0.0 111.502 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.574 -179.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.57 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 5.8 ttt . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.795 0.331 . . . . 0.0 110.634 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 m -65.07 -48.88 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -87.26 -12.73 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.638 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.636 HD21 ' HD3' ' A' ' 51' ' ' LYS . 5.1 tt -74.27 -39.89 62.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.415 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.86 4.93 2.06 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.725 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -135.77 -61.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.545 0.212 . . . . 0.0 111.347 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.473 ' O ' HD13 ' A' ' 50' ' ' LEU . 3.0 tm? -48.2 -44.37 32.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' HD21 ' A' ' 47' ' ' LEU . 43.2 tttm -84.05 -20.36 32.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.649 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.84 -15.91 60.71 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.121 0.486 . . . . 0.0 110.059 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.63 -33.3 75.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.432 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 t -69.21 -22.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.204 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.444 ' HB3' ' HE2' ' A' ' 60' ' ' MET . 48.8 mtt -75.38 -52.62 10.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.52 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' H ' ' A' ' 61' ' ' LEU . 5.8 ptpp? -65.73 -16.42 63.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 3.0 tpm_? -70.93 -32.59 69.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 pt -102.37 23.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.228 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 60.95 49.83 5.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.559 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.507 ' HG3' ' HG2' ' A' ' 70' ' ' PRO . 5.7 ttp -120.41 -18.33 7.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.446 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 56' ' ' LYS . 19.1 tp -130.48 108.77 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.815 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 mmpt? -104.53 78.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.31 -70.71 2.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.038 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.0 p -137.35 9.7 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.18 103.34 15.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.93 114.62 23.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.452 . . . . 0.0 110.211 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -109.53 -167.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.968 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' A' ' 97' ' ' ILE . 10.6 p -163.1 -14.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.672 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 41.8 mt-10 -53.15 -54.37 45.35 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 60' ' ' MET . 10.8 Cg_endo -55.29 -29.4 67.26 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.006 1.804 . . . . 0.0 111.829 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 20.8 t -72.65 -39.44 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.352 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -57.48 -22.3 42.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -85.17 -37.11 20.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.105 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 11.9 ptm -80.4 -30.1 37.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.876 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.731 HG22 HG23 ' A' ' 86' ' ' ILE . 96.8 mt -59.39 -22.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 -54.72 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.266 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.01 -45.05 16.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -48.53 -27.19 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.271 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.408 ' CD2' HG23 ' A' ' 75' ' ' ILE . 85.4 m-70 -118.54 54.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.609 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.92 51.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.97 -72.18 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.317 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.6 m120 -110.84 155.3 22.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 110.716 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -81.45 -37.44 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.52 -28.96 41.31 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.137 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -56.25 -31.88 63.96 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 75' ' ' ILE . 87.9 mt -78.36 -32.92 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.08 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 13.2 mm100 -74.99 -19.8 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 tp -76.13 -55.58 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.618 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HD12 ' A' ' 92' ' ' ILE . 38.8 t -55.59 -28.89 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -58.12 -49.06 78.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.618 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.9 -26.96 69.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.253 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 120' ' ' LYS . 58.3 mt -61.49 -45.09 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.61 69.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.598 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.6 tp10 -65.42 -27.33 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.2 m -80.1 -28.81 38.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.951 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD11 ' HB ' ' A' ' 68' ' ' VAL . 78.0 mt -77.15 -43.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.87 -14.92 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.51 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t30 -94.22 -43.78 8.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 110.625 179.737 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p . . . . . 0 C--O 1.233 0.186 0 CA-C-O 120.766 0.317 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.1 t70 -77.94 139.94 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.935 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.65 -61.73 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.0 m -54.17 -27.69 35.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.5 t-20 -72.28 -44.05 63.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.65 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 98.3 mt -60.52 -47.27 93.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.025 0.441 . . . . 0.0 110.673 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.33 -41.42 85.68 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.337 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.57 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 2.2 t-20 -58.08 -36.94 73.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.11 0.455 . . . . 0.0 110.824 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 11.0 mmpt? -78.39 -37.54 43.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.52 -27.18 58.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.603 HG21 HD22 ' A' ' 47' ' ' LEU . 11.1 t -79.71 -46.88 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 110.249 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 114' ' ' THR . 26.3 t70 -46.45 -60.26 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -40.58 70.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.797 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -27.41 67.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.236 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -84.68 -32.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -69.83 -44.71 69.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.027 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 71.0 mmtt -87.05 -58.56 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.3 tm? -97.63 -15.73 20.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER 73.36 -19.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.592 0.234 . . . . 0.0 111.302 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 121' ' ' LEU . 36.8 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.818 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.875 0.369 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.8 m-20 -83.85 -55.89 4.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.195 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 81.0 p -52.03 -31.52 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.715 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.47 -64.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.822 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.13 -60.67 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -53.29 -31.18 42.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.97 -59.13 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.113 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -52.56 -23.46 6.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 111.366 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 tpp -80.48 -56.78 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.15 -23.61 67.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.139 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.04 -33.75 72.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.024 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 58' ' ' ILE . 65.5 mt -146.9 50.91 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.2 tmm? -71.45 -50.57 10.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.409 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 15' ' ' MET . 73.7 Cg_endo -75.05 -24.7 12.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.232 1.955 . . . . 0.0 112.62 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.39 -9.95 59.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.329 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.13 -27.81 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.361 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 62.3 mtt -53.1 -48.58 91.52 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 33.2 Cg_exo -60.85 -36.13 85.25 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.396 2.064 . . . . 0.0 112.703 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.8 m -54.83 -46.27 74.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.866 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.98 -46.53 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 . . . . . 0 C--N 1.326 -0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.148 179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.45 ' HB2' HD21 ' A' ' 111' ' ' ASN . 5.0 ptt? . . . . . 0 N--CA 1.461 0.12 0 CA-C-O 120.776 0.322 . . . . 0.0 110.575 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -65.39 -51.84 57.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.913 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 50' ' ' LEU . 4.3 mm100 -87.15 -12.89 45.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HG ' HG21 ' A' ' 114' ' ' THR . 48.8 tp -66.51 -25.73 66.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -88.17 8.26 78.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.388 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 13.6 m -137.01 -71.49 0.44 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.673 -0.263 . . . . 0.0 111.428 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.749 HD23 ' HB3' ' A' ' 46' ' ' GLN . 0.4 OUTLIER -48.26 -39.72 22.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB2' HD12 ' A' ' 47' ' ' LEU . 8.4 tptp -84.26 -23.76 30.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.601 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.74 -16.86 62.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.45 -37.9 79.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.914 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 14' ' ' LEU . 59.0 t -63.22 -30.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.452 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 54.6 mtt -70.56 -58.5 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -61.1 -19.36 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -72.44 -29.55 63.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.479 HD11 ' SD ' ' A' ' 60' ' ' MET . 49.3 pt -106.24 13.98 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.64 55.69 1.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.07 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 17.6 ptm -133.3 15.01 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 0.0 110.183 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 66' ' ' LEU . 66.6 tp -164.57 109.77 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.507 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -108.56 77.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.14 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.41 -28.48 0.7 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.224 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -175.54 -15.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -84.55 110.47 18.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 66' ' ' LEU . 2.9 mm? -77.27 149.97 35.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 111.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 74.9 m-85 -147.07 136.04 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.9 15.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.841 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.8 mt-10 -67.64 -51.91 28.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 39.6 Cg_endo -70.77 -24.06 25.48 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.039 1.826 . . . . 0.0 112.564 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.506 HG12 HD11 ' A' ' 75' ' ' ILE . 11.0 t -73.32 -50.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.253 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.52 ' HA ' HD12 ' A' ' 75' ' ' ILE . 5.7 m-30 -51.37 -22.16 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.643 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -78.85 -42.36 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -77.76 -36.84 50.21 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 121.338 -0.145 . . . . 0.0 110.875 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.555 HG22 HG23 ' A' ' 86' ' ' ILE . 72.4 mt -51.45 -21.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.361 0.601 . . . . 0.0 109.918 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 44.9 mt-10 -63.89 -59.31 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.376 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.4 -41.64 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.904 0.383 . . . . 0.0 110.896 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 9' ' ' LYS . 25.1 t -47.54 -26.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.485 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -125.11 55.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.76 55.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.71 -79.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.341 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.08 133.64 44.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 111.013 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.6 66.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.71 -28.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.959 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.74 -29.21 64.59 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.555 HG23 HG22 ' A' ' 75' ' ' ILE . 82.7 mt -76.56 -30.72 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.111 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -81.5 -19.19 42.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.908 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.509 HG22 HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -61.4 -32.48 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.808 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.53 -32.65 58.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.672 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.51 -23.32 43.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.04 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.6 mt -69.14 -30.74 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -64.39 -23.48 67.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.276 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -79.58 -33.56 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.15 -31.21 72.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 10.8 m -79.4 -21.45 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 93' ' ' ALA . 94.5 mt -76.12 -46.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 111.285 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.61 -30.16 70.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 4.7 t30 -80.51 -51.29 8.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.34 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.744 -179.501 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.569 0.223 . . . . 0.0 111.214 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 14.5 t70 -74.41 136.42 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -50.91 -68.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.92 -33.83 38.88 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 9.6 m120 -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 78.3 mt -74.01 -32.62 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.846 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.49 -56.44 9.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.976 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.45 HD21 ' HB2' ' A' ' 44' ' ' MET . 3.6 t-20 -48.95 -24.61 1.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 60.4 mtpt -86.6 -44.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.63 -59.32 4.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.059 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 110' ' ' GLY . 8.9 t -53.44 -46.14 69.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.207 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.459 ' N ' HG23 ' A' ' 114' ' ' THR . 16.6 t70 -42.28 -52.32 4.52 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.98 0.419 . . . . 0.0 111.264 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -44.32 93.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.06 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.285 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 40.6 mt -83.23 -20.46 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.76 -59.09 4.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.07 -54.9 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 123' ' ' SER . 33.0 tp -86.32 -10.82 53.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 19.8 t80 67.21 -9.23 0.4 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 110.783 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 121' ' ' LEU . 60.7 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.801 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.726 0.298 . . . . 0.0 111.065 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 2.7 p30 -74.31 -27.0 60.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.3 p -82.66 -20.69 35.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.681 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.37 -63.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.726 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.01 -51.94 60.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.48 -29.64 70.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.3 mmmt -88.27 -59.35 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.554 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -50.39 -20.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 0.0 111.019 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.7 mmm -85.39 -62.06 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.801 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.42 -51.9 32.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.772 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -52.87 -21.06 3.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.634 HD13 HG11 ' A' ' 54' ' ' VAL . 48.0 mt -133.92 26.03 3.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.596 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.6 ttp -71.95 -49.41 10.33 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 15' ' ' MET . 29.7 Cg_endo -61.8 -21.97 73.35 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.005 1.803 . . . . 0.0 112.649 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 14' ' ' LEU . 2.2 p30 -102.03 -7.35 22.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -44.17 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.006 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 57.6 mtt -47.02 -49.83 48.54 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.52 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -57.89 -49.35 13.21 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.206 1.937 . . . . 0.0 112.671 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -56.55 -44.35 80.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.474 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -55.44 -47.17 76.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.166 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.445 . . . . 0.0 110.332 179.897 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.749 ' HG2' HD22 ' A' ' 111' ' ' ASN . 54.8 ttp . . . . . 0 N--CA 1.463 0.181 0 CA-C-O 120.971 0.415 . . . . 0.0 110.02 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -49.07 -55.23 12.77 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -86.9 -12.43 47.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.54 HD13 ' HB3' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -64.91 -37.48 87.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.026 0.441 . . . . 0.0 110.045 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 5.04 20.63 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.147 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -135.34 -70.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 2.3 tm? -45.77 -51.39 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.54 ' HB3' HD13 ' A' ' 47' ' ' LEU . 1.6 tpmt? -74.4 -24.65 59.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.418 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.0 -14.12 60.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 3.6 t -64.41 -39.23 93.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 14' ' ' LEU . 63.2 t -68.13 -28.86 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.755 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 86.9 mtp -58.86 -41.27 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -79.82 -15.69 56.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.079 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 2.8 mmp_? -71.91 -42.6 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.096 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 pt -92.1 24.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.564 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 57.25 30.47 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.421 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 25.7 ttt -99.95 -0.87 38.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.039 0.447 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 64.1 tp -157.95 99.87 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.96 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.3 mmpt? -86.9 76.56 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.225 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.3 3.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.54 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -147.12 4.03 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.697 0.284 . . . . 0.0 111.155 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 37.4 mt-10 -96.63 120.77 37.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.624 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 100' ' ' ALA . 36.4 mt -78.91 151.06 31.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.946 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.496 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 60.9 m-85 -143.15 148.57 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.637 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.09 7.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.57 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mm-40 -73.5 -49.17 6.72 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.79 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 71.8 Cg_endo -77.26 -23.74 9.99 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.105 1.87 . . . . 0.0 113.137 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 2.3 p -73.41 -44.91 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.642 0.258 . . . . 0.0 111.192 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 18.6 m-30 -60.04 -22.32 62.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.81 -44.05 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.882 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 25.5 ptm -72.47 -43.21 64.03 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.202 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -49.2 -23.58 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 86' ' ' ILE . 30.8 mt-10 -60.38 -59.49 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.414 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.31 -34.88 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.21 0.529 . . . . 0.0 110.951 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.494 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 40.7 t -58.71 -8.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.087 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 92.6 m-70 -141.04 52.11 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.429 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.69 136.54 53.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.182 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.53 -67.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.158 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 3.5 m-20 -124.37 142.6 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.55 -28.52 69.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 5.6 m-20 -83.78 -25.83 30.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.287 . . . . 0.0 110.349 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.1 t70 -57.97 -30.06 65.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.604 HG23 HG22 ' A' ' 75' ' ' ILE . 79.5 mt -83.95 -26.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.616 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -79.71 -22.01 43.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.497 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 92' ' ' ILE . 57.2 tp -78.23 -58.5 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.019 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.41 -36.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 72' ' ' TYR . 1.7 mttm -60.66 -34.97 75.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.61 -25.14 54.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.39 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.644 HD12 ' HB3' ' A' ' 120' ' ' LYS . 42.3 mm -69.71 -43.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.126 0.488 . . . . 0.0 111.109 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.36 -17.62 59.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.677 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.65 -22.67 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.973 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -82.54 -37.71 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.275 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 5.8 m -64.05 -27.65 69.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.506 HG23 HD12 ' A' ' 66' ' ' LEU . 62.0 mt -74.49 -34.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.608 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.1 p30 -91.42 -17.64 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 111.058 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.53 ' O ' HD11 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.265 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.716 0.293 . . . . 0.0 111.561 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -92.26 123.56 35.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp10 -37.15 -65.58 0.29 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.934 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 96.0 m -46.76 -50.52 18.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.21 -36.14 68.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 106' ' ' GLU . 56.2 mt -67.15 -41.4 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 114' ' ' THR . . . -73.41 -45.37 30.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.147 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.749 HD22 ' HG2' ' A' ' 44' ' ' MET . 17.5 m120 -48.56 -60.78 2.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.883 0.341 . . . . 0.0 111.273 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 14.3 mmtm -54.49 -37.08 64.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -69.31 -64.07 0.94 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.227 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 4.1 t -47.3 -56.98 5.76 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.509 ' H ' HG23 ' A' ' 114' ' ' THR . 70.6 m-20 -35.32 -54.54 0.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -51.4 -48.04 62.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.872 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -34.5 65.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.452 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 3.6 mp -81.77 -27.82 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.262 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.49 -47.28 56.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.812 0.339 . . . . 0.0 111.271 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.644 ' HB3' HD12 ' A' ' 92' ' ' ILE . 71.6 mmtt -87.02 -58.33 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.468 ' C ' ' H ' ' A' ' 123' ' ' SER . 26.1 tp -96.06 -10.18 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.74 -24.12 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.434 0.159 . . . . 0.0 110.602 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 121.048 0.451 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 18.1 t70 -65.84 -54.86 21.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 53.5 p -57.36 -35.69 70.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 123' ' ' SER . 57.6 t -87.22 -64.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -58.78 -62.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.76 -25.78 42.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.2 mptm? -88.23 -54.6 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.714 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -57.88 -23.37 52.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -82.75 -56.13 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.84 -25.73 68.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.272 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -53.19 -46.26 68.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.263 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -152.1 45.11 0.74 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.766 0.317 . . . . 0.0 111.453 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.546 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 ttp -52.39 -50.25 80.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 15' ' ' MET . 33.4 Cg_endo -63.84 -32.33 66.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.051 1.834 . . . . 0.0 112.749 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 m-20 -84.45 -9.66 58.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 mt -86.37 -29.11 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.324 . . . . 0.0 110.855 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 25.5 mmt -54.75 -47.27 98.57 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.965 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 19' ' ' MET . 48.8 Cg_exo -37.83 -49.43 2.05 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.939 2.426 . . . . 0.0 113.475 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.9 m -85.01 -35.57 21.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.72 47.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 179.654 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.42 ' CA ' HD21 ' A' ' 111' ' ' ASN . 22.7 ttt . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.591 0.234 . . . . 0.0 111.26 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -48.03 -40.47 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.445 HE21 ' HB2' ' A' ' 49' ' ' CYS . 13.2 tp60 -87.43 -27.93 22.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 2.9 mp -66.81 -7.5 21.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -94.05 7.07 73.03 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.187 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.445 ' HB2' HE21 ' A' ' 46' ' ' GLN . 36.2 m -131.75 -70.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.227 . . . . 0.0 111.452 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.7 tp -51.56 -55.07 21.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 1.4 tpmt? -64.68 -23.2 67.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.215 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.17 -15.85 57.48 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.581 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.06 -25.45 66.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.081 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.31 -36.87 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.524 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.408 ' HB2' ' HE3' ' A' ' 55' ' ' MET . 72.6 mtm -68.5 -40.42 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -73.09 -20.02 61.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -86.06 -27.49 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' A' ' 60' ' ' MET . 48.5 pt -94.75 17.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.1 34.22 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.413 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.447 ' HB2' HG13 ' A' ' 58' ' ' ILE . 26.6 ttt -104.35 1.9 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.166 0.507 . . . . 0.0 110.544 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 66' ' ' LEU . 50.0 tp -153.18 98.79 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.757 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 mmpt? -104.67 104.67 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 48.14 51.61 19.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.356 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 109' ' ' ILE . 8.8 p 73.66 34.55 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.242 0.617 . . . . 0.0 111.479 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.0 106.08 9.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.679 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.2 mm? -68.45 147.27 52.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.378 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.97 169.31 13.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.35 . . . . 0.0 111.223 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.06 -25.69 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.358 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 48.1 mt-10 -62.37 -47.96 88.18 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.115 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 36.9 Cg_endo -65.07 -42.46 13.95 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.275 1.983 . . . . 0.0 113.445 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.544 HG13 ' HD1' ' A' ' 72' ' ' TYR . 3.1 p -65.23 -46.51 90.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.592 0.234 . . . . 0.0 111.395 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HD1' HG13 ' A' ' 71' ' ' VAL . 4.6 m-30 -59.29 -22.0 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.278 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 21.8 tptm -84.62 -45.56 12.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.4 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 1.2 ptp -70.84 -42.66 69.88 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.461 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.599 HG22 HG23 ' A' ' 86' ' ' ILE . 95.5 mt -48.73 -27.81 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.739 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 36.9 mt-10 -59.64 -59.22 5.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.716 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.5 -39.72 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.083 0.468 . . . . 0.0 110.811 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.77 -9.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.362 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 93.5 m-70 -143.47 56.75 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.9 137.54 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.11 -53.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.43 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -128.05 154.66 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.81 -29.4 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.351 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 4.1 p30 -83.52 -29.34 27.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.76 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -28.56 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 75' ' ' ILE . 88.9 mt -83.33 -29.06 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.237 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.78 -22.4 53.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.357 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 92' ' ' ILE . 69.6 tp -75.94 -60.12 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.768 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 121' ' ' LEU . 35.0 t -55.23 -35.97 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.93 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -33.96 60.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.25 -28.75 24.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 120' ' ' LYS . 31.3 mm -65.39 -36.29 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.0 64.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -74.21 -40.99 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.634 ' HG2' ' HE2' ' A' ' 120' ' ' LYS . 8.2 tp10 -62.57 -18.14 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.544 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 57.9 m -86.18 -53.89 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.747 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.6 mt -51.07 -30.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 111.295 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.52 -51.94 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.804 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.5 p30 -81.74 -5.93 58.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.647 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.863 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m . . . . . 0 N--CA 1.453 -0.321 0 CA-C-O 120.689 0.281 . . . . 0.0 111.695 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 108' ' ' ASN . 15.1 t70 -99.96 144.95 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.01 -70.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.0 m -50.02 -24.15 2.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.684 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.406 ' CG ' ' HB3' ' A' ' 105' ' ' ASP . 5.5 m-20 -70.09 -58.18 4.1 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.461 HD12 ' HB ' ' A' ' 64' ' ' THR . 0.6 OUTLIER -52.44 -41.66 36.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.87 -36.0 85.88 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.58 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.579 ' HA ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -68.62 -40.49 80.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.989 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -61.7 -27.15 68.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -59.32 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.001 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 111' ' ' ASN . 8.7 t -46.76 -45.14 19.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.814 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 114' ' ' THR . 13.7 t70 -48.12 -61.72 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -49.27 73.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -36.91 42.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.4 mm -79.49 -28.66 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 110.93 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 37.9 tt0 -69.53 -53.13 20.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 11.3 mptt -85.13 -55.94 3.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 HG13 ' A' ' 89' ' ' VAL . 39.0 tp -95.56 -11.32 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER 69.14 -16.93 0.22 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 121' ' ' LEU . 37.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.92 0.39 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 9.6 m-20 -73.13 -26.7 61.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 69.4 p -81.54 -20.87 39.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 109.716 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 123' ' ' SER . 87.0 t -82.38 -63.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.813 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -65.13 -52.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.39 -27.98 68.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.05 -55.88 3.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.783 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -54.05 -24.24 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -79.23 -62.03 1.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.64 -23.62 67.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.792 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 5.2 t80 -56.56 -35.89 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.425 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.544 HD12 HG13 ' A' ' 54' ' ' VAL . 41.4 mt -151.59 28.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.6 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 36.3 ttp -47.41 -50.44 49.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 21.5 Cg_exo -65.84 -30.7 49.12 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.213 1.942 . . . . 0.0 112.351 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.37 -7.55 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.425 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 14' ' ' LEU . 93.3 mt -83.95 -25.78 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.635 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.519 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.4 mmt -49.11 -50.06 65.65 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.192 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 96.0 Cg_exo -41.93 -53.92 3.19 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.614 2.209 . . . . 0.0 113.251 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.0 m -82.29 -20.98 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.897 0.38 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -74.86 -2.73 28.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 . . . . . 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.769 179.6 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.603 ' SD ' HG23 ' A' ' 114' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 112.34 0.496 . . . . 0.0 112.34 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 64.3 m -52.41 -51.52 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -87.66 -28.5 21.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.766 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 44' ' ' MET . 6.5 mp -64.13 -21.85 66.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.77 -8.18 63.21 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.296 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -137.31 -62.47 0.62 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' HD22 ' A' ' 50' ' ' LEU . 1.9 tm? -48.42 -41.81 30.3 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 26.2 ttpp -82.3 -23.93 34.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.622 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.66 -6.62 57.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.273 0.558 . . . . 0.0 109.753 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.1 t -64.58 -28.19 69.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.722 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 HD12 ' A' ' 14' ' ' LEU . 59.0 t -70.17 -26.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.933 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.25 -56.63 7.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 46.1 mtmt -55.12 -26.7 40.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -72.1 -33.51 67.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 14' ' ' LEU . 42.7 pt -100.2 22.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.477 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 58.26 29.29 17.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -97.43 -10.04 26.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.75 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 5.6 tt -149.15 114.66 5.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -107.82 77.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.58 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 -74.1 1.75 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -126.77 -1.57 6.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.503 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -91.0 156.16 18.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.638 HD21 HG13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -135.55 131.19 35.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.515 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' HD12 ' A' ' 66' ' ' LEU . 31.3 m-85 -118.84 170.83 8.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.4 m -137.72 -3.67 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 42.6 mt-10 -67.54 -49.51 40.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.1 Cg_endo -65.47 -28.23 53.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.101 1.867 . . . . 0.0 113.107 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' MET . 0.3 OUTLIER -72.02 -41.63 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 111.083 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 21.6 m-30 -56.6 -22.06 31.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.263 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.82 -40.49 22.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.791 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 14.4 ptm -77.44 -38.44 49.47 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.101 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 86' ' ' ILE . 94.1 mt -50.97 -23.57 2.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.041 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 37.1 mt-10 -60.59 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.912 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.095 0.474 . . . . 0.0 110.983 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 34.0 t -64.14 -7.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.402 ' NE2' HG21 ' A' ' 89' ' ' VAL . 94.6 m-70 -144.58 50.76 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.58 134.83 55.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.52 -68.51 0.48 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.559 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.06 147.53 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.36 -21.47 53.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.408 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.547 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 7.5 m-20 -84.14 -27.17 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.956 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.22 -27.22 63.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 75' ' ' ILE . 83.5 mt -85.93 -26.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.475 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -81.26 -21.41 39.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.819 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 92' ' ' ILE . 42.6 tp -81.33 -57.78 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 121' ' ' LEU . 87.5 t -54.27 -36.22 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 72' ' ' TYR . 9.2 mttt -62.66 -31.42 72.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.975 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.26 47.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.221 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 88' ' ' LEU . 74.3 mt -73.06 -40.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.684 0.278 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.89 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.55 -26.07 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.487 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.7 tp10 -77.97 -19.64 54.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.043 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -86.28 -43.4 12.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.501 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.638 HG13 HD21 ' A' ' 66' ' ' LEU . 2.0 mp -58.89 -41.67 83.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.678 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.31 -14.46 61.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.7 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.549 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 6.4 t30 -98.66 -75.21 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.111 179.637 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t . . . . . 0 CA--C 1.528 0.133 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 109' ' ' ILE . 24.0 t70 -87.93 122.84 32.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.55 0.214 . . . . 0.0 110.763 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.6 tt0 -42.07 -66.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.128 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.94 -36.13 16.62 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -67.46 -42.54 82.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 105' ' ' ASP . 50.6 mt -58.75 -50.75 78.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.491 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 114' ' ' THR . . . -64.82 -36.85 93.59 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.719 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -48.36 -38.36 19.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.011 0.405 . . . . 0.0 111.372 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 3.3 mptp? -86.43 -24.15 25.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.03 -64.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 110' ' ' GLY . 5.2 t -54.06 -28.51 39.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -53.36 -70.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.337 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -34.53 62.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.572 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -33.97 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 0.0 110.562 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.597 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 75.1 mt -85.08 -17.14 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 110.271 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.21 -58.66 3.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.493 ' HD2' ' H ' ' A' ' 120' ' ' LYS . 2.8 mptp? -87.36 -49.15 7.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -91.0 -12.02 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 71.54 -23.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -179.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.551 ' HB3' HG11 ' A' ' 6' ' ' VAL . 64.0 p . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.996 0.427 . . . . 0.0 110.639 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.94 -52.93 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.053 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.0 p -51.21 -29.98 15.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.128 0.49 . . . . 0.0 110.97 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 53.7 t -77.48 -63.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.589 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.05 -59.46 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.79 -35.91 15.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.1 mmmt -88.74 -59.42 2.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 13.7 m-85 -49.86 -29.1 7.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.31 . . . . 0.0 111.551 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.6 tpp -71.98 -55.46 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.69 -46.49 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.452 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.448 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 2.5 t80 -45.34 -39.87 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.352 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 54' ' ' VAL . 26.3 mt -145.3 63.53 1.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.447 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.495 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 57.2 ttp -83.9 -52.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.599 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 71.6 Cg_endo -77.41 -27.31 6.52 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.968 1.779 . . . . 0.0 111.721 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 9.6 m-20 -72.38 -10.87 60.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.576 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 14' ' ' LEU . 2.8 mt -77.29 -39.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.604 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 17.0 mmt -48.54 -51.66 50.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.935 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 74.2 Cg_exo -49.57 -51.5 10.62 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.265 1.977 . . . . 0.0 112.746 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.44 -43.23 83.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.499 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.617 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -60.18 -44.08 95.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 179.808 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.409 ' HG2' ' ND2' ' A' ' 111' ' ' ASN . 49.9 ttp . . . . . 0 N--CA 1.463 0.191 0 CA-C-O 120.737 0.304 . . . . 0.0 111.376 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -51.98 -57.07 10.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.278 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 mm-40 -85.05 -12.33 53.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.483 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 16.5 tp -62.73 -39.74 95.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.084 0.468 . . . . 0.0 110.139 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 110' ' ' GLY . . . -69.87 4.7 7.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.478 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 107' ' ' CYS . 1.8 m -131.48 -72.54 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.703 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm? -47.32 -54.05 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.36 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 16.8 tptp -71.97 -23.5 61.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.596 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.12 -18.63 61.88 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.036 0.446 . . . . 0.0 110.092 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.92 -36.13 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.222 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 14' ' ' LEU . 67.0 t -59.58 -27.53 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 60' ' ' MET . 56.2 mtt -65.65 -51.84 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.575 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 56' ' ' LYS . 47.2 mttt -66.09 -15.94 63.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.209 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 5.6 tpm_? -69.33 -45.81 68.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 60' ' ' MET . 36.8 pt -91.55 29.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.442 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 55.33 29.94 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 ttt -94.34 -17.73 22.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 60.4 tp -144.13 101.94 3.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 5.9 mmpt? -84.16 77.45 9.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.945 0.402 . . . . 0.0 110.124 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.42 -57.09 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.2 p -153.52 9.32 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 28.7 mm-40 -94.5 108.18 20.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 HG12 ' A' ' 109' ' ' ILE . 7.6 mp -67.66 138.22 56.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 60' ' ' MET . 62.5 m-85 -139.31 159.75 41.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.26 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.22 -10.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.363 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.1 mt-10 -56.85 -50.27 89.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.8 -14.13 35.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.001 1.801 . . . . 0.0 112.001 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 HD11 ' A' ' 75' ' ' ILE . 24.5 t -78.76 -47.44 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.045 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -63.3 -27.35 69.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -76.56 -30.08 56.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.256 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.5 ptm -85.73 -43.94 12.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.35 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.726 HG22 HG23 ' A' ' 86' ' ' ILE . 93.7 mt -51.62 -33.84 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 110.549 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.453 ' HA ' HD13 ' A' ' 86' ' ' ILE . 29.5 mt-10 -53.8 -57.49 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.97 -24.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 111.171 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 9' ' ' LYS . 6.3 t -67.61 -11.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.944 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 90.5 m-70 -134.05 49.96 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.467 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.23 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.55 -70.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.16 148.35 31.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.913 0.387 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.09 -35.84 36.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.719 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 -30.85 51.32 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.955 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -21.78 6.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.726 HG23 HG22 ' A' ' 75' ' ' ILE . 63.5 mt -85.93 -55.03 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.5 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 90' ' ' LYS . 9.1 mm100 -52.81 -25.68 12.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.732 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 92' ' ' ILE . 63.8 tp -71.66 -46.55 58.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.588 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 75' ' ' ILE . 43.0 t -69.15 -41.71 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.317 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 86' ' ' ILE . 9.2 mtmt -55.11 -27.12 42.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.28 -24.52 36.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.356 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 121' ' ' LEU . 47.2 mm -61.87 -40.16 86.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.725 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -59.88 -30.1 68.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.72 -23.53 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.04 -38.65 31.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.422 ' HA ' ' OD1' ' A' ' 99' ' ' ASN . 72.9 m -74.13 -36.36 64.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.653 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 93' ' ' ALA . 93.4 mt -56.46 -27.35 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -52.35 7.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.196 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -70.78 -17.13 62.79 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.467 ' N ' HD22 ' A' ' 99' ' ' ASN . . . . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 120.635 0.255 . . . . 0.0 111.272 -179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.753 0.311 . . . . 0.0 111.503 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.6 t70 -72.87 134.73 44.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.35 -61.6 2.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.726 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 54.0 m -60.59 -10.3 4.99 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.1 t-20 -86.66 -53.61 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 110.243 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.553 HG12 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -51.31 -34.81 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 48' ' ' GLY . . . -85.93 -51.47 3.58 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.891 -0.671 . . . . 0.0 114.296 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 2.3 t-20 -52.96 -23.86 8.16 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.7 0.75 . . . . 0.0 110.446 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -87.49 -40.82 13.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.923 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.15 -64.96 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.843 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 p -46.21 -45.57 17.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.988 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 14.7 t70 -43.9 -72.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.823 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.18 -32.32 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.822 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -56.18 -38.46 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 110.532 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.8 mt -83.45 -19.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 110.275 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -71.24 -60.11 2.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 92' ' ' ILE . 67.2 mttm -87.17 -50.77 6.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.5 HD22 HG13 ' A' ' 89' ' ' VAL . 57.0 tp -85.35 -11.87 53.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 6.3 t80 66.72 -6.03 0.58 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 0.0 110.504 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 121' ' ' LEU . 68.1 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 . . . . . 0 N--CA 1.461 0.096 0 CA-C-O 120.832 0.348 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.6 -43.98 87.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.552 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 5.6 t -52.54 -25.48 10.56 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.8 t -87.67 -64.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.449 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.72 -61.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.03 -28.27 23.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.4 mmtm -88.62 -59.6 2.19 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.53 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -51.14 -21.29 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.8 mtt -83.31 -61.59 1.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.306 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -52.56 64.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 4.8 t80 -43.9 -33.82 1.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.46 HD11 HG21 ' A' ' 58' ' ' ILE . 90.9 mt -146.64 59.75 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.452 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 37.9 tpp -89.15 -51.28 0.37 Allowed Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.7 Cg_endo -72.69 -12.46 26.68 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.991 1.794 . . . . 0.0 111.685 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.01 -9.86 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.884 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 mt -89.21 -47.35 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.707 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.483 ' CG ' ' HD3' ' A' ' 20' ' ' PRO . 19.3 ptp -53.84 -34.05 18.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HD3' ' CG ' ' A' ' 19' ' ' MET . 52.2 Cg_exo -54.48 -52.55 7.92 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.419 1.413 . . . . 0.0 112.978 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 11.3 m -72.84 -22.88 60.72 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.514 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -53.92 -42.17 68.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.646 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.332 179.667 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.587 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 10.2 ttt . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 120.558 0.218 . . . . 0.0 111.047 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.7 p -59.05 -43.54 91.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.27 . . . . 0.0 110.703 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -87.81 -30.25 20.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.5 tm? -54.29 -44.9 72.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 110.054 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 110' ' ' GLY . . . -66.15 6.49 1.59 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.807 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.6 m -134.3 -72.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.2 tm? -46.56 -51.49 15.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.522 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HB3' HD13 ' A' ' 47' ' ' LEU . 27.4 tptp -75.37 -22.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.37 -20.13 62.98 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.5 t -60.99 -34.23 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.5 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.86 -26.88 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.7 mtm -69.06 -51.98 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.826 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 30.7 pttt -75.82 -15.75 60.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.5 tpm_? -70.45 -30.15 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.751 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 14' ' ' LEU . 45.9 pt -105.86 26.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.488 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 57.93 63.11 1.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -139.65 -10.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.53 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 30.0 tp -134.84 99.48 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.54 ' N ' ' HE3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -94.16 76.61 4.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.188 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.26 -58.73 3.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.285 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.9 p -148.25 4.26 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.714 0.292 . . . . 0.0 110.994 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt-10 -94.16 131.26 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.1 mt -113.74 113.83 25.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.139 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -106.15 177.85 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.61 25.49 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.541 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 43.7 mt-10 -79.19 -50.21 1.39 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.625 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 60.0 Cg_endo -74.44 -38.45 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.148 1.898 . . . . 0.0 113.067 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.58 HG13 ' HE3' ' A' ' 74' ' ' MET . 11.8 t -63.59 -46.1 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.633 0.254 . . . . 0.0 111.13 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -60.88 -21.81 63.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.371 . . . . 0.0 110.62 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -82.12 -48.01 11.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.743 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.58 ' HE3' HG13 ' A' ' 71' ' ' VAL . 14.7 ptt? -74.61 -35.43 62.94 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.91 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.692 HG22 HG23 ' A' ' 86' ' ' ILE . 9.6 mt -49.68 -26.15 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.076 0.465 . . . . 0.0 110.418 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -59.05 5.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.497 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.68 -24.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.198 0.523 . . . . 0.0 111.146 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 25.1 t -67.27 -7.39 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 88.9 m-70 -138.05 43.28 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.56 134.65 57.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.86 -60.92 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.408 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.681 ' HB3' ' HB2' ' A' ' 85' ' ' ASP . 30.3 t30 -116.87 132.16 56.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 110.514 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.87 67.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 -22.3 30.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.681 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 13.8 t70 -62.04 -24.18 66.92 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.692 HG23 HG22 ' A' ' 75' ' ' ILE . 93.3 mt -85.13 -29.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.661 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -81.48 -21.98 38.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.578 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.97 -60.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.24 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.666 HG12 HD13 ' A' ' 121' ' ' LEU . 24.3 m -54.93 -31.5 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -58.02 -41.95 84.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.648 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.7 -18.88 72.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.802 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 89' ' ' VAL . 50.9 mt -67.54 -41.03 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.728 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.96 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.283 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.3 -48.81 39.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.259 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.9 -21.21 57.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.463 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 29.3 m -86.24 -39.39 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.696 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 66' ' ' LEU . 93.2 mt -69.74 -42.04 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.808 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.98 -19.97 64.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.905 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 0.8 OUTLIER -109.33 -8.43 15.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.256 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.72 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.592 0.234 . . . . 0.0 111.507 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -102.4 139.99 37.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.54 -65.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.415 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 64.9 m -50.34 -31.1 13.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -68.66 -40.36 80.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 105' ' ' ASP . 85.9 mt -69.41 -47.29 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.866 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 114' ' ' THR . . . -62.08 -52.3 50.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.909 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.587 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.0 t-20 -54.56 -39.47 67.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.078 0.439 . . . . 0.0 110.319 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -69.23 -25.65 64.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -83.72 -61.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 47' ' ' LEU . 7.7 t -47.36 -47.93 25.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.375 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.473 ' N ' HG23 ' A' ' 114' ' ' THR . 4.8 t70 -44.93 -61.55 1.57 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.57 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -48.03 73.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -25.68 54.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.489 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.9 mm -85.12 -32.15 7.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.963 0.411 . . . . 0.0 111.171 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.23 -45.22 57.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.857 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 92' ' ' ILE . 73.0 mmtt -86.64 -56.53 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 89' ' ' VAL . 28.9 tp -98.93 -11.84 21.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.0 OUTLIER 69.05 -16.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 110.862 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.228 -0.033 0 CA-C-O 120.86 0.362 . . . . 0.0 111.14 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -53.42 -50.5 65.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.416 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 40.3 p -64.91 -20.67 66.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 87.9 t -83.28 -63.18 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.09 -57.13 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.498 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.55 64.94 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.43 -59.29 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.959 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -51.49 -22.98 3.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 110.851 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.2 ttp -85.52 -62.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.346 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.6 -31.31 67.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.076 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -55.92 -45.22 78.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.437 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -141.03 40.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.56 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttp -58.34 -51.81 79.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.47 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 15' ' ' MET . 57.9 Cg_endo -70.83 -13.47 31.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.007 1.805 . . . . 0.0 112.218 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -101.96 -6.95 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.41 -43.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.512 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 84.8 mmm -53.02 -48.73 90.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 76.4 Cg_exo -43.79 -51.38 6.37 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.719 2.28 . . . . 0.0 113.149 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 78.9 m -58.3 -31.91 67.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.771 -178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.67 71.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 179.501 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.425 ' CG ' ' ND2' ' A' ' 111' ' ' ASN . 46.3 ttm . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.5 t -64.6 -57.43 9.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.498 0.189 . . . . 0.0 111.359 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 0.9 OUTLIER -86.9 -12.14 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 0.0 110.776 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.2 -41.99 80.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -74.54 13.61 4.88 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.504 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.558 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 5.1 m -147.3 -70.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 111.737 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.453 ' N ' ' O ' ' A' ' 46' ' ' GLN . 12.2 tp -44.35 -55.91 4.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.398 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -79.16 -22.18 45.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -76.15 -7.8 55.61 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.026 0.441 . . . . 0.0 110.626 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.0 t -72.15 -36.09 69.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.83 -22.22 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.0 mtt -69.84 -46.48 65.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.505 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 49.5 mttm -60.2 -18.8 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 4.4 tpm_? -67.59 -45.31 75.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.381 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.04 34.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.29 13.55 3.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.754 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.4 tpt -71.9 -14.3 61.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 31.9 tp -155.18 103.71 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.1 mmpt? -95.3 80.87 3.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 -70.56 1.61 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.893 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.7 p -145.54 27.19 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.21 110.53 21.08 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.413 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 109' ' ' ILE . 86.0 mt -73.63 131.94 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.707 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -119.81 172.15 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 97' ' ' ILE . 11.2 m -149.26 -17.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.3 mt-10 -58.61 -51.14 83.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.82 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 21.9 Cg_endo -61.21 -32.67 90.83 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.216 1.944 . . . . 0.0 112.625 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 75' ' ' ILE . 46.2 t -72.94 -48.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.179 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -54.09 -24.71 18.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -86.0 -36.76 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 20.0 ptm -75.75 -39.57 56.96 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.508 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.631 HG22 HG23 ' A' ' 86' ' ' ILE . 90.3 mt -50.48 -23.64 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.053 0.454 . . . . 0.0 110.189 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.481 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.9 mt-10 -59.01 -58.82 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 9' ' ' LYS . 21.2 t -88.05 -24.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.151 0.5 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 9' ' ' LYS . 41.8 t -66.26 -8.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.941 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' NE2' HG21 ' A' ' 89' ' ' VAL . 92.0 m-70 -143.37 49.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.613 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.58 127.32 30.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -73.53 0.34 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.595 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.4 m-20 -104.6 136.69 43.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.688 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.5 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.613 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.07 -24.89 30.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.758 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.0 t70 -59.58 -26.56 65.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.631 HG23 HG22 ' A' ' 75' ' ' ILE . 81.1 mt -84.34 -27.73 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.475 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.83 -19.76 43.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.617 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.8 tp -78.25 -55.06 5.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.582 HG13 ' HG ' ' A' ' 121' ' ' LEU . 26.4 t -55.94 -36.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.572 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -61.83 -30.04 70.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.722 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.19 51.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.261 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.609 HG13 HD23 ' A' ' 121' ' ' LEU . 47.9 mm -74.38 -39.91 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 0.0 110.893 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -58.34 -23.72 57.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -75.48 -37.48 60.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -56.64 -28.45 60.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.546 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 59.8 m -80.68 -27.68 37.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD11 HG11 ' A' ' 68' ' ' VAL . 39.6 mt -74.15 -21.8 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.933 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.0 -29.44 55.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 3.9 p30 -97.51 -40.74 8.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.191 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 179.854 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 C--O 1.231 0.115 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -96.03 143.34 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.303 . . . . 0.0 110.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.558 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 12.9 tp10 -65.41 -69.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.697 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 14.3 m -50.25 -24.11 2.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.516 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -76.81 -49.35 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.655 HG23 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -56.79 -43.82 80.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.5 -50.21 39.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.752 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.7 t-20 -54.83 -33.78 62.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.08 -31.49 58.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.852 0.358 . . . . 0.0 111.014 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.96 -65.57 1.0 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.76 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -46.73 -42.9 17.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.142 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 17.0 t70 -46.0 -63.77 0.9 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.77 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.332 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.35 -51.21 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.898 0.38 . . . . 0.0 110.669 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.4 mt -78.17 -17.76 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.54 -60.01 3.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.602 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.93 -55.96 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.609 HD23 HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -85.34 -11.32 54.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.32 -14.24 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 110.524 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 121' ' ' LEU . 70.0 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.72 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.941 0.4 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.52 -57.0 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.458 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 15.3 t -49.8 -28.17 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.387 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -86.93 -64.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.844 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.89 -58.11 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.19 -29.49 22.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 mptp? -88.54 -59.09 2.33 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.517 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -51.28 -20.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.727 0.299 . . . . 0.0 111.362 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -85.0 -58.6 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.37 -23.48 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.55 -23.41 56.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.694 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HB3' HG11 ' A' ' 54' ' ' VAL . 79.0 mt -135.02 15.98 3.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tmm? -58.27 -51.91 78.41 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.316 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 16.3 Cg_exo -69.86 -7.15 20.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.551 2.167 . . . . 0.0 112.321 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -104.75 -16.88 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 HG21 ' A' ' 54' ' ' VAL . 67.7 mt -89.21 -49.51 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.262 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.594 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 91.9 mmm -49.07 -49.65 67.88 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.7 Cg_exo -51.29 -52.18 9.6 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.242 1.961 . . . . 0.0 113.118 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -22.14 54.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.531 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.569 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -54.82 -35.78 64.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.561 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.572 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 11.3 ttm . . . . . 0 N--CA 1.465 0.317 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.4 p -63.06 -57.06 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.28 -12.54 59.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.648 ' HG ' HG21 ' A' ' 114' ' ' THR . 30.3 tp -84.46 -30.92 24.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -92.13 14.94 63.19 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -132.28 -74.2 0.51 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.988 -0.606 . . . . 0.0 111.305 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -50.84 -45.67 59.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.351 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 58.3 tttm -74.65 -24.94 58.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -68.15 -22.11 64.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.3 0.571 . . . . 0.0 109.851 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.4 t -73.75 -37.84 64.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.277 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.533 HG21 HG12 ' A' ' 18' ' ' ILE . 5.7 t -63.55 -20.9 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.46 ' HE2' ' HG2' ' A' ' 51' ' ' LYS . 17.1 mmt -63.92 -51.94 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.647 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.86 -16.19 48.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.17 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.2 mmp_? -73.08 -34.15 66.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.086 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.447 HD11 ' SD ' ' A' ' 60' ' ' MET . 33.1 pt -107.13 34.91 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 42.68 40.95 2.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.894 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 55' ' ' MET . 18.2 ptm -112.02 8.97 20.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 110.091 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 56' ' ' LYS . 44.4 tp -157.72 99.01 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 11.7 mmpt? -104.37 95.8 6.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.059 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.15 57.6 14.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.39 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p 73.03 22.85 2.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.038 0.535 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 20.3 mm-40 -115.75 104.94 12.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 100' ' ' ALA . 5.7 mp -78.51 141.27 38.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -112.86 -178.48 3.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 HD13 ' A' ' 97' ' ' ILE . 30.6 m -129.18 -28.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm-40 -64.71 -52.86 48.21 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.933 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 12.7 Cg_endo -58.13 -13.76 16.94 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.054 1.836 . . . . 0.0 112.402 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.7 t -91.53 -46.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.4 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.9 m-85 -62.77 -22.25 66.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.213 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -82.35 -47.68 12.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -71.59 -41.27 69.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.861 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 89' ' ' VAL . 26.5 mt -49.37 -30.5 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.005 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 48.0 mt-10 -54.71 -59.53 4.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.814 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.57 -29.09 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 111.142 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 35.5 t -65.05 -7.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -139.05 33.35 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.38 56.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.319 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.15 -53.08 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.209 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.8 m120 -116.19 110.28 18.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.69 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.51 69.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.1 m-20 -79.71 -18.84 50.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.81 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 37.2 t0 -62.9 -34.09 76.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 75' ' ' ILE . 88.5 mt -76.42 -31.76 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.561 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -75.55 -30.95 59.89 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.779 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -83.75 -47.14 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 ' HG ' ' A' ' 121' ' ' LEU . 9.9 p -64.73 -32.88 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -52.69 -34.53 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.1 -30.44 31.28 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.38 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.591 HG13 HD23 ' A' ' 121' ' ' LEU . 34.8 mm -65.69 -35.64 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.36 -33.54 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.966 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.32 -21.73 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.29 -33.38 69.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.679 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.614 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 69.5 m -87.25 -53.65 4.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.47 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.57 HD13 HG12 ' A' ' 68' ' ' VAL . 65.1 mt -49.46 -28.8 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.63 -34.68 53.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.5 p30 -94.37 -3.88 49.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.443 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 66' ' ' LEU . . . . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.832 179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.664 0.269 . . . . 0.0 111.396 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 109' ' ' ILE . 11.1 t70 -79.83 131.23 35.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.835 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -49.16 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 83.4 m -56.58 -21.53 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -81.61 -31.19 32.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.013 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 105' ' ' ASP . 90.7 mt -66.74 -40.49 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -82.59 -37.03 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.368 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.572 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.6 t-20 -56.92 -48.31 78.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.674 0.273 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -53.59 -26.83 23.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.706 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.83 -65.8 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.917 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.648 HG21 ' HG ' ' A' ' 47' ' ' LEU . 9.7 t -53.19 -46.18 68.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.454 ' N ' HG23 ' A' ' 114' ' ' THR . 14.9 t70 -38.81 -58.44 1.08 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 p -76.81 -34.94 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.93 -32.5 66.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.876 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 54.3 mt -83.77 -20.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.224 0.535 . . . . 0.0 110.426 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.62 -58.26 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.0 -52.06 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.591 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -92.45 -11.44 34.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.19 -15.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.587 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 121' ' ' LEU . 58.8 m . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.935 0.398 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.81 -48.51 75.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.446 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.6 p -54.84 -24.52 23.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 123' ' ' SER . 58.4 t -86.41 -63.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.592 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.41 -62.11 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.24 -28.65 19.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.7 mmpt? -87.72 -59.15 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.491 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -52.06 -29.03 19.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -76.95 -62.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.98 -23.65 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.53 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -63.72 -48.19 78.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.483 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 58' ' ' ILE . 80.4 mt -137.89 36.68 2.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.0 ttm -55.3 -50.89 84.1 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 15' ' ' MET . 70.0 Cg_endo -71.24 -8.44 23.45 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.215 1.943 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 7.1 m-20 -100.29 -16.1 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 14' ' ' LEU . 78.3 mt -80.88 -49.87 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.471 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 87.8 mtp -48.4 -47.98 67.52 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.068 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 19' ' ' MET . 53.3 Cg_exo -38.51 -60.31 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.684 2.256 . . . . 0.0 113.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 64.8 m -69.64 -26.49 64.43 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.53 -44.83 66.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.877 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.207 179.465 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.449 ' HG2' HD22 ' A' ' 111' ' ' ASN . 20.6 ttm . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.637 0.256 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.9 t -86.5 -58.03 2.77 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 110.772 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.96 -16.38 36.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.058 0.456 . . . . 0.0 109.99 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 118' ' ' ILE . 19.3 tp -71.59 -35.31 70.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.623 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.26 9.38 9.92 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.734 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -146.64 -62.99 0.3 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.9 tm? -48.68 -42.68 35.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -81.16 -20.47 41.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.599 178.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.53 -21.95 62.67 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 1.7 t -59.64 -31.44 69.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.02 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.97 -28.93 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' MET . 71.1 mtm -72.68 -65.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.16 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HG2' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -58.07 -15.34 9.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.471 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.1 tpm_? -72.18 -34.26 68.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.175 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 14' ' ' LEU . 40.2 pt -113.29 34.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.827 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 64.01 11.05 5.81 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.563 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.0 tpt -79.05 4.16 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 56' ' ' LYS . 34.2 tp -166.81 99.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 2.5 mmpt? -85.93 78.33 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.452 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.7 -64.58 3.28 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.049 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 109' ' ' ILE . 63.8 p -147.36 15.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.709 0.29 . . . . 0.0 110.835 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -108.83 110.22 21.53 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.6 mm? -69.68 135.01 49.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.33 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 2.6 m-85 -106.4 174.31 5.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.73 -25.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.346 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.2 mm-40 -56.54 -51.86 77.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.504 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -63.53 -13.67 37.79 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.969 1.779 . . . . 0.0 112.099 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 75' ' ' ILE . 2.8 t -86.05 -50.37 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -56.86 -22.54 37.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.839 0.352 . . . . 0.0 110.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -85.33 -44.21 13.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.319 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 24.8 ptp -71.98 -41.71 67.36 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.697 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.572 HD13 HG23 ' A' ' 89' ' ' VAL . 89.0 mt -48.66 -28.52 2.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.01 -56.36 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.12 -24.73 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 75' ' ' ILE . 40.8 t -69.83 -8.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.856 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -144.67 45.53 1.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.652 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.77 119.91 10.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.61 -74.4 0.27 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.47 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.0 m120 -100.13 123.89 44.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.66 -25.27 67.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.024 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 9.5 m-20 -84.3 -24.98 29.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.436 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.8 t0 -56.68 -36.1 69.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 75' ' ' ILE . 96.9 mt -74.39 -28.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.6 tp60 -81.66 -23.56 36.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tt -78.37 -62.11 1.79 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.285 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 75' ' ' ILE . 28.5 m -58.85 -27.77 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.653 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.4 tttt -56.82 -35.91 69.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.713 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.46 -19.15 62.69 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 89' ' ' VAL . 29.1 mm -73.87 -35.27 42.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 0.0 110.76 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.13 68.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -82.94 -27.15 30.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.86 -19.64 63.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.4 m -86.07 -42.3 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.48 -36.9 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.16 -36.93 76.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -5.06 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.605 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.853 -179.867 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 C--O 1.232 0.155 0 N-CA-C 111.72 0.267 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 26.3 t70 -102.52 140.47 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.36 -69.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.666 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.9 m -53.82 -16.81 1.94 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.896 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 26.3 t-20 -87.06 -35.13 18.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.438 HD11 HG22 ' A' ' 64' ' ' THR . 84.6 mt -69.88 -55.57 14.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 114' ' ' THR . . . -61.25 -43.34 99.5 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.613 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.449 HD22 ' HG2' ' A' ' 44' ' ' MET . 26.5 t-20 -50.92 -30.39 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.6 -25.79 23.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.976 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -86.29 -63.47 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.735 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.6 t -49.3 -43.1 43.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 114' ' ' THR . 12.7 t70 -45.92 -38.54 7.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.59 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.22 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.339 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.51 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 0.0 111.584 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 61.4 mt -77.86 -21.23 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 110.718 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.57 -57.0 4.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.568 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -44.6 11.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.507 HD13 HG12 ' A' ' 89' ' ' VAL . 42.9 tp -99.9 -10.54 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER 72.79 -22.93 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.277 . . . . 0.0 110.968 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.516 ' HB2' HG11 ' A' ' 6' ' ' VAL . 57.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.778 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 . . . . . 0 C--O 1.229 0.026 0 CA-C-O 120.751 0.31 . . . . 0.0 111.086 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.1 -48.44 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 6.6 t -59.32 -24.96 63.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.08 -64.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.008 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.89 -59.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -27.58 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 5' ' ' THR . 13.5 mptt -88.42 -59.4 2.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.585 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -50.22 -24.7 3.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 15' ' ' MET . 0.7 OUTLIER -81.75 -62.21 1.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.99 -54.52 17.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -51.68 -23.41 4.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.459 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' HG11 ' A' ' 54' ' ' VAL . 96.3 mt -139.86 62.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.519 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.616 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 50.7 ttp -110.01 -51.45 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.366 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 31.3 Cg_exo -58.89 -14.79 24.02 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.989 1.793 . . . . 0.0 111.806 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -94.56 -19.86 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 22' ' ' ALA . 38.9 mt -81.09 -36.91 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 58.5 mtt -45.57 -50.27 32.4 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 77.1 Cg_exo -50.19 -52.41 9.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.272 1.982 . . . . 0.0 113.302 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.3 m -85.29 -15.04 44.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.661 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -66.33 -7.84 21.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 179.492 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.52 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 27.6 ttt . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 120.382 0.134 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 32.6 t -92.41 -57.35 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.1 mm-40 -88.06 -27.41 22.01 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 47' ' ' LEU . 4.6 tt -49.77 -46.78 51.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -76.02 29.65 1.35 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.65 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -132.71 -73.0 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 56.1 tp -51.99 -45.46 64.49 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -74.44 -25.27 59.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.485 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -78.83 -16.75 56.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 40.0 t -70.21 -33.39 71.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 14' ' ' LEU . 15.2 t -68.28 -24.99 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.985 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.79 -45.83 92.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 2.0 pttm -75.51 -15.84 60.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.615 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 2.9 mmp_? -76.94 -23.16 52.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 pt -113.01 26.08 3.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.81 63.21 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -139.31 -20.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 13.6 tp -124.93 99.99 6.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.559 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 10.4 mmpt? -124.14 87.57 2.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.14 59.44 10.03 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.367 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 109' ' ' ILE . 6.1 p 72.29 8.84 5.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.27 0.628 . . . . 0.0 111.171 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 42.8 mt-10 -92.91 122.51 35.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.21 113.85 25.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.958 0.409 . . . . 0.0 110.926 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.73 178.43 8.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.778 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 -12.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.754 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 36.6 mt-10 -70.65 -49.76 14.61 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.607 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 33.8 Cg_endo -66.6 -29.28 44.05 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.917 1.745 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 74' ' ' MET . 22.0 t -64.21 -53.64 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.926 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -55.26 -21.69 15.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -85.21 -38.43 18.96 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.13 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -72.92 -42.99 62.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.349 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.51 HG22 HG23 ' A' ' 86' ' ' ILE . 76.4 mt -51.91 -27.75 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 0.0 110.749 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 86' ' ' ILE . 47.4 mt-10 -57.58 -58.22 9.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.855 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -86.35 -25.79 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.184 0.516 . . . . 0.0 110.835 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 79' ' ' HIS . 39.7 t -72.61 -8.15 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.644 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.425 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 90.0 m-70 -145.21 43.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 132.12 48.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.185 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.65 -62.26 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -126.72 147.57 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -65.93 -33.6 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -82.91 -30.19 28.65 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.548 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -53.02 -30.73 37.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 HG22 ' A' ' 75' ' ' ILE . 95.0 mt -83.29 -34.56 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.412 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 15.0 mm100 -71.27 -19.76 62.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -78.06 -44.68 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 75' ' ' ILE . 21.3 t -70.43 -29.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.78 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.58 -35.9 54.99 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.408 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.83 -31.32 32.86 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.193 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 120' ' ' LYS . 34.6 mm -60.18 -35.36 61.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 -19.07 57.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -74.67 -42.04 59.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.343 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.95 -18.27 62.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -85.15 -38.03 19.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.471 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.76 -35.63 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.379 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.8 -13.27 62.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.299 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -106.75 -49.18 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.131 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.216 -179.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.713 0.292 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 109' ' ' ILE . 19.5 t70 -95.15 139.78 31.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -45.47 -64.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.908 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -56.3 -43.6 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.588 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.73 -37.98 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 105' ' ' ASP . 97.5 mt -60.12 -41.49 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -86.33 -29.22 25.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.17 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 21.3 m120 -58.15 -36.66 73.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.177 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.39 -38.26 30.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -68.65 -24.68 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.592 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 115' ' ' ASP . 11.1 t -88.0 -42.81 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 110.25 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.408 ' N ' HG23 ' A' ' 114' ' ' THR . 17.7 t70 -43.17 -68.97 0.15 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.46 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 p -54.26 -39.62 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.022 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.42 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.2 OUTLIER -54.34 -37.01 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.535 ' HA ' ' N ' ' A' ' 123' ' ' SER . 87.8 mt -85.29 -35.88 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.068 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.15 -46.25 72.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.931 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 92' ' ' ILE . 12.3 mptt -86.14 -44.97 11.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -100.16 -53.93 3.01 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 135.74 -6.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.254 1.422 . . . . 0.0 111.02 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.535 ' N ' ' HA ' ' A' ' 118' ' ' ILE . 89.9 p . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.782 0.325 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.4 m-20 -76.6 -44.6 33.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.485 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 79' ' ' HIS . 25.9 m -47.49 -41.93 21.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.44 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.11 -62.43 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -52.18 -26.25 11.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -89.37 -59.34 2.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.875 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -56.5 -23.77 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.716 0.293 . . . . 0.0 111.479 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.3 ttt -84.49 -56.02 3.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.63 -23.86 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.65 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.506 ' HB3' HD12 ' A' ' 14' ' ' LEU . 1.2 t80 -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 13' ' ' TYR . 4.5 mp -137.97 32.45 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 ttp -50.43 -51.67 62.05 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.608 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 15' ' ' MET . 42.5 Cg_endo -67.14 -33.3 31.78 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.889 1.726 . . . . 0.0 112.112 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.443 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 m-20 -78.78 0.72 25.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 15' ' ' MET . 37.8 mt -89.42 -43.42 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.432 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 26.9 ptt? -57.87 -33.32 17.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 19' ' ' MET . 78.6 Cg_exo -50.37 -51.9 10.08 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.684 1.589 . . . . 0.0 112.68 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 66.0 m -74.68 -28.99 61.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.559 -178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.54 -40.53 62.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.729 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.464 0.269 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 78.8 p -78.11 -58.75 3.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.686 0.279 . . . . 0.0 110.96 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 9.9 mm100 -88.74 -13.52 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.305 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.613 HD23 ' HB3' ' A' ' 51' ' ' LYS . 2.6 tt -60.04 -43.26 95.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.065 0.46 . . . . 0.0 109.845 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -72.48 9.3 6.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.037 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.91 -78.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.232 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.487 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -48.64 -52.62 22.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.613 ' HB3' HD23 ' A' ' 47' ' ' LEU . 5.3 tmtt? -73.55 -22.87 59.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.39 59.38 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.341 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.1 t -60.7 -35.71 76.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.753 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.99 -28.83 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.122 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.448 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 39.5 mtt -65.18 -49.02 71.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.171 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 53' ' ' CYS . 7.9 mtmp? -64.38 -27.3 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.795 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.3 -30.42 66.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' A' ' 60' ' ' MET . 49.1 pt -96.45 15.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.828 0.347 . . . . 0.0 111.216 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 58.41 45.45 16.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.668 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 2.8 ppp? -121.11 -8.96 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.088 0.47 . . . . 0.0 110.447 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 58.6 tp -139.47 99.87 3.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.471 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.25 77.84 3.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.35 -63.73 3.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.741 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -147.23 15.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.641 0.257 . . . . 0.0 110.659 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -107.5 111.2 23.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.739 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.583 HD11 HG23 ' A' ' 109' ' ' ILE . 95.7 mt -84.23 139.14 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 6.4 m-85 -111.67 -172.55 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.57 -15.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.608 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 47.0 mt-10 -72.95 -47.33 8.41 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 50.0 Cg_exo -52.65 -51.42 11.16 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.274 1.983 . . . . 0.0 112.834 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.89 -44.38 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.764 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -55.51 -23.7 27.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.945 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -85.46 -34.79 21.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.22 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.7 mtm -71.6 -50.49 30.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.555 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 86' ' ' ILE . 70.0 mt -49.35 -22.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.59 -59.71 3.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.427 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.8 -32.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 9' ' ' LYS . 37.6 t -61.08 -11.93 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.83 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HA ' HG23 ' A' ' 5' ' ' THR . 89.6 m-70 -139.09 53.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.93 109.19 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.48 -67.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.359 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.7 m-20 -107.11 153.18 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 -46.72 14.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.89 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.45 -26.46 61.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.925 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.2 t70 -57.45 -32.53 67.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 75' ' ' ILE . 93.8 mt -75.71 -29.79 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.123 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 87' ' ' GLN . 17.7 mt-30 -81.34 -19.42 42.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.448 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -61.39 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.551 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -58.64 -30.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -60.0 -32.95 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.823 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.53 -24.96 37.36 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.633 HG13 HD23 ' A' ' 121' ' ' LEU . 38.7 mm -69.25 -35.77 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 110.977 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.46 -15.89 63.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.98 -27.68 57.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.8 tp10 -69.9 -20.81 63.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.576 ' HA ' HD22 ' A' ' 99' ' ' ASN . 97.1 m -87.05 -45.49 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.24 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.5 -18.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.668 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.2 -12.89 29.18 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 96' ' ' CYS . 0.5 OUTLIER -121.6 -0.91 9.62 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.26 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.521 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--O 1.23 0.061 0 N-CA-C 111.647 0.24 . . . . 0.0 111.647 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -104.31 142.04 35.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.968 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.178 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.0 m -51.3 -29.38 14.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.421 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -72.59 -43.87 62.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.917 0.389 . . . . 0.0 110.113 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.583 HG23 HD11 ' A' ' 66' ' ' LEU . 13.6 mt -63.82 -44.96 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.61 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -45.11 85.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.949 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HA ' HG22 ' A' ' 114' ' ' THR . 1.9 t-20 -58.98 -47.66 84.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.928 0.364 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -61.04 -20.16 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.104 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -86.88 -56.84 3.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.333 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 111' ' ' ASN . 9.7 t -61.99 -36.39 81.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 111.622 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -48.3 -45.44 34.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.169 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -40.27 16.74 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.33 -35.1 64.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 58.1 mt -84.56 -17.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 0.0 110.252 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.74 -56.08 5.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 2.2 mptp? -85.23 -48.68 8.87 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -99.18 -10.02 23.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.42 -21.18 0.27 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.59 0.234 . . . . 0.0 110.937 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 121' ' ' LEU . 41.0 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.073 0 CA-C-O 120.825 0.345 . . . . 0.0 111.184 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.33 -44.81 62.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -53.98 -31.3 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' SER . 54.5 t -88.73 -65.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.03 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.99 -62.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.99 -24.83 56.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.08 -58.1 2.66 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.836 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -55.11 -30.67 60.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.689 0.281 . . . . 0.0 111.572 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.0 tpp -77.04 -52.5 9.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.403 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.62 -23.51 63.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 4.3 t80 -60.98 -36.06 78.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.127 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 18' ' ' ILE . 96.1 mt -142.34 38.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.129 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 9.0 tmm? -54.06 -51.01 81.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.083 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 15' ' ' MET . 60.5 Cg_endo -70.17 -8.67 24.17 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 14.9 m-20 -106.71 -15.11 14.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' LEU . 70.5 mt -83.69 -44.2 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.884 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.525 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 25.0 mmt -53.46 -48.2 93.64 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 95.0 Cg_exo -42.96 -51.64 5.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.677 2.252 . . . . 0.0 112.749 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' O ' HD23 ' A' ' 50' ' ' LEU . 4.9 m -56.85 -42.04 78.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.13 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.28 -50.33 62.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.976 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 . . . . . 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.551 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.683 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.2 tpt . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 120.438 0.161 . . . . 0.0 111.295 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.683 ' H ' ' HG3' ' A' ' 44' ' ' MET . 41.6 t -79.45 -44.53 21.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.063 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.425 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 5.5 tp60 -70.95 -39.96 72.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.525 HD21 ' HD3' ' A' ' 51' ' ' LYS . 2.3 tm? -68.56 -45.16 72.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.156 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -55.4 -7.54 1.38 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.302 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m -103.88 -60.9 1.5 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.416 HD23 ' O ' ' A' ' 21' ' ' CYS . 0.4 OUTLIER -53.94 -36.07 62.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.752 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HD3' HD21 ' A' ' 47' ' ' LEU . 13.6 tptt -80.65 -20.55 42.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.313 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -75.03 -23.86 58.22 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -26.17 68.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 18' ' ' ILE . 21.3 t -77.72 -24.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.6 mtt -67.08 -55.03 16.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.623 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HE2' HD23 ' A' ' 61' ' ' LEU . 45.1 mttm -58.27 -23.14 55.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -62.15 -36.51 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.895 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 pt -113.21 26.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.89 58.21 3.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.502 ' O ' ' HG2' ' A' ' 60' ' ' MET . 12.5 ttt -124.9 3.72 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 65' ' ' GLU . 33.9 tp -161.75 127.88 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.0 111.134 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.1 mmpt? -115.83 80.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.761 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 -72.74 0.92 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.754 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.3 p -139.55 29.46 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.89 0.376 . . . . 0.0 110.47 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 61' ' ' LEU . 7.0 tp10 -117.37 108.73 15.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.426 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -67.39 146.26 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.893 0.377 . . . . 0.0 111.418 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -142.33 155.41 45.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.501 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.65 5.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.736 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 38.0 mt-10 -59.5 -52.08 76.7 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -69.01 -28.87 28.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.171 1.914 . . . . 0.0 112.62 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 75' ' ' ILE . 21.5 t -63.94 -48.34 86.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.079 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HA ' HD12 ' A' ' 75' ' ' ILE . 7.1 m-30 -51.47 -22.21 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.935 0.398 . . . . 0.0 110.422 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 39.9 tptt -83.22 -37.57 23.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.4 mtm -74.59 -43.85 53.6 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.35 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 72' ' ' TYR . 58.9 mt -48.87 -24.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 44.3 mt-10 -65.94 -59.26 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.328 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -80.96 -44.93 21.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 18.8 t -46.52 -40.79 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.266 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 78.8 m-70 -106.31 53.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.29 122.33 16.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.308 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.92 -76.14 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -96.04 144.42 26.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.31 -28.67 34.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.42 -26.79 38.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.8 m-20 -58.36 -23.65 57.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 75' ' ' ILE . 73.5 mt -86.74 -32.76 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.447 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -75.57 -21.15 58.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.973 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.09 -55.46 4.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 121' ' ' LEU . 58.5 t -56.11 -32.46 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -34.13 68.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.753 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.43 -27.12 33.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.375 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' A' ' 121' ' ' LEU . 43.6 mm -69.06 -38.01 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -19.29 65.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -84.2 -29.79 26.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -27.38 62.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -22.16 54.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.39 -49.51 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.35 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.5 -40.8 80.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -57.85 -48.3 80.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.889 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.098 0.475 . . . . 0.0 110.971 179.731 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p . . . . . 0 CA--C 1.522 -0.108 0 CA-C-O 120.7 0.286 . . . . 0.0 111.634 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.2 t70 -91.65 142.66 27.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.414 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.6 tp10 -55.18 -67.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.254 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.479 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 61.1 m -50.26 -35.35 26.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 39.7 t-20 -59.3 -50.42 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -59.17 -32.95 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.146 177.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 114' ' ' THR . . . -66.58 -57.17 10.51 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.419 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 3.7 t-20 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.653 0.263 . . . . 0.0 111.491 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.15 -30.75 19.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.864 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -82.69 -63.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 110' ' ' GLY . 10.1 t -53.68 -30.57 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.27 -59.61 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -49.84 -37.03 28.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.427 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 38.0 mm -82.27 -27.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.146 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.85 -59.57 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 116' ' ' CYS . 3.2 mptp? -86.85 -43.56 12.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 46.7 tp -99.66 -15.75 18.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.9 t80 67.83 -13.61 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.92 0.391 . . . . 0.0 110.911 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 121' ' ' LEU . 48.2 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.319 -179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 111.471 0.174 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.71 -37.22 86.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 3.0 t -54.54 -29.35 50.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.89 -64.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.048 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.68 -62.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.17 -28.19 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.7 mmmt -88.48 -59.45 2.23 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.687 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -52.89 -20.52 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.202 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 78.9 mmm -85.54 -60.48 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.9 -28.19 69.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.704 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -62.07 -46.68 88.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.004 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 mt -123.12 34.79 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.092 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.481 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.4 tmm? -55.5 -50.62 85.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.665 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 15' ' ' MET . 74.0 Cg_endo -73.7 -4.19 15.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.065 1.844 . . . . 0.0 112.183 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.0 -14.93 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.11 -42.4 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 56.3 mtm -54.94 -48.78 95.03 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.326 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -53.32 -43.93 53.19 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.174 1.916 . . . . 0.0 112.568 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -57.87 -55.6 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.04 -42.03 37.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.671 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.435 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 16.1 ptp . . . . . 0 N--CA 1.465 0.287 0 CA-C-O 121.081 0.467 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.1 p -53.17 -49.29 66.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.809 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' HD23 ' A' ' 50' ' ' LEU . 18.3 tp60 -87.83 -18.42 29.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.719 0.295 . . . . 0.0 111.157 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' HA ' ' CE ' ' A' ' 51' ' ' LYS . 10.5 mt -70.11 -28.29 65.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.99 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -71.52 10.99 3.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.486 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.9 m -134.59 -62.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.891 0.376 . . . . 0.0 110.594 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.68 HD23 ' HG3' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -50.76 -46.81 59.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.756 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.526 ' HE2' ' H ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -81.58 -20.63 39.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.634 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -69.4 -17.82 63.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.27 -46.24 70.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.751 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.91 -25.4 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.859 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 34.3 mtm -65.38 -46.43 80.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -67.95 -25.83 65.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.74 -38.17 86.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.73 17.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.26 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.22 59.85 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.7 ttp -124.12 5.47 8.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.262 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 67.7 tp -152.47 99.48 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.459 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.552 ' N ' ' HE3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -95.8 96.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.161 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.51 60.13 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.7 p 73.45 27.3 1.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.284 0.634 . . . . 0.0 111.819 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 43.3 mt-10 -114.4 113.06 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.0 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.633 HD21 HG23 ' A' ' 109' ' ' ILE . 91.9 mt -70.37 139.43 51.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.766 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -145.82 169.03 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.474 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.24 25.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.0 mt-10 -75.36 -50.66 3.56 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.4 Cg_endo -66.04 -44.07 8.02 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.039 1.826 . . . . 0.0 112.972 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HG3' ' A' ' 74' ' ' MET . 14.1 m -57.49 -45.16 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -53.77 -22.94 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.644 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 73' ' ' LYS . 4.0 tmtp? -85.37 -36.56 20.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 71' ' ' VAL . 13.8 mtp -68.32 -48.0 66.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.397 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' HIS . 62.6 mt -48.32 -24.51 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.7 mt-10 -60.65 -59.55 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 -36.26 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 9' ' ' LYS . 68.8 t -60.75 -7.74 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.103 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 78.7 m-70 -143.62 43.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 135.57 55.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.18 -60.49 0.54 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.4 m120 -117.84 150.12 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.44 -33.87 31.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.536 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 8.7 m-20 -81.27 -25.54 36.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.794 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.6 t70 -58.76 -31.93 68.81 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 76' ' ' GLU . 95.7 mt -77.68 -29.64 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.134 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -77.01 -24.14 52.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.236 179.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.7 -49.35 18.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.491 ' HB ' HG21 ' A' ' 75' ' ' ILE . 45.5 t -61.9 -34.08 61.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.782 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -60.01 -35.41 75.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.78 -22.9 65.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.588 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.634 HG23 ' HB2' ' A' ' 120' ' ' LYS . 51.4 mt -63.76 -41.72 93.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -62.35 -29.48 70.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -62.68 -41.04 98.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.249 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.96 -39.18 84.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.545 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 65.9 m -71.05 -37.68 72.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.792 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 93' ' ' ALA . 83.3 mt -65.74 -19.3 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -85.13 -32.8 22.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.2 p30 -96.35 -17.26 20.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.508 -179.665 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.3 p . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.722 0.296 . . . . 0.0 111.598 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.46 144.19 28.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -59.6 -67.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 54.2 m -52.75 -23.72 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.719 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.96 -43.38 54.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.562 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.633 HG23 HD21 ' A' ' 66' ' ' LEU . 1.5 mt -66.5 -41.66 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 110.691 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -71.17 -49.46 26.76 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.077 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.5 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.7 t-20 -51.68 -59.25 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.906 0.353 . . . . 0.0 110.927 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 10.3 mmpt? -54.0 -45.11 71.37 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 41.3 t80 -73.72 -65.9 0.77 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 32.3 p -50.55 -41.73 54.43 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 22.0 t70 -42.99 -67.31 0.28 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -55.95 -25.4 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -29.91 64.88 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.487 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -85.35 -25.94 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.3 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.16 -53.83 15.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.808 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HB2' HG23 ' A' ' 92' ' ' ILE . 71.8 mmtt -86.7 -58.06 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 123' ' ' SER . 49.6 tp -85.53 -10.72 55.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 3.9 t80 69.66 -19.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.555 0.217 . . . . 0.0 111.118 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.8 t . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.86 0.362 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 12.2 t70 -49.41 -43.27 44.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.39 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.494 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 2.1 t -54.17 -33.18 57.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.23 -65.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.32 -62.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.72 -26.16 43.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.81 -59.32 2.26 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.905 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -54.54 -20.31 7.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.3 mmt -84.29 -57.39 3.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.2 -47.8 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.463 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -45.72 -34.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.742 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 18' ' ' ILE . 52.1 mt -138.54 46.07 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.317 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 49.1 ttp -71.92 -51.74 8.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.683 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.2 Cg_endo -69.71 -3.08 11.25 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.116 1.878 . . . . 0.0 112.117 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -103.21 -19.66 14.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 14' ' ' LEU . 75.9 mt -84.61 -37.1 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.537 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -49.47 -52.73 47.21 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 19' ' ' MET . 59.7 Cg_exo -37.88 -52.87 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.017 2.478 . . . . 0.0 114.192 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -88.43 -42.33 12.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.586 0.231 . . . . 0.0 111.583 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.05 -6.75 6.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.533 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.29 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 51.0 m -66.07 -57.6 7.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.593 0.235 . . . . 0.0 111.497 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.48 ' HA ' ' SG ' ' A' ' 49' ' ' CYS . 12.2 mm100 -87.29 -13.1 44.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 114' ' ' THR . 1.4 tt -57.67 -42.63 83.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -77.91 38.17 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 46' ' ' GLN . 3.8 m -144.37 -79.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 110.556 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.63 HD12 ' HA ' ' A' ' 22' ' ' ALA . 4.6 mm? -52.6 -47.36 66.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.601 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -79.76 -30.6 40.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.782 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.3 4.69 29.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' CYS . 5.9 t -85.12 -30.25 24.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.015 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 51' ' ' LYS . 7.4 p -69.3 -20.19 24.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 60' ' ' MET . 59.8 mtt -66.09 -46.39 77.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.49 -16.9 41.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.341 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.41 -47.62 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.523 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 60' ' ' MET . 46.2 pt -92.06 33.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.723 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 54.25 30.2 11.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.4 tpt -91.55 -12.9 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -154.27 112.53 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -108.1 77.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.575 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.31 -70.21 2.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.004 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.6 p -143.2 18.46 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.574 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -102.72 110.82 22.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.053 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD11 HG23 ' A' ' 109' ' ' ILE . 18.6 mt -84.15 115.6 22.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.421 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -96.4 -166.86 1.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.57 -15.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.1 mt-10 -60.79 -51.23 81.01 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 18.6 Cg_endo -60.95 -18.91 60.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.111 1.874 . . . . 0.0 112.539 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 75' ' ' ILE . 5.0 t -76.28 -49.2 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 24.6 m-85 -52.48 -22.27 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -78.74 -43.53 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.723 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.0 ptm -77.12 -36.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.546 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 86' ' ' ILE . 88.2 mt -51.9 -25.49 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 110.193 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 86' ' ' ILE . 50.2 mt-10 -61.71 -59.42 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.825 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.82 -35.61 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.916 0.389 . . . . 0.0 111.545 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.461 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 25.1 t -57.53 -11.62 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 73.8 m-70 -134.11 49.15 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.407 . . . . 0.0 110.521 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.7 135.68 54.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.6 -55.84 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.9 m120 -128.01 129.07 46.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.04 68.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.0 m-20 -84.24 -25.29 29.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.8 t0 -59.11 -32.71 70.08 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 75' ' ' ILE . 68.0 mt -76.17 -29.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.539 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -78.42 -26.5 46.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 92' ' ' ILE . 55.5 tp -67.39 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.545 HG22 HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.04 -28.97 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.489 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.526 ' HE2' ' HB3' ' A' ' 72' ' ' TYR . 3.7 tptm -48.3 -46.62 36.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.74 -27.75 49.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 121' ' ' LEU . 49.3 mm -62.91 -31.13 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.38 -22.94 66.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.18 -36.24 22.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.408 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.62 -24.43 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 111.266 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.498 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 37.7 m -86.35 -31.53 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.45 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.52 -35.66 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.463 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.179 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.9 p30 -109.87 -14.41 14.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -179.655 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 C--O 1.231 0.094 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t70 -97.33 143.56 27.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 0.0 111.25 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.79 -69.05 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.602 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.1 m -51.69 -26.24 8.84 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.73 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 6.2 m120 -70.85 -39.71 72.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 109.917 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 66' ' ' LEU . 7.2 mt -69.15 -36.71 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.95 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.37 -53.71 27.44 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.583 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.515 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.4 t-20 -52.78 -58.12 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.539 0.209 . . . . 0.0 111.101 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.4 mmpt? -55.23 -21.19 13.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.273 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -86.76 -64.78 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.601 HG21 HD22 ' A' ' 47' ' ' LEU . 10.1 t -55.86 -31.04 62.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.93 -56.51 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -40.36 91.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.684 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -41.74 78.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 65.0 mt -77.73 -22.0 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -59.65 2.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.243 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -87.07 -54.23 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 92' ' ' ILE . 38.0 tp -83.32 -10.21 58.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 11.0 t80 68.49 -9.55 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.707 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 121' ' ' LEU . 33.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 . . . . . 0 CA--C 1.522 -0.116 0 CA-C-O 121.116 0.484 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -52.1 -47.42 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.787 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 79' ' ' HIS . 91.1 m -48.69 -37.0 17.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.143 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.86 -66.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.49 -62.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.34 -26.5 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' THR . 34.0 mmtp -89.51 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.77 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.497 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 35.6 m-85 -55.47 -19.29 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.377 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.0 ttm -84.33 -59.23 2.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.71 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.354 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -64.88 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.374 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.57 47.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.262 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.51 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 31.4 ttm -64.71 -51.12 60.48 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.947 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 15' ' ' MET . 58.2 Cg_endo -69.89 -9.43 26.04 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.28 -17.16 20.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.79 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 54' ' ' VAL . 73.5 mt -83.53 -48.25 17.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.501 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 59.7 mtt -43.61 -49.33 18.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.051 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 70.9 Cg_exo -40.12 -63.35 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.596 2.197 . . . . 0.0 113.494 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 39.0 m -72.1 -27.37 62.6 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.553 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.12 -42.4 63.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.84 0.352 . . . . 0.0 110.663 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.524 179.572 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.572 ' HG2' ' ND2' ' A' ' 111' ' ' ASN . 39.4 ttp . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.3 t -71.53 -58.34 3.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.594 0.235 . . . . 0.0 111.598 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.68 -13.25 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.839 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 51' ' ' LYS . 16.3 tp -67.78 -29.59 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.289 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -75.22 11.65 8.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.319 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -140.74 -71.26 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 111.674 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.553 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.4 tm? -48.75 -46.96 41.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HZ2' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -76.6 -24.9 53.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.232 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -67.16 -14.6 63.06 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.324 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.56 -41.4 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.467 HG21 HG12 ' A' ' 18' ' ' ILE . 40.5 t -61.89 -28.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.599 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' MET . 64.7 mtp -63.78 -56.14 17.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.538 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -66.72 -17.81 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 3.7 tpm_? -68.86 -31.3 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -113.23 31.48 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.602 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 58.94 13.64 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.607 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 55' ' ' MET . 10.8 tpt -77.98 -8.44 58.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.218 0.532 . . . . 0.0 110.622 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 66' ' ' LEU . 59.1 tp -156.86 103.55 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 76.7 10.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.36 -59.9 3.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.474 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -147.56 7.73 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.599 0.238 . . . . 0.0 111.137 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.6 tp10 -96.72 110.82 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.585 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 61' ' ' LEU . 2.6 mm? -73.42 109.99 7.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.66 -167.81 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -169.38 -8.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.2 mp0 -73.44 -51.46 5.6 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 19.6 Cg_endo -58.46 -38.19 91.23 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.296 1.998 . . . . 0.0 113.011 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' ILE . 59.4 t -57.87 -43.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.439 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 9.1 m-30 -53.02 -32.91 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -74.28 -30.79 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.252 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.2 mtm -78.63 -46.6 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.404 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.525 HG22 HG23 ' A' ' 86' ' ' ILE . 64.8 mt -50.77 -27.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 41.4 mt-10 -60.78 -59.17 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.86 -44.86 16.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.551 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 10' ' ' TYR . 55.5 t -49.99 -17.91 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.806 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.675 ' HA ' HG23 ' A' ' 5' ' ' THR . 50.5 m-70 -128.77 53.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.781 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 127.68 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -81.36 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.1 145.05 25.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.95 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.08 32.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.767 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.13 -28.47 35.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.706 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -56.82 -27.22 59.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 75' ' ' ILE . 79.7 mt -80.54 -31.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.988 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -78.16 -19.36 54.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.467 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.8 -59.18 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 92' ' ' ILE . 21.4 t -57.59 -23.59 20.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.94 0.4 . . . . 0.0 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 9.6 tptt -53.95 -48.48 70.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.182 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.2 58.77 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.074 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 89' ' ' VAL . 68.4 mt -60.63 -40.76 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.641 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.17 -26.98 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.685 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.68 -30.22 25.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 9.7 tp10 -57.3 -28.86 63.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 1.5 m -86.65 -45.32 11.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.197 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.7 mt -53.91 -37.91 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.69 0.281 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.77 -31.98 70.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.85 -7.16 19.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.383 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.475 -179.66 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.608 0.242 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 109' ' ' ILE . 23.1 t70 -76.35 119.29 20.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.0 tp10 -48.96 -58.36 5.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.493 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.7 m -54.06 -24.95 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.4 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.94 -32.2 25.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.372 . . . . 0.0 110.55 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 105' ' ' ASP . 55.3 mt -70.12 -38.85 76.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.556 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 114' ' ' THR . . . -77.86 -51.65 5.77 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.7 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.572 ' ND2' ' HG2' ' A' ' 44' ' ' MET . 7.4 t-20 -49.93 -32.36 14.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.751 0.275 . . . . 0.0 111.083 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -80.02 -38.65 31.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 110.133 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -70.11 -64.68 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.776 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.9 t -49.53 -31.82 11.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.142 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 25.7 t70 -46.79 -71.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.66 -24.27 61.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.89 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.501 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -64.56 -58.59 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.656 0.265 . . . . 0.0 110.753 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.6 mm -59.79 -16.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.141 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 10.1 tp10 -68.49 -59.67 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.248 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 1.4 mptp? -87.25 -40.96 14.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.683 0.277 . . . . 0.0 111.541 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 6.7 tt -58.6 -46.41 87.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.34 42.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.048 0.451 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.67 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 . . . . . 0 N--CA 1.46 0.05 0 CA-C-O 120.943 0.401 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.99 -44.23 15.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 51.9 p -56.96 -26.76 60.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.465 HG22 ' HE1' ' A' ' 79' ' ' HIS . 62.0 t -89.96 -67.36 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.89 -62.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -22.63 67.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HB3' HG22 ' A' ' 78' ' ' VAL . 1.6 mptm? -90.44 -56.79 3.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.228 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -54.32 -50.25 67.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.99 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.9 tpp -56.08 -40.57 73.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -80.6 -24.7 38.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.039 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.79 -29.01 67.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 0.0 111.192 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 18' ' ' ILE . 97.4 mt -148.13 39.26 0.91 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.604 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.587 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 34.6 ttm -60.04 -51.17 82.43 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.292 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 23.7 Cg_exo -63.59 -22.84 70.49 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.088 1.859 . . . . 0.0 112.468 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.81 -10.62 53.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.393 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 14' ' ' LEU . 74.2 mt -87.95 -28.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.22 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.494 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 63.5 mtm -46.77 -48.79 49.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.6 Cg_exo -41.74 -56.51 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.61 2.207 . . . . 0.0 113.379 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -85.42 -18.52 33.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 111.144 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -69.75 -10.87 60.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 t70 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.879 179.564 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' MET . . . . . 0.691 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.0 tpt . . . . . 0 CA--C 1.53 0.193 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.691 ' H ' ' HG3' ' A' ' 44' ' ' MET . 22.8 t -78.23 -52.23 8.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -79.94 -23.25 41.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.084 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.597 HD23 ' N ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -87.12 -39.1 15.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -69.06 -10.92 62.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -73.26 -67.45 0.58 Allowed 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.4 tp -51.7 -33.61 34.98 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 -28.62 61.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.546 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -74.54 -24.73 58.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.154 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.3 t -60.67 -31.49 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 18' ' ' ILE . 4.0 t -68.47 -24.5 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.776 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 57.4 mtt -70.32 -58.38 3.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.099 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.96 -19.14 28.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.533 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.4 tpm_? -72.91 -31.12 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.361 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.18 33.95 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.44 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 61.22 10.52 3.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.689 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -77.09 -6.95 54.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.027 0.442 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.605 HD11 HG21 ' A' ' 109' ' ' ILE . 7.1 tt -152.62 99.49 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.686 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 7.5 mmpt? -86.27 77.8 9.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.44 -60.44 4.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.0 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 p -153.52 11.85 0.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 13.6 mm-40 -100.21 109.26 21.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.771 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.682 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -67.12 147.09 53.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.619 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 27.9 m-85 -136.51 165.63 25.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -140.26 -11.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mp0 -57.31 -53.64 63.26 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.401 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.8 Cg_endo -66.05 -25.21 51.63 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.992 1.795 . . . . 0.0 112.107 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 75' ' ' ILE . 17.6 t -68.86 -43.88 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.401 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 19.3 m-30 -55.35 -22.29 18.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.981 0.42 . . . . 0.0 110.524 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -80.67 -48.99 11.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 7.1 ptp -68.56 -37.0 79.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.371 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 86' ' ' ILE . 95.0 mt -53.69 -21.94 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.286 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.39 -58.28 3.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.408 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.75 -39.79 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -56.77 -9.18 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.98 0.419 . . . . 0.0 111.661 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HE1' HG22 ' A' ' 6' ' ' VAL . 84.6 m-70 -130.49 40.86 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.3 122.84 14.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.411 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.11 -65.16 0.34 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.186 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -114.78 151.59 33.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.649 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.57 -20.74 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -84.81 -30.54 24.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 86' ' ' ILE . 4.2 p30 -59.09 -21.12 58.73 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 75' ' ' ILE . 68.8 mt -85.67 -30.02 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.119 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.24 -19.84 42.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.118 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 92' ' ' ILE . 64.3 tp -83.11 -63.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.329 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.549 HG13 HD22 ' A' ' 121' ' ' LEU . 46.5 t -52.27 -41.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.517 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 11.1 mttt -53.32 -32.39 48.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.549 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.57 -23.01 41.09 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.533 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 88' ' ' LEU . 39.6 mm -68.69 -37.83 78.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.01 66.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -79.22 -22.41 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.3 -18.9 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 -49.34 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.735 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mt -48.55 -24.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.91 -45.74 73.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.56 -21.31 32.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.343 -179.575 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.664 0.269 . . . . 0.0 111.629 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 108' ' ' ASN . 12.7 t70 -108.18 147.41 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.03 -68.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.827 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 23.3 m -57.74 -41.49 81.95 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.219 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -56.81 -42.88 80.34 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.605 HG21 HD11 ' A' ' 61' ' ' LEU . 1.6 mt -63.06 -31.82 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.499 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.71 -45.13 78.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 7.3 t-20 -72.6 -45.74 57.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -56.28 -47.56 78.37 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.652 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -74.16 -42.93 59.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 111' ' ' ASN . 5.7 t -69.37 -23.41 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.05 -61.48 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.153 0.502 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -40.92 84.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -31.09 65.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.358 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 114' ' ' THR . 32.6 mm -83.76 -31.02 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.924 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 38.6 tt0 -68.76 -56.1 9.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.966 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 9.3 mptt -86.62 -48.65 8.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.549 HD22 HG13 ' A' ' 89' ' ' VAL . 45.9 tp -97.81 -14.61 20.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.0 t80 68.45 -13.08 0.32 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 121' ' ' LEU . 46.8 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.874 0.369 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 mm . . . . . 0 N--CA 1.484 1.262 0 CA-C-O 120.887 0.375 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -59.14 143.19 49.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.68 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -55.54 -34.62 64.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.303 0.573 . . . . 0.0 109.91 179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -58.81 -26.96 64.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.997 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.9 m -88.9 -23.45 22.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.262 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HD11 ' A' ' 121' ' ' LEU . 48.2 t -71.82 -51.41 31.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.222 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.5 t -73.96 -30.42 27.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.46 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -75.24 -31.42 60.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.655 -0.248 . . . . 0.0 111.419 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -79.53 -55.73 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.297 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -56.21 -28.25 57.65 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.751 0.31 . . . . 0.0 111.225 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.8 ttm -81.29 -54.99 5.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.102 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -63.75 -23.61 67.43 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.164 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -70.24 -25.31 63.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.908 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 89.6 mt -147.07 39.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.138 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 34.8 ttm -61.41 -51.86 74.49 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.362 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.6 Cg_endo -70.45 0.17 6.57 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 121.915 1.744 . . . . 0.0 111.944 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' O ' ' HD2' ' A' ' 20' ' ' PRO . 10.3 m-20 -112.26 -14.22 13.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.074 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 44.2 mt -90.02 -31.61 5.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.606 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.652 ' HG3' ' HD3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -62.3 -31.99 8.68 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -179.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.652 ' HD3' ' HG3' ' A' ' 19' ' ' MET . 15.1 Cg_exo -68.9 -35.49 15.33 Favored 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.768 1.645 . . . . 0.0 111.942 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -62.56 -52.7 62.37 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.405 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.431 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -55.39 -34.42 64.33 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.697 0.284 . . . . 0.0 111.502 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -81.71 -16.38 51.41 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.059 0.457 . . . . 0.0 110.574 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -60.02 -54.14 49.48 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.977 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.498 HD12 HD23 ' A' ' 50' ' ' LEU . 36.2 mt -97.25 -41.57 8.22 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 120.051 -0.659 . . . . 0.0 112.622 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 23.2 t-80 176.67 -65.17 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.663 0.744 . . . . 0.0 111.008 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.2 pt -134.9 173.04 15.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.319 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.422 ' HA ' HD11 ' A' ' 50' ' ' LEU . 0.7 OUTLIER -86.06 128.51 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.547 ' HG3' HD12 ' A' ' 50' ' ' LEU . 0.0 OUTLIER -51.8 -20.17 2.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.335 -179.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.532 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 21.7 t70 -73.76 -65.88 0.77 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.829 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 ' O ' HG22 ' A' ' 31' ' ' ILE . 23.5 mt -70.03 -5.61 5.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.4 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -46.97 -35.84 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.542 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 41' ' ' GLY . 1.6 t -179.0 125.32 0.09 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.185 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -37.45 -82.71 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.432 0.531 . . . . 0.0 112.432 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.613 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 21.2 pt -140.06 55.76 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.934 0.397 . . . . 0.0 111.155 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 36' ' ' GLN . 0.1 OUTLIER -133.19 14.56 4.2 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.89 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 38' ' ' ALA . . . -85.08 -76.43 0.32 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.433 ' HB2' ' O ' ' A' ' 37' ' ' ALA . . . 175.93 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HE2' HD21 ' A' ' 111' ' ' ASN . 12.9 mptt -48.7 -60.86 2.37 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.248 -0.433 . . . . 0.0 112.047 -178.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -125.8 -1.94 7.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 110.827 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.613 ' HA3' ' HA ' ' A' ' 35' ' ' ILE . . . 102.5 -16.49 54.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.711 179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.532 ' HB1' ' HA ' ' A' ' 30' ' ' ASP . . . -85.73 -51.28 6.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.721 0.296 . . . . 0.0 110.69 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 4.4 t70 -177.16 178.15 1.15 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.547 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.57 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 5.8 ttt -154.71 -59.84 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.634 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 61.4 m -65.07 -48.88 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.901 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.7 tp60 -87.26 -12.73 45.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.638 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.679 ' HB2' ' HB3' ' A' ' 43' ' ' ASP . 5.1 tt -74.27 -39.89 62.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.415 179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -65.86 4.93 2.06 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.725 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.606 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.1 OUTLIER -135.77 -61.92 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.545 0.212 . . . . 0.0 111.347 179.745 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.547 HD12 ' HG3' ' A' ' 29' ' ' GLU . 3.0 tm? -48.2 -44.37 32.77 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.636 ' HD3' HD21 ' A' ' 47' ' ' LEU . 43.2 tttm -84.05 -20.36 32.83 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.649 178.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.606 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.84 -15.91 60.71 Favored 'General case' 0 N--CA 1.456 -0.135 0 CA-C-O 121.121 0.486 . . . . 0.0 110.059 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -63.63 -33.3 75.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.432 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 15.7 t -69.21 -22.01 25.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.204 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.444 ' HB3' ' HE2' ' A' ' 60' ' ' MET . 48.8 mtt -75.38 -52.62 10.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.52 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.431 ' HA ' ' H ' ' A' ' 61' ' ' LEU . 5.8 ptpp? -65.73 -16.42 63.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.624 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.632 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 3.0 tpm_? -70.93 -32.59 69.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.691 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 41.7 pt -102.37 23.97 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.228 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 60.95 49.83 5.57 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.559 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.507 ' HG3' ' HG2' ' A' ' 70' ' ' PRO . 5.7 ttp -120.41 -18.33 7.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.025 0.44 . . . . 0.0 110.446 179.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.431 ' H ' ' HA ' ' A' ' 56' ' ' LYS . 19.1 tp -130.48 108.77 10.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.815 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.559 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.2 mmpt? -104.53 78.68 1.49 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.31 -70.71 2.11 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.038 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 61.0 p -137.35 9.7 2.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.519 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -95.18 103.34 15.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.112 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.93 114.62 23.72 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.048 0.452 . . . . 0.0 110.211 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -109.53 -167.28 1.18 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.968 -179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.525 ' HB ' HD11 ' A' ' 97' ' ' ILE . 10.6 p -163.1 -14.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.672 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.506 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 41.8 mt-10 -53.15 -54.37 45.35 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 111.686 0.254 . . . . 0.0 111.686 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.507 ' HG2' ' HG3' ' A' ' 60' ' ' MET . 10.8 Cg_endo -55.29 -29.4 67.26 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.006 1.804 . . . . 0.0 111.829 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 20.8 t -72.65 -39.44 60.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.352 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.0 m-30 -57.48 -22.3 42.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.463 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 44.7 mtpt -85.17 -37.11 20.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.0 112.105 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.456 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 11.9 ptm -80.4 -30.1 37.76 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.876 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.731 HG22 HG23 ' A' ' 86' ' ' ILE . 96.8 mt -59.39 -22.64 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -61.44 -54.72 39.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.266 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.3 t -87.01 -45.05 16.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.153 -179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 6.5 t -48.53 -27.19 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.271 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.408 ' CD2' HG23 ' A' ' 75' ' ' ILE . 85.4 m-70 -118.54 54.35 0.95 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.989 0.423 . . . . 0.0 110.609 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -69.28 135.92 51.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.203 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.97 -72.18 0.37 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.317 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.6 m120 -110.84 155.3 22.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.876 0.37 . . . . 0.0 110.716 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.436 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -81.45 -37.44 28.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.58 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -79.52 -28.96 41.31 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.137 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -56.25 -31.88 63.96 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.734 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.731 HG23 HG22 ' A' ' 75' ' ' ILE . 87.9 mt -78.36 -32.92 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.08 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.436 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 13.2 mm100 -74.99 -19.8 59.93 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.921 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 37.7 tp -76.13 -55.58 5.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.618 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.483 ' HA ' HD12 ' A' ' 92' ' ' ILE . 38.8 t -55.59 -28.89 23.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.464 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.547 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 0.9 OUTLIER -58.12 -49.06 78.27 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.618 179.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -72.9 -26.96 69.8 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.253 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.561 HG23 ' HB2' ' A' ' 120' ' ' LYS . 58.3 mt -61.49 -45.09 99.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.821 0.343 . . . . 0.0 111.104 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.61 69.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.12 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 48.5 t-20 -59.96 -43.02 95.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.021 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.598 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.6 tp10 -65.42 -27.33 68.45 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.986 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 57.2 m -80.1 -28.81 38.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.951 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD11 ' HB ' ' A' ' 68' ' ' VAL . 78.0 mt -77.15 -43.72 31.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -66.87 -14.92 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.51 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t30 -94.22 -43.78 8.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.096 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.492 ' O ' ' HG2' ' A' ' 101' ' ' LYS . . . -78.07 -19.97 53.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.195 0.521 . . . . 0.0 110.625 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.492 ' HG2' ' O ' ' A' ' 100' ' ' ALA . 0.2 OUTLIER 33.06 33.73 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.174 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.49 67.53 2.14 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.52 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.408 ' N ' HG12 ' A' ' 109' ' ' ILE . 13.3 mm-40 -60.23 175.8 0.39 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.788 0.327 . . . . 0.0 111.144 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 67.4 p -84.43 -47.65 10.44 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.27 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.501 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.1 t70 -77.94 139.94 39.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.935 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -57.65 -61.73 2.3 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.923 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.0 m -54.17 -27.69 35.53 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.501 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.5 t-20 -72.28 -44.05 63.34 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.65 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.408 HG12 ' N ' ' A' ' 103' ' ' GLU . 98.3 mt -60.52 -47.27 93.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.025 0.441 . . . . 0.0 110.673 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.33 -41.42 85.68 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 113.337 -179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.57 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 2.2 t-20 -58.08 -36.94 73.56 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 117.11 0.455 . . . . 0.0 110.824 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 11.0 mmpt? -78.39 -37.54 43.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.71 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -75.52 -27.18 58.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.636 -179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.603 HG21 HD22 ' A' ' 47' ' ' LEU . 11.1 t -79.71 -46.88 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.694 0.283 . . . . 0.0 110.249 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.469 ' N ' HG23 ' A' ' 114' ' ' THR . 26.3 t70 -46.45 -60.26 2.46 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -55.06 -40.58 70.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.797 -179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -60.31 -27.41 67.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.236 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.578 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -84.68 -32.3 7.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 121.148 0.499 . . . . 0.0 110.966 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -69.83 -44.71 69.39 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.266 -0.425 . . . . 0.0 112.027 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.598 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 71.0 mmtt -87.05 -58.56 2.54 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 -178.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 121' ' ' LEU . 1.3 tm? -97.63 -15.73 20.31 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 -177.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.578 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER 73.36 -19.29 0.34 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.592 0.234 . . . . 0.0 111.302 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 121' ' ' LEU . 36.8 t . . . . . 0 C--N 1.328 -0.342 0 CA-C-O 120.993 0.425 . . . . 0.0 110.818 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.404 HD12 ' N ' ' A' ' 1' ' ' ILE . 5.0 mp . . . . . 0 N--CA 1.486 1.354 0 CA-C-O 120.746 0.308 . . . . 0.0 110.991 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -101.83 133.63 46.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.677 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -55.81 -24.42 36.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.85 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.43 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.8 m-20 -83.85 -55.89 4.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.195 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 81.0 p -52.03 -31.52 30.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.715 -179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 63.0 t -85.47 -64.8 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.822 -179.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 66.4 t -62.13 -60.67 2.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.43 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -53.29 -31.18 42.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.417 ' HB2' ' O ' ' A' ' 5' ' ' THR . 32.1 mmmt -88.97 -59.13 2.31 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.563 -0.455 . . . . 0.0 112.113 -178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -52.56 -23.46 6.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.699 0.285 . . . . 0.0 111.366 -179.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 43.6 tpp -80.48 -56.78 3.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.95 0.405 . . . . 0.0 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -65.15 -23.61 67.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.139 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -70.04 -33.75 72.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.024 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.435 HD11 HG21 ' A' ' 58' ' ' ILE . 65.5 mt -146.9 50.91 1.1 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.181 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.2 tmm? -71.45 -50.57 10.57 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.409 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 15' ' ' MET . 73.7 Cg_endo -75.05 -24.7 12.48 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.232 1.955 . . . . 0.0 112.62 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -76.39 -9.95 59.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.329 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 34.1 mt -89.13 -27.81 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.62 -0.263 . . . . 0.0 111.361 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.566 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 62.3 mtt -53.1 -48.58 91.52 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.746 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.566 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 33.2 Cg_exo -60.85 -36.13 85.25 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.396 2.064 . . . . 0.0 112.703 -179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.8 m -54.83 -46.27 74.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.866 -179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -55.98 -46.53 78.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.792 0.33 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -77.38 -15.88 59.15 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.148 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -61.13 -52.59 64.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.795 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.79 HD12 HD22 ' A' ' 50' ' ' LEU . 68.2 mt -108.82 -40.58 5.0 Favored 'General case' 0 C--O 1.231 0.124 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 3.9 t60 177.84 -62.69 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.507 0.67 . . . . 0.0 111.806 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.575 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -150.17 131.04 4.53 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 114.866 -1.061 . . . . 0.0 112.034 -176.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 55.0 p -63.97 161.82 15.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.334 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HG2' HD13 ' A' ' 47' ' ' LEU . 0.4 OUTLIER -57.81 -22.35 47.03 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.102 -179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -63.19 -39.08 93.61 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.775 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 14.2 mt -100.68 -7.24 9.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.609 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . . . -67.87 -12.53 60.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.391 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 49.8 m -59.22 -89.02 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.129 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 50.82 56.61 7.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 0.0 110.882 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.4 mt 58.54 52.12 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.021 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -146.43 113.58 6.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.365 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.757 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -72.6 -64.98 0.85 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.723 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.451 ' HB1' ' HB3' ' A' ' 44' ' ' MET . . . 66.65 -93.13 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.452 -179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' HE3' ' HA ' ' A' ' 115' ' ' ASP . 8.8 tmtt? -104.03 -62.05 1.36 Allowed 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -127.66 14.53 7.01 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 120.798 0.333 . . . . 0.0 111.561 -179.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.757 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.69 -17.64 30.29 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.127 -0.559 . . . . 0.0 112.128 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.72 -71.8 0.55 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.948 0.404 . . . . 0.0 110.426 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -177.89 170.61 1.88 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.217 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.451 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 5.0 ptt? -130.13 -41.56 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.575 179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.8 m -65.39 -51.84 57.57 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.913 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.749 ' HB3' HD23 ' A' ' 50' ' ' LEU . 4.3 mm100 -87.15 -12.89 45.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.932 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HG ' HG21 ' A' ' 114' ' ' THR . 48.8 tp -66.51 -25.73 66.82 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.661 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.408 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -88.17 8.26 78.97 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.388 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.496 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 13.6 m -137.01 -71.49 0.44 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.673 -0.263 . . . . 0.0 111.428 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.79 HD22 HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -48.26 -39.72 22.37 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' HB2' HD12 ' A' ' 47' ' ' LEU . 8.4 tptp -84.26 -23.76 30.24 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.601 178.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.74 -16.86 62.8 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.811 179.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.7 t -59.45 -37.9 79.34 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.417 -0.811 . . . . 0.0 109.914 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.418 HG13 HD13 ' A' ' 14' ' ' LEU . 59.0 t -63.22 -30.55 50.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.452 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.513 ' HB3' ' HG3' ' A' ' 60' ' ' MET . 54.6 mtt -70.56 -58.5 3.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.783 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 39.8 mtmt -61.1 -19.36 61.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.873 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.589 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -72.44 -29.55 63.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.248 -179.677 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.479 HD11 ' SD ' ' A' ' 60' ' ' MET . 49.3 pt -106.24 13.98 7.85 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 120.766 0.317 . . . . 0.0 111.526 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.64 55.69 1.67 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.04 -0.527 . . . . 0.0 112.07 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.548 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 17.6 ptm -133.3 15.01 4.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.965 0.412 . . . . 0.0 110.183 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.458 HD13 HD13 ' A' ' 66' ' ' LEU . 66.6 tp -164.57 109.77 0.97 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.507 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.436 ' C ' ' H ' ' A' ' 64' ' ' THR . 0.0 OUTLIER -108.56 77.55 1.09 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.14 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.41 -28.48 0.7 Allowed Glycine 0 CA--C 1.519 0.293 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.224 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' LYS . 0.4 OUTLIER -175.54 -15.54 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.065 0.394 . . . . 0.0 112.065 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -84.55 110.47 18.72 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.716 0.293 . . . . 0.0 111.246 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' N ' HD22 ' A' ' 66' ' ' LEU . 2.9 mm? -77.27 149.97 35.36 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 120.985 0.422 . . . . 0.0 111.324 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.548 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 74.9 m-85 -147.07 136.04 22.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.332 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 m -114.9 15.08 8.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.841 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.479 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.8 mt-10 -67.64 -51.91 28.9 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.166 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 39.6 Cg_endo -70.77 -24.06 25.48 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.039 1.826 . . . . 0.0 112.564 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.506 HG12 HD11 ' A' ' 75' ' ' ILE . 11.0 t -73.32 -50.7 29.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.253 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.52 ' HA ' HD12 ' A' ' 75' ' ' ILE . 5.7 m-30 -51.37 -22.16 2.74 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.895 0.379 . . . . 0.0 110.643 179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -78.85 -42.36 27.68 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.636 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 16.6 ptp -77.76 -36.84 50.21 Favored 'General case' 0 C--O 1.225 -0.207 0 C-N-CA 121.338 -0.145 . . . . 0.0 110.875 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.555 HG22 HG23 ' A' ' 86' ' ' ILE . 72.4 mt -51.45 -21.84 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.361 0.601 . . . . 0.0 109.918 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 44.9 mt-10 -63.89 -59.31 4.68 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.376 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.9 t -84.4 -41.64 16.32 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-O 120.904 0.383 . . . . 0.0 110.896 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG22 ' HB3' ' A' ' 9' ' ' LYS . 25.1 t -47.54 -26.51 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.485 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 81.7 m-70 -125.11 55.79 1.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.769 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.98 135.76 55.14 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.186 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.71 -79.12 0.31 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.341 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -100.08 133.64 44.18 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.856 0.36 . . . . 0.0 111.013 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -67.29 -25.6 66.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.736 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -84.71 -28.11 26.55 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.959 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -57.74 -29.21 64.59 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.555 HG23 HG22 ' A' ' 75' ' ' ILE . 82.7 mt -76.56 -30.72 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.111 178.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 26.7 mt-30 -81.5 -19.19 42.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.212 -0.904 . . . . 0.0 110.908 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.7 -62.87 1.34 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.604 -179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.509 HG22 HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -61.4 -32.48 53.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.808 179.866 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.5 mttt -54.53 -32.65 58.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.672 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.51 -23.32 43.75 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.04 179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.6 mt -69.14 -30.74 47.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.763 0.316 . . . . 0.0 110.684 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.41 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -64.39 -23.48 67.3 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.276 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -79.58 -33.56 41.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.18 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -63.15 -31.21 72.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.899 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 10.8 m -79.4 -21.45 45.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.41 HG13 ' O ' ' A' ' 93' ' ' ALA . 94.5 mt -76.12 -46.76 33.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.811 0.339 . . . . 0.0 111.285 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -65.61 -30.16 70.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.027 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 4.7 t30 -80.51 -51.29 8.96 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.34 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -59.74 -20.63 57.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.744 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.538 ' HE3' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -72.62 137.29 46.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.864 0.364 . . . . 0.0 111.16 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.538 ' H ' ' HE3' ' A' ' 101' ' ' LYS . . . 125.51 -0.35 8.01 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.165 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.585 ' HB2' HG12 ' A' ' 109' ' ' ILE . 20.8 mm-40 -125.22 -179.37 4.56 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.797 0.332 . . . . 0.0 110.777 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 66.8 p -135.16 -30.89 1.02 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.214 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 14.5 t70 -74.41 136.42 42.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.722 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -50.91 -68.6 0.16 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 64.6 m -51.92 -33.83 38.88 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 9.6 m120 -66.96 -43.71 82.39 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.847 0.356 . . . . 0.0 111.06 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.585 HG12 ' HB2' ' A' ' 103' ' ' GLU . 78.3 mt -74.01 -32.62 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.846 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.58 ' O ' HG22 ' A' ' 114' ' ' THR . . . -68.49 -56.44 9.95 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.976 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.45 HD21 ' HB2' ' A' ' 44' ' ' MET . 3.6 t-20 -48.95 -24.61 1.56 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.974 0.416 . . . . 0.0 110.83 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.445 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 60.4 mtpt -86.6 -44.2 12.07 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.398 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -64.63 -59.32 4.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.059 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.58 HG22 ' O ' ' A' ' 110' ' ' GLY . 8.9 t -53.44 -46.14 69.73 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.207 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.615 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 16.6 t70 -42.28 -52.32 4.52 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.98 0.419 . . . . 0.0 111.264 179.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.95 -44.32 93.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.514 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -41.06 79.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.285 -179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.532 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 40.6 mt -83.23 -20.46 9.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.158 0.504 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.76 -59.09 4.24 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.034 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -87.07 -54.9 4.07 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.485 ' C ' ' H ' ' A' ' 123' ' ' SER . 33.0 tp -86.32 -10.82 53.72 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 19.8 t80 67.21 -9.23 0.4 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.021 0.438 . . . . 0.0 110.783 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.485 ' H ' ' C ' ' A' ' 121' ' ' LEU . 60.7 p . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.801 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.569 HD13 HD11 ' A' ' 121' ' ' LEU . 49.7 pt . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.401 ' HB3' ' OD2' ' A' ' 4' ' ' ASP . 9.1 m-20 -81.41 118.66 22.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.688 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -66.21 -17.93 65.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.065 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 2.7 p30 -74.31 -27.0 60.51 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.3 p -82.66 -20.69 35.73 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.39 0.614 . . . . 0.0 109.681 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 41.3 t -83.37 -63.61 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.726 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 45.6 t -65.01 -51.94 60.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 -178.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.48 -29.64 70.1 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -177.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.3 mmmt -88.27 -59.35 2.26 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.41 -0.516 . . . . 0.0 111.554 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 12.2 m-85 -50.39 -20.57 1.14 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.795 0.331 . . . . 0.0 111.019 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 70.7 mmm -85.39 -62.06 1.62 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.801 178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -69.42 -51.9 32.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.772 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -52.87 -21.06 3.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.447 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.634 HD13 HG11 ' A' ' 54' ' ' VAL . 48.0 mt -133.92 26.03 3.95 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.67 -0.241 . . . . 0.0 111.596 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.571 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 41.6 ttp -71.95 -49.41 10.33 Favored Pre-proline 0 C--N 1.327 -0.411 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 15' ' ' MET . 29.7 Cg_endo -61.8 -21.97 73.35 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.005 1.803 . . . . 0.0 112.649 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.407 ' OD2' ' HA ' ' A' ' 14' ' ' LEU . 2.2 p30 -102.03 -7.35 22.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.237 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -85.09 -44.17 17.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.006 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.618 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 57.6 mtt -47.02 -49.83 48.54 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.52 -179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.618 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -57.89 -49.35 13.21 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 122.206 1.937 . . . . 0.0 112.671 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 58.1 m -56.55 -44.35 80.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.483 -178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.685 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -55.44 -47.17 76.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.753 0.311 . . . . 0.0 111.166 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.09 -15.96 59.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.033 0.445 . . . . 0.0 110.332 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -61.03 -48.28 82.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.437 -179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.0 mt -105.32 -41.56 5.49 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.325 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.48 ' CD2' ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER 177.46 -59.29 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.56 0.695 . . . . 0.0 110.73 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.48 ' H ' ' CD2' ' A' ' 26' ' ' HIS . 1.0 OUTLIER -147.72 164.27 6.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.438 -178.676 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.685 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 59.7 p -85.23 147.66 26.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.796 0.331 . . . . 0.0 110.622 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.677 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -59.42 -20.73 57.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.736 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -79.14 -56.71 4.16 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.329 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.405 HG22 ' O ' ' A' ' 31' ' ' ILE . 36.0 mm -67.92 -8.34 8.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.343 0.592 . . . . 0.0 109.807 178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -51.58 -43.12 62.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.285 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.8 t -168.99 101.54 0.38 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.711 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.5 p30 38.69 75.6 0.07 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.928 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 67.4 mt 55.17 -87.89 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.041 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.533 ' HB3' ' HB2' ' A' ' 42' ' ' ALA . 3.2 tp-100 65.98 151.83 0.06 Allowed 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.171 0.51 . . . . 0.0 110.55 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -85.7 -74.09 0.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.505 -178.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.55 ' HB1' ' HG ' ' A' ' 47' ' ' LEU . . . -156.42 -103.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.647 0.26 . . . . 0.0 111.699 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 115' ' ' ASP . 59.0 pttt -68.56 -3.47 11.82 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -82.33 27.12 0.51 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.758 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.48 -5.24 26.44 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.809 -0.71 . . . . 0.0 113.827 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . . . -82.96 25.71 0.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.09 0.472 . . . . 0.0 110.282 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 15.8 t70 64.93 77.14 0.32 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.398 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.749 ' HG2' HD22 ' A' ' 111' ' ' ASN . 54.8 ttp -47.65 -37.64 13.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.02 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.6 t -49.07 -55.23 12.77 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.953 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.666 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -86.9 -12.43 47.76 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.761 0.315 . . . . 0.0 110.869 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.55 ' HG ' ' HB1' ' A' ' 38' ' ' ALA . 0.6 OUTLIER -64.91 -37.48 87.77 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.026 0.441 . . . . 0.0 110.045 179.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -73.02 5.04 20.63 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.147 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.527 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -135.34 -70.1 0.49 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.666 ' HB2' ' HG3' ' A' ' 46' ' ' GLN . 2.3 tm? -45.77 -51.39 12.74 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.677 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 1.6 tpmt? -74.4 -24.65 59.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.418 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -74.0 -14.12 60.97 Favored 'General case' 0 N--CA 1.456 -0.139 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.268 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 57' ' ' ARG . 3.6 t -64.41 -39.23 93.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.325 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.634 HG11 HD13 ' A' ' 14' ' ' LEU . 63.2 t -68.13 -28.86 42.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.755 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 86.9 mtp -58.86 -41.27 86.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.789 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 31.3 mtmt -79.82 -15.69 56.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.079 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.583 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 2.8 mmp_? -71.91 -42.6 66.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.096 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.9 pt -92.1 24.1 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.564 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 57.25 30.47 18.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.421 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.496 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 25.7 ttt -99.95 -0.87 38.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.039 0.447 . . . . 0.0 110.591 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 64.1 tp -157.95 99.87 1.7 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.96 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 9.3 mmpt? -86.9 76.56 9.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.225 179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.93 -60.3 3.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.871 -0.681 . . . . 0.0 112.54 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.1 p -147.12 4.03 0.81 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.697 0.284 . . . . 0.0 111.155 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 37.4 mt-10 -96.63 120.77 37.55 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.624 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 100' ' ' ALA . 36.4 mt -78.91 151.06 31.96 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.886 0.374 . . . . 0.0 110.946 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.496 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 60.9 m-85 -143.15 148.57 36.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.637 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.09 7.38 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.57 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 16.0 mm-40 -73.5 -49.17 6.72 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.79 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 71.8 Cg_endo -77.26 -23.74 9.99 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 122.105 1.87 . . . . 0.0 113.137 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' HA ' ' HG2' ' A' ' 74' ' ' MET . 2.3 p -73.41 -44.91 53.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.642 0.258 . . . . 0.0 111.192 -179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.437 ' CD1' ' HG2' ' A' ' 90' ' ' LYS . 18.6 m-30 -60.04 -22.32 62.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.905 0.383 . . . . 0.0 110.536 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -82.81 -44.05 15.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.882 -179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.428 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 25.5 ptm -72.47 -43.21 64.03 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 121.17 -0.212 . . . . 0.0 111.202 -179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.604 HG22 HG23 ' A' ' 86' ' ' ILE . 96.6 mt -49.2 -23.58 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-O 120.901 0.381 . . . . 0.0 110.735 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 86' ' ' ILE . 30.8 mt-10 -60.38 -59.49 5.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.414 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 67.6 t -87.31 -34.88 7.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.21 0.529 . . . . 0.0 110.951 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.494 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 40.7 t -58.71 -8.55 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.087 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 92.6 m-70 -141.04 52.11 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.429 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -68.69 136.54 53.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.182 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.53 -67.12 0.35 Allowed Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.158 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.57 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 3.5 m-20 -124.37 142.6 51.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 110.818 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -64.55 -28.52 69.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.273 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 5.6 m-20 -83.78 -25.83 30.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.704 0.287 . . . . 0.0 110.349 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.1 t70 -57.97 -30.06 65.7 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 178.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.604 HG23 HG22 ' A' ' 75' ' ' ILE . 79.5 mt -83.95 -26.46 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.616 178.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.536 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -79.71 -22.01 43.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.497 179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.405 ' O ' HG12 ' A' ' 92' ' ' ILE . 57.2 tp -78.23 -58.5 3.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.019 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 36.1 t -52.41 -36.92 22.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.165 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.437 ' HG2' ' CD1' ' A' ' 72' ' ' TYR . 1.7 mttm -60.66 -34.97 75.11 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.15 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.61 -25.14 54.59 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.39 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.644 HD12 ' HB3' ' A' ' 120' ' ' LYS . 42.3 mm -69.71 -43.17 80.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.126 0.488 . . . . 0.0 111.109 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.36 -17.62 59.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.677 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -74.65 -22.67 58.77 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.951 0.405 . . . . 0.0 110.973 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -82.54 -37.71 24.79 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.275 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.45 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 5.8 m -64.05 -27.65 69.25 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.21 -179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.506 HG23 HD12 ' A' ' 66' ' ' LEU . 62.0 mt -74.49 -34.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.493 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -67.27 -35.16 78.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.608 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.45 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.1 p30 -91.42 -17.64 25.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.787 0.327 . . . . 0.0 111.058 -179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.53 ' O ' HD11 ' A' ' 66' ' ' LEU . . . -134.44 50.85 2.15 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.265 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -47.16 -31.39 3.52 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.68 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 101' ' ' LYS . . . 146.04 82.78 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.542 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.53 ' N ' HG12 ' A' ' 109' ' ' ILE . 1.0 OUTLIER -62.29 -178.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.794 0.33 . . . . 0.0 110.983 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 5.1 t -84.82 -40.98 16.52 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.561 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.453 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -92.26 123.56 35.68 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.822 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.526 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp10 -37.15 -65.58 0.29 Allowed 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.934 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 96.0 m -46.76 -50.52 18.04 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.122 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -56.21 -36.14 68.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.53 HG12 ' N ' ' A' ' 103' ' ' GLU . 56.2 mt -67.15 -41.4 86.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.933 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.564 ' O ' HG22 ' A' ' 114' ' ' THR . . . -73.41 -45.37 30.24 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.147 -179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.749 HD22 ' HG2' ' A' ' 44' ' ' MET . 17.5 m120 -48.56 -60.78 2.43 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.883 0.341 . . . . 0.0 111.273 -179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 14.3 mmtm -54.49 -37.08 64.86 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.469 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -69.31 -64.07 0.94 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.022 -0.536 . . . . 0.0 112.227 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.564 HG22 ' O ' ' A' ' 110' ' ' GLY . 4.1 t -47.3 -56.98 5.76 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.509 ' H ' HG23 ' A' ' 114' ' ' THR . 70.6 m-20 -35.32 -54.54 0.65 Allowed 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.417 ' SG ' ' N ' ' A' ' 96' ' ' CYS . 0.0 OUTLIER -51.4 -48.04 62.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.872 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.91 -34.5 65.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.452 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.544 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 3.6 mp -81.77 -27.82 9.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.075 0.464 . . . . 0.0 111.262 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -71.49 -47.28 56.49 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.812 0.339 . . . . 0.0 111.271 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.644 ' HB3' HD12 ' A' ' 92' ' ' ILE . 71.6 mmtt -87.02 -58.33 2.63 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.569 HD11 HD13 ' A' ' 1' ' ' ILE . 26.1 tp -96.06 -10.18 29.05 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -177.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.544 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.74 -24.12 0.21 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.434 0.159 . . . . 0.0 110.602 -178.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.468 ' H ' ' C ' ' A' ' 121' ' ' LEU . 47.7 t . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.837 0.351 . . . . 0.0 111.158 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.462 HG13 HD11 ' A' ' 121' ' ' LEU . 31.9 mt . . . . . 0 N--CA 1.485 1.296 0 CA-C-O 120.795 0.331 . . . . 0.0 110.913 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -125.57 141.73 51.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.717 179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -56.16 -37.24 69.25 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.911 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 18.1 t70 -65.84 -54.86 21.23 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.228 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.494 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 53.5 p -57.36 -35.69 70.27 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.214 0.449 . . . . 0.0 112.214 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG11 ' HA ' ' A' ' 123' ' ' SER . 57.6 t -87.22 -64.89 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.4 t -58.78 -62.28 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.443 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.76 -25.78 42.53 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.2 mptm? -88.23 -54.6 4.12 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.714 -179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -57.88 -23.37 52.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.787 0.327 . . . . 0.0 110.992 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -82.75 -56.13 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.898 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -62.84 -25.73 68.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.272 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -53.19 -46.26 68.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.263 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 46.3 mt -152.1 45.11 0.74 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.766 0.317 . . . . 0.0 111.453 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.546 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.6 ttp -52.39 -50.25 80.85 Favored Pre-proline 0 CA--C 1.534 0.327 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 15' ' ' MET . 33.4 Cg_endo -63.84 -32.33 66.89 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.051 1.834 . . . . 0.0 112.749 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.404 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 m-20 -84.45 -9.66 58.19 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.043 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 39.4 mt -86.37 -29.11 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.779 0.324 . . . . 0.0 110.855 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 25.5 mmt -54.75 -47.27 98.57 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.965 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 19' ' ' MET . 48.8 Cg_exo -37.83 -49.43 2.05 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.939 2.426 . . . . 0.0 113.475 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 68.9 m -85.01 -35.57 21.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.343 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -64.55 -12.72 47.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.744 0.307 . . . . 0.0 110.682 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -83.54 -50.47 8.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.81 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -81.67 -54.44 5.4 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.386 179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.629 ' HB2' HD13 ' A' ' 50' ' ' LEU . 41.0 mt -86.17 38.72 0.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.4 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' HG23 ' A' ' 27' ' ' ILE . 37.0 t60 -63.09 75.42 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.338 -179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 26' ' ' HIS . 1.7 pt -160.97 54.92 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.093 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.581 ' HA ' HD23 ' A' ' 50' ' ' LEU . 10.9 m -57.68 177.09 0.11 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.66 -179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.437 ' HG3' ' H ' ' A' ' 29' ' ' GLU . 7.2 mt-10 -46.61 -21.88 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.523 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -82.46 -63.97 1.27 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.575 -179.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.434 HG22 ' O ' ' A' ' 31' ' ' ILE . 35.1 mm -73.05 -6.59 8.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 43' ' ' ASP . . . -51.32 -55.15 19.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.058 -179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 1.7 t 179.76 107.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.347 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -83.13 17.0 2.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.195 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 41.0 pt -138.99 15.24 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.777 0.322 . . . . 0.0 111.356 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -149.92 129.86 13.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.075 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.573 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -83.04 -40.57 19.74 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.538 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 61.98 -94.35 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.694 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.641 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.1 OUTLIER -104.02 -62.13 1.35 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 115' ' ' ASP . 37.8 m-80 -127.13 30.43 5.42 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.085 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.573 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 105.29 -16.33 45.54 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.838 -0.696 . . . . 0.0 111.923 -179.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.85 -142.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.217 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.596 ' HB2' ' HB1' ' A' ' 32' ' ' ALA . 18.3 t70 -108.94 -15.17 14.43 Favored 'General case' 0 CA--C 1.527 0.089 0 CA-C-N 116.747 -0.206 . . . . 0.0 111.047 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.443 ' HG3' ' HB2' ' A' ' 39' ' ' LYS . 22.7 ttt 69.66 -72.14 0.11 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.26 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 47.0 t -48.03 -40.47 22.93 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.643 0.609 . . . . 0.0 112.643 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.445 HE21 ' HB2' ' A' ' 49' ' ' CYS . 13.2 tp60 -87.43 -27.93 22.42 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -178.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 2.9 mp -66.81 -7.5 21.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.776 0.322 . . . . 0.0 111.249 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -94.05 7.07 73.03 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.237 -0.983 . . . . 0.0 111.187 179.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.445 ' HB2' HE21 ' A' ' 46' ' ' GLN . 36.2 m -131.75 -70.37 0.58 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.747 -0.227 . . . . 0.0 111.452 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.629 HD13 ' HB2' ' A' ' 25' ' ' LEU . 42.7 tp -51.56 -55.07 21.23 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 1.4 tpmt? -64.68 -23.2 67.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.215 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.17 -15.85 57.48 Favored 'General case' 0 C--N 1.339 0.151 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.581 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.2 t -61.06 -25.45 66.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.081 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 38.8 t -76.31 -36.87 30.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.524 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.408 ' HB2' ' HE3' ' A' ' 55' ' ' MET . 72.6 mtm -68.5 -40.42 80.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.763 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 7.8 mtmp? -73.09 -20.02 61.04 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.816 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.463 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 0.5 OUTLIER -86.06 -27.49 24.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.936 -179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.447 HG13 ' HB2' ' A' ' 60' ' ' MET . 48.5 pt -94.75 17.64 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.97 0.414 . . . . 0.0 110.938 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 57.1 34.22 24.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.413 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.447 ' HB2' HG13 ' A' ' 58' ' ' ILE . 26.6 ttt -104.35 1.9 30.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.166 0.507 . . . . 0.0 110.544 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 66' ' ' LEU . 50.0 tp -153.18 98.79 2.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.757 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.511 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.3 mmpt? -104.67 104.67 14.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.364 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 48.14 51.61 19.57 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.352 -0.928 . . . . 0.0 112.356 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 109' ' ' ILE . 8.8 p 73.66 34.55 0.93 Allowed 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 123.242 0.617 . . . . 0.0 111.479 179.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -126.0 106.08 9.36 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.679 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.451 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.2 mm? -68.45 147.27 52.28 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.378 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -126.97 169.31 13.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.836 0.35 . . . . 0.0 111.223 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 39.8 t -125.06 -25.69 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.358 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.582 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 48.1 mt-10 -62.37 -47.96 88.18 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.115 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.582 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 36.9 Cg_endo -65.07 -42.46 13.95 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.275 1.983 . . . . 0.0 113.445 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.544 HG13 ' HD1' ' A' ' 72' ' ' TYR . 3.1 p -65.23 -46.51 90.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.592 0.234 . . . . 0.0 111.395 -179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.544 ' HD1' HG13 ' A' ' 71' ' ' VAL . 4.6 m-30 -59.29 -22.0 60.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.955 0.407 . . . . 0.0 110.278 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 21.8 tptm -84.62 -45.56 12.39 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.896 -0.593 . . . . 0.0 112.062 -179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.4 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 1.2 ptp -70.84 -42.66 69.88 Favored 'General case' 0 C--O 1.223 -0.32 0 C-N-CA 121.13 -0.228 . . . . 0.0 111.461 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.599 HG22 HG23 ' A' ' 86' ' ' ILE . 95.5 mt -48.73 -27.81 2.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.828 0.347 . . . . 0.0 110.739 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.468 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 36.9 mt-10 -59.64 -59.22 5.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.716 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 49.1 t -84.5 -39.72 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-O 121.083 0.468 . . . . 0.0 110.811 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 57.0 t -57.77 -9.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.362 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.416 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 93.5 m-70 -143.47 56.75 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.601 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -77.9 137.54 38.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.309 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 145.11 -53.24 0.57 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.43 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -128.05 154.66 45.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.845 0.355 . . . . 0.0 110.687 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.81 -29.4 36.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.351 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 4.1 p30 -83.52 -29.34 27.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.76 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -28.56 56.38 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.599 HG23 HG22 ' A' ' 75' ' ' ILE . 88.9 mt -83.33 -29.06 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.237 178.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -76.78 -22.4 53.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.357 179.32 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG12 ' A' ' 92' ' ' ILE . 69.6 tp -75.94 -60.12 2.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.768 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.534 HG13 HD22 ' A' ' 121' ' ' LEU . 35.0 t -55.23 -35.97 38.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.93 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.35 -33.96 60.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.764 179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.25 -28.75 24.34 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.454 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.524 HG23 ' HB2' ' A' ' 120' ' ' LYS . 31.3 mm -65.39 -36.29 77.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.79 0.329 . . . . 0.0 110.844 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.57 -18.0 64.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.069 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -74.21 -40.99 62.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.358 -179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.634 ' HG2' ' HE2' ' A' ' 120' ' ' LYS . 8.2 tp10 -62.57 -18.14 61.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.388 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.544 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 57.9 m -86.18 -53.89 4.78 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.747 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 47.6 mt -51.07 -30.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.817 0.342 . . . . 0.0 111.295 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.52 -51.94 51.16 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.804 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.544 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.5 p30 -81.74 -5.93 58.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.647 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.43 39.72 3.89 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.451 179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -41.91 -34.64 0.7 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.843 -179.918 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.471 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 150.85 73.52 0.01 OUTLIER Glycine 0 C--N 1.332 0.354 0 C-N-CA 120.263 -0.97 . . . . 0.0 113.403 179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.51 ' HB2' HG13 ' A' ' 109' ' ' ILE . 7.9 mm-40 -61.73 150.14 37.64 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 24.2 m -74.25 -24.51 59.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.695 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' HB3' ' CG ' ' A' ' 108' ' ' ASN . 15.1 t70 -99.96 144.95 28.41 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.919 0.39 . . . . 0.0 111.232 -179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -57.01 -70.58 0.12 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.355 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.0 m -50.02 -24.15 2.47 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.684 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.406 ' CG ' ' HB3' ' A' ' 105' ' ' ASP . 5.5 m-20 -70.09 -58.18 4.1 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.186 -0.206 . . . . 0.0 110.706 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.51 HG13 ' HB2' ' A' ' 103' ' ' GLU . 0.6 OUTLIER -52.44 -41.66 36.42 Favored 'Isoleucine or valine' 0 C--O 1.231 0.088 0 CA-C-O 121.065 0.459 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.87 -36.0 85.88 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.58 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.579 ' HA ' HG22 ' A' ' 114' ' ' THR . 0.0 OUTLIER -68.62 -40.49 80.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.845 0.355 . . . . 0.0 110.989 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -61.7 -27.15 68.5 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.159 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -87.19 -59.32 2.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.001 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.579 HG22 ' HA ' ' A' ' 111' ' ' ASN . 8.7 t -46.76 -45.14 19.56 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.814 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.444 ' N ' HG23 ' A' ' 114' ' ' THR . 13.7 t70 -48.12 -61.72 1.84 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.77 -49.27 73.63 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -36.91 42.39 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -178.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.4 mm -79.49 -28.66 13.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-O 120.991 0.424 . . . . 0.0 110.93 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.435 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 37.9 tt0 -69.53 -53.13 20.53 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HE2' ' HG2' ' A' ' 95' ' ' GLU . 11.3 mptt -85.13 -55.94 3.79 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD22 HG13 ' A' ' 89' ' ' VAL . 39.0 tp -95.56 -11.32 27.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.536 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.8 OUTLIER 69.14 -16.93 0.22 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 120.715 0.293 . . . . 0.0 111.011 -179.074 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.5 ' H ' ' C ' ' A' ' 121' ' ' LEU . 37.9 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.843 0.354 . . . . 0.0 110.984 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 N--CA 1.485 1.295 0 CA-C-O 120.73 0.3 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -83.24 129.12 34.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.4 mp0 -78.87 -16.89 56.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.681 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 9.6 m-20 -73.13 -26.7 61.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.896 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.437 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 69.4 p -81.54 -20.87 39.09 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.43 0.633 . . . . 0.0 109.716 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 123' ' ' SER . 87.0 t -82.38 -63.64 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.269 -0.878 . . . . 0.0 111.813 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 24.4 t -65.13 -52.77 48.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -178.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -61.39 -27.98 68.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.488 ' HG3' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.05 -55.88 3.56 Favored 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.783 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -54.05 -24.24 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.81 0.338 . . . . 0.0 111.185 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 32.4 mtm -79.23 -62.03 1.82 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.216 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.64 -23.62 67.45 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.792 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.477 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 5.2 t80 -56.56 -35.89 68.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.425 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.544 HD12 HG13 ' A' ' 54' ' ' VAL . 41.4 mt -151.59 28.34 0.63 Allowed 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.092 0.404 . . . . 0.0 112.092 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.6 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 36.3 ttp -47.41 -50.44 49.17 Favored Pre-proline 0 CA--C 1.533 0.319 0 N-CA-C 111.556 0.206 . . . . 0.0 111.556 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.6 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 21.5 Cg_exo -65.84 -30.7 49.12 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.213 1.942 . . . . 0.0 112.351 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -81.37 -7.55 59.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.425 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.502 HG13 ' O ' ' A' ' 14' ' ' LEU . 93.3 mt -83.95 -25.78 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.803 0.335 . . . . 0.0 110.635 179.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.519 ' HA ' ' HB3' ' A' ' 22' ' ' ALA . 32.4 mmt -49.11 -50.06 65.65 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.098 -0.501 . . . . 0.0 112.192 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 96.0 Cg_exo -41.93 -53.92 3.19 Favored 'Trans proline' 0 C--N 1.356 0.938 0 C-N-CA 122.614 2.209 . . . . 0.0 113.251 -179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 92.0 m -82.29 -20.98 36.38 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.897 0.38 . . . . 0.0 110.862 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.519 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -74.86 -2.73 28.12 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.067 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 51.9 m-20 -83.65 -57.22 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.847 0.356 . . . . 0.0 110.769 179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -83.65 -47.86 10.79 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.955 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.685 ' HB2' HD23 ' A' ' 50' ' ' LEU . 49.6 mt -90.65 39.09 0.97 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.609 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 22' ' ' ALA . 26.8 p-80 -63.88 68.17 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.487 -179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.495 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.3 pp -156.3 56.37 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.582 179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.4 m -50.22 160.1 0.4 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.111 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.613 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -40.84 -32.46 0.23 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.59 -50.55 73.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.552 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.412 HG22 ' O ' ' A' ' 31' ' ' ILE . 52.0 mt -94.28 -8.65 9.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.315 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' HB2' ' O ' ' A' ' 27' ' ' ILE . . . -76.64 -1.6 28.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.099 -179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 81.3 p -67.44 4.43 1.02 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 36' ' ' GLN . 42.9 t30 -59.56 138.38 57.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.598 0.237 . . . . 0.0 110.514 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.1 pt -51.77 86.49 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.446 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 34' ' ' ASN . 55.0 mt-30 -122.97 -98.54 0.43 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.461 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 43' ' ' ASP . . . -85.45 -31.8 22.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.686 0.279 . . . . 0.0 111.659 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 63.55 25.66 14.47 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.897 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.479 ' HB3' ' HB2' ' A' ' 44' ' ' MET . 46.7 tptt -46.07 -59.95 2.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.767 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 39.1 m-80 -125.47 24.01 7.37 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.26 57.82 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.191 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' THR . . . -88.43 -81.87 0.25 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.963 0.411 . . . . 0.0 110.688 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.535 ' O ' ' HB3' ' A' ' 37' ' ' ALA . 10.9 t70 -178.14 -46.23 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.458 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.907 ' H ' HD13 ' A' ' 47' ' ' LEU . 0.0 OUTLIER 71.62 -34.26 0.29 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.34 179.64 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' H ' ' C ' ' A' ' 43' ' ' ASP . 64.3 m -52.41 -51.52 58.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.641 0.257 . . . . 0.0 111.023 -179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -87.66 -28.5 21.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.766 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.907 HD13 ' H ' ' A' ' 44' ' ' MET . 6.5 mp -64.13 -21.85 66.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.77 -8.18 63.21 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.296 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.622 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -137.31 -62.47 0.62 Allowed 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 25' ' ' LEU . 1.9 tm? -48.42 -41.81 30.3 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.484 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 26.2 ttpp -82.3 -23.93 34.93 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.622 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -79.66 -6.62 57.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 121.273 0.558 . . . . 0.0 109.753 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 45.1 t -64.58 -28.19 69.46 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.722 179.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.544 HG13 HD12 ' A' ' 14' ' ' LEU . 59.0 t -70.17 -26.58 29.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.933 178.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.7 mtt -69.25 -56.63 7.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.727 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 46.1 mtmt -55.12 -26.7 40.08 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.08 -179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.521 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -72.1 -33.51 67.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.148 -179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.535 HG23 HD11 ' A' ' 14' ' ' LEU . 42.7 pt -100.2 22.99 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.477 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 58.26 29.29 17.82 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.242 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.436 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -97.43 -10.04 26.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.75 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.409 ' HB3' ' HG2' ' A' ' 56' ' ' LYS . 5.6 tt -149.15 114.66 5.58 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.579 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HE3' ' HA ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -107.82 77.68 1.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.58 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.4 -74.1 1.75 Allowed Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.7 p -126.77 -1.57 6.67 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.316 -0.442 . . . . 0.0 111.503 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -91.0 156.16 18.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.716 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.638 HD21 HG13 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -135.55 131.19 35.65 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.515 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.444 ' N ' HD12 ' A' ' 66' ' ' LEU . 31.3 m-85 -118.84 170.83 8.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.096 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 71' ' ' VAL . 31.4 m -137.72 -3.67 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.149 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 42.6 mt-10 -67.54 -49.51 40.68 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.729 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.1 Cg_endo -65.47 -28.23 53.97 Favored 'Trans proline' 0 C--N 1.354 0.838 0 C-N-CA 122.101 1.867 . . . . 0.0 113.107 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 74' ' ' MET . 0.3 OUTLIER -72.02 -41.63 68.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 111.083 -179.74 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.4 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 21.6 m-30 -56.6 -22.06 31.24 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.06 0.457 . . . . 0.0 110.263 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.8 tppp? -81.82 -40.49 22.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.791 -179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 14.4 ptm -77.44 -38.44 49.47 Favored 'General case' 0 CA--C 1.518 -0.263 0 C-N-CA 121.166 -0.213 . . . . 0.0 111.101 -178.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 86' ' ' ILE . 94.1 mt -50.97 -23.57 2.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-O 121.157 0.503 . . . . 0.0 110.041 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HA ' HD13 ' A' ' 86' ' ' ILE . 37.1 mt-10 -60.59 -58.6 7.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.912 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.8 t -88.06 -25.75 5.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 121.095 0.474 . . . . 0.0 110.983 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.488 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 34.0 t -64.14 -7.88 3.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.756 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.402 ' NE2' HG21 ' A' ' 89' ' ' VAL . 94.6 m-70 -144.58 50.76 1.28 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.723 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.58 134.83 55.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.337 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 140.52 -68.51 0.48 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.559 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -114.06 147.53 38.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.853 0.358 . . . . 0.0 110.733 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -77.36 -21.47 53.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.408 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.547 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 7.5 m-20 -84.14 -27.17 28.33 Favored 'General case' 0 C--N 1.331 -0.207 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.956 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -58.22 -27.22 63.74 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 75' ' ' ILE . 83.5 mt -85.93 -26.71 6.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.003 -0.999 . . . . 0.0 109.475 178.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.547 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -81.26 -21.41 39.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.819 179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.429 ' O ' HG13 ' A' ' 92' ' ' ILE . 42.6 tp -81.33 -57.78 3.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.925 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.477 HG22 HD11 ' A' ' 121' ' ' LEU . 87.5 t -54.27 -36.22 32.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.06 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.4 ' HE3' ' HB3' ' A' ' 72' ' ' TYR . 9.2 mttt -62.66 -31.42 72.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.975 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.72 -23.26 47.07 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.221 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 88' ' ' LEU . 74.3 mt -73.06 -40.08 58.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.684 0.278 . . . . 0.0 110.852 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.68 -30.89 71.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.825 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -58.55 -26.07 63.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.487 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.459 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.7 tp10 -77.97 -19.64 54.16 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.043 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 35.0 m -86.28 -43.4 12.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.501 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.638 HG13 HD21 ' A' ' 66' ' ' LEU . 2.0 mp -58.89 -41.67 83.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.861 0.362 . . . . 0.0 110.678 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -73.31 -14.46 61.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.7 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.549 ' ND2' ' HB3' ' A' ' 112' ' ' LYS . 6.4 t30 -98.66 -75.21 0.56 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.861 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -53.62 -47.24 70.44 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.111 179.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 3.9 tmmm? 67.64 -73.51 0.08 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.645 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 159.5 74.96 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.497 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.487 ' N ' HG12 ' A' ' 109' ' ' ILE . 11.4 mm-40 -61.3 -178.37 0.12 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.858 0.361 . . . . 0.0 111.342 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.1 t -84.61 -43.23 14.63 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.72 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.477 ' O ' HG13 ' A' ' 109' ' ' ILE . 24.0 t70 -87.93 122.84 32.02 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.55 0.214 . . . . 0.0 110.763 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.46 ' HA ' HD12 ' A' ' 109' ' ' ILE . 36.6 tt0 -42.07 -66.62 0.33 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.224 -0.444 . . . . 0.0 112.128 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 73.0 m -48.94 -36.13 16.62 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.645 0.26 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -67.46 -42.54 82.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.861 0.362 . . . . 0.0 110.604 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.487 HG12 ' N ' ' A' ' 103' ' ' GLU . 50.6 mt -58.75 -50.75 78.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.491 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.661 ' O ' HG22 ' A' ' 114' ' ' THR . . . -64.82 -36.85 93.59 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.719 -179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -48.36 -38.36 19.09 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 117.011 0.405 . . . . 0.0 111.372 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.549 ' HB3' ' ND2' ' A' ' 99' ' ' ASN . 3.3 mptp? -86.43 -24.15 25.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.888 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -77.03 -64.51 1.12 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.334 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 110' ' ' GLY . 5.2 t -54.06 -28.51 39.23 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.802 0.334 . . . . 0.0 110.849 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -53.36 -70.58 0.09 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.337 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -54.7 -34.53 62.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.572 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -61.15 -33.97 74.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 0.0 110.562 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.725 HD12 ' HE1' ' A' ' 44' ' ' MET . 75.1 mt -85.08 -17.14 9.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.353 0.597 . . . . 0.0 110.271 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -71.21 -58.66 3.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.175 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.493 ' HD2' ' H ' ' A' ' 120' ' ' LYS . 2.8 mptp? -87.36 -49.15 7.43 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 0.5 OUTLIER -91.0 -12.02 37.14 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -178.064 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.597 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 71.54 -23.75 0.18 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 120.683 0.277 . . . . 0.0 110.877 -179.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.551 ' HB3' HG11 ' A' ' 6' ' ' VAL . 64.0 p . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.838 0.351 . . . . 0.0 110.967 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.5 pt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.871 0.367 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -74.83 134.08 41.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -64.58 -24.85 67.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.639 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -64.94 -52.93 53.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.756 -0.657 . . . . 0.0 111.053 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.555 ' HB ' ' HA ' ' A' ' 79' ' ' HIS . 71.0 p -51.21 -29.98 15.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.128 0.49 . . . . 0.0 110.97 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.425 ' O ' ' HB2' ' A' ' 10' ' ' TYR . 53.7 t -77.48 -63.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.589 -179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 74.1 t -63.05 -59.46 4.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -48.79 -35.91 15.45 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.419 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.1 mmmt -88.74 -59.42 2.23 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -178.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 6' ' ' VAL . 13.7 m-85 -49.86 -29.1 7.44 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.75 0.31 . . . . 0.0 111.551 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.6 tpp -71.98 -55.46 7.39 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.89 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -63.69 -46.49 85.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.452 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 2.5 t80 -45.34 -39.87 7.21 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.352 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.495 HD13 HG13 ' A' ' 54' ' ' VAL . 26.3 mt -145.3 63.53 1.28 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.447 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.495 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 57.2 ttp -83.9 -52.96 0.56 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.599 179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.495 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 71.6 Cg_endo -77.41 -27.31 6.52 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 121.968 1.779 . . . . 0.0 111.721 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.453 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 9.6 m-20 -72.38 -10.87 60.34 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.576 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 14' ' ' LEU . 2.8 mt -77.29 -39.31 28.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.197 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.604 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 17.0 mmt -48.54 -51.66 50.3 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.935 -179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.604 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 74.2 Cg_exo -49.57 -51.5 10.62 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.265 1.977 . . . . 0.0 112.746 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 70.9 m -57.44 -43.23 83.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.499 -179.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.665 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -60.18 -44.08 95.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.832 0.348 . . . . 0.0 111.06 179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -73.77 -15.96 61.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.54 179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -59.68 -54.37 47.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.7 -179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.565 HD12 HD23 ' A' ' 50' ' ' LEU . 10.8 mt -102.36 -41.07 6.46 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.166 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.448 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 11.0 t60 176.71 -67.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 110.391 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -133.96 163.48 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 114.13 -1.396 . . . . 0.0 110.573 -178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.665 ' HB3' ' HB2' ' A' ' 22' ' ' ALA . 91.8 p -85.25 148.17 26.21 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.641 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.3 OUTLIER -54.52 -22.7 13.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.242 -179.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -71.55 -52.39 18.48 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.39 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.409 HG22 ' O ' ' A' ' 31' ' ' ILE . 51.0 mt -79.75 -8.52 11.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.251 0.548 . . . . 0.0 110.067 179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.33 6.01 2.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.604 -0.725 . . . . 0.0 111.46 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 20.9 p -60.04 -9.04 2.71 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.694 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -72.07 2.12 6.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.792 0.33 . . . . 0.0 111.012 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 87.9 mt -118.91 -46.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.301 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.5 mm-40 60.01 99.78 0.02 OUTLIER 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.722 -179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . . . -85.38 -76.38 0.33 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.371 -179.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.506 ' HB2' ' O ' ' A' ' 37' ' ' ALA . . . 170.4 -27.48 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.293 0.371 . . . . 0.0 111.962 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.653 ' HB2' ' HB2' ' A' ' 44' ' ' MET . 2.0 tmtt? -59.63 -63.18 1.39 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.788 -0.365 . . . . 0.0 111.112 -178.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.471 ' HB3' HG21 ' A' ' 118' ' ' ILE . 6.9 p30 -127.78 -4.14 5.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.23 -7.45 43.72 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 121.023 -0.608 . . . . 0.0 111.922 -179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' HB1' ' O ' ' A' ' 29' ' ' GLU . . . -85.4 -79.87 0.23 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.568 0.223 . . . . 0.0 111.163 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 62.7 t0 176.18 83.54 0.0 OUTLIER 'General case' 0 C--O 1.226 -0.136 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.736 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.653 ' HB2' ' HB2' ' A' ' 39' ' ' LYS . 49.9 ttp -51.3 -39.54 57.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.376 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 67.2 m -51.98 -57.07 10.55 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.278 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.538 ' OE1' HD13 ' A' ' 25' ' ' LEU . 12.8 mm-40 -85.05 -12.33 53.32 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.483 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 51' ' ' LYS . 16.5 tp -62.73 -39.74 95.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.084 0.468 . . . . 0.0 110.139 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.488 ' HA2' ' HA3' ' A' ' 110' ' ' GLY . . . -69.87 4.7 7.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.2 -1.0 . . . . 0.0 112.478 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' A' ' 107' ' ' CYS . 1.8 m -131.48 -72.54 0.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 110.703 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.617 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.3 tm? -47.32 -54.05 12.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.58 -0.737 . . . . 0.0 109.36 178.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.641 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 16.8 tptp -71.97 -23.5 61.44 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.596 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.12 -18.63 61.88 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.036 0.446 . . . . 0.0 110.092 179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 6.6 t -67.92 -36.13 79.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.222 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.495 HG13 HD13 ' A' ' 14' ' ' LEU . 67.0 t -59.58 -27.53 37.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.239 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.41 ' O ' ' HB3' ' A' ' 60' ' ' MET . 56.2 mtt -65.65 -51.84 56.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.575 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.404 ' HG3' ' H ' ' A' ' 56' ' ' LYS . 47.2 mttt -66.09 -15.94 63.52 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.209 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.442 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 5.6 tpm_? -69.33 -45.81 68.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.062 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' HB2' ' A' ' 60' ' ' MET . 36.8 pt -91.55 29.37 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.442 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 55.33 29.94 13.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 67' ' ' TYR . 20.8 ttt -94.34 -17.73 22.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.143 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 60.4 tp -144.13 101.94 3.79 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.974 -179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.469 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 5.9 mmpt? -84.16 77.45 9.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.945 0.402 . . . . 0.0 110.124 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.42 -57.09 4.12 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.906 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.2 p -153.52 9.32 0.4 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.769 0.319 . . . . 0.0 111.016 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.492 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 28.7 mm-40 -94.5 108.18 20.13 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.466 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.553 HD11 HG12 ' A' ' 109' ' ' ILE . 7.6 mp -67.66 138.22 56.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.21 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.424 ' HB2' ' O ' ' A' ' 60' ' ' MET . 62.5 m-85 -139.31 159.75 41.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.26 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.22 -10.63 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.363 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.512 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 43.1 mt-10 -56.85 -50.27 89.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.512 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 53.2 Cg_endo -69.8 -14.13 35.55 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.001 1.801 . . . . 0.0 112.001 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.437 HG12 HD11 ' A' ' 75' ' ' ILE . 24.5 t -78.76 -47.44 23.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.045 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -63.3 -27.35 69.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.972 0.415 . . . . 0.0 110.294 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -76.56 -30.08 56.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.256 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.5 ptm -85.73 -43.94 12.95 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.933 -0.307 . . . . 0.0 110.35 -179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.726 HG22 HG23 ' A' ' 86' ' ' ILE . 93.7 mt -51.62 -33.84 15.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.021 0.438 . . . . 0.0 110.549 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.453 ' HA ' HD13 ' A' ' 86' ' ' ILE . 29.5 mt-10 -53.8 -57.49 10.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.746 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -83.97 -24.56 7.65 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 121.075 0.464 . . . . 0.0 111.171 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.419 HG22 ' HB3' ' A' ' 9' ' ' LYS . 6.3 t -67.61 -11.45 14.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.944 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.555 ' HA ' ' HB ' ' A' ' 5' ' ' THR . 90.5 m-70 -134.05 49.96 2.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.467 179.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.97 133.23 54.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.208 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 135.55 -70.01 0.51 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.149 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -110.16 148.35 31.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.913 0.387 . . . . 0.0 110.539 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.09 -35.84 36.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.719 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -77.83 -30.85 51.32 Favored 'General case' 0 CA--C 1.519 -0.223 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.955 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.34 -21.78 6.24 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.726 HG23 HG22 ' A' ' 75' ' ' ILE . 63.5 mt -85.93 -55.03 7.19 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 114.75 -1.114 . . . . 0.0 108.5 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.437 ' HA ' ' HG3' ' A' ' 90' ' ' LYS . 9.1 mm100 -52.81 -25.68 12.13 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.732 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.462 ' O ' HG12 ' A' ' 92' ' ' ILE . 63.8 tp -71.66 -46.55 58.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.588 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.574 ' HB ' HG21 ' A' ' 75' ' ' ILE . 43.0 t -69.15 -41.71 81.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.317 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.489 ' HD3' HG22 ' A' ' 86' ' ' ILE . 9.2 mtmt -55.11 -27.12 42.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.618 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.28 -24.52 36.6 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.356 179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.485 HG21 ' HB2' ' A' ' 121' ' ' LEU . 47.2 mm -61.87 -40.16 86.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.907 0.384 . . . . 0.0 110.725 179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -59.88 -30.1 68.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -58.72 -23.53 59.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.217 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -80.04 -38.65 31.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.389 . . . . 0.0 110.661 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.422 ' HA ' ' OD1' ' A' ' 99' ' ' ASN . 72.9 m -74.13 -36.36 64.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.653 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 93' ' ' ALA . 93.4 mt -56.46 -27.35 24.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.748 0.308 . . . . 0.0 111.101 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -81.22 -52.35 7.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.196 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.467 HD22 ' N ' ' A' ' 100' ' ' ALA . 0.4 OUTLIER -70.78 -17.13 62.79 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.449 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.467 ' N ' HD22 ' A' ' 99' ' ' ASN . . . -81.58 -49.15 10.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.635 0.255 . . . . 0.0 111.272 -179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt 61.13 -177.33 0.11 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.366 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -87.85 44.5 3.24 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.307 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -59.79 125.6 24.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.865 0.364 . . . . 0.0 110.831 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 9.9 t -72.98 -26.58 61.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.503 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.412 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.6 t70 -72.87 134.73 44.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.942 0.401 . . . . 0.0 110.569 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.35 -61.6 2.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.726 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.414 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 54.0 m -60.59 -10.3 4.99 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.048 0.388 . . . . 0.0 112.048 -179.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.412 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 42.1 t-20 -86.66 -53.61 4.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.794 0.331 . . . . 0.0 110.243 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.553 HG12 HD11 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -51.31 -34.81 15.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.014 179.308 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.488 ' HA3' ' HA2' ' A' ' 48' ' ' GLY . . . -85.93 -51.47 3.58 Favored Glycine 0 CA--C 1.52 0.4 0 C-N-CA 120.891 -0.671 . . . . 0.0 114.296 -178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.488 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 2.3 t-20 -52.96 -23.86 8.16 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 117.7 0.75 . . . . 0.0 110.446 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -87.49 -40.82 13.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.923 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.0 t80 -79.15 -64.96 1.06 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.843 -179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 27.8 p -46.21 -45.57 17.02 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.988 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 14.7 t70 -43.9 -72.75 0.05 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.823 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.4 p -57.18 -32.32 66.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.822 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.445 ' O ' ' HB3' ' A' ' 121' ' ' LEU . 0.1 OUTLIER -56.18 -38.46 70.97 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.951 0.405 . . . . 0.0 110.532 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.8 mt -83.45 -19.39 9.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 110.275 179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.3 tp10 -71.24 -60.11 2.41 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.153 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.469 ' HB3' HD12 ' A' ' 92' ' ' ILE . 67.2 mttm -87.17 -50.77 6.39 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.5 HD22 HG13 ' A' ' 89' ' ' VAL . 57.0 tp -85.35 -11.87 53.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.562 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 6.3 t80 66.72 -6.03 0.58 Allowed 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.157 0.503 . . . . 0.0 110.504 -179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 121' ' ' LEU . 68.1 m . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.788 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.836 0.35 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -100.78 137.54 39.02 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.926 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -66.14 -7.94 20.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.899 179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -65.6 -43.98 87.98 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.552 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.599 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 5.6 t -52.54 -25.48 10.56 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.594 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 91.8 t -87.67 -64.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.449 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.72 -61.88 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.317 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.03 -28.27 23.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' O ' ' A' ' 5' ' ' THR . 1.4 mmtm -88.62 -59.6 2.19 Favored 'General case' 0 C--O 1.225 -0.224 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.53 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.7 m-85 -51.14 -21.29 1.87 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.84 0.352 . . . . 0.0 111.115 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.8 mtt -83.31 -61.59 1.81 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.306 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -61.26 -52.56 64.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.159 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HD1' ' HG ' ' A' ' 14' ' ' LEU . 4.8 t80 -43.9 -33.82 1.47 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.362 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.46 HD11 HG21 ' A' ' 58' ' ' ILE . 90.9 mt -146.64 59.75 1.2 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.452 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 37.9 tpp -89.15 -51.28 0.37 Allowed Pre-proline 0 CA--C 1.536 0.406 0 N-CA-C 111.639 0.237 . . . . 0.0 111.639 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.7 Cg_endo -72.69 -12.46 26.68 Favored 'Trans proline' 0 C--N 1.352 0.738 0 C-N-CA 121.991 1.794 . . . . 0.0 111.685 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.01 -9.86 44.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.884 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.41 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 8.3 mt -89.21 -47.35 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.707 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.483 ' CG ' ' HD3' ' A' ' 20' ' ' PRO . 19.3 ptp -53.84 -34.05 18.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HD3' ' CG ' ' A' ' 19' ' ' MET . 52.2 Cg_exo -54.48 -52.55 7.92 Favored 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.419 1.413 . . . . 0.0 112.978 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.496 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 11.3 m -72.84 -22.88 60.72 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.514 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -53.92 -42.17 68.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.879 0.371 . . . . 0.0 110.646 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -83.95 -16.18 45.1 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.332 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 33.2 tt0 -61.5 -54.37 44.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.956 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' HIS . 19.1 mt -90.23 -41.42 11.59 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.095 -0.642 . . . . 0.0 112.099 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.431 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 3.9 t60 176.5 -62.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.77 0.795 . . . . 0.0 110.658 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.478 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 1.2 pt -146.45 164.35 8.86 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 114.135 -1.393 . . . . 0.0 110.793 -177.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.46 148.59 25.9 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.631 ' HB2' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -54.5 -17.76 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.757 -179.565 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -70.12 -53.38 17.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.913 0.387 . . . . 0.0 110.481 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 31' ' ' ILE . 36.5 mt -88.7 -6.7 10.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.211 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.558 ' HB3' ' HA ' ' A' ' 29' ' ' GLU . . . -72.36 -1.05 14.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.245 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 34' ' ' ASN . 4.0 t -49.07 -51.62 30.39 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.583 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.44 ' N ' HG23 ' A' ' 33' ' ' THR . 13.3 t-20 42.46 42.16 2.58 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.881 0.372 . . . . 0.0 111.286 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 10.9 mm 55.8 52.25 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.798 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -147.62 123.28 10.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.354 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.756 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -79.28 -63.07 1.5 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.618 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.46 ' HB1' ' HB3' ' A' ' 44' ' ' MET . . . 64.45 -92.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.626 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -103.75 -61.39 1.43 Allowed 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.533 HD22 ' H ' ' A' ' 42' ' ' ALA . 0.2 OUTLIER -127.06 4.32 6.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.852 -179.278 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.756 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.49 -4.23 31.1 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.717 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.631 ' HB1' ' HB2' ' A' ' 29' ' ' GLU . . . -85.2 -69.74 0.63 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.592 0.234 . . . . 0.0 111.529 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.532 ' O ' ' HB3' ' A' ' 44' ' ' MET . 23.4 t70 -176.16 -30.23 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.587 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 10.2 ttt 74.59 -65.78 0.33 Allowed 'General case' 0 N--CA 1.468 0.47 0 O-C-N 123.175 0.297 . . . . 0.0 111.047 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 79.7 p -59.05 -43.54 91.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.27 . . . . 0.0 110.703 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.463 ' HG3' ' HB2' ' A' ' 50' ' ' LEU . 6.0 tp60 -87.81 -30.25 20.37 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.729 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 47' ' ' LEU . 1.5 tm? -54.29 -44.9 72.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.022 0.439 . . . . 0.0 110.054 179.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.407 ' O ' ' HA3' ' A' ' 110' ' ' GLY . . . -66.15 6.49 1.59 Allowed Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.807 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.422 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.6 m -134.3 -72.79 0.48 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.981 0.419 . . . . 0.0 111.306 179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.2 tm? -46.56 -51.49 15.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.522 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.606 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 27.4 tptp -75.37 -22.3 57.63 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.649 178.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.37 -20.13 62.98 Favored 'General case' 0 C--N 1.339 0.137 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.26 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.442 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.5 t -60.99 -34.23 74.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.5 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.1 t -65.86 -26.88 39.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.744 179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 56.7 mtm -69.06 -51.98 33.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.826 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 30.7 pttt -75.82 -15.75 60.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.76 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.414 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.5 tpm_? -70.45 -30.15 66.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.751 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.46 HG21 HD11 ' A' ' 14' ' ' LEU . 45.9 pt -105.86 26.37 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.488 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 57.93 63.11 1.87 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.344 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 11.8 tmm? -139.65 -10.94 1.19 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.53 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.553 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 30.0 tp -134.84 99.48 4.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.034 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.54 ' N ' ' HE3' ' A' ' 62' ' ' LYS . 0.0 OUTLIER -94.16 76.61 4.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.188 179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.26 -58.73 3.23 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.285 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.9 p -148.25 4.26 0.7 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.714 0.292 . . . . 0.0 110.994 -179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 33.5 mt-10 -94.16 131.26 39.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.333 -179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.576 ' HB2' HG23 ' A' ' 97' ' ' ILE . 73.1 mt -113.74 113.83 25.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.777 0.322 . . . . 0.0 111.139 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -106.15 177.85 4.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.043 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.6 m -134.61 25.49 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.541 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.474 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 43.7 mt-10 -79.19 -50.21 1.39 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.625 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.474 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 60.0 Cg_endo -74.44 -38.45 1.93 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.148 1.898 . . . . 0.0 113.067 -179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.58 HG13 ' HE3' ' A' ' 74' ' ' MET . 11.8 t -63.59 -46.1 95.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.633 0.254 . . . . 0.0 111.13 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -60.88 -21.81 63.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.878 0.371 . . . . 0.0 110.62 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.8 tptm -82.12 -48.01 11.87 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.743 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.58 ' HE3' HG13 ' A' ' 71' ' ' VAL . 14.7 ptt? -74.61 -35.43 62.94 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 121.072 -0.251 . . . . 0.0 110.91 -179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.692 HG22 HG23 ' A' ' 86' ' ' ILE . 9.6 mt -49.68 -26.15 2.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.076 0.465 . . . . 0.0 110.418 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -58.05 -59.05 5.88 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.497 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.68 -24.77 6.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 121.198 0.523 . . . . 0.0 111.146 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.505 ' HA ' ' HG3' ' A' ' 9' ' ' LYS . 25.1 t -67.27 -7.39 6.21 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.699 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 88.9 m-70 -138.05 43.28 2.22 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.54 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.56 134.65 57.08 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.148 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 136.86 -60.92 0.61 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.408 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.681 ' HB3' ' HB2' ' A' ' 85' ' ' ASP . 30.3 t30 -116.87 132.16 56.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.835 0.35 . . . . 0.0 110.514 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -68.06 -28.87 67.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.983 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -84.46 -22.3 30.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.879 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.681 ' HB2' ' HB3' ' A' ' 82' ' ' ASN . 13.8 t70 -62.04 -24.18 66.92 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.692 HG23 HG22 ' A' ' 75' ' ' ILE . 93.3 mt -85.13 -29.98 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.661 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -81.48 -21.98 38.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.578 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 29.2 tp -83.97 -60.87 1.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.92 0.39 . . . . 0.0 111.24 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.666 HG12 HD13 ' A' ' 121' ' ' LEU . 24.3 m -54.93 -31.5 24.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.672 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -58.02 -41.95 84.27 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.97 0.414 . . . . 0.0 110.648 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.7 -18.88 72.07 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 111.802 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 89' ' ' VAL . 50.9 mt -67.54 -41.03 85.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.874 0.368 . . . . 0.0 110.728 179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.69 -16.96 30.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.283 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -72.3 -48.81 39.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.259 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -58.9 -21.21 57.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.381 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.463 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 29.3 m -86.24 -39.39 16.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.696 -179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.576 HG23 ' HB2' ' A' ' 66' ' ' LEU . 93.2 mt -69.74 -42.04 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.808 -179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -62.98 -19.97 64.83 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.905 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.463 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 0.8 OUTLIER -109.33 -8.43 15.08 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 -179.531 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -101.17 -29.4 12.14 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.552 ' HG2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -73.59 -177.64 2.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.975 -179.624 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.552 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 75.89 -26.46 1.43 Allowed Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.91 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.618 ' HB2' HG12 ' A' ' 109' ' ' ILE . 14.5 mm-40 -64.62 176.03 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.702 0.287 . . . . 0.0 110.72 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 82.1 p -123.77 -20.28 5.5 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.507 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.423 ' O ' HG13 ' A' ' 109' ' ' ILE . 17.4 t70 -102.4 139.99 37.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.753 0.311 . . . . 0.0 110.922 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -56.54 -65.99 0.52 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.192 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.415 ' N ' ' SG ' ' A' ' 49' ' ' CYS . 64.9 m -50.34 -31.1 13.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.649 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -68.66 -40.36 80.24 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.774 0.321 . . . . 0.0 110.573 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.618 HG12 ' HB2' ' A' ' 103' ' ' GLU . 85.9 mt -69.41 -47.29 73.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.866 179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' O ' HG22 ' A' ' 114' ' ' THR . . . -62.08 -52.3 50.85 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.909 -179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.587 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.0 t-20 -54.56 -39.47 67.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 117.078 0.439 . . . . 0.0 110.319 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 36.4 mmtm -69.23 -25.65 64.4 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.427 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -83.72 -61.82 1.73 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.083 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.484 HG21 HD12 ' A' ' 47' ' ' LEU . 7.7 t -47.36 -47.93 25.86 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.375 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.473 ' N ' HG23 ' A' ' 114' ' ' THR . 4.8 t70 -44.93 -61.55 1.57 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.57 179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -48.03 73.04 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.766 -0.652 . . . . 0.0 112.035 -179.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -56.69 -25.68 54.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.736 0.303 . . . . 0.0 111.489 -179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.526 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 36.9 mm -85.12 -32.15 7.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.963 0.411 . . . . 0.0 111.171 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.23 -45.22 57.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.857 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.483 ' HB2' HG23 ' A' ' 92' ' ' ILE . 73.0 mmtt -86.64 -56.53 3.37 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -178.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.666 HD13 HG12 ' A' ' 89' ' ' VAL . 28.9 tp -98.93 -11.84 21.26 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.0 OUTLIER 69.05 -16.59 0.23 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.8 0.333 . . . . 0.0 110.862 -179.27 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.6 t . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.95 0.405 . . . . 0.0 110.918 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 47.4 pt . . . . . 0 N--CA 1.485 1.282 0 CA-C-O 120.827 0.346 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 6' ' ' VAL . 10.9 m-20 -99.08 104.46 16.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 3' ' ' GLN . 0.1 OUTLIER -58.74 -39.33 80.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.14 -179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -53.42 -50.5 65.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.416 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 40.3 p -64.91 -20.67 66.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 2' ' ' ASP . 87.9 t -83.28 -63.18 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.778 -179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -60.09 -57.13 13.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.498 -178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.55 64.94 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.59 ' HB3' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -84.43 -59.29 2.42 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.959 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -51.49 -22.98 3.51 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.811 0.339 . . . . 0.0 110.851 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 59.2 ttp -85.52 -62.55 1.5 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.346 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -58.6 -31.31 67.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.076 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 0.7 OUTLIER -55.92 -45.22 78.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.437 -179.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 72.8 mt -141.03 40.85 1.8 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.56 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.5 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.5 ttp -58.34 -51.81 79.14 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.779 -0.191 . . . . 0.0 111.47 -179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 15' ' ' MET . 57.9 Cg_endo -70.83 -13.47 31.99 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 122.007 1.805 . . . . 0.0 112.218 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -101.96 -6.95 22.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.06 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 14.4 mt -86.41 -43.68 16.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.723 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.512 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 84.8 mmm -53.02 -48.73 90.78 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.217 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.512 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 76.4 Cg_exo -43.79 -51.38 6.37 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 122.719 2.28 . . . . 0.0 113.149 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 24' ' ' GLU . 78.9 m -58.3 -31.91 67.95 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.771 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -67.62 -46.67 71.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.875 0.369 . . . . 0.0 110.86 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -76.2 -15.97 59.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 21' ' ' CYS . 3.0 mm-40 -60.7 -38.86 86.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.819 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 HD22 ' OE1' ' A' ' 46' ' ' GLN . 0.9 OUTLIER -117.88 -39.58 3.09 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.417 -179.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.47 ' HD2' ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER 178.9 -58.29 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 121.205 0.526 . . . . 0.0 112.094 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.47 ' H ' ' HD2' ' A' ' 26' ' ' HIS . 0.0 OUTLIER -143.56 178.37 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.295 -177.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.602 ' C ' HD21 ' A' ' 50' ' ' LEU . 10.9 m -86.24 171.28 11.39 Favored 'General case' 0 CA--C 1.522 -0.13 0 CA-C-O 121.003 0.43 . . . . 0.0 110.851 178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.561 ' HB2' ' HB2' ' A' ' 51' ' ' LYS . 2.1 tm-20 -68.67 -21.82 64.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.221 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.29 -47.08 9.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.223 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 18.1 mt -70.38 -7.0 7.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.608 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -50.65 -49.71 56.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.454 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.564 HG22 ' HB2' ' A' ' 36' ' ' GLN . 8.2 m -152.57 -11.92 0.17 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.856 0.36 . . . . 0.0 111.279 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 64.46 63.24 0.76 Allowed 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.757 179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.407 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . 11.0 mt 52.83 46.77 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.832 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.564 ' HB2' HG22 ' A' ' 33' ' ' THR . 46.4 mt-30 -146.96 12.92 1.12 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.26 179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.709 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -85.42 -72.96 0.46 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.46 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -149.45 -75.46 0.16 Allowed 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.536 ' HG3' HD22 ' A' ' 40' ' ' ASN . 12.8 ptmm? -89.68 -58.22 2.6 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.536 HD22 ' HG3' ' A' ' 39' ' ' LYS . 8.8 p30 -122.19 -3.74 8.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.761 0.315 . . . . 0.0 111.248 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.709 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 102.73 0.63 49.28 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.199 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.453 ' C ' ' H ' ' A' ' 44' ' ' MET . . . -85.32 -3.3 58.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.825 0.345 . . . . 0.0 110.918 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' HA ' ' HB1' ' A' ' 37' ' ' ALA . 15.0 t70 70.94 -14.39 0.45 Allowed 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.518 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.453 ' H ' ' C ' ' A' ' 42' ' ' ALA . 46.3 ttm 71.22 -27.18 0.17 Allowed 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 43' ' ' ASP . 47.5 t -64.6 -57.43 9.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.498 0.189 . . . . 0.0 111.359 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.468 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 0.9 OUTLIER -86.9 -12.14 48.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.804 0.335 . . . . 0.0 110.776 179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.2 -41.99 80.41 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.909 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 107' ' ' CYS . . . -74.54 13.61 4.88 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.504 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.558 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 5.1 m -147.3 -70.58 0.23 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 111.737 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.602 HD21 ' C ' ' A' ' 28' ' ' SER . 12.2 tp -44.35 -55.91 4.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.398 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 29' ' ' GLU . 84.6 tttt -79.16 -22.18 45.4 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -76.15 -7.8 55.61 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-O 121.026 0.441 . . . . 0.0 110.626 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 2.0 t -72.15 -36.09 69.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 56.6 t -62.83 -22.22 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.15 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.0 mtt -69.84 -46.48 65.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.505 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 61' ' ' LEU . 49.5 mttm -60.2 -18.8 50.86 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.771 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.431 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 4.4 tpm_? -67.59 -45.31 75.89 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.381 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.5 pt -103.04 34.13 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.892 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 59.29 13.55 3.16 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.754 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.4 tpt -71.9 -14.3 61.9 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 0.0 110.564 179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 31.9 tp -155.18 103.71 2.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.472 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.1 mmpt? -95.3 80.87 3.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.255 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 74.4 -70.56 1.61 Allowed Glycine 0 C--N 1.331 0.279 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.893 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 42.7 p -145.54 27.19 1.24 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.055 0.455 . . . . 0.0 110.484 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -111.21 110.53 21.08 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.413 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.655 HD21 HG23 ' A' ' 109' ' ' ILE . 86.0 mt -73.63 131.94 42.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.707 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -119.81 172.15 7.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.538 HG11 HD11 ' A' ' 97' ' ' ILE . 11.2 m -149.26 -17.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.536 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.559 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.3 mt-10 -58.61 -51.14 83.96 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.82 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 21.9 Cg_endo -61.21 -32.67 90.83 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 122.216 1.944 . . . . 0.0 112.625 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.492 HG12 HD11 ' A' ' 75' ' ' ILE . 46.2 t -72.94 -48.2 45.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.179 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 14.6 m-30 -54.09 -24.71 18.51 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.961 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -86.0 -36.76 19.57 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.444 ' HG2' ' O ' ' A' ' 71' ' ' VAL . 20.0 ptm -75.75 -39.57 56.96 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 120.541 -0.463 . . . . 0.0 110.508 -179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.631 HG22 HG23 ' A' ' 86' ' ' ILE . 90.3 mt -50.48 -23.64 1.89 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.215 0 CA-C-O 121.053 0.454 . . . . 0.0 110.189 179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.481 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.9 mt-10 -59.01 -58.82 6.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.165 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.541 HG12 ' HD2' ' A' ' 9' ' ' LYS . 21.2 t -88.05 -24.75 6.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 121.151 0.5 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.59 HG22 ' HB3' ' A' ' 9' ' ' LYS . 41.8 t -66.26 -8.48 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.941 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' NE2' HG21 ' A' ' 89' ' ' VAL . 92.0 m-70 -143.37 49.92 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.613 179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.58 127.32 30.9 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -73.53 0.34 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.448 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.595 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.4 m-20 -104.6 136.69 43.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.915 0.388 . . . . 0.0 110.688 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -70.37 -28.5 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.613 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -84.07 -24.89 30.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.758 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.0 t70 -59.58 -26.56 65.51 Favored 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 178.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.631 HG23 HG22 ' A' ' 75' ' ' ILE . 81.1 mt -84.34 -27.73 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-N 114.595 -1.184 . . . . 0.0 109.475 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -80.83 -19.76 43.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.617 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 67.8 tp -78.25 -55.06 5.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.629 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.582 HG13 ' HG ' ' A' ' 121' ' ' LEU . 26.4 t -55.94 -36.65 44.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.572 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 4.6 mttm -61.83 -30.04 70.57 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.722 179.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.34 -24.19 51.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.261 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.609 HG13 HD23 ' A' ' 121' ' ' LEU . 47.9 mm -74.38 -39.91 49.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.78 0.324 . . . . 0.0 110.893 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.408 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -58.34 -23.72 57.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.859 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.1 t-20 -75.48 -37.48 60.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.77 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -56.64 -28.45 60.59 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.546 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 59.8 m -80.68 -27.68 37.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.495 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD11 HG11 ' A' ' 68' ' ' VAL . 39.6 mt -74.15 -21.8 17.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.908 0.385 . . . . 0.0 110.933 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -77.0 -29.44 55.44 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.326 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.546 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 3.9 p30 -97.51 -40.74 8.51 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.191 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.78 -46.09 22.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.865 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt 59.88 -79.87 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.709 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 179.68 63.84 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 121.055 -0.593 . . . . 0.0 111.948 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.516 ' HB2' HG13 ' A' ' 109' ' ' ILE . 6.8 mm-40 -60.45 166.25 3.2 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.882 0.372 . . . . 0.0 111.175 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 8.9 t -90.42 -20.87 22.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.735 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -96.03 143.34 27.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.735 0.303 . . . . 0.0 110.73 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.558 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 12.9 tp10 -65.41 -69.07 0.32 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.697 -179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 14.3 m -50.25 -24.11 2.67 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.516 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 45.6 t-20 -76.81 -49.35 16.04 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.655 HG23 HD21 ' A' ' 66' ' ' LEU . 0.8 OUTLIER -56.79 -43.82 80.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.736 179.225 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.5 -50.21 39.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.752 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 115' ' ' ASP . 1.7 t-20 -54.83 -33.78 62.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.802 0.334 . . . . 0.0 110.61 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -76.08 -31.49 58.76 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.852 0.358 . . . . 0.0 111.014 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -86.96 -65.57 1.0 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.76 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 64.7 p -46.73 -42.9 17.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.142 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 17.0 t70 -46.0 -63.77 0.9 Allowed 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -66.3 -31.77 72.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.877 -0.601 . . . . 0.0 112.332 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -52.35 -51.21 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.898 0.38 . . . . 0.0 110.669 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.598 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 55.4 mt -78.17 -17.76 13.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.63 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -65.54 -60.01 3.38 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.602 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -86.93 -55.96 3.6 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.609 HD23 HG13 ' A' ' 92' ' ' ILE . 0.3 OUTLIER -85.34 -11.32 54.9 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -177.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.598 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.32 -14.24 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 120.97 0.414 . . . . 0.0 110.524 -179.3 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.511 ' H ' ' C ' ' A' ' 121' ' ' LEU . 70.0 m . . . . . 0 C--N 1.33 -0.24 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.72 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.473 HG21 ' OD1' ' A' ' 85' ' ' ASP . 45.6 pt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.886 0.374 . . . . 0.0 111.111 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 5' ' ' THR . 38.6 t0 -75.68 143.03 42.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.81 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -68.0 -4.24 12.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.997 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.52 -57.0 3.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.393 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 2' ' ' ASP . 15.3 t -49.8 -28.17 5.97 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.387 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 93.0 t -86.93 -64.37 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.844 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 70.1 t -62.89 -58.11 9.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.19 -29.49 22.67 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 5' ' ' THR . 5.1 mptp? -88.54 -59.09 2.33 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 120.93 -0.308 . . . . 0.0 111.517 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -51.28 -20.17 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.727 0.299 . . . . 0.0 111.362 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.6 tpt -85.0 -58.6 2.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.1 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -70.37 -23.48 62.79 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.146 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.0 t80 -75.55 -23.41 56.61 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.694 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.501 ' HB3' HG11 ' A' ' 54' ' ' VAL . 79.0 mt -135.02 15.98 3.52 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 111.729 0.27 . . . . 0.0 111.729 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.483 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 4.8 tmm? -58.27 -51.91 78.41 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.316 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 16.3 Cg_exo -69.86 -7.15 20.36 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 122.551 2.167 . . . . 0.0 112.321 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -104.75 -16.88 14.81 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.757 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.533 HG12 HG21 ' A' ' 54' ' ' VAL . 67.7 mt -89.21 -49.51 13.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.262 -179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.594 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 91.9 mmm -49.07 -49.65 67.88 Favored Pre-proline 0 CA--C 1.533 0.29 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.594 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.7 Cg_exo -51.29 -52.18 9.6 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.242 1.961 . . . . 0.0 113.118 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.462 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -76.65 -22.14 54.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.531 -178.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.569 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -54.82 -35.78 64.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.863 0.363 . . . . 0.0 110.521 179.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -83.76 -16.54 44.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.346 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 0.7 OUTLIER -59.95 -51.07 71.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.701 -179.319 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD12 HD23 ' A' ' 50' ' ' LEU . 13.2 mt -96.52 -41.43 8.57 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 120.13 -0.628 . . . . 0.0 111.805 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.451 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 18.3 t60 176.26 -59.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.903 0.859 . . . . 0.0 110.132 179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.1 pt -149.2 171.28 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 113.899 -1.5 . . . . 0.0 110.35 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 90.0 p -81.88 151.43 27.29 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' HG3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -61.35 -9.13 4.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.576 -179.309 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -87.85 -42.73 12.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 110.287 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 23.7 mt -90.64 -6.7 10.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.177 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -76.83 6.5 6.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.09 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 42' ' ' ALA . 9.4 t -63.37 -3.32 1.92 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.581 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -69.88 -10.76 59.68 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.774 0.321 . . . . 0.0 110.938 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.7 mt -103.71 -44.79 9.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.944 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.434 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 90.8 mt-30 60.28 101.18 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.446 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . . . -85.66 -75.6 0.36 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.718 179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HB2' ' O ' ' A' ' 37' ' ' ALA . . . 172.05 -21.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.325 0.39 . . . . 0.0 112.049 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.56 ' HD3' ' HA ' ' A' ' 115' ' ' ASP . 0.4 OUTLIER -64.52 -62.25 1.71 Allowed 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.803 0.298 . . . . 0.0 111.803 -178.677 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.832 HD22 ' H ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -127.38 -1.99 6.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.794 0.331 . . . . 0.0 111.237 179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 36' ' ' GLN . . . 105.0 -11.1 48.69 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.262 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.512 ' HB3' HD21 ' A' ' 40' ' ' ASN . . . -85.99 -77.96 0.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.597 0.237 . . . . 0.0 111.32 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 37' ' ' ALA . 25.8 t0 174.38 96.11 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.165 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.398 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.572 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 11.3 ttm -46.3 -41.19 12.85 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.014 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 71.4 p -63.06 -57.06 11.92 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.044 0.387 . . . . 0.0 112.044 -178.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -77.28 -12.54 59.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.648 ' HG ' HG21 ' A' ' 114' ' ' THR . 30.3 tp -84.46 -30.92 24.86 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -92.13 14.94 63.19 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 177.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.4 ' O ' ' HB3' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -132.28 -74.2 0.51 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 114.988 -0.606 . . . . 0.0 111.305 -178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.569 HD21 ' HA ' ' A' ' 22' ' ' ALA . 3.1 tm? -50.84 -45.67 59.73 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.351 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 47' ' ' LEU . 58.3 tttm -74.65 -24.94 58.9 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.574 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -68.15 -22.11 64.87 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 121.3 0.571 . . . . 0.0 109.851 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.4 t -73.75 -37.84 64.93 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.277 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.533 HG21 HG12 ' A' ' 18' ' ' ILE . 5.7 t -63.55 -20.9 27.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.887 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.46 ' HE2' ' HG2' ' A' ' 51' ' ' LYS . 17.1 mmt -63.92 -51.94 62.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.647 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.486 ' NZ ' ' HB2' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -61.86 -16.19 48.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.17 -179.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.423 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 2.2 mmp_? -73.08 -34.15 66.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.086 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.447 HD11 ' SD ' ' A' ' 60' ' ' MET . 33.1 pt -107.13 34.91 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.176 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 42.68 40.95 2.21 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.894 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.451 ' HG3' ' HB3' ' A' ' 55' ' ' MET . 18.2 ptm -112.02 8.97 20.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.201 0.524 . . . . 0.0 110.091 178.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.418 ' HB3' ' HG3' ' A' ' 56' ' ' LYS . 44.4 tp -157.72 99.01 1.69 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.768 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 11.7 mmpt? -104.37 95.8 6.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.059 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 53.15 57.6 14.46 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.39 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 p 73.03 22.85 2.85 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.038 0.535 . . . . 0.0 111.224 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 20.3 mm-40 -115.75 104.94 12.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.238 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 100' ' ' ALA . 5.7 mp -78.51 141.27 38.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -112.86 -178.48 3.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.933 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.57 HG12 HD13 ' A' ' 97' ' ' ILE . 30.6 m -129.18 -28.51 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.429 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 11.3 mm-40 -64.71 -52.86 48.21 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.933 -179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 12.7 Cg_endo -58.13 -13.76 16.94 Favored 'Trans proline' 0 C--N 1.353 0.787 0 C-N-CA 122.054 1.836 . . . . 0.0 112.402 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.7 t -91.53 -46.39 14.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.13 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.4 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 18.9 m-85 -62.77 -22.25 66.45 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.867 0.365 . . . . 0.0 110.213 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.512 ' HA ' ' HE3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -82.35 -47.68 12.04 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.01 -179.394 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 25.0 ptt? -71.59 -41.27 69.16 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.861 -179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.56 HD13 HG13 ' A' ' 89' ' ' VAL . 26.5 mt -49.37 -30.5 4.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.99 0.424 . . . . 0.0 111.005 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.4 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 48.0 mt-10 -54.71 -59.53 4.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.814 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 25.8 t -86.57 -29.09 5.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.051 0.453 . . . . 0.0 111.142 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.414 ' HA ' ' HB3' ' A' ' 9' ' ' LYS . 35.5 t -65.05 -7.99 4.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.873 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -139.05 33.35 2.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.326 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.38 56.74 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.319 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 130.15 -53.08 0.81 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.209 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.588 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.8 m120 -116.19 110.28 18.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.761 0.315 . . . . 0.0 110.69 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -30.51 69.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.174 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.513 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.1 m-20 -79.71 -18.84 50.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.81 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.588 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 37.2 t0 -62.9 -34.09 76.7 Favored 'General case' 0 CA--C 1.515 -0.37 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.46 HG23 HG22 ' A' ' 75' ' ' ILE . 88.5 mt -76.42 -31.76 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.934 -1.03 . . . . 0.0 109.561 178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -75.55 -30.95 59.89 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.779 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 7.4 tt -83.75 -47.14 11.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.734 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.581 HG23 ' HG ' ' A' ' 121' ' ' LEU . 9.9 p -64.73 -32.88 59.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.589 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 0.7 OUTLIER -52.69 -34.53 52.47 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.919 0.39 . . . . 0.0 110.801 -179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.1 -30.44 31.28 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.38 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.591 HG13 HD23 ' A' ' 121' ' ' LEU . 34.8 mm -65.69 -35.64 75.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 0.0 110.919 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.36 -33.54 73.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.966 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -68.32 -21.73 64.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.119 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -71.29 -33.38 69.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 110.679 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.614 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 69.5 m -87.25 -53.65 4.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.47 -179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.57 HD13 HG12 ' A' ' 68' ' ' VAL . 65.1 mt -49.46 -28.8 3.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -77.63 -34.68 53.21 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.5 p30 -94.37 -3.88 49.51 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.017 -0.273 . . . . 0.0 111.443 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.486 ' HB3' HD22 ' A' ' 66' ' ' LEU . . . -100.63 -33.68 10.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.698 -0.228 . . . . 0.0 110.832 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 25.5 -85.37 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 O-C-N 124.052 0.845 . . . . 0.0 113.048 179.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.543 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . -167.18 77.76 0.12 Allowed Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.716 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -66.94 168.76 9.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.811 0.339 . . . . 0.0 110.94 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 65.5 p -87.77 -43.12 12.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.406 ' O ' HG13 ' A' ' 109' ' ' ILE . 11.1 t70 -79.83 131.23 35.84 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.835 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -49.16 -64.51 0.79 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.856 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.405 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 83.4 m -56.58 -21.53 27.35 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -81.61 -31.19 32.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 111.013 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.406 HG13 ' O ' ' A' ' 105' ' ' ASP . 90.7 mt -66.74 -40.49 86.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.777 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.574 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -82.59 -37.03 14.77 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.368 -179.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.572 ' ND2' ' HG3' ' A' ' 44' ' ' MET . 3.6 t-20 -56.92 -48.31 78.56 Favored 'General case' 0 CA--C 1.519 -0.229 0 CA-C-O 120.674 0.273 . . . . 0.0 110.609 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -53.59 -26.83 23.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.706 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -86.83 -65.8 0.97 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.917 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.648 HG21 ' HG ' ' A' ' 47' ' ' LEU . 9.7 t -53.19 -46.18 68.88 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.56 ' HA ' ' HD3' ' A' ' 39' ' ' LYS . 14.9 t70 -38.81 -58.44 1.08 Allowed 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.3 p -76.81 -34.94 57.91 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -56.93 -32.5 66.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.747 0.308 . . . . 0.0 110.876 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.58 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 54.3 mt -83.77 -20.18 9.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.224 0.535 . . . . 0.0 110.426 179.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -69.62 -58.26 4.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.424 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -86.0 -52.06 5.95 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.591 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -92.45 -11.44 34.74 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.58 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 70.19 -15.83 0.33 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.852 0.358 . . . . 0.0 110.587 -179.035 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 121' ' ' LEU . 58.8 m . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.825 0.345 . . . . 0.0 110.935 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.549 HD11 HD11 ' A' ' 121' ' ' LEU . 44.7 pt . . . . . 0 N--CA 1.485 1.324 0 CA-C-O 120.87 0.367 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -71.07 125.21 26.25 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.08 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -71.33 -38.38 71.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.447 179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -55.81 -48.51 75.3 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.446 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 77.6 p -54.84 -24.52 23.41 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.904 0.383 . . . . 0.0 111.193 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.516 HG11 ' HB2' ' A' ' 123' ' ' SER . 58.4 t -86.41 -63.62 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.592 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 57.7 t -60.41 -62.11 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -52.24 -28.65 19.45 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 -178.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.588 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.7 mmpt? -87.72 -59.15 2.32 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.491 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 25.4 m-85 -52.06 -29.03 19.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.971 0.415 . . . . 0.0 111.041 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.9 mmm -76.95 -62.35 1.68 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.117 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.98 -23.65 61.98 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.53 -179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.432 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -63.72 -48.19 78.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.483 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.495 HD11 HG21 ' A' ' 58' ' ' ILE . 80.4 mt -137.89 36.68 2.38 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.503 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 45.0 ttm -55.3 -50.89 84.1 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 15' ' ' MET . 70.0 Cg_endo -71.24 -8.44 23.45 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.215 1.943 . . . . 0.0 112.839 -179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 14' ' ' LEU . 7.1 m-20 -100.29 -16.1 17.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.835 0.35 . . . . 0.0 110.904 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.478 HG13 ' O ' ' A' ' 14' ' ' LEU . 78.3 mt -80.88 -49.87 17.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.471 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 87.8 mtp -48.4 -47.98 67.52 Favored Pre-proline 0 CA--C 1.534 0.338 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.068 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 19' ' ' MET . 53.3 Cg_exo -38.51 -60.31 0.49 Allowed 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.684 2.256 . . . . 0.0 113.762 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.579 ' O ' HD12 ' A' ' 25' ' ' LEU . 64.8 m -69.64 -26.49 64.43 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.589 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.53 -44.83 66.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.978 0.418 . . . . 0.0 110.877 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -84.15 -15.95 45.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.207 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 7.9 tp10 -66.47 -54.56 22.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.621 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.579 HD12 ' O ' ' A' ' 21' ' ' CYS . 1.2 mp -88.29 -41.34 12.96 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 119.739 -0.785 . . . . 0.0 112.289 -178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 39.8 t60 177.19 -62.16 0.01 OUTLIER 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.719 0.771 . . . . 0.0 111.033 178.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.428 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -149.58 163.22 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.938 -177.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.404 ' HA ' ' CD1' ' A' ' 50' ' ' LEU . 60.4 p -85.49 163.19 18.59 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 110.189 -0.301 . . . . 0.0 110.189 178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.538 ' HG2' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -73.84 0.46 13.16 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.415 -179.639 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -87.26 -37.88 16.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.305 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 29.1 mm -101.64 -16.09 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.448 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' HB2' HD12 ' A' ' 27' ' ' ILE . . . -60.52 -18.71 53.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.349 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.8 t -82.11 34.81 0.42 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.046 0.45 . . . . 0.0 111.31 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -72.08 -6.09 39.97 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.535 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.442 ' H ' HD13 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -120.98 -29.0 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.268 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 84.8 mt-30 61.78 109.41 0.02 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.884 0.373 . . . . 0.0 110.997 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -80.82 -74.64 0.31 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.658 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -173.22 -62.35 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.151 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -55.29 -61.37 2.37 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.676 -178.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.755 HD22 ' H ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -126.39 -23.35 3.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.624 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.494 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 109.57 -14.2 32.62 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.583 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -83.48 -2.54 56.16 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.675 0.274 . . . . 0.0 110.922 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 68.56 -3.8 1.29 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.543 179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.449 ' HG2' HD22 ' A' ' 111' ' ' ASN . 20.6 ttm 59.79 9.71 1.78 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.263 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 44.9 t -86.5 -58.03 2.77 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 110.772 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -86.96 -16.38 36.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.058 0.456 . . . . 0.0 109.99 179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.496 HD21 HD11 ' A' ' 118' ' ' ILE . 19.3 tp -71.59 -35.31 70.49 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.623 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -74.26 9.38 9.92 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.734 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.505 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.5 OUTLIER -146.64 -62.99 0.3 Allowed 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 22' ' ' ALA . 1.9 tm? -48.68 -42.68 35.52 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.538 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . 81.2 tttt -81.16 -20.47 41.19 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.599 178.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -70.53 -21.95 62.67 Favored 'General case' 0 CA--C 1.521 -0.155 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 57' ' ' ARG . 1.7 t -59.64 -31.44 69.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.02 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 43.0 t -66.97 -28.93 44.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.592 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.43 ' O ' ' HB3' ' A' ' 60' ' ' MET . 71.1 mtm -72.68 -65.05 0.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.16 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.599 ' HG2' HD23 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -58.07 -15.34 9.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.471 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.448 ' NE ' ' HA ' ' A' ' 57' ' ' ARG . 6.1 tpm_? -72.18 -34.26 68.29 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.541 -0.299 . . . . 0.0 111.175 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 14' ' ' LEU . 40.2 pt -113.29 34.69 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.827 -179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 64.01 11.05 5.81 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.563 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.43 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.0 tpt -79.05 4.16 15.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.282 0.563 . . . . 0.0 110.134 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 56' ' ' LYS . 34.2 tp -166.81 99.28 0.56 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.56 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.401 ' HG3' ' CE1' ' A' ' 67' ' ' TYR . 2.5 mmpt? -85.93 78.33 9.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.452 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.7 -64.58 3.28 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.049 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.438 HG22 HD11 ' A' ' 109' ' ' ILE . 63.8 p -147.36 15.15 1.13 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.709 0.29 . . . . 0.0 110.835 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -108.83 110.22 21.53 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' N ' HD22 ' A' ' 66' ' ' LEU . 3.6 mm? -69.68 135.01 49.34 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.33 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.428 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 2.6 m-85 -106.4 174.31 5.94 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.903 0.382 . . . . 0.0 111.348 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 28.5 m -140.73 -25.35 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.346 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.2 mm-40 -56.54 -51.86 77.87 Favored Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.504 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 28.6 Cg_endo -63.53 -13.67 37.79 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 121.969 1.779 . . . . 0.0 112.099 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.441 HG12 HD11 ' A' ' 75' ' ' ILE . 2.8 t -86.05 -50.37 14.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.274 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 16.5 m-85 -56.86 -22.54 37.73 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.839 0.352 . . . . 0.0 110.751 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.2 mmtt -85.33 -44.21 13.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.319 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 24.8 ptp -71.98 -41.71 67.36 Favored 'General case' 0 C--O 1.224 -0.279 0 C-N-CA 120.871 -0.332 . . . . 0.0 110.697 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.572 HD13 HG23 ' A' ' 89' ' ' VAL . 89.0 mt -48.66 -28.52 2.25 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-O 120.938 0.399 . . . . 0.0 110.631 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -57.01 -56.36 22.75 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.12 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.9 t -88.12 -24.73 6.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 121.239 0.542 . . . . 0.0 111.09 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 75' ' ' ILE . 40.8 t -69.83 -8.32 10.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.856 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -144.67 45.53 1.38 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.652 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.77 119.91 10.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.103 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 149.61 -74.4 0.27 Allowed Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.47 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.657 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.0 m120 -100.13 123.89 44.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.781 0.324 . . . . 0.0 111.03 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.66 -25.27 67.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.024 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.491 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 9.5 m-20 -84.3 -24.98 29.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.436 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.657 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.8 t0 -56.68 -36.1 69.21 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.494 HG23 HG22 ' A' ' 75' ' ' ILE . 96.9 mt -74.39 -28.15 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 114.899 -1.046 . . . . 0.0 109.959 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.491 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 2.6 tp60 -81.66 -23.56 36.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.268 -179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 9.9 tt -78.37 -62.11 1.79 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.285 -179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.572 HG23 HD13 ' A' ' 75' ' ' ILE . 28.5 m -58.85 -27.77 36.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.653 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 1.4 tttt -56.82 -35.91 69.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 110.713 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.46 -19.15 62.69 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.151 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' A' ' 89' ' ' VAL . 29.1 mm -73.87 -35.27 42.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.836 0.351 . . . . 0.0 110.76 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.7 -25.13 68.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.896 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -82.94 -27.15 30.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.588 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -69.86 -19.64 63.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.204 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 27.4 m -86.07 -42.3 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.031 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 69.5 mt -60.48 -36.9 72.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 120.674 0.273 . . . . 0.0 111.279 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.16 -36.93 76.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.826 0.346 . . . . 0.0 110.846 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -99.5 -5.06 29.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.605 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -137.97 50.73 1.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.853 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.601 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -44.78 -28.28 0.61 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.63 -179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.601 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . 132.32 91.62 0.51 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.929 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.464 ' N ' HG12 ' A' ' 109' ' ' ILE . 7.5 mm-40 -67.42 -179.14 0.98 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.0 110.705 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.5 t -93.91 -27.75 16.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.72 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 26.3 t70 -102.52 140.47 36.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.929 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -48.36 -69.14 0.13 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.666 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 76.9 m -53.82 -16.81 1.94 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.896 -179.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 26.3 t-20 -87.06 -35.13 18.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.714 0.292 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.464 HG12 ' N ' ' A' ' 103' ' ' GLU . 84.6 mt -69.88 -55.57 14.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.182 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.473 ' O ' HG22 ' A' ' 114' ' ' THR . . . -61.25 -43.34 99.5 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.613 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.449 HD22 ' HG2' ' A' ' 44' ' ' MET . 26.5 t-20 -50.92 -30.39 14.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -87.6 -25.79 23.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.976 179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -86.29 -63.47 1.31 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.735 -179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.6 t -49.3 -43.1 43.04 Favored 'General case' 0 CA--C 1.528 0.108 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.399 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.419 ' N ' HG23 ' A' ' 114' ' ' THR . 12.7 t70 -45.92 -38.54 7.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.59 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -80.07 -49.22 12.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.339 -178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.76 -38.51 72.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.661 0.267 . . . . 0.0 111.584 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.55 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 61.4 mt -77.86 -21.23 13.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.183 0.516 . . . . 0.0 110.718 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -72.57 -57.0 4.49 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.568 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.2 -44.6 11.35 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.549 HD11 HD11 ' A' ' 1' ' ' ILE . 42.9 tp -99.9 -10.54 21.59 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.55 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.2 OUTLIER 72.79 -22.93 0.21 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.683 0.277 . . . . 0.0 110.968 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.516 ' HB2' HG11 ' A' ' 6' ' ' VAL . 57.9 m . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 120.738 0.304 . . . . 0.0 110.778 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.426 HD11 HD21 ' A' ' 121' ' ' LEU . 44.2 pt . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.799 0.333 . . . . 0.0 111.039 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.408 ' O ' HG22 ' A' ' 5' ' ' THR . 8.9 m-20 -65.61 137.15 57.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.766 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -72.99 -5.67 40.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.1 -48.44 52.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.074 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.489 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 6.6 t -59.32 -24.96 63.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -87.08 -64.19 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.358 -0.383 . . . . 0.0 112.008 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 60.4 t -60.89 -59.29 4.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -55.52 -27.58 49.54 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -178.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 5' ' ' THR . 13.5 mptt -88.42 -59.4 2.25 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.949 -0.3 . . . . 0.0 111.585 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -50.22 -24.7 3.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.764 0.316 . . . . 0.0 111.328 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 15' ' ' MET . 0.7 OUTLIER -81.75 -62.21 1.7 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.667 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -67.99 -54.52 17.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.036 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -51.68 -23.41 4.39 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.459 -179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.625 ' HB3' HG11 ' A' ' 54' ' ' VAL . 96.3 mt -139.86 62.67 1.51 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.644 0.259 . . . . 0.0 111.519 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.616 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 50.7 ttp -110.01 -51.45 0.06 OUTLIER Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.366 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.616 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 31.3 Cg_exo -58.89 -14.79 24.02 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 121.989 1.793 . . . . 0.0 111.806 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -94.56 -19.86 20.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.826 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.471 HG22 ' HB2' ' A' ' 22' ' ' ALA . 38.9 mt -81.09 -36.91 15.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.422 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.575 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 58.5 mtt -45.57 -50.27 32.4 Favored Pre-proline 0 CA--C 1.537 0.464 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 77.1 Cg_exo -50.19 -52.41 9.01 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.272 1.982 . . . . 0.0 113.302 -179.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 25.3 m -85.29 -15.04 44.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.661 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -66.33 -7.84 21.41 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.773 0.321 . . . . 0.0 111.138 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -83.88 -52.75 6.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.855 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.63 -19.16 31.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.391 -179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.627 ' HB2' HD13 ' A' ' 50' ' ' LEU . 71.4 mt -125.47 40.44 3.74 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.028 -178.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -63.73 67.92 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.516 -179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.467 ' O ' ' HB2' ' A' ' 32' ' ' ALA . 1.2 pp -159.2 55.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 122.818 0.447 . . . . 0.0 110.33 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.57 ' HA ' HD23 ' A' ' 50' ' ' LEU . 8.9 p -56.71 -176.42 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.871 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -66.82 10.69 0.12 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.667 0.27 . . . . 0.0 111.272 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.507 ' H ' ' C ' ' A' ' 28' ' ' SER . 19.6 t70 -106.73 -28.28 10.27 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.386 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 27' ' ' ILE . 46.5 mm -106.34 -40.27 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.795 179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 27' ' ' ILE . . . -66.69 1.08 1.94 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.982 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.519 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 12.4 t -119.64 49.99 1.31 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.994 0.426 . . . . 0.0 111.757 -179.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.409 ' ND2' ' N ' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -49.55 98.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.209 179.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' O ' ' HG2' ' A' ' 36' ' ' GLN . 12.7 mm 61.08 60.5 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.132 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.893 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 35' ' ' ILE . 4.7 mm-40 -167.54 176.76 6.31 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.432 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . . . -87.93 -68.56 0.75 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.493 ' H ' ' ND2' ' A' ' 40' ' ' ASN . . . -156.58 -146.51 0.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.374 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.482 ' C ' ' H ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -46.3 -16.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.043 0.449 . . . . 0.0 110.383 179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 38' ' ' ALA . 7.6 p30 -71.63 34.24 0.05 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.071 178.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . 115.84 19.14 5.75 Favored Glycine 0 CA--C 1.519 0.317 0 CA-C-N 116.249 -0.432 . . . . 0.0 113.676 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' HB1' ' HA ' ' A' ' 33' ' ' THR . . . -85.87 -50.18 7.31 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 177.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.516 ' C ' ' H ' ' A' ' 45' ' ' SER . 21.8 t70 -172.3 -46.25 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.732 -1.122 . . . . 0.0 109.536 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.52 ' O ' ' ND2' ' A' ' 111' ' ' ASN . 27.6 ttt 61.25 -5.66 0.12 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.357 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 43' ' ' ASP . 32.6 t -92.41 -57.35 2.72 Favored 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HB3' HD13 ' A' ' 27' ' ' ILE . 65.1 mm-40 -88.06 -27.41 22.01 Favored 'General case' 0 CA--C 1.528 0.126 0 N-CA-C 113.117 0.784 . . . . 0.0 113.117 -178.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 47' ' ' LEU . 4.6 tt -49.77 -46.78 51.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.827 0.346 . . . . 0.0 110.794 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.55 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -76.02 29.65 1.35 Allowed Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.65 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' H ' ' C ' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -132.71 -73.0 0.51 Allowed 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 111.361 0.134 . . . . 0.0 111.361 -179.825 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.627 HD13 ' HB2' ' A' ' 25' ' ' LEU . 56.1 tp -51.99 -45.46 64.49 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 45.0 tttp -74.44 -25.27 59.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.485 178.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.408 ' HB2' ' HA3' ' A' ' 110' ' ' GLY . . . -78.83 -16.75 56.71 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 56' ' ' LYS . 40.0 t -70.21 -33.39 71.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.248 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.625 HG11 ' HB3' ' A' ' 14' ' ' LEU . 15.2 t -68.28 -24.99 30.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.985 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 51.3 mtm -60.79 -45.83 92.85 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.993 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 61' ' ' LEU . 2.0 pttm -75.51 -15.84 60.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.791 0.329 . . . . 0.0 110.615 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.539 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 2.9 mmp_? -76.94 -23.16 52.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.72 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 45.2 pt -113.01 26.08 3.56 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.522 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 57.81 63.21 1.86 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.379 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 1.8 tmt? -139.31 -20.78 0.94 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.775 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 56' ' ' LYS . 13.6 tp -124.93 99.99 6.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.013 0.435 . . . . 0.0 110.559 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.597 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 10.4 mmpt? -124.14 87.57 2.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.937 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 61.14 59.44 10.03 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.346 -0.93 . . . . 0.0 112.367 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.449 HG22 HD11 ' A' ' 109' ' ' ILE . 6.1 p 72.29 8.84 5.86 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.27 0.628 . . . . 0.0 111.171 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.418 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 42.8 mt-10 -92.91 122.51 35.35 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.833 179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 18.8 mt -113.21 113.85 25.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.958 0.409 . . . . 0.0 110.926 179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -80.73 178.43 8.38 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.778 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.63 -12.51 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.754 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.534 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 36.6 mt-10 -70.65 -49.76 14.61 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.607 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 33.8 Cg_endo -66.6 -29.28 44.05 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.917 1.745 . . . . 0.0 112.658 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' O ' ' HG3' ' A' ' 74' ' ' MET . 22.0 t -64.21 -53.64 40.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.926 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -55.26 -21.69 15.39 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.259 179.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -85.21 -38.43 18.96 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.13 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 71' ' ' VAL . 0.0 OUTLIER -72.92 -42.99 62.92 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 120.978 -0.289 . . . . 0.0 110.349 -179.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.51 HG22 HG23 ' A' ' 86' ' ' ILE . 76.4 mt -51.91 -27.75 9.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-O 121.023 0.439 . . . . 0.0 110.749 179.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HA ' HD13 ' A' ' 86' ' ' ILE . 47.4 mt-10 -57.58 -58.22 9.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.883 -0.598 . . . . 0.0 111.855 -179.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.6 t -86.35 -25.79 6.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.184 0.516 . . . . 0.0 110.835 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.4 HG12 ' CD2' ' A' ' 79' ' ' HIS . 39.7 t -72.61 -8.15 10.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.644 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.425 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 90.0 m-70 -145.21 43.84 1.32 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.695 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.5 132.12 48.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.185 -179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 155.65 -62.26 0.35 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.346 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -126.72 147.57 49.95 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.79 0.328 . . . . 0.0 110.812 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 87' ' ' GLN . . . -65.93 -33.6 76.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.27 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -82.91 -30.19 28.65 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.548 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -53.02 -30.73 37.17 Favored 'General case' 0 CA--C 1.518 -0.252 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.51 HG23 HG22 ' A' ' 75' ' ' ILE . 95.0 mt -83.29 -34.56 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.412 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.417 ' HG2' ' O ' ' A' ' 83' ' ' ALA . 15.0 mm100 -71.27 -19.76 62.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.991 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 58.8 tp -78.06 -44.68 25.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.67 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HB ' HG21 ' A' ' 75' ' ' ILE . 21.3 t -70.43 -29.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.78 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -52.58 -35.9 54.99 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.408 179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.83 -31.32 32.86 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.193 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.546 HD12 ' HB3' ' A' ' 120' ' ' LYS . 34.6 mm -60.18 -35.36 61.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.888 0.375 . . . . 0.0 110.439 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.9 -19.07 57.86 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.835 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -74.67 -42.04 59.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.343 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -71.95 -18.27 62.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.309 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 0.5 OUTLIER -85.15 -38.03 19.51 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.471 -179.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.76 -35.63 61.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.379 -179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -69.8 -13.27 62.19 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.299 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -106.75 -49.18 3.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.131 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -96.96 43.64 1.07 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.216 -179.627 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -41.67 -28.34 0.14 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 112.064 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 101' ' ' LYS . . . 143.85 92.66 0.16 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.585 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' N ' HG12 ' A' ' 109' ' ' ILE . 16.7 mm-40 -66.32 -178.54 0.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.348 . . . . 0.0 110.951 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.4 t -91.78 -32.59 15.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.157 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.451 ' O ' HG13 ' A' ' 109' ' ' ILE . 19.5 t70 -95.15 139.78 31.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.829 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -45.47 -64.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.908 -179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 79.8 m -56.3 -43.6 79.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.588 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -56.73 -37.98 71.74 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.451 HG13 ' O ' ' A' ' 105' ' ' ASP . 97.5 mt -60.12 -41.49 86.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.756 0.313 . . . . 0.0 111.195 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.408 ' HA3' ' HB2' ' A' ' 52' ' ' ALA . . . -86.33 -29.22 25.47 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.758 -0.734 . . . . 0.0 113.17 -179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.55 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 21.3 m120 -58.15 -36.66 73.32 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.757 0.313 . . . . 0.0 111.177 -179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -80.39 -38.26 30.68 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.199 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -68.65 -24.68 64.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.592 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 115' ' ' ASP . 11.1 t -88.0 -42.81 12.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.874 0.368 . . . . 0.0 110.25 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.44 ' HA ' ' HG3' ' A' ' 39' ' ' LYS . 17.7 t70 -43.17 -68.97 0.15 Allowed 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.46 178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.6 p -54.26 -39.62 67.03 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.496 -0.774 . . . . 0.0 112.022 -179.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.42 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.2 OUTLIER -54.34 -37.01 64.41 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.834 0.349 . . . . 0.0 110.898 -179.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.535 ' HA ' ' N ' ' A' ' 123' ' ' SER . 87.8 mt -85.29 -35.88 10.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.068 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -54.15 -46.25 72.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.931 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.546 ' HB3' HD12 ' A' ' 92' ' ' ILE . 12.3 mptt -86.14 -44.97 11.8 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.608 ' O ' ' HB3' ' A' ' 122' ' ' PHE . 0.5 OUTLIER -100.16 -53.93 3.01 Favored 'General case' 0 CA--C 1.53 0.206 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.608 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER 135.74 -6.74 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.254 1.422 . . . . 0.0 111.02 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.535 ' N ' ' HA ' ' A' ' 118' ' ' ILE . 89.9 p . . . . . 0 C--N 1.332 -0.165 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 31.5 pt . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.871 0.367 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.2 139.17 57.2 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.042 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -59.89 -15.41 21.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.983 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 10.4 m-20 -76.6 -44.6 33.7 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.485 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.43 HG23 ' HA ' ' A' ' 79' ' ' HIS . 25.9 m -47.49 -41.93 21.84 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.002 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 68.8 t -87.44 -65.18 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.956 -0.565 . . . . 0.0 112.18 -179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 42.8 t -63.11 -62.43 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.509 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -52.18 -26.25 11.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.925 0.713 . . . . 0.0 112.925 -178.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.452 ' HB2' HG13 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -89.37 -59.34 2.24 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.875 -179.277 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -56.5 -23.77 41.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.716 0.293 . . . . 0.0 111.479 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 27.3 ttt -84.49 -56.02 3.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.351 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -63.63 -23.86 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.65 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.506 ' HB3' HD12 ' A' ' 14' ' ' LEU . 1.2 t80 -58.32 -44.19 88.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.307 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD12 ' HB3' ' A' ' 13' ' ' TYR . 4.5 mp -137.97 32.45 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.554 -0.293 . . . . 0.0 111.597 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.521 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 39.9 ttp -50.43 -51.67 62.05 Favored Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.608 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 15' ' ' MET . 42.5 Cg_endo -67.14 -33.3 31.78 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 121.889 1.726 . . . . 0.0 112.112 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.443 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 10.6 m-20 -78.78 0.72 25.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.274 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.482 HD12 ' HA ' ' A' ' 15' ' ' MET . 37.8 mt -89.42 -43.42 14.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.432 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.507 ' N ' ' CD ' ' A' ' 20' ' ' PRO . 26.9 ptt? -57.87 -33.32 17.17 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 113.476 0.917 . . . . 0.0 113.476 -178.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' CD ' ' N ' ' A' ' 19' ' ' MET . 78.6 Cg_exo -50.37 -51.9 10.08 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 121.684 1.589 . . . . 0.0 112.68 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.474 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 66.0 m -74.68 -28.99 61.06 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.559 -178.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.54 -40.53 62.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.953 0.406 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -84.48 -16.38 42.67 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.33 179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 37.6 tt0 -61.11 -54.68 41.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.01 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 50' ' ' LEU . 20.8 mt -91.06 -40.66 11.5 Favored 'General case' 0 C--N 1.333 -0.139 0 C-N-CA 120.259 -0.576 . . . . 0.0 112.274 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.428 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 12.0 t60 177.25 -60.09 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.666 0.746 . . . . 0.0 110.552 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 0.8 OUTLIER -145.94 175.47 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 CA-C-N 114.417 -1.265 . . . . 0.0 111.307 -178.19 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.61 ' HA ' HD11 ' A' ' 50' ' ' LEU . 68.7 p -85.81 178.83 7.18 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.062 0.458 . . . . 0.0 111.233 179.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 42' ' ' ALA . 1.5 tm-20 -67.62 -19.84 65.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.39 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p-10 -93.04 -36.43 12.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.165 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.543 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 35.0 mm -83.42 -6.31 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.191 0.519 . . . . 0.0 110.201 179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -47.07 -55.64 7.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.657 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -151.46 -35.08 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.577 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 45.41 25.12 0.2 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.062 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.55 ' HB ' ' NE2' ' A' ' 36' ' ' GLN . 95.2 mt -138.74 -36.68 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.272 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.55 ' NE2' ' HB ' ' A' ' 35' ' ' ILE . 0.9 OUTLIER -97.16 97.67 9.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.106 0.479 . . . . 0.0 109.865 179.48 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.541 ' HA ' ' HA2' ' A' ' 41' ' ' GLY . . . -74.17 -61.2 1.94 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.587 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 57.44 -89.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.243 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -103.19 -60.23 1.59 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.889 0.376 . . . . 0.0 110.682 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -125.84 -20.89 4.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.449 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.541 ' HA2' ' HA ' ' A' ' 37' ' ' ALA . . . 109.71 -16.94 30.86 Favored Glycine 0 C--N 1.33 0.22 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.646 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.695 ' HB3' HD12 ' A' ' 47' ' ' LEU . . . -86.91 -0.34 56.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.785 0.326 . . . . 0.0 110.847 179.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.437 ' C ' ' H ' ' A' ' 45' ' ' SER . 18.7 t70 70.02 -3.07 1.86 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.925 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 43' ' ' ASP . 1.0 OUTLIER 61.83 -3.22 0.24 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.794 179.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.437 ' H ' ' C ' ' A' ' 43' ' ' ASP . 78.8 p -78.11 -58.75 3.09 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.686 0.279 . . . . 0.0 110.96 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.521 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 9.9 mm100 -88.74 -13.52 39.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.305 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.695 HD12 ' HB3' ' A' ' 42' ' ' ALA . 2.6 tt -60.04 -43.26 95.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.065 0.46 . . . . 0.0 109.845 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.42 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -72.48 9.3 6.05 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.037 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 1.2 m -138.91 -78.78 0.34 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.968 0.413 . . . . 0.0 111.232 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD11 ' HA ' ' A' ' 28' ' ' SER . 3.1 tm? -48.64 -52.62 22.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.672 179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.613 ' HB3' HD23 ' A' ' 47' ' ' LEU . 5.3 tmtt? -73.55 -22.87 59.96 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.06 -10.39 59.38 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.341 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.444 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 1.1 t -60.7 -35.71 76.98 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.753 178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 39.9 t -60.99 -28.83 44.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.122 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.448 ' HB3' ' SD ' ' A' ' 60' ' ' MET . 39.5 mtt -65.18 -49.02 71.4 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.171 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.444 ' HE3' ' HA ' ' A' ' 53' ' ' CYS . 7.9 mtmp? -64.38 -27.3 68.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.795 179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -71.3 -30.42 66.23 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.097 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.537 HD11 ' HG2' ' A' ' 60' ' ' MET . 49.1 pt -96.45 15.23 2.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.828 0.347 . . . . 0.0 111.216 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 58.41 45.45 16.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.668 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.546 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 2.8 ppp? -121.11 -8.96 9.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.088 0.47 . . . . 0.0 110.447 179.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 58.6 tp -139.47 99.87 3.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.471 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.2 mmmt -95.25 77.84 3.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.417 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.35 -63.73 3.28 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.741 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -147.23 15.82 1.16 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.641 0.257 . . . . 0.0 110.659 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -107.5 111.2 23.36 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.739 -179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.583 HD11 HG23 ' A' ' 109' ' ' ILE . 95.7 mt -84.23 139.14 32.56 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.653 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.546 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 6.4 m-85 -111.67 -172.55 2.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.394 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.57 -15.16 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.809 0.338 . . . . 0.0 111.608 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' HB2' ' HD3' ' A' ' 70' ' ' PRO . 47.0 mt-10 -72.95 -47.33 8.41 Favored Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 69' ' ' GLU . 50.0 Cg_exo -52.65 -51.42 11.16 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.274 1.983 . . . . 0.0 112.834 -179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -55.89 -44.38 77.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.764 -179.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 5.2 m-30 -55.51 -23.7 27.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.945 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -85.46 -34.79 21.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.22 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.7 mtm -71.6 -50.49 30.41 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.555 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.465 HG22 HG23 ' A' ' 86' ' ' ILE . 70.0 mt -49.35 -22.05 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.364 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.59 -59.71 3.97 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.427 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.3 t -83.8 -32.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.089 0.471 . . . . 0.0 110.796 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.452 HG13 ' HB2' ' A' ' 9' ' ' LYS . 37.6 t -61.08 -11.93 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.83 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.43 ' HA ' HG23 ' A' ' 5' ' ' THR . 89.6 m-70 -139.09 53.61 1.74 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.738 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.93 109.19 4.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.195 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 165.48 -67.75 0.2 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.879 -0.676 . . . . 0.0 112.359 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 2.7 m-20 -107.11 153.18 23.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.746 0.307 . . . . 0.0 110.648 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.21 -46.72 14.41 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.89 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -72.45 -26.46 61.84 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.925 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.441 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.2 t70 -57.45 -32.53 67.03 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.465 HG23 HG22 ' A' ' 75' ' ' ILE . 93.8 mt -75.71 -29.79 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.123 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 87' ' ' GLN . 17.7 mt-30 -81.34 -19.42 42.82 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.448 179.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.44 -61.39 1.79 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.551 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -58.64 -30.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.8 mttt -60.0 -32.95 71.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.823 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.53 -24.96 37.36 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.244 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.633 HG13 HD23 ' A' ' 121' ' ' LEU . 38.7 mm -69.25 -35.77 69.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.374 . . . . 0.0 110.977 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.46 -15.89 63.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.193 -179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -75.98 -27.68 57.56 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.135 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.525 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 8.8 tp10 -69.9 -20.81 63.36 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.883 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.576 ' HA ' HD22 ' A' ' 99' ' ' ASN . 97.1 m -87.05 -45.49 10.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.24 -179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 46.0 mt -59.5 -18.09 13.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.668 -179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.2 -12.89 29.18 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.013 0.375 . . . . 0.0 112.013 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 96' ' ' CYS . 0.5 OUTLIER -121.6 -0.91 9.62 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.683 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -106.4 -22.22 12.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.535 ' HD3' ' H ' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -69.69 -167.96 0.16 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.453 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.42 11.7 2.74 Favored Glycine 0 C--N 1.332 0.326 0 CA-C-N 116.091 -0.504 . . . . 0.0 113.47 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.428 ' HB2' HG13 ' A' ' 109' ' ' ILE . 16.1 mm-40 -96.35 178.07 5.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.877 0.339 . . . . 0.0 110.696 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 6.8 t -133.33 -17.47 2.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.647 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -104.31 142.04 35.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.825 0.345 . . . . 0.0 110.968 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -60.51 -63.77 1.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.178 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 74.0 m -51.3 -29.38 14.72 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.421 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -72.59 -43.87 62.77 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.917 0.389 . . . . 0.0 110.113 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.583 HG23 HD11 ' A' ' 66' ' ' LEU . 13.6 mt -63.82 -44.96 98.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.61 179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.06 -45.11 85.51 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.949 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.453 ' HA ' HG22 ' A' ' 114' ' ' THR . 1.9 t-20 -58.98 -47.66 84.35 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.928 0.364 . . . . 0.0 110.599 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 45.4 mmtm -61.04 -20.16 62.22 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.105 0.479 . . . . 0.0 110.104 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 20.9 t80 -86.88 -56.84 3.21 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.333 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.453 HG22 ' HA ' ' A' ' 111' ' ' ASN . 9.7 t -61.99 -36.39 81.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.955 0.407 . . . . 0.0 111.622 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -48.3 -45.44 34.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.169 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -85.31 -40.27 16.74 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -55.33 -35.1 64.81 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 110.689 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.585 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 58.1 mt -84.56 -17.75 9.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.327 0.585 . . . . 0.0 110.252 179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -73.74 -56.08 5.43 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.748 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.525 ' HE3' ' HG2' ' A' ' 95' ' ' GLU . 2.2 mptp? -85.23 -48.68 8.87 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -178.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD23 HG13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -99.18 -10.02 23.0 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -177.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.585 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER 73.42 -21.18 0.27 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.59 0.234 . . . . 0.0 110.937 -179.14 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.453 ' H ' ' C ' ' A' ' 121' ' ' LEU . 41.0 t . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 110.931 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 43.9 pt . . . . . 0 N--CA 1.485 1.316 0 CA-C-O 120.923 0.392 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -62.46 120.39 10.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.857 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.406 ' H ' ' CD ' ' A' ' 3' ' ' GLN . 0.4 OUTLIER -53.62 -37.22 62.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.184 -179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -51.33 -44.81 62.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.33 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 79' ' ' HIS . 0.6 OUTLIER -53.98 -31.3 50.33 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.915 0.388 . . . . 0.0 110.958 179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 123' ' ' SER . 54.5 t -88.73 -65.82 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 116.313 -0.403 . . . . 0.0 112.03 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.99 -62.62 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.99 -24.83 56.36 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HD3' ' HA ' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -89.08 -58.1 2.66 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.836 -179.193 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -55.11 -30.67 60.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.689 0.281 . . . . 0.0 111.572 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 42.0 tpp -77.04 -52.5 9.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.403 -179.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -69.62 -23.51 63.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.602 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.425 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 4.3 t80 -60.98 -36.06 78.44 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.127 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 18' ' ' ILE . 96.1 mt -142.34 38.01 1.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.129 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.499 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 9.0 tmm? -54.06 -51.01 81.08 Favored Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 116.11 -0.496 . . . . 0.0 112.083 -179.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 15' ' ' MET . 60.5 Cg_endo -70.17 -8.67 24.17 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . 0.405 ' C ' ' HD2' ' A' ' 20' ' ' PRO . 14.9 m-20 -106.71 -15.11 14.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.012 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 14' ' ' LEU . 70.5 mt -83.69 -44.2 18.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.884 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.525 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 25.0 mmt -53.46 -48.2 93.64 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 95.0 Cg_exo -42.96 -51.64 5.31 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.677 2.252 . . . . 0.0 112.749 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.431 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 4.9 m -56.85 -42.04 78.99 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.13 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.703 ' HB2' ' HB2' ' A' ' 28' ' ' SER . . . -52.28 -50.33 62.35 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.902 0.382 . . . . 0.0 110.976 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -77.83 -16.12 58.55 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.041 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 6.3 tp10 -63.31 -50.68 69.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.504 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD12 ' HG ' ' A' ' 50' ' ' LEU . 11.0 mt -106.6 -43.17 4.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 119.526 -0.87 . . . . 0.0 112.67 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.436 ' CD2' ' H ' ' A' ' 27' ' ' ILE . 0.1 OUTLIER 176.96 -61.87 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 N-CA-C 112.294 0.479 . . . . 0.0 112.294 179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 31' ' ' ILE . 2.3 pt -148.06 138.49 17.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.855 -176.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.703 ' HB2' ' HB2' ' A' ' 22' ' ' ALA . 29.3 t -85.61 -176.64 6.14 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.334 178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.607 ' HG3' ' HG ' ' A' ' 47' ' ' LEU . 13.7 tt0 -57.48 -17.73 14.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.782 0.325 . . . . 0.0 111.283 -179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 28' ' ' SER . 8.6 p-10 -74.47 -30.92 62.05 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.014 -179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.637 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 39.2 mt -112.15 -7.62 11.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.018 0.437 . . . . 0.0 110.535 179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.55 -29.28 70.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.276 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.5 t -86.25 41.77 0.95 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.17 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.596 ' H ' HD22 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -71.25 -33.9 70.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.171 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.45 HG12 ' ND2' ' A' ' 34' ' ' ASN . 38.8 pt -142.51 28.62 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.263 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 64.7 126.96 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 121.087 0.47 . . . . 0.0 110.774 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.685 ' H ' ' HA2' ' A' ' 41' ' ' GLY . . . -85.19 -75.56 0.36 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.64 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.617 ' HB3' ' SD ' ' A' ' 44' ' ' MET . . . -179.93 -65.95 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' HG2' ' SD ' ' A' ' 44' ' ' MET . 24.4 mmmt -51.49 -64.7 0.73 Allowed 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.093 0.473 . . . . 0.0 110.844 -178.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.553 HD21 ' HB2' ' A' ' 43' ' ' ASP . 2.2 p30 -128.94 5.12 5.38 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.649 0.738 . . . . 0.0 109.238 177.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.685 ' HA2' ' H ' ' A' ' 37' ' ' ALA . . . 81.11 -21.07 6.08 Favored Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 114.654 -1.157 . . . . 0.0 112.21 -178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.475 ' HB3' ' OD1' ' A' ' 40' ' ' ASN . . . -92.55 -42.04 9.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.261 0.553 . . . . 0.0 110.826 178.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.553 ' HB2' HD21 ' A' ' 40' ' ' ASN . 0.8 OUTLIER -106.42 153.88 21.62 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.197 -178.26 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.683 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.2 tpt -175.53 -143.22 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.295 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.683 ' H ' ' HG3' ' A' ' 44' ' ' MET . 41.6 t -79.45 -44.53 21.15 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.684 0.278 . . . . 0.0 111.063 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.425 ' NE2' ' HA ' ' A' ' 46' ' ' GLN . 5.5 tp60 -70.95 -39.96 72.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.624 ' HB3' ' H ' ' A' ' 44' ' ' MET . 2.3 tm? -68.56 -45.16 72.84 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.156 178.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.587 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -55.4 -7.54 1.38 Allowed Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.302 178.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' A' ' 106' ' ' GLU . 1.3 m -103.88 -60.9 1.5 Allowed 'General case' 0 CA--C 1.52 -0.19 0 CA-C-O 120.868 0.366 . . . . 0.0 111.149 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.658 ' HG ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -53.94 -36.07 62.41 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.752 179.42 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.525 ' HD3' HD21 ' A' ' 47' ' ' LEU . 13.6 tptt -80.65 -20.55 42.8 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.313 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -75.03 -23.86 58.22 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -63.35 -26.17 68.64 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.251 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.421 HG21 HG12 ' A' ' 18' ' ' ILE . 21.3 t -77.72 -24.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.501 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 58.6 mtt -67.08 -55.03 16.04 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.623 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' HE2' HD23 ' A' ' 61' ' ' LEU . 45.1 mttm -58.27 -23.14 55.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.876 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 1.6 tpm_? -62.15 -36.51 82.05 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.895 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.7 pt -113.21 26.71 3.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.523 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 57.89 58.21 3.74 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.502 ' O ' ' HG2' ' A' ' 60' ' ' MET . 12.5 ttt -124.9 3.72 8.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.547 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.455 HD12 ' O ' ' A' ' 65' ' ' GLU . 33.9 tp -161.75 127.88 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.002 0.43 . . . . 0.0 111.134 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.462 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 8.1 mmpt? -115.83 80.41 1.44 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.761 178.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 72.18 -72.74 0.92 Allowed Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 111.754 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 77.3 p -139.55 29.46 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.89 0.376 . . . . 0.0 110.47 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.455 ' O ' HD12 ' A' ' 61' ' ' LEU . 7.0 tp10 -117.37 108.73 15.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.426 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD22 ' H ' ' A' ' 66' ' ' LEU . 1.1 mm? -67.39 146.26 54.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.893 0.377 . . . . 0.0 111.418 179.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -142.33 155.41 45.17 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.501 179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 17.4 m -140.65 5.3 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.736 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.49 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 38.0 mt-10 -59.5 -52.08 76.7 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.585 -0.28 . . . . 0.0 111.482 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 40.6 Cg_endo -69.01 -28.87 28.35 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 122.171 1.914 . . . . 0.0 112.62 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.428 ' O ' HG13 ' A' ' 75' ' ' ILE . 21.5 t -63.94 -48.34 86.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.079 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.472 ' HA ' HD12 ' A' ' 75' ' ' ILE . 7.1 m-30 -51.47 -22.21 2.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.935 0.398 . . . . 0.0 110.422 179.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.409 ' HD2' ' OE1' ' A' ' 76' ' ' GLU . 39.9 tptt -83.22 -37.57 23.41 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.4 mtm -74.59 -43.85 53.6 Favored 'General case' 0 C--O 1.224 -0.266 0 CA-C-O 120.698 0.285 . . . . 0.0 110.35 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 72' ' ' TYR . 58.9 mt -48.87 -24.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.515 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.409 ' OE1' ' HD2' ' A' ' 73' ' ' LYS . 44.3 mt-10 -65.94 -59.26 4.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.328 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.3 t -80.96 -44.93 21.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.0 110.96 -179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.617 ' HA ' ' HD3' ' A' ' 9' ' ' LYS . 18.8 t -46.52 -40.79 4.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.266 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 78.8 m-70 -106.31 53.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.835 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.29 122.33 16.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.308 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 143.92 -76.14 0.3 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.598 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -96.04 144.42 26.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.877 0.37 . . . . 0.0 111.018 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.31 -28.67 34.48 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.176 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.42 -26.79 38.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.698 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 89' ' ' VAL . 85.8 m-20 -58.36 -23.65 57.5 Favored 'General case' 0 CA--C 1.518 -0.262 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.413 ' HA ' HG22 ' A' ' 75' ' ' ILE . 73.5 mt -86.74 -32.76 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.447 178.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -75.57 -21.15 58.11 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.973 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 43.0 tp -82.09 -55.46 4.55 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.486 HG13 HD22 ' A' ' 121' ' ' LEU . 58.5 t -56.11 -32.46 34.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.22 -179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.48 -34.13 68.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.753 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.43 -27.12 33.8 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.375 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.482 HG21 ' HB2' ' A' ' 121' ' ' LEU . 43.6 mm -69.06 -38.01 77.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 179.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.36 -19.29 65.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.803 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -84.2 -29.79 26.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.921 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -72.34 -27.38 62.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 8.5 m -76.68 -22.16 54.37 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.154 -179.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.39 -49.51 31.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.35 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -68.5 -40.8 80.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.662 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -57.85 -48.3 80.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.889 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.421 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -77.07 -14.08 59.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.098 0.475 . . . . 0.0 110.971 179.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 100' ' ' ALA . 0.0 OUTLIER 35.11 30.73 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.947 -1.024 . . . . 0.0 112.948 179.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 58.08 72.61 0.57 Allowed Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.984 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.555 ' HB2' HG13 ' A' ' 109' ' ' ILE . 13.7 mm-40 -61.77 166.28 4.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.693 179.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 76.0 p -77.5 -39.92 44.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.634 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.538 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 18.2 t70 -91.65 142.66 27.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.175 -179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.414 ' HG3' ' SG ' ' A' ' 49' ' ' CYS . 8.6 tp10 -55.18 -67.36 0.28 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.254 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.479 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 61.1 m -50.26 -35.35 26.67 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.12 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.538 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 39.7 t-20 -59.3 -50.42 74.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.598 HG23 HD11 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -59.17 -32.95 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.146 177.663 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.546 ' O ' HG22 ' A' ' 114' ' ' THR . . . -66.58 -57.17 10.51 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.646 -0.706 . . . . 0.0 113.419 -178.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.621 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 3.7 t-20 -60.49 -24.62 65.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.653 0.263 . . . . 0.0 111.491 -179.016 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -88.15 -30.75 19.57 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.864 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -82.69 -63.69 1.32 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 110' ' ' GLY . 10.1 t -53.68 -30.57 44.11 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.487 -179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -56.27 -59.61 4.69 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.38 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 120' ' ' LYS . 0.0 OUTLIER -49.84 -37.03 28.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.427 -179.518 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -63.79 -34.8 78.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 38.0 mm -82.27 -27.53 9.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.146 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -68.85 -59.57 2.98 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 116' ' ' CYS . 3.2 mptp? -86.85 -43.56 12.37 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.509 ' C ' ' H ' ' A' ' 123' ' ' SER . 46.7 tp -99.66 -15.75 18.44 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.473 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 1.9 t80 67.83 -13.61 0.25 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.92 0.391 . . . . 0.0 110.911 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.509 ' H ' ' C ' ' A' ' 121' ' ' LEU . 48.2 t . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.319 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . 0.445 HG12 HG21 ' A' ' 5' ' ' THR . 9.1 tp . . . . . 0 N--CA 1.485 1.299 0 CA-C-O 120.808 0.337 . . . . 0.0 111.086 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -71.77 142.54 49.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.099 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -61.78 -14.77 35.71 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.471 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.71 -37.22 86.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.78 0.324 . . . . 0.0 110.95 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.445 HG21 HG12 ' A' ' 1' ' ' ILE . 3.0 t -54.54 -29.35 50.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.241 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.9 t -86.89 -64.06 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.311 -0.404 . . . . 0.0 112.048 -179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.68 -62.51 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -178.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -53.17 -28.19 25.08 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -178.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.496 ' HB3' HG22 ' A' ' 78' ' ' VAL . 31.7 mmmt -88.48 -59.45 2.23 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.669 -0.412 . . . . 0.0 111.687 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -52.89 -20.52 3.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.296 . . . . 0.0 111.202 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 78.9 mmm -85.54 -60.48 2.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.52 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.9 -28.19 69.66 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.704 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' HB2' ' O ' ' A' ' 9' ' ' LYS . 1.4 t80 -62.07 -46.68 88.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.004 -179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 47.4 mt -123.12 34.79 5.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.092 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.481 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 8.4 tmm? -55.5 -50.62 85.83 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.665 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 15' ' ' MET . 74.0 Cg_endo -73.7 -4.19 15.01 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 122.065 1.844 . . . . 0.0 112.183 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -111.0 -14.93 13.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.121 -179.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 66.1 mt -89.11 -42.4 14.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.174 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.569 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 56.3 mtm -54.94 -48.78 95.03 Favored Pre-proline 0 CA--C 1.531 0.243 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.326 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 53.1 Cg_exo -53.32 -43.93 53.19 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.174 1.916 . . . . 0.0 112.568 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.5 m -57.87 -55.6 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.659 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HB2' ' HB3' ' A' ' 28' ' ' SER . . . -49.04 -42.03 37.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.761 0.315 . . . . 0.0 111.289 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.1 m-20 -83.42 -16.55 45.4 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.359 179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -60.42 -54.25 47.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.57 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.71 HD12 HD22 ' A' ' 50' ' ' LEU . 53.0 mt -96.14 -42.21 8.33 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 119.714 -0.794 . . . . 0.0 112.326 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.483 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 3.2 t-80 176.19 -64.19 0.01 OUTLIER 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.302 0.572 . . . . 0.0 112.467 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 0.4 OUTLIER -151.76 145.94 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.935 -175.506 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.501 ' HA ' ' HZ3' ' A' ' 51' ' ' LYS . 68.6 p -85.41 -177.8 6.55 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.111 178.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.455 ' HG3' ' CE ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -64.31 -17.84 64.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -71.88 -55.07 8.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.216 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . 0.49 ' HB ' ' HB ' ' A' ' 27' ' ' ILE . 27.4 mm -75.84 -16.93 15.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.1 179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -53.09 -41.48 64.97 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.028 179.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.557 HG22 ' H ' ' A' ' 35' ' ' ILE . 24.0 m -161.56 118.46 2.19 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.229 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.547 HD22 ' N ' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -54.92 -9.84 0.41 Allowed 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.914 0.709 . . . . 0.0 112.914 -179.241 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.557 ' H ' HG22 ' A' ' 33' ' ' THR . 2.2 pp -127.42 41.31 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 121.062 0.458 . . . . 0.0 111.517 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.527 ' HB2' ' HB ' ' A' ' 33' ' ' THR . 83.8 mm-40 -148.66 126.76 12.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.763 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -78.27 -57.06 3.98 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -178.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.568 ' C ' ' H ' ' A' ' 40' ' ' ASN . . . -147.61 -141.86 0.12 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.619 0.247 . . . . 0.0 111.316 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.768 ' HD2' ' H ' ' A' ' 39' ' ' LYS . 7.9 mptt -59.27 0.62 0.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.223 0.535 . . . . 0.0 110.187 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.568 ' H ' ' C ' ' A' ' 38' ' ' ALA . 1.8 t-20 -77.68 32.68 0.16 Allowed 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.954 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.452 ' H ' ' C ' ' A' ' 39' ' ' LYS . . . 114.35 5.09 21.55 Favored Glycine 0 CA--C 1.523 0.587 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.967 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB2' ' HB3' ' A' ' 36' ' ' GLN . . . -86.47 28.58 0.84 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 117.161 0.481 . . . . 0.0 110.088 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.479 ' O ' ' HG ' ' A' ' 47' ' ' LEU . 8.3 m-20 66.06 72.7 0.39 Allowed 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.581 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.435 ' HG3' ' ND2' ' A' ' 111' ' ' ASN . 16.1 ptp -49.59 -22.01 1.17 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.521 179.326 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 88.1 p -53.17 -49.29 66.97 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.564 -0.743 . . . . 0.0 111.809 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.68 ' HG3' HD23 ' A' ' 50' ' ' LEU . 18.3 tp60 -87.83 -18.42 29.34 Favored 'General case' 0 N--CA 1.455 -0.187 0 CA-C-O 120.719 0.295 . . . . 0.0 111.157 -179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.584 HD12 ' HG3' ' A' ' 39' ' ' LYS . 10.5 mt -70.11 -28.29 65.26 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.99 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -71.52 10.99 3.39 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.486 179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.482 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 3.9 m -134.59 -62.47 0.74 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.891 0.376 . . . . 0.0 110.594 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.71 HD22 HD12 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -50.76 -46.81 59.59 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.756 179.254 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.526 ' HE2' ' H ' ' A' ' 51' ' ' LYS . 0.9 OUTLIER -81.58 -20.63 39.45 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.634 178.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -69.4 -17.82 63.7 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.27 -46.24 70.94 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 114.922 -1.036 . . . . 0.0 110.751 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.9 t -61.91 -25.4 37.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.859 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.408 ' HG3' ' HA ' ' A' ' 52' ' ' ALA . 34.3 mtm -65.38 -46.43 80.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.783 179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 mtmm -67.95 -25.83 65.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.883 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -61.74 -38.17 86.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.058 -179.838 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.0 pt -98.73 17.6 2.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.26 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 58.22 59.85 2.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.231 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 12.7 ttp -124.12 5.47 8.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.262 179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 65' ' ' GLU . 67.7 tp -152.47 99.48 2.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.459 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.552 ' N ' ' HE3' ' A' ' 62' ' ' LYS . 0.1 OUTLIER -95.8 96.64 9.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.161 -179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 47.51 60.13 5.49 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.762 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.7 p 73.45 27.3 1.88 Allowed 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.284 0.634 . . . . 0.0 111.819 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 43.3 mt-10 -114.4 113.06 24.0 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.0 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.633 HD21 HG23 ' A' ' 109' ' ' ILE . 91.9 mt -70.37 139.43 51.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.766 -179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -145.82 169.03 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.474 179.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.7 m -148.24 25.49 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.537 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 45.0 mt-10 -75.36 -50.66 3.56 Favored Pre-proline 0 CA--C 1.534 0.365 0 N-CA-C 111.719 0.266 . . . . 0.0 111.719 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.4 Cg_endo -66.04 -44.07 8.02 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.039 1.826 . . . . 0.0 112.972 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' HA ' ' HG3' ' A' ' 74' ' ' MET . 14.1 m -57.49 -45.16 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 6.5 m-30 -53.77 -22.94 10.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.855 0.36 . . . . 0.0 110.644 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.478 ' HD3' ' O ' ' A' ' 73' ' ' LYS . 4.0 tmtp? -85.37 -36.56 20.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.412 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.431 ' HG3' ' HA ' ' A' ' 71' ' ' VAL . 13.8 mtp -68.32 -48.0 66.07 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.397 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.503 ' O ' ' HB2' ' A' ' 79' ' ' HIS . 62.6 mt -48.32 -24.51 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.266 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.442 ' HA ' HD13 ' A' ' 86' ' ' ILE . 43.7 mt-10 -60.65 -59.55 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.26 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 23.8 t -84.83 -36.26 11.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.176 0.512 . . . . 0.0 110.612 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.496 HG22 ' HB3' ' A' ' 9' ' ' LYS . 68.8 t -60.75 -7.74 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.103 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 75' ' ' ILE . 78.7 m-70 -143.62 43.93 1.5 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.832 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.21 135.57 55.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 142.18 -60.49 0.54 Allowed Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.995 -0.622 . . . . 0.0 112.472 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 18.4 m120 -117.84 150.12 39.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 110.674 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.44 -33.87 31.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.536 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 8.7 m-20 -81.27 -25.54 36.48 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.0 -0.28 . . . . 0.0 110.794 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 36.6 t70 -58.76 -31.93 68.81 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.442 HD13 ' HA ' ' A' ' 76' ' ' GLU . 95.7 mt -77.68 -29.64 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 CA-C-N 115.25 -0.886 . . . . 0.0 109.134 178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -77.01 -24.14 52.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.236 179.606 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.1 tp -75.7 -49.35 18.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.567 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.491 ' HB ' HG21 ' A' ' 75' ' ' ILE . 45.5 t -61.9 -34.08 61.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.782 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.407 ' HD2' ' O ' ' A' ' 86' ' ' ILE . 0.2 OUTLIER -60.01 -35.41 75.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.073 179.319 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.78 -22.9 65.47 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.907 -0.663 . . . . 0.0 111.588 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.634 HG23 ' HB2' ' A' ' 120' ' ' LYS . 51.4 mt -63.76 -41.72 93.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.79 0.328 . . . . 0.0 110.57 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.405 ' O ' HG13 ' A' ' 97' ' ' ILE . . . -62.35 -29.48 70.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -62.68 -41.04 98.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.249 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.96 -39.18 84.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.861 0.362 . . . . 0.0 110.793 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.545 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 65.9 m -71.05 -37.68 72.52 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.792 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 93' ' ' ALA . 83.3 mt -65.74 -19.3 25.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.292 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -85.13 -32.8 22.56 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 2.2 p30 -96.35 -17.26 20.79 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 111.675 0.25 . . . . 0.0 111.675 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.43 ' O ' ' HD2' ' A' ' 101' ' ' LYS . . . -101.32 -19.75 15.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.767 -0.197 . . . . 0.0 111.508 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.591 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 29.9 -88.22 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.436 0.694 . . . . 0.0 112.689 179.774 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.591 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . -167.48 76.56 0.12 Allowed Glycine 0 C--N 1.334 0.461 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.52 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.543 ' HB2' HG13 ' A' ' 109' ' ' ILE . 10.4 mm-40 -70.5 147.34 49.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.864 0.364 . . . . 0.0 110.829 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 70.3 p -76.91 -18.76 58.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.598 -179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.46 144.19 28.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.904 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -59.6 -67.96 0.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.466 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 54.2 m -52.75 -23.72 7.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.719 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -74.96 -43.38 54.38 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.818 0.342 . . . . 0.0 110.562 179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.633 HG23 HD21 ' A' ' 66' ' ' LEU . 1.5 mt -66.5 -41.66 88.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.035 0.445 . . . . 0.0 110.691 179.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 48' ' ' GLY . . . -71.17 -49.46 26.76 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.87 -0.681 . . . . 0.0 113.077 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.5 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.7 t-20 -51.68 -59.25 4.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.906 0.353 . . . . 0.0 110.927 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.53 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 10.3 mmpt? -54.0 -45.11 71.37 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 111.963 0.357 . . . . 0.0 111.963 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.403 ' O ' ' SG ' ' A' ' 116' ' ' CYS . 41.3 t80 -73.72 -65.9 0.77 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.476 ' HB ' ' HE2' ' A' ' 39' ' ' LYS . 32.3 p -50.55 -41.73 54.43 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -178.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.477 ' HA ' ' HG2' ' A' ' 39' ' ' LYS . 22.0 t70 -42.99 -67.31 0.28 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . 0.403 ' SG ' ' O ' ' A' ' 113' ' ' TYR . 0.8 OUTLIER -55.95 -25.4 43.31 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -177.803 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.6 -29.91 64.88 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.766 -0.374 . . . . 0.0 110.487 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.59 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 42.5 mm -85.35 -25.94 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.176 0.512 . . . . 0.0 110.3 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -70.16 -53.83 15.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.808 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.634 ' HB2' HG23 ' A' ' 92' ' ' ILE . 71.8 mmtt -86.7 -58.06 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.516 ' C ' ' H ' ' A' ' 123' ' ' SER . 49.6 tp -85.53 -10.72 55.6 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.742 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.59 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 3.9 t80 69.66 -19.53 0.19 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 120.555 0.217 . . . . 0.0 111.118 -179.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 121' ' ' LEU . 30.8 t . . . . . 0 C--N 1.331 -0.205 0 CA-C-O 120.846 0.355 . . . . 0.0 110.843 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 30.8 pt . . . . . 0 N--CA 1.485 1.303 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.512 ' O ' HG22 ' A' ' 5' ' ' THR . 6.6 m-20 -77.27 137.84 39.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.118 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -56.73 -32.45 65.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.934 179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 12.2 t70 -49.41 -43.27 44.35 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.39 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 2' ' ' ASP . 2.1 t -54.17 -33.18 57.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.86 0.362 . . . . 0.0 111.393 -179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.23 -65.74 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 36.1 t -61.32 -62.45 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 4' ' ' ASP . . . -55.72 -26.16 43.86 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -178.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.461 ' HE2' ' HA ' ' A' ' 78' ' ' VAL . 32.1 mmmt -88.81 -59.32 2.26 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.6 -0.44 . . . . 0.0 111.905 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -54.54 -20.31 7.58 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.766 0.317 . . . . 0.0 111.266 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.3 mmt -84.29 -57.39 3.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -65.2 -47.8 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.463 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -45.72 -34.59 3.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.742 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.418 ' O ' HG13 ' A' ' 18' ' ' ILE . 52.1 mt -138.54 46.07 2.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.317 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.494 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 49.1 ttp -71.92 -51.74 8.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.683 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 15' ' ' MET . 56.2 Cg_endo -69.71 -3.08 11.25 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.116 1.878 . . . . 0.0 112.117 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -103.21 -19.66 14.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.041 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG13 ' O ' ' A' ' 14' ' ' LEU . 75.9 mt -84.61 -37.1 12.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.537 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.412 ' N ' ' HD2' ' A' ' 20' ' ' PRO . 0.9 OUTLIER -49.47 -52.73 47.21 Favored Pre-proline 0 CA--C 1.537 0.452 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 19' ' ' MET . 59.7 Cg_exo -37.88 -52.87 1.66 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 123.017 2.478 . . . . 0.0 114.192 -178.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.8 m -88.43 -42.33 12.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.586 0.231 . . . . 0.0 111.583 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.63 ' HA ' HD12 ' A' ' 50' ' ' LEU . . . -64.05 -6.75 6.87 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.533 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -85.11 -29.76 24.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.721 0.296 . . . . 0.0 111.516 179.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -85.66 -54.7 4.38 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.789 ' HB2' HD21 ' A' ' 50' ' ' LEU . 0.1 OUTLIER -112.18 44.52 1.41 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.364 -178.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 22' ' ' ALA . 39.4 t60 -56.18 82.56 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.763 0.792 . . . . 0.0 112.155 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.585 HG12 ' O ' ' A' ' 25' ' ' LEU . 43.0 pt -140.46 49.88 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.225 -1.352 . . . . 0.0 108.95 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 30' ' ' ASP . 48.4 t -50.82 -179.74 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.051 -0.977 . . . . 0.0 112.562 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.5 ' HG2' ' HB2' ' A' ' 42' ' ' ALA . 9.0 mt-10 -43.18 -18.16 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.536 -0.757 . . . . 0.0 112.774 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 28' ' ' SER . 11.7 m-20 -84.66 -68.07 0.75 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 51.4 mt -73.94 -14.48 16.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.839 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -48.23 -49.96 31.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.0 110.492 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.568 HG21 ' HB3' ' A' ' 36' ' ' GLN . 3.1 m -171.17 118.18 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.787 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' CG ' ' H ' ' A' ' 35' ' ' ILE . 7.8 p-10 -36.82 -80.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.965 -0.561 . . . . 0.0 112.282 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.445 ' H ' ' CG ' ' A' ' 34' ' ' ASN . 11.1 pt -151.6 32.2 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HB3' HG21 ' A' ' 33' ' ' THR . 8.7 tt0 -70.84 -68.72 0.41 Allowed 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.804 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -57.7 -43.39 85.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.954 0.407 . . . . 0.0 110.743 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . 65.62 1.15 1.65 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.582 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -53.7 -61.16 2.48 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.178 0.513 . . . . 0.0 109.908 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.502 ' HB3' HG21 ' A' ' 118' ' ' ILE . 1.9 m-80 -127.48 9.9 6.64 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.194 178.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.08 -16.91 60.12 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.023 -178.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.5 ' HB2' ' HG2' ' A' ' 29' ' ' GLU . . . -88.05 -152.07 0.21 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.959 0.409 . . . . 0.0 111.448 179.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 45' ' ' SER . 26.1 t0 -107.82 -27.7 10.09 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.487 179.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 75.41 -33.1 0.23 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.63 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HB2' ' OD2' ' A' ' 43' ' ' ASP . 51.0 m -66.07 -57.6 7.35 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.593 0.235 . . . . 0.0 111.497 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.48 ' HA ' ' SG ' ' A' ' 49' ' ' CYS . 12.2 mm100 -87.29 -13.1 44.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 114' ' ' THR . 1.4 tt -57.67 -42.63 83.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 179.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -77.91 38.17 1.73 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.48 ' SG ' ' HA ' ' A' ' 46' ' ' GLN . 3.8 m -144.37 -79.13 0.2 Allowed 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 120.969 0.414 . . . . 0.0 110.556 -178.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.789 HD21 ' HB2' ' A' ' 25' ' ' LEU . 4.6 mm? -52.6 -47.36 66.99 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.601 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.511 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -79.76 -30.6 40.78 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.782 178.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -84.3 4.69 29.9 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.951 -179.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.472 ' N ' ' O ' ' A' ' 49' ' ' CYS . 5.9 t -85.12 -30.25 24.16 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.015 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 51' ' ' LYS . 7.4 p -69.3 -20.19 24.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.921 179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 60' ' ' MET . 59.8 mtt -66.09 -46.39 77.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.252 179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.49 -16.9 41.36 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.341 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 3.9 mmp_? -73.41 -47.62 40.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.4 -0.363 . . . . 0.0 111.523 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 60' ' ' MET . 46.2 pt -92.06 33.91 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.723 -179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 54.25 30.2 11.97 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.997 0.427 . . . . 0.0 111.049 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 55' ' ' MET . 13.4 tpt -91.55 -12.9 33.09 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.896 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 59.0 tp -154.27 112.53 3.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.06 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -108.1 77.95 1.14 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.575 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.31 -70.21 2.43 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.004 -179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 46.6 p -143.2 18.46 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.86 0.362 . . . . 0.0 110.574 179.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -102.72 110.82 22.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.053 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD11 HG23 ' A' ' 109' ' ' ILE . 18.6 mt -84.15 115.6 22.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.421 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 67.8 m-85 -96.4 -166.86 1.48 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.954 178.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -174.57 -15.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.552 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 46.1 mt-10 -60.79 -51.23 81.01 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 18.6 Cg_endo -60.95 -18.91 60.14 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.111 1.874 . . . . 0.0 112.539 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.488 HG12 HD11 ' A' ' 75' ' ' ILE . 5.0 t -76.28 -49.2 25.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.129 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.526 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 24.6 m-85 -52.48 -22.27 4.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.853 0.359 . . . . 0.0 110.619 179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -78.74 -43.53 25.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.723 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 15.0 ptm -77.12 -36.95 55.11 Favored 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 121.118 -0.233 . . . . 0.0 110.546 -179.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.686 HG22 HG23 ' A' ' 86' ' ' ILE . 88.2 mt -51.9 -25.49 6.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.17 0.51 . . . . 0.0 110.193 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.411 ' HA ' HD13 ' A' ' 86' ' ' ILE . 50.2 mt-10 -61.71 -59.42 5.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.825 -179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 21.7 t -84.82 -35.61 10.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.916 0.389 . . . . 0.0 111.545 -179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.461 ' HA ' ' HE2' ' A' ' 9' ' ' LYS . 25.1 t -57.53 -11.62 1.38 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.327 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' HA ' ' OG1' ' A' ' 5' ' ' THR . 73.8 m-70 -134.11 49.15 2.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.954 0.407 . . . . 0.0 110.521 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.7 135.68 54.4 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.193 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.6 -55.84 0.64 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.419 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 85' ' ' ASP . 17.9 m120 -128.01 129.07 46.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.943 0.401 . . . . 0.0 110.797 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.04 68.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.946 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.471 ' HA ' ' HB3' ' A' ' 87' ' ' GLN . 6.0 m-20 -84.24 -25.29 29.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.938 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.546 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 26.8 t0 -59.11 -32.71 70.08 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.686 HG23 HG22 ' A' ' 75' ' ' ILE . 68.0 mt -76.17 -29.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 CA-C-N 114.548 -1.205 . . . . 0.0 109.539 178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -78.42 -26.5 46.35 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.982 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.423 ' O ' HG12 ' A' ' 92' ' ' ILE . 55.5 tp -67.39 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.373 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.545 HG22 HD13 ' A' ' 75' ' ' ILE . 0.2 OUTLIER -60.04 -28.97 42.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.489 179.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.526 ' HE2' ' HB3' ' A' ' 72' ' ' TYR . 3.7 tptm -48.3 -46.62 36.4 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.726 179.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.74 -27.75 49.47 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.355 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.498 HG21 ' HB2' ' A' ' 121' ' ' LEU . 49.3 mm -62.91 -31.13 51.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.884 0.373 . . . . 0.0 110.786 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.38 -22.94 66.52 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.079 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -84.18 -36.24 22.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.408 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -61.62 -24.43 66.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.856 0.36 . . . . 0.0 111.266 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.498 ' HA ' ' ND2' ' A' ' 99' ' ' ASN . 37.7 m -86.35 -31.53 21.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.45 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.4 mt -73.52 -35.66 45.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.463 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -69.71 -15.13 63.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.179 -178.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 96' ' ' CYS . 1.9 p30 -109.87 -14.41 14.29 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 111.717 0.266 . . . . 0.0 111.717 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -99.55 -18.37 17.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -66.63 179.69 1.01 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.876 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.505 ' N ' ' HG2' ' A' ' 101' ' ' LYS . . . 65.29 4.19 15.77 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.024 -0.607 . . . . 0.0 113.031 179.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -89.88 162.6 15.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.704 0.288 . . . . 0.0 110.734 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 7.8 t -119.76 -22.21 6.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.907 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.519 ' HB3' ' HB2' ' A' ' 108' ' ' ASN . 21.1 t70 -97.33 143.56 27.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.858 0.361 . . . . 0.0 111.25 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.79 -69.05 0.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.602 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 48' ' ' GLY . 19.1 m -51.69 -26.24 8.84 Favored 'General case' 0 C--O 1.23 0.076 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.73 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.519 ' HB2' ' HB3' ' A' ' 105' ' ' ASP . 6.2 m120 -70.85 -39.71 72.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.013 0.435 . . . . 0.0 109.917 178.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 66' ' ' LEU . 7.2 mt -69.15 -36.71 74.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.95 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -66.37 -53.71 27.44 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.583 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.515 ' N ' ' HA3' ' A' ' 48' ' ' GLY . 1.4 t-20 -52.78 -58.12 7.93 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.539 0.209 . . . . 0.0 111.101 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.525 ' HE2' ' HA ' ' A' ' 112' ' ' LYS . 11.4 mmpt? -55.23 -21.19 13.14 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.273 -179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -86.76 -64.78 1.1 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.494 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.601 HG21 HD22 ' A' ' 47' ' ' LEU . 10.1 t -55.86 -31.04 62.43 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.372 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -57.93 -56.51 21.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.816 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -40.36 91.91 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.684 -179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -56.73 -41.74 78.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.245 -179.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.561 ' O ' ' HA ' ' A' ' 122' ' ' PHE . 65.0 mt -77.73 -22.0 13.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.104 0.478 . . . . 0.0 110.893 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -59.65 2.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.243 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -87.07 -54.23 4.44 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 92' ' ' ILE . 38.0 tp -83.32 -10.21 58.63 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -178.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.561 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 11.0 t80 68.49 -9.55 0.52 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.101 0.477 . . . . 0.0 110.707 -179.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 121' ' ' LEU . 33.5 t . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 28.7 pt . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 120.902 0.382 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -69.06 135.63 51.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.003 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -51.0 -35.45 33.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.443 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -52.1 -47.42 65.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.787 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.675 HG23 ' HA ' ' A' ' 79' ' ' HIS . 91.1 m -48.69 -37.0 17.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.143 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -88.86 -66.9 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.3 t -62.49 -62.93 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 -177.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.34 -26.5 63.19 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 5' ' ' THR . 34.0 mmtp -89.51 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.77 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.497 ' CZ ' HD11 ' A' ' 121' ' ' LEU . 35.6 m-85 -55.47 -19.29 9.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.377 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.0 ttm -84.33 -59.23 2.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -62.71 -23.79 67.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.354 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -64.88 -38.11 89.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.374 -179.233 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.2 mt -144.57 47.15 1.37 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.262 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.51 ' N ' ' HD2' ' A' ' 16' ' ' PRO . 31.4 ttm -64.71 -51.12 60.48 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.947 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 15' ' ' MET . 58.2 Cg_endo -69.89 -9.43 26.04 Favored 'Trans proline' 0 C--N 1.352 0.763 0 C-N-CA 122.131 1.887 . . . . 0.0 112.578 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -96.28 -17.16 20.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.79 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG12 HG21 ' A' ' 54' ' ' VAL . 73.5 mt -83.53 -48.25 17.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.501 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 59.7 mtt -43.61 -49.33 18.97 Favored Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.051 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 70.9 Cg_exo -40.12 -63.35 0.3 Allowed 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 122.596 2.197 . . . . 0.0 113.494 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.545 ' HA ' ' HB2' ' A' ' 24' ' ' GLU . 39.0 m -72.1 -27.37 62.6 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.553 ' HA ' HD21 ' A' ' 50' ' ' LEU . . . -52.12 -42.4 63.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.84 0.352 . . . . 0.0 110.663 179.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -84.13 -16.67 42.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.524 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.545 ' HB2' ' HA ' ' A' ' 21' ' ' CYS . 8.4 tp10 -59.64 -54.63 44.17 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.924 -179.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.588 HD12 HD23 ' A' ' 50' ' ' LEU . 19.3 mt -90.06 -41.05 11.91 Favored 'General case' 0 CA--C 1.52 -0.184 0 C-N-CA 120.171 -0.611 . . . . 0.0 111.676 -179.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' HB2' ' O ' ' A' ' 25' ' ' LEU . 12.9 t-80 176.44 -63.1 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.765 0.793 . . . . 0.0 110.841 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.9 pt -145.66 168.14 8.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 114.197 -1.365 . . . . 0.0 111.343 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.49 ' HA ' HD11 ' A' ' 50' ' ' LEU . 0.3 OUTLIER -86.02 125.94 33.78 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.597 ' H ' HD12 ' A' ' 50' ' ' LEU . 1.5 mm-40 -52.87 -41.42 64.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.842 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.414 ' HA ' ' HB2' ' A' ' 42' ' ' ALA . 8.8 m-20 -61.29 -26.9 68.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.909 0.385 . . . . 0.0 110.956 -179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 17.6 mt -104.62 -8.03 9.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.476 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.42 -45.2 65.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.612 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.413 HG23 ' O ' ' A' ' 41' ' ' GLY . 0.5 OUTLIER -150.52 113.58 4.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.615 179.567 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -39.74 -74.45 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.481 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.447 ' H ' ' NE2' ' A' ' 36' ' ' GLN . 23.1 pt -145.32 48.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.943 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.527 HE21 ' N ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -122.1 9.31 9.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.064 -179.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.455 ' HB3' ' HA2' ' A' ' 41' ' ' GLY . . . -85.32 -75.34 0.37 Allowed 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -177.24 -77.62 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.115 0 N-CA-C 112.397 0.517 . . . . 0.0 112.397 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -70.34 -61.07 1.91 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -178.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.644 HD22 HG21 ' A' ' 118' ' ' ILE . 6.0 p30 -125.04 -11.64 7.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.722 0.296 . . . . 0.0 111.429 -179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.455 ' HA2' ' HB3' ' A' ' 37' ' ' ALA . . . 109.37 -16.59 31.95 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.827 -0.701 . . . . 0.0 113.053 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' HB2' ' HA ' ' A' ' 30' ' ' ASP . . . -85.9 4.99 34.95 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.582 -0.364 . . . . 0.0 111.401 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t70 60.74 171.96 0.1 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.7 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.572 ' HG2' ' ND2' ' A' ' 111' ' ' ASN . 39.4 ttp -122.97 -10.09 8.22 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.3 t -71.53 -58.34 3.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.594 0.235 . . . . 0.0 111.598 -179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.428 ' OE1' ' HB2' ' A' ' 50' ' ' LEU . 0.0 OUTLIER -87.68 -13.25 43.06 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.862 0.363 . . . . 0.0 110.839 -179.877 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.516 HD12 ' HB2' ' A' ' 51' ' ' LYS . 16.3 tp -67.78 -29.59 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.289 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.484 ' HA3' ' N ' ' A' ' 111' ' ' ASN . . . -75.22 11.65 8.2 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.319 179.661 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -140.74 -71.26 0.37 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.64 0.257 . . . . 0.0 111.674 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.597 HD12 ' H ' ' A' ' 29' ' ' GLU . 3.4 tm? -48.75 -46.96 41.89 Favored 'General case' 0 CA--C 1.519 -0.247 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.769 ' HZ2' ' HB3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -76.6 -24.9 53.45 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.232 178.648 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 49' ' ' CYS . . . -67.16 -14.6 63.06 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.324 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.56 -41.4 84.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.618 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.467 HG21 HG12 ' A' ' 18' ' ' ILE . 40.5 t -61.89 -28.28 43.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.599 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.403 ' O ' ' HB3' ' A' ' 60' ' ' MET . 64.7 mtp -63.78 -56.14 17.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.538 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.6 mtmt -66.72 -17.81 65.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.654 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.525 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 3.7 tpm_? -68.86 -31.3 70.16 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.159 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.4 pt -113.23 31.48 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.602 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 58.94 13.64 2.91 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.607 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.403 ' HB3' ' O ' ' A' ' 55' ' ' MET . 10.8 tpt -77.98 -8.44 58.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.218 0.532 . . . . 0.0 110.622 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 66' ' ' LEU . 59.1 tp -156.86 103.55 2.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.851 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.67 76.7 10.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.897 0.379 . . . . 0.0 110.355 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.36 -59.9 3.22 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.474 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -147.56 7.73 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.599 0.238 . . . . 0.0 111.137 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 8.6 tp10 -96.72 110.82 23.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.585 -179.079 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.572 HD13 HD13 ' A' ' 61' ' ' LEU . 2.6 mm? -73.42 109.99 7.37 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.016 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -86.66 -167.81 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.595 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.5 p -169.38 -8.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 112.031 0.382 . . . . 0.0 112.031 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.577 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 2.2 mp0 -73.44 -51.46 5.6 Favored Pre-proline 0 CA--C 1.535 0.388 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -179.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 19.6 Cg_endo -58.46 -38.19 91.23 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.296 1.998 . . . . 0.0 113.011 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 75' ' ' ILE . 59.4 t -57.87 -43.39 84.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.439 -179.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 90' ' ' LYS . 9.1 m-30 -53.02 -32.91 49.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.959 0.409 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.7 mmtp -74.28 -30.79 62.26 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.252 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 12.2 mtm -78.63 -46.6 18.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.404 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.525 HG22 HG23 ' A' ' 86' ' ' ILE . 64.8 mt -50.77 -27.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.87 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 72' ' ' TYR . 41.4 mt-10 -60.78 -59.17 5.81 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.781 -179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.86 -44.86 16.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.914 0.388 . . . . 0.0 111.551 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG11 ' CE1' ' A' ' 10' ' ' TYR . 55.5 t -49.99 -17.91 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.426 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.806 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.675 ' HA ' HG23 ' A' ' 5' ' ' THR . 50.5 m-70 -128.77 53.44 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.781 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.24 127.68 32.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.104 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 144.0 -81.36 0.22 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.485 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -91.1 145.05 25.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.856 0.36 . . . . 0.0 110.95 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.08 32.14 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.767 -179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -81.13 -28.47 35.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.999 -0.281 . . . . 0.0 110.706 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -56.82 -27.22 59.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.525 HG23 HG22 ' A' ' 75' ' ' ILE . 79.7 mt -80.54 -31.75 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.988 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -78.16 -19.36 54.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.467 179.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 35.5 tp -74.8 -59.18 2.85 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.049 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.587 ' HA ' HD12 ' A' ' 92' ' ' ILE . 21.4 t -57.59 -23.59 20.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.94 0.4 . . . . 0.0 110.964 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.495 ' HD3' ' O ' ' A' ' 86' ' ' ILE . 9.6 tptt -53.95 -48.48 70.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.182 179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.76 -25.2 58.77 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.074 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.587 HD12 ' HA ' ' A' ' 89' ' ' VAL . 68.4 mt -60.63 -40.76 85.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.921 0.391 . . . . 0.0 110.641 179.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.17 -26.98 66.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.685 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -84.68 -30.22 25.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.446 ' HG2' ' HE3' ' A' ' 120' ' ' LYS . 9.7 tp10 -57.3 -28.86 63.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.061 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . 0.501 ' SG ' ' N ' ' A' ' 117' ' ' TYR . 1.5 m -86.65 -45.32 11.11 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 116.069 -0.514 . . . . 0.0 112.197 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 70.7 mt -53.91 -37.91 35.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.69 0.281 . . . . 0.0 111.49 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -59.77 -31.98 70.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.328 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.85 -7.16 19.59 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.806 0.336 . . . . 0.0 111.383 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.432 ' O ' ' C ' ' A' ' 101' ' ' LYS . . . -103.18 -3.45 25.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.475 -179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.531 ' HD2' ' H ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER 21.99 -87.17 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 O-C-N 124.068 0.855 . . . . 0.0 112.829 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HD2' ' A' ' 101' ' ' LYS . . . 178.51 70.2 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 121.195 -0.526 . . . . 0.0 111.823 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.506 ' HG2' ' HE3' ' A' ' 101' ' ' LYS . 16.7 mm-40 -60.69 172.44 0.93 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.878 0.37 . . . . 0.0 111.284 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 77.7 p -91.97 -45.47 8.32 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.217 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.481 ' O ' HG13 ' A' ' 109' ' ' ILE . 23.1 t70 -76.35 119.29 20.02 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.61 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.459 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.0 tp10 -48.96 -58.36 5.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.493 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.7 m -54.06 -24.95 19.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.4 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -83.94 -32.2 25.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.88 0.372 . . . . 0.0 110.55 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.488 HG12 ' HB2' ' A' ' 103' ' ' GLU . 55.3 mt -70.12 -38.85 76.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.556 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.458 ' O ' HG22 ' A' ' 114' ' ' THR . . . -77.86 -51.65 5.77 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.7 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.572 ' ND2' ' HG2' ' A' ' 44' ' ' MET . 7.4 t-20 -49.93 -32.36 14.6 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.751 0.275 . . . . 0.0 111.083 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -80.02 -38.65 31.54 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.147 0.498 . . . . 0.0 110.133 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -70.11 -64.68 0.84 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.776 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 110' ' ' GLY . 14.9 t -49.53 -31.82 11.06 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.142 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 111' ' ' ASN . 25.7 t70 -46.79 -71.18 0.08 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.388 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.66 -24.27 61.82 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.89 -179.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.501 ' N ' ' SG ' ' A' ' 96' ' ' CYS . 0.6 OUTLIER -64.56 -58.59 5.93 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.656 0.265 . . . . 0.0 110.753 -179.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.644 HG21 HD22 ' A' ' 40' ' ' ASN . 46.6 mm -59.79 -16.38 10.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.141 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.48 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 10.1 tp10 -68.49 -59.67 2.99 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.248 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.48 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 1.4 mptp? -87.25 -40.96 14.05 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 120.683 0.277 . . . . 0.0 111.541 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD11 ' CZ ' ' A' ' 10' ' ' TYR . 6.7 tt -58.6 -46.41 87.05 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -78.34 42.81 0.43 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.048 0.451 . . . . 0.0 110.49 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.913 179.67 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 34.0 pt . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 120.933 0.396 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -83.82 143.09 30.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.312 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -13.95 62.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.758 179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -82.99 -44.23 15.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.799 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.569 ' O ' ' HB2' ' A' ' 9' ' ' LYS . 51.9 p -56.96 -26.76 60.38 Favored 'General case' 0 CA--C 1.52 -0.205 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.348 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.465 HG22 ' HE1' ' A' ' 79' ' ' HIS . 62.0 t -89.96 -67.36 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.603 179.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 56.4 t -64.89 -62.37 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -177.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.77 -22.63 67.0 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.677 ' HB3' HG22 ' A' ' 78' ' ' VAL . 1.6 mptm? -90.44 -56.79 3.06 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.352 -0.539 . . . . 0.0 112.228 -178.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -54.32 -50.25 67.81 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.826 0.346 . . . . 0.0 110.99 -179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 58.9 tpp -56.08 -40.57 73.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.859 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -80.6 -24.7 38.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.039 -179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -59.79 -29.01 67.92 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.625 0.25 . . . . 0.0 111.192 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.454 ' O ' HG13 ' A' ' 18' ' ' ILE . 97.4 mt -148.13 39.26 0.91 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.604 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.587 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 34.6 ttm -60.04 -51.17 82.43 Favored Pre-proline 0 CA--C 1.535 0.381 0 CA-C-N 116.795 -0.184 . . . . 0.0 111.292 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 15' ' ' MET . 23.7 Cg_exo -63.59 -22.84 70.49 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 122.088 1.859 . . . . 0.0 112.468 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -86.81 -10.62 53.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.393 -179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 14' ' ' LEU . 74.2 mt -87.95 -28.14 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.22 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.494 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . 63.5 mtm -46.77 -48.79 49.96 Favored Pre-proline 0 CA--C 1.536 0.409 0 N-CA-C 112.279 0.474 . . . . 0.0 112.279 -179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.494 ' HD3' ' HB2' ' A' ' 19' ' ' MET . 75.6 Cg_exo -41.74 -56.51 1.86 Allowed 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 122.61 2.207 . . . . 0.0 113.379 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 57.8 m -85.42 -18.52 33.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.66 0.267 . . . . 0.0 111.144 -179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.481 ' HB3' ' HA ' ' A' ' 19' ' ' MET . . . -69.75 -10.87 60.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.987 0.422 . . . . 0.0 110.474 179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -83.77 -56.47 3.69 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.879 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -80.97 -50.33 9.84 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-O 121.135 0.493 . . . . 0.0 111.006 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.69 ' O ' HD22 ' A' ' 50' ' ' LEU . 51.9 mt -90.17 40.08 0.99 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.444 179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 10.5 p80 -62.3 72.06 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.489 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.704 HG22 ' HA ' ' A' ' 32' ' ' ALA . 0.7 OUTLIER -153.4 45.73 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.013 178.791 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.663 ' HA ' HD23 ' A' ' 50' ' ' LEU . 3.0 p -47.73 156.57 0.31 Allowed 'General case' 0 CA--C 1.518 -0.265 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.255 -179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.432 ' HG2' ' C ' ' A' ' 42' ' ' ALA . 10.4 mt-10 -41.23 -26.56 0.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.021 -0.536 . . . . 0.0 112.254 -179.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -70.81 -66.64 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.791 0.329 . . . . 0.0 110.838 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ILE . . . . . . . . . . . . . 19.4 mm -75.18 -5.44 7.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.211 0.529 . . . . 0.0 110.756 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.704 ' HA ' HG22 ' A' ' 27' ' ' ILE . . . -64.2 -10.25 22.06 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.694 -0.685 . . . . 0.0 111.392 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.8 m -49.84 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.359 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 70.72 -86.85 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.501 179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 35' ' ' ILE . 4.5 tt -166.31 22.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.299 0.571 . . . . 0.0 111.443 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -132.9 109.04 9.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.059 -179.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.454 ' O ' ' N ' ' A' ' 41' ' ' GLY . . . -62.19 -7.93 4.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.79 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.621 ' HB1' ' SD ' ' A' ' 44' ' ' MET . . . 37.27 -108.24 0.06 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.457 178.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -93.66 -60.37 1.78 Allowed 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.786 HD22 ' H ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -126.73 4.63 6.7 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.122 178.209 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 37' ' ' ALA . . . 93.68 -18.03 57.36 Favored Glycine 0 N--CA 1.45 -0.396 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.672 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.519 ' H ' ' ND2' ' A' ' 40' ' ' ASN . . . -89.48 -59.55 2.18 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.766 ' HA ' ' HB2' ' A' ' 47' ' ' LEU . 1.7 p-10 -111.37 162.2 15.29 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 113.407 0.891 . . . . 0.0 113.407 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' MET . . . . . 0.691 ' HG3' ' H ' ' A' ' 45' ' ' SER . 10.0 tpt -176.06 -142.62 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.601 -1.182 . . . . 0.0 109.65 178.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.691 ' H ' ' HG3' ' A' ' 44' ' ' MET . 22.8 t -78.23 -52.23 8.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.0 110.182 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.5 tp60 -79.94 -23.25 41.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.084 -179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 0.2 OUTLIER -87.12 -39.1 15.85 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 52' ' ' ALA . . . -69.06 -10.92 62.76 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.673 -0.971 . . . . 0.0 110.673 177.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.402 ' O ' ' N ' ' A' ' 52' ' ' ALA . 0.0 OUTLIER -73.26 -67.45 0.58 Allowed 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 111.726 0.269 . . . . 0.0 111.726 -179.332 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 25' ' ' LEU . 16.4 tp -51.7 -33.61 34.98 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.39 -28.62 61.17 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.546 179.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.459 ' HB2' ' O ' ' A' ' 48' ' ' GLY . . . -74.54 -24.73 58.99 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.154 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 37.3 t -60.67 -31.49 70.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.705 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.413 HG22 HG12 ' A' ' 18' ' ' ILE . 4.0 t -68.47 -24.5 29.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.776 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 57.4 mtt -70.32 -58.38 3.82 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.099 179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.58 ' HG2' ' HB3' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.96 -19.14 28.19 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.533 -179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.449 ' HA ' ' HE ' ' A' ' 57' ' ' ARG . 6.4 tpm_? -72.91 -31.12 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.361 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.18 33.95 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.826 0.346 . . . . 0.0 111.44 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 61.22 10.52 3.04 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.689 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.522 ' HA ' ' HB2' ' A' ' 67' ' ' TYR . 28.0 ttt -77.09 -6.95 54.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.027 0.442 . . . . 0.0 110.505 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.605 HD11 HG21 ' A' ' 109' ' ' ILE . 7.1 tt -152.62 99.49 2.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.686 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.51 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 7.5 mmpt? -86.27 77.8 9.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.44 -60.44 4.54 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.0 -179.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 23.3 p -153.52 11.85 0.45 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.447 ' O ' ' HA ' ' A' ' 61' ' ' LEU . 13.6 mm-40 -100.21 109.26 21.5 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.771 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.682 HD22 ' H ' ' A' ' 66' ' ' LEU . 0.4 OUTLIER -67.12 147.09 53.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.619 178.903 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . 0.522 ' HB2' ' HA ' ' A' ' 60' ' ' MET . 27.9 m-85 -136.51 165.63 25.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.104 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 m -140.26 -11.04 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.533 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 1.5 mp0 -57.31 -53.64 63.26 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.401 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 69' ' ' GLU . 35.8 Cg_endo -66.05 -25.21 51.63 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 121.992 1.795 . . . . 0.0 112.107 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.449 ' O ' HG13 ' A' ' 75' ' ' ILE . 17.6 t -68.86 -43.88 82.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.874 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.401 ' HB3' ' HE2' ' A' ' 90' ' ' LYS . 19.3 m-30 -55.35 -22.29 18.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.981 0.42 . . . . 0.0 110.524 179.638 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -80.67 -48.99 11.8 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.615 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 71' ' ' VAL . 7.1 ptp -68.56 -37.0 79.53 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.822 -0.172 . . . . 0.0 111.371 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 86' ' ' ILE . 95.0 mt -53.69 -21.94 5.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.198 0.523 . . . . 0.0 110.286 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -70.39 -58.28 3.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.408 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 38.7 t -87.75 -39.79 13.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.677 HG22 ' HB3' ' A' ' 9' ' ' LYS . 0.4 OUTLIER -56.77 -9.18 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.98 0.419 . . . . 0.0 111.661 -179.274 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.465 ' HE1' HG22 ' A' ' 6' ' ' VAL . 84.6 m-70 -130.49 40.86 3.46 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.322 178.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.3 122.84 14.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.411 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.11 -65.16 0.34 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.186 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -114.78 151.59 33.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.907 0.384 . . . . 0.0 110.649 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -81.57 -20.74 39.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.455 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -84.81 -30.54 24.49 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.897 0.332 . . . . 0.0 111.897 -179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 86' ' ' ILE . 4.2 p30 -59.09 -21.12 58.73 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.469 ' HA ' HG22 ' A' ' 75' ' ' ILE . 68.8 mt -85.67 -30.02 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.385 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.119 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -81.24 -19.84 42.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.118 179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.413 ' O ' HG12 ' A' ' 92' ' ' ILE . 64.3 tp -83.11 -63.18 1.41 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.329 -179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.549 HG13 HD22 ' A' ' 121' ' ' LEU . 46.5 t -52.27 -41.98 35.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.517 -179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 86' ' ' ILE . 11.1 mttt -53.32 -32.39 48.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.549 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.57 -23.01 41.09 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.533 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 88' ' ' LEU . 39.6 mm -68.69 -37.83 78.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.8 0.333 . . . . 0.0 110.787 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.65 -20.01 66.04 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.432 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -79.22 -22.41 44.88 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.75 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -82.3 -18.9 40.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.844 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' CYS . . . . . . . . . . . . . 18.1 m -78.64 -49.34 13.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.735 -179.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.2 mt -48.55 -24.95 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.54 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.91 -45.74 73.51 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.224 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -83.56 -21.31 32.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.995 0.426 . . . . 0.0 110.739 -179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.88 -40.63 68.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.343 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 38.57 35.72 0.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 54.96 68.82 1.49 Allowed Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.462 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.499 ' HB2' HG13 ' A' ' 109' ' ' ILE . 12.4 mm-40 -68.57 160.1 30.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.583 0.23 . . . . 0.0 110.449 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 72.8 p -107.77 4.12 25.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.629 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.495 ' HB3' ' HB3' ' A' ' 108' ' ' ASN . 12.7 t70 -108.18 147.41 31.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.418 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -70.03 -68.94 0.38 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.827 -179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.427 ' HB3' ' OG ' ' A' ' 45' ' ' SER . 23.3 m -57.74 -41.49 81.95 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.219 -179.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 105' ' ' ASP . 0.1 OUTLIER -56.81 -42.88 80.34 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.605 HG21 HD11 ' A' ' 61' ' ' LEU . 1.6 mt -63.06 -31.82 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.499 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -67.71 -45.13 78.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.45 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 44' ' ' MET . 7.3 t-20 -72.6 -45.74 57.62 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -178.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.652 ' HD2' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -56.28 -47.56 78.37 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -178.822 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.652 ' N ' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -74.16 -42.93 59.14 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.919 0.34 . . . . 0.0 111.919 -178.228 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . 0.608 HG21 ' HB2' ' A' ' 43' ' ' ASP . 5.7 t -69.37 -23.41 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.788 0.328 . . . . 0.0 111.002 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.05 -61.48 2.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.153 0.502 . . . . 0.0 110.978 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -58.67 -40.92 84.89 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.809 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.22 -31.09 65.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.358 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.459 HG12 ' O ' ' A' ' 114' ' ' THR . 32.6 mm -83.76 -31.02 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.131 0.491 . . . . 0.0 110.924 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.418 ' HB3' ' HD2' ' A' ' 120' ' ' LYS . 38.6 tt0 -68.76 -56.1 9.14 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.966 -179.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.418 ' HD2' ' HB3' ' A' ' 119' ' ' GLU . 9.3 mptt -86.62 -48.65 8.14 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -178.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.549 HD22 HG13 ' A' ' 89' ' ' VAL . 45.9 tp -97.81 -14.61 20.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 118' ' ' ILE . 2.0 t80 68.45 -13.08 0.32 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 120.809 0.338 . . . . 0.0 110.957 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.499 ' H ' ' C ' ' A' ' 121' ' ' LEU . 46.8 t . . . . . 0 C--N 1.331 -0.21 0 CA-C-O 120.874 0.369 . . . . 0.0 110.998 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TSD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_